FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Takemoto, MLS
   Menezes, MO
   Andreucci, CB
   Knobel, R
   Sousa, L
   Katz, L
   Fonseca, EB
   Nakamura-Pereira, M
   Magalhaes, CG
   Diniz, CSG
   Melo, ASO
   Amorim, MMR
AF Takemoto, M. L. S.
   Menezes, M. O.
   Andreucci, C. B.
   Knobel, R.
   Sousa, L.
   Katz, L.
   Fonseca, E. B.
   Nakamura-Pereira, M.
   Magalhaes, C. G.
   Diniz, C. S. G.
   Melo, A. S. O.
   Amorim, M. M. R.
TI Clinical characteristics and risk factors for mortality in obstetric
   patients with severe COVID-19 in Brazil: a surveillance database
   analysis
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Article
DE COVID-19; health services accessibility; health status indicators;
   maternal death
ID DISEASE 2019 COVID-19; SARS-COV-2 INFECTION; PREGNANCY; IMPACT
AB Objective To describe clinical characteristics of pregnant and postpartum women with severe COVID-19 in Brazil and to examine risk factors for mortality. Design Cross-sectional study based on secondary surveillance database analysis. Setting Nationwide Brazil. Population or sample 978 Brazilian pregnant and postpartum women notified as COVID-19 Acute Respiratory Distress Syndrome (ARDS) cases with complete outcome (death or cure) up to 18 June 2020. Methods Data was abstracted from the Brazilian ARDS Surveillance System (ARDS-SS) database. All eligible cases were included. Data on demographics, clinical characteristics, intensive care resources use and outcomes were collected. Risk factors for mortality were examined by multivariate logistic regression. Main outcome measures Case fatality rate. Results We identified 124 maternal deaths, corresponding to a case fatality rate among COVID-19 ARDS cases in the obstetric population of 12.7%. At least one comorbidity was present in 48.4% of fatal cases compared with 24.9% in survival cases. Among women who died, 58.9% were admitted to ICU, 53.2% had invasive ventilation and 29.0% had no respiratory support. The multivariate logistic regression showed that the main risk factors for maternal death by COVID-19 were being postpartum at onset of ARDS, obesity, diabetes and cardiovascular disease, whereas white ethnicity had a protective effect. Conclusions Negative outcomes of COVID-19 in this population are affected by clinical characteristics but social determinants of health also seem to play a role. It is urgent to reinforce containment measures targeting the obstetric population and ensure high quality care throughout pregnancy and the postpartum period. Tweetable abstract A total of 124 COVID-19 maternal deaths were identified in Brazil. Symptoms onset at postpartum and comorbidities are risk factors.
C1 [Takemoto, M. L. S.; Menezes, M. O.] Sao Paulo State Univ UNESP, Med Sch Botucatu, Programa Posgrad Tocoginecol, Ave Prof Montenegro S-N, BR-18618687 Botucatu, SP, Brazil.
   [Andreucci, C. B.] Univ Fed Sao Carlos UFSCAR, Dept Med, Sao Carlos, Brazil.
   [Knobel, R.] Univ Fed Santa Catarina UFSC, Dept Gynecol & Obstet, Florianopolis, SC, Brazil.
   [Sousa, L.] Univ Fed Ceara UFC, Programa Posgrad Profiss Saude Mulher & Crianca, Fortaleza, Ceara, Brazil.
   [Katz, L.; Amorim, M. M. R.] Inst Med Integral Prof Fernando Figueira IMIP, Programa Posgrad Saude Materno Infantil IMIP, Recife, PE, Brazil.
   [Fonseca, E. B.] Univ Fed Paraiba, Div Obstet & Gynecol, Joao Pessoa, Paraiba, Brazil.
   [Nakamura-Pereira, M.] Fundacao Oswaldo Cruz, Inst Nacl Saude Mulher Crianca & Adolescente Fern, Rio De Janeiro, Brazil.
   [Magalhaes, C. G.] Sao Paulo State Univ UNESP, Med Sch Botucatu, Dept Gynecol & Obstet, Botucatu, SP, Brazil.
   [Diniz, C. S. G.] Univ Sao Paulo, Sch Publ Hlth, Dept Hlth Life Cycles & Soc, Sao Paulo, Brazil.
   [Melo, A. S. O.] IPESQ, Inst Pesquisa Prof Joaquim Amorim Neto, Dept Saude Mulher, Campina Grande, Paraiba, Brazil.
RP Menezes, MO (corresponding author), Sao Paulo State Univ UNESP, Med Sch Botucatu, Programa Posgrad Tocoginecol, Ave Prof Montenegro S-N, BR-18618687 Botucatu, SP, Brazil.
EM mariane.menezes@unesp.br
RI Amorim, Melania M/C-5807-2013; TAKEMOTO, MAIRA LS/G-7889-2018; de
   Oliveira Menezes, Mariane/F-1627-2013; Andreucci, Carla B/J-4845-2015;
   Nakamura-Pereira, Marcos/X-1107-2019; Simone Grilo Diniz,
   Carmen/M-1938-2017; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; TAKEMOTO, MAIRA
   LS/0000-0002-7016-2879; de Oliveira Menezes,
   Mariane/0000-0002-8525-0521; Andreucci, Carla B/0000-0002-5590-108X;
   Nakamura-Pereira, Marcos/0000-0002-4231-0205; Simone Grilo Diniz,
   Carmen/0000-0002-0069-2532; Katz, Leila/0000-0001-9854-7917
CR Baqui P, 2020, LANCET GLOB HEALTH, V8, P1018, DOI 10.1016/S2214-109X(20)30285-0
   Blitz MJ, 2020, AM J OBSTET GYNECOL
   Brasil. Ministerio da Saude, 2009, MORT INF SYST
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2019, HLTH SURV GUID, P1
   Breslin N, 2020, AM J OBSTET GYNECOL, DOI [10.1016/j.ajogmf.2020.100118, DOI 10.1016/J.AJ0GMF.2020.100118]
   Buekens P, 2020, LANCET GLOB HEALTH, V20, P2019
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Collin J, 2020, ACTA OBSTET GYN SCAN, V99, P819, DOI 10.1111/aogs.13901
   de Santos D, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1066/5877027, DOI 10.1093/CID/CIAA1066/5877027]
   do Carmo Leal M, 2017, CAD SAUDE PUBLICA S, V33
   Dong L, 2020, JAMA-J AM MED ASSOC, V323, P1846, DOI 10.1001/jama.2020.4621
   Ellington S, 2020, MMWR-MORBID MORTAL W, V69, P769, DOI [10.15585/mmwr.mm6925a1, 10.15585/mmwr.mm6925a1externalicon]
   Esteves-Pereira AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153396
   Gajbhiye R, 2020, PREGNANCY OUTCOMES N
   Hantoushzadeh S, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.030
   Harmon AC, 2016, CLIN SCI, V130, P409, DOI 10.1042/CS20150702
   Horta BL, 2019, INT J EPIDEMIOL, V48, pi26, DOI 10.1093/ije/dyy278
   Horton R., 2020, LANCET, V6736, P31095
   Juan J, 2020, ULTRASOUND OBST GYN, V56, P15, DOI 10.1002/uog.22088
   Kayem G, 2020, J GYNECOL OBSTET HUM, V49, DOI 10.1016/j.jogoh.2020.101826
   KNIGHT M, 2020, BMJ-BRIT MED J, V369, DOI DOI 10.1136/BMJ.M2107
   Lei C, 2020, CHIN J TUBERC RESP D, V43, P1
   Lumbreras-Marquez MI, 2020, INT J GYNECOL OBSTET, V150, P266, DOI 10.1002/ijgo.13250
   Gabriel MMA, 2020, ACTA PAEDIATR, V109, P2302, DOI 10.1111/apa.15474
   Martinez-Portilla RJ, 2020, RISK FACTORS MORTALI
   Nakamura-Pereira M, 2020, INT J GYNECOL OBSTET, V151, P148, DOI 10.1002/ijgo.13328
   Poorolajal J, 2016, J MATERN-FETAL NEO M, V29, P3670, DOI 10.3109/14767058.2016.1140738
   Amorim MMR, 2020, AM J OBSTET GYNECOL, V223, P298, DOI 10.1016/j.ajog.2020.04.023
   Siddiqui A, 2019, PAEDIATR PERINAT EP, V33, P7, DOI 10.1111/ppe.12522
   Domingues RMSM, 2012, CAD SAUDE PUBLICA, V28, P425, DOI 10.1590/S0102-311X2012000300003
   Somerville LK, 2018, FUTURE MICROBIOL, V13, P263, DOI 10.2217/fmb-2017-0096
   Stefan N, 2020, NAT REV ENDOCRINOL, V16, P341, DOI 10.1038/s41574-020-0364-6
   Stumpfe FM, 2020, GEBURTSH FRAUENHEILK, V80, P380, DOI 10.1055/a-1134-5951
   Szwarcwald Celia Landmann, 2014, Cad Saude Publica, V30 Suppl 1, pS1
   Takemoto MLS, 2020, J MATERN-FETAL NEO M, DOI 10.1080/14767058.2020.1786056
   Takemoto MLS, 2020, INT J GYNECOL OBSTET, V151, P154, DOI 10.1002/ijgo.13300
   Vallejo V, 2020, OBSTET GYNECOL, V136, P52, DOI 10.1097/AOG.0000000000003950
   World Health Organization, 2020, 133 WHO
   Yan J, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.014
   Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017
NR 40
TC 2
Z9 2
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD DEC
PY 2020
VL 127
IS 13
BP 1618
EP 1626
DI 10.1111/1471-0528.16470
EA SEP 2020
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA OO6AK
UT WOS:000568899800001
PM 32799381
OA Green Published
DA 2020-12-01
ER

PT J
AU Melo, A
   Oliveira-Szejnfeld, PS
   Malinger, G
   Tavares, JS
   Melo, FO
   Coutinho, LCQM
   Gama, GL
   Moll, FT
   Aguiar, RS
   Tanuri, A
   Amorim, MM
AF Melo, Adriana
   Oliveira-Szejnfeld, Patricia S.
   Malinger, Gustavo
   Tavares, Jousilene S.
   Melo, Fabiana O.
   Coutinho, Larissa Cristina Q. M.
   Gama, Gabriela L.
   Moll, Fernanda T.
   Aguiar, Renato S.
   Tanuri, Amilcar
   Amorim, Melania M.
TI Outcomes of subsequent pregnancies following Zika virus infection: A
   comparative case series
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article; Early Access
DE Congenital abnormalities; Microcephaly; Pregnancy; Zika; Zika virus
AB Neither microcephaly nor neurological damage was found in children born from pregnancies subsequent to one resulting in an infant with congenital Zika syndrome.
C1 [Melo, Adriana; Tavares, Jousilene S.; Melo, Fabiana O.; Coutinho, Larissa Cristina Q. M.; Gama, Gabriela L.; Amorim, Melania M.] Inst Pesquisa Prof Joaquim Amor Neto, Campina Grande, Paraiba, Brazil.
   [Melo, Adriana; Gama, Gabriela L.] UNIFACISA, Campina Grande, Paraiba, Brazil.
   [Melo, Adriana; Amorim, Melania M.] Fed Univ Campina Grande UFCG, Campina Grande, Paraiba, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Univ Fed Sao Paulo, UNIFESP, Dept Radiol, Sao Paulo, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Lis Matern Hosp, Tel Aviv Med Ctr, Tel Aviv, Israel.
   [Malinger, Gustavo] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel.
   [Moll, Fernanda T.] DOr Inst Res, Rio De Janeiro, Brazil.
   [Moll, Fernanda T.] DOr Inst Res, Sao Paulo, Brazil.
   [Aguiar, Renato S.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil.
   [Amorim, Melania M.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Melo, A (corresponding author), Rua Salvino de Oliveira Neto 87, BR-58402040 Campina Grande, Paraiba, Brazil.
EM asomelo@gmail.com
RI Moll, Fernanda Tovar/N-3320-2018; Amorim, Melania M/C-5807-2013
OI Moll, Fernanda Tovar/0000-0002-0292-5985; Amorim, Melania
   M/0000-0003-1047-2514
FU Improvement of Higher Education Personnel (CAPES)CAPES; Ministry of
   Education (MEC)Spanish Government; National Council for Scientific and
   Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); Ministry of Science, Technology,
   Innovation and Communication (MCTI); Department of Science and
   Technology (Decit)Department of Science & Technology (India);
   Secretariat of Science, Technology and Strategic Supplies (SCTIE);
   Ministry of HealthMinistry of Health - Turkey
FX Improvement of Higher Education Personnel (CAPES); Ministry of Education
   (MEC); National Council for Scientific and Technological Development
   (CNPq); Ministry of Science, Technology, Innovation and Communication
   (MCTI); Department of Science and Technology (Decit); Secretariat of
   Science, Technology and Strategic Supplies (SCTIE); Ministry of Health
CR Almeida KJ, 2019, REV ASSOC MED BRAS, V65, P1249, DOI 10.1590/1806-9282.65.10.1249
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Melo A, 2020, DEV MED CHILD NEUROL, V62, P221, DOI 10.1111/dmcn.14227
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
NR 4
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
DI 10.1002/ijgo.13288
EA AUG 2020
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA MX0NC
UT WOS:000557424500001
PM 32623712
DA 2020-12-01
ER

PT J
AU Amorim, MMR
   Takemoto, MLS
   da Fonseca, EB
AF Ramos Amorim, Melania Maria
   Soligo Takemoto, Maira Libertad
   da Fonseca, Eduardo Borges
TI Maternal deaths with coronavirus disease 2019: a different outcome from
   low- to middle-resource countries?
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Letter
C1 [Ramos Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira IMIP, Caruaru, Brazil.
   [Soligo Takemoto, Maira Libertad] UNESP, Fac Med Botucatu, Botucatu, SP, Brazil.
   [da Fonseca, Eduardo Borges] Paraiba Fed Univ, Av Epitacio Pessoa 557, BR-58038381 Joao Pessoa, PB, Brazil.
RP da Fonseca, EB (corresponding author), Paraiba Fed Univ, Av Epitacio Pessoa 557, BR-58038381 Joao Pessoa, PB, Brazil.
EM fonseca2003@yahoo.com
RI Amorim, Melania M/C-5807-2013; TAKEMOTO, MAIRA LS/G-7889-2018
OI Amorim, Melania M/0000-0003-1047-2514; TAKEMOTO, MAIRA
   LS/0000-0002-7016-2879
CR Cirelli JF, 2018, REV BRAS GINECOL OBS, V40, P106, DOI 10.1055/s-0038-1623511
   Karimi-Zarchi M, 2020, FETAL PEDIATR PATHOL, DOI 10.1080/15513815.2020.1745970
   Naccasha N, 2001, AM J OBSTET GYNECOL, V185, P1118, DOI 10.1067/mob.2001.117682
   Rasmussen SA, 2020, AM J OBSTET GYNECOL
NR 4
TC 2
Z9 3
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD AUG
PY 2020
VL 223
IS 2
BP 298
EP 299
DI 10.1016/j.ajog.2020.04.023
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA MW4CD
UT WOS:000556986200052
PM 32348744
OA Bronze, Green Published
DA 2020-12-01
ER

PT J
AU Amorim, MM
   Takemoto, MLS
   Katz, L
AF Amorim, Melania Maria
   Takemoto, Maira Libertad Soligo
   Katz, Leila
TI Re: Pre-eclampsia-like syndrome induced by severe coronavirus disease
   2019: a prospective observational study
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Letter
C1 [Amorim, Melania Maria; Katz, Leila] Inst Med Integral Prof Fernando Figueira, Programme Postgrad Integral Hlth, Recife, PE, Brazil.
   [Takemoto, Maira Libertad Soligo] UNESP, Botucatu Med Sch, Botucatu, SP, Brazil.
RP Amorim, MM (corresponding author), Inst Med Integral Prof Fernando Figueira, Programme Postgrad Integral Hlth, Recife, PE, Brazil.
EM profmelania.amorim@gmail.com
RI TAKEMOTO, MAIRA LS/G-7889-2018; Amorim, Melania M/C-5807-2013; Katz,
   Leila/M-5291-2013
OI TAKEMOTO, MAIRA LS/0000-0002-7016-2879; Amorim, Melania
   M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
CR Del Valle Diane Marie, 2020, medRxiv, DOI 10.1101/2020.05.28.20115758
   Mendoza M, 2020, BJOG-INT J OBSTET GY, V127, P1374, DOI 10.1111/1471-0528.16339
   Murthi P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041406
   Tasta Oriane, 2020, Am J Perinatol, DOI 10.1055/s-0040-1709696
NR 4
TC 4
Z9 4
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD NOV
PY 2020
VL 127
IS 12
BP 1577
EP 1577
DI 10.1111/1471-0528.16402
EA JUL 2020
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA OD0OW
UT WOS:000552391900001
PM 32716116
OA Bronze
DA 2020-12-01
ER

PT J
AU Pereira, HVFS
   dos Santos, SP
   Amancio, APRL
   de Oliveira-Szejnfeld, PS
   Flor, EO
   Tavares, JD
   Ferreira, RVB
   Tovar-Moll, F
   de Amorim, MMR
   Melo, A
AF Fernandes Souza Pereira, Heloisa Viscaino
   dos Santos, Stella Pinto
   Rodrigues Lazzari Amancio, Ana Paula
   de Oliveira-Szejnfeld, Patricia Soares
   Flor, Edneusa Oliveira
   Tavares, Jousilene de Sales
   Brandao Ferreira, Rayssa Vieira
   Tovar-Moll, Fernanda
   Ramos de Amorim, Melania Maria
   Melo, Adriana
TI Neurological outcomes of congenital Zika syndrome in toddlers and
   preschoolers: a case series
SO LANCET CHILD & ADOLESCENT HEALTH
LA English
DT Article
ID CLASSIFICATION-SYSTEM; CEREBRAL-PALSY; VIRUS; CHILDREN; INFANTS;
   RELIABILITY; SPECTRUM; EPILEPSY; CLASSIFY; ABILITY
AB Background Congenital Zika syndrome causes a spectrum of neurological symptoms with varying effects on function that require different therapeutic strategies. To date, this spectrum of effects and its clinical implications have not been completely described. We describe the neurological examination findings in toddlers and preschoolers, including predominant symptom complexes and comorbidities.
   Methods This study is a case-series neurological evaluation of 75 children with congenital Zika syndrome in Campina Grande, Brazil. The study is part of a cohort of children with congenital Zika syndrome that started in 2015 and is still ongoing. Children with Zika virus infection detected during pregnancy (mothers exhibited rash and were followed and diagnosed by fetal ultrasound abnormalities or RT-PCR) or through microcephaly screening after birth, using Intergrowth 21 guidelines, were selected by laboratory and radiological criteria. Children were examined during a 10-day period in September, 2018, and underwent neurological interview, examination, and assessment of functional outcomes and comorbidities. Children were divided in groups of predominant corticospinal or neuromuscular clinical signs and the associations between these groups and clinical comorbidities were assessed.
   Findings All of the children recruited to the study from Nov 29, 2015 to Nov 30, 2017 had imaging correlates of congenital Zika syndrome. Children were assigned to groups depending on the signs exhibited, either corticospinal or neuromuscular, with or without dyskinetic signs. 75 children completed the evaluation, 38 (51%) girls and 37 (49%) boys. Median age was 33 months (range 26-40 months; IQR 29-34). Microcephaly was present at birth in 56 (75%) children, and 19 (25%) children were born with normal head circumference, 15 of whom later developed microcephaly. Neurological examination grouped four children as having isolated dyskinetic signs, 48 children were assigned to the corticospinal group and 23 into the neuromuscular group. Dyskinetic findings were present in 30 (40%) children, either alone (four [5%]) or combined with corticospinal (19 [40%] of 48) or neuromuscular (seven [30%] of 23) findings. Comorbidities were highly prevalent, and the neuromuscular group had worse functional outcomes, evaluated by gross motor function (p=0.026), manual abilities (p=0.0013), and communication function (p<0.0005) classification scales, than the corticospinal group, whereas pneumonia (p<0.0005) and urinary tract infections (p<0.0005) were more frequent in the corticospinal group. Cortical hyperexcitability was supported by several clinical correlates, such as early onset epilepsy, persistence of primitive reflexes, and dystonia.
   Interpretation We describe distinct neurological profiles in the congenital Zika syndrome spectrum, with functional outcomes tending to correlate with these groups. The clinical division of children based on the disease signs proposed here is supported by the literature on central and peripheral nervous system pathology in congenital Zika syndrome. The high prevalence of dyskinetic symptoms merits special attention. Copyright (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Fernandes Souza Pereira, Heloisa Viscaino; dos Santos, Stella Pinto; Flor, Edneusa Oliveira] Univ Estado Rio De Janeiro, Pediat Neurol Clin, Dept Pediat, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Fed Univ Rio Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Fed Univ Rio Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Fernandes Souza Pereira, Heloisa Viscaino; de Oliveira-Szejnfeld, Patricia Soares; Tovar-Moll, Fernanda] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Rodrigues Lazzari Amancio, Ana Paula] Adao Pereira Nunes State Hosp, Rio De Janeiro, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Sao Paulo, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Fed Sao Paulo, Fdn Inst Educ & Res Diagnost Imaging, Sao Paulo, Brazil.
   [Tavares, Jousilene de Sales; Brandao Ferreira, Rayssa Vieira; Ramos de Amorim, Melania Maria; Melo, Adriana] Res Inst Prof Amorim Neto, Campina Grande, Paraiba, Brazil.
   [Ramos de Amorim, Melania Maria; Melo, Adriana] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
RP Pereira, HVFS (corresponding author), Univ Estado Rio De Janeiro, Pediat Neurol Clin, Dept Pediat, Rio De Janeiro, Brazil.
EM heloisa.pereira@hupe.uerj.br
RI Amorim, Melania M/C-5807-2013; Moll, Fernanda Tovar/N-3320-2018
OI Amorim, Melania M/0000-0003-1047-2514; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Soares de Oliveira Szejnfeld,
   Patricia/0000-0002-3780-5182
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq); Coordination for the Improvement of Higher Education Personnel
FX Brazilian National Council for Scientific and Technological Development
   and by the Coordination for the Improvement of Higher Education
   Personnel.
CR Abramov DM, 2018, NEUROLOGY, V90, pE606, DOI 10.1212/WNL.0000000000004974
   Barbeito-Andres J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006592
   Campbell SK, 2005, TEST INFANT MOTOR PE
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Monteiro LMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193514
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Einspieler C., 2008, PRECHTLS METHOD QUAL
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162
   Hadders-Algra M, 2018, DEV MED CHILD NEUROL, V60, P39, DOI 10.1111/dmcn.13540
   Hallett M, 2001, EPILEPSY MOVEMENT DI, P111
   Hidecker MJC, 2011, DEV MED CHILD NEUROL, V53, P704, DOI 10.1111/j.1469-8749.2011.03996.x
   Himmelmann K, 2007, DEV MED CHILD NEUROL, V49, P246, DOI 10.1111/j.1469-8749.2007.00246.x
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x
   PediTools, CDC GROWTH CALC 2 20
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Pinato L, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy009
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Sellers D, 2014, DEV MED CHILD NEUROL, V56, P245, DOI 10.1111/dmcn.12352
   Swaiman KF, 2018, SWAIMANS PEDIAT NEUR, P7
   The International Fetal and Newborn Growth Consortium for the 21st Century, INTERGROWTH 21
   van der Linden H, 2018, NEW ENGL J MED, V379, P891, DOI 10.1056/NEJMc1716070
   van der Linden V, 2017, ZIKA IN FOCUS
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
NR 30
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2352-4642
J9 LANCET CHILD ADOLESC
JI Lancet Child. Adolesc. Health
PD MAY
PY 2020
VL 4
IS 5
BP 378
EP 387
DI 10.1016/S2352-4642(20)30041-9
PG 10
WC Pediatrics
SC Pediatrics
GA LS9XC
UT WOS:000536730700016
PM 32199080
OA Bronze
DA 2020-12-01
ER

PT J
AU Leal, CC
   Amorim, MMR
   Souza, GFA
   Lima, AKS
   Souza, ASR
AF Leal-Junior, Carlos C.
   Amorim, Melania M. R.
   Souza, Gustavo F. A.
   Lima, Anna K. S.
   Souza, Alex S. R.
TI Effectiveness of an oral versus sublingual loading dose of nifedipine
   for tocolysis
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Nifedipine; Oral administration; Pregnant; Premature; Premature labor;
   Sublingual administration; Tocolysis
ID PRETERM LABOR
AB Objective To determine the effectiveness of an oral versus sublingual loading dose of nifedipine for tocolysis. Methods An open, randomized clinical trial conducted between March 1, 2013, and April 31, 2014. Participants were pregnant women with a diagnosis of premature labor, single live fetus, topical pregnancy, gestational age 24-36 weeks, normal fetal vitality, cervical dilatation less than or equal to 4 cm, cervical effacement less than or equal to 80%, and intact amniotic membranes. They were randomized into two groups, oral and sublingual nifedipine, 20 mg loading dose, repeated every 30 minutes (maximum dose of 60 mg). The primary endpoint was the time until tocolysis and the secondary endpoints were the effectiveness of tocolysis within 90 minutes, 12 hours, and 48 hours; premature delivery within 48 hours; and maternal hemodynamic parameters and side effects. Results There were 80 patients randomized to oral (n=40) and sublingual (n=40) nifedipine. The time required for tocolysis was significantly less with sublingual nifedipine (160 minutes vs 340 minutes; P=0.0003). Sublingual nifedipine was also more successful than oral nifedipine at inhibiting premature labor within 90 minutes (n=8 [20.0%] vs n=1 [2.5%], P=0.014). There was no statistically significant difference between the groups for the other secondary endpoints. Conclusion Compared with oral administration, a sublingual loading dose of nifedipine resulted in faster tocolysis in patients with premature labor. Brazilian Clinical Trials Registry (ReBEC): U1111-11566186.
C1 [Leal-Junior, Carlos C.; Amorim, Melania M. R.; Souza, Alex S. R.] Inst Med Integral Prof Fernando Figueira IMIP, Womens Healthcare Ctr, Recife, PE, Brazil.
   [Amorim, Melania M. R.] Fed Univ Campina Grande UFCG, Dept Obstet & Gynecol, Campina Grande, Paraiba, Brazil.
   [Amorim, Melania M. R.] Elpidio Almeida Hlth Inst ISEA, Dept Obstet, Campina Grande, Paraiba, Brazil.
   [Souza, Gustavo F. A.; Souza, Alex S. R.] Catholic Univ Pernambuco UNICAP, Biol Sci & Hlth Ctr, Recife, PE, Brazil.
   [Lima, Anna K. S.; Souza, Alex S. R.] Fed Univ Pernambuco UFPE, Dept Maternal & Child Healthcare, Recife, PE, Brazil.
RP Souza, ASR (corresponding author), Rua Parc 100,Apto 403, BR-51160035 Recife, PE, Brazil.
EM alexrolland@uol.com.br
RI Amorim, Melania M/C-5807-2013; Souza, Alex Sandro Rolland/G-3446-2013
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052
CR Abdel-Aleem H, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007873.pub3
   BRAUNWALD E, 1982, NEW ENGL J MED, V307, P1618
   Brazilian Ministry of Health, DATASUS SINASC LIV B
   Crowther CA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003935.pub3
   De Souza AR, 2008, ACTA MEDICA PORT, V21, P351
   Dodd JM, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004947.pub3
   Doyle LW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004661.pub3
   Flenady V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002255.pub2
   Flenady V, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004452.pub3
   França Elisabeth Barboza, 2017, Rev. bras. epidemiol., V20, P46, DOI 10.1590/1980-5497201700050005
   Goswami T, 2008, CRIT REV THER DRUG, V25, P449, DOI 10.1615/CritRevTherDrugCarrierSyst.v25.i5.20
   Guclu S, 2006, ULTRASOUND OBST GYN, V27, P403, DOI 10.1002/uog.2728
   Howson CP, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S1
   Lamont R F, 2003, J Obstet Gynaecol, V23, P469
   Lyndrup J, 2007, EXPERT OPIN INV DRUG, V16, P843, DOI 10.1517/13543784.16.6.843
   McCubbin K, 2015, PREHOSP EMERG CARE, V19, P103, DOI 10.3109/10903127.2014.942475
   Neilson JP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004352.pub3
   Ohlsson A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007467.pub4
   Amorim MMR, 2009, REV BRAS GINECOL OBS, V31, P552, DOI 10.1590/S0100-72032009001100005
   Souza AS, 2008, FEMINA, V36, P491
   Travers Colm P, 2017, Evid Based Med, V22, P189, DOI 10.1136/ebmed-2017-110742
   Utama DP, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008981.pub3
   van Vliet EOG, 2016, LANCET, V387, P2117, DOI 10.1016/S0140-6736(16)00548-1
   Vis JY, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-38
   Younger JD, 2017, SEMIN PERINATOL, V41, P493, DOI 10.1053/j.semperi.2017.08.008
NR 25
TC 0
Z9 0
U1 2
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD MAR
PY 2020
VL 148
IS 3
BP 310
EP 315
DI 10.1002/ijgo.13067
EA DEC 2019
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KH5WT
UT WOS:000502027500001
PM 31774552
DA 2020-12-01
ER

PT J
AU Cunhal, CMP
   Katz, L
   Lemos, A
   Amorim, MM
AF Pires Cunhal, Carolina Maria
   Katz, Leila
   Lemos, Andrea
   Amorim, Melania Maria
TI Knowledge, Attitude and Practice of Brazilian Obstetricians Regarding
   Episiotomy
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE episiotomy; health knowledge; attitudes in health; practices in health;
   obstetrics; delivery; perineum
ID PREVENTION; GUIDELINES; MANAGEMENT; DOCTORS; RATES; WOMEN
AB Objective To determine the prevalence of episiotomy and the factors associated with the knowledge, attitude and practice (KAP) of Brazilian obstetricians in relation to this procedure.
   Methods A KAP survey was conducted with obstetricians working in Brazil. An electronic form containing structured questions previously evaluated using the Delphi method was created in Google Docs and sent by e-mail. A multivariate logistic regression was performed to determine the principal factors associated with adequate KAP. For each dependent variable (knowledge, attitude and practice) coded as adequate (1 = yes; 0 = no), a multiple logistic regression model was developed. Binary codes (1 =yes and 0 = no) were assigned to every independent or predictor variables. Prevalence ratios (PRs) and their respective 95% confidence intervals (95%Cls) were calculated as measures of relative risk, at a significance level of 5%.
   Results Out of the 13 thousand physicians contacted, 1,163 replied, and 50 respondents were excluded. The mean episiotomy rate reported was of 42%. Knowledge was determined as adequate in 44.5% of the cases, attitude, in 10.9%, and practice, in 26.8% of the cases.
   Conclusion Most respondents had inadequate knowledge, attitudes and practices regarding episiotomy. Although some factors such as age, teaching, working in the public sector and attending congresses improved knowledge, attitude and practice, we must recognize that episiotomy rates remain well above what would be considered ideal. Adequate knowledge is more prevalent than adequate attitude or practice, indicating that improving knowledge is crucial but insufficient to change the outlook of episiotomies in Brazil.
C1 [Pires Cunhal, Carolina Maria; Katz, Leila; Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira, Rua Barao Itamaraca 16011-501, BR-52020070 Recife, PE, Brazil.
   [Lemos, Andrea] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Katz, L (corresponding author), Inst Med Integral Prof Fernando Figueira, Rua Barao Itamaraca 16011-501, BR-52020070 Recife, PE, Brazil.
EM katzleila@gmail.com
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
CR Ahmed Hamdia M, 2014, Sultan Qaboos Univ Med J, V14, pe369
   Althabe F, 2002, BRIT MED J, V324, P945, DOI 10.1136/bmj.324.7343.945
   Amorim MM, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0315-4
   Amorim MM, 2014, OBSTET GYNECOL, V123, p38S, DOI 10.1097/01.AOG.0000447314.51968.54
   Badran IG, 1995, E MEDITERANIAN HLTH, V1, P8, DOI 10.26719/1995.1.1.8
   BELIZAN J, 1993, LANCET, V342, P1517
   Braga GC, 2014, REV ASSOC MED BRAS, V60, P465, DOI 10.1590/1806-9282.60.05.015
   Camano L, 2002, MANUAL ORIENTACAO FE
   Dannecker C, 2004, ACTA OBSTET GYN SCAN, V83, P364, DOI 10.1111/j.0001-6349.2004.00366.x
   Davis-Floyd R, 2004, BIRTH AM RITE PASSAG
   Diniz D, 2009, CIENC SAUDE COLETIVA, V14, P1619, DOI 10.1590/S1413-81232009000800035
   Diniz Simone Grilo, 2002, Rev. Estud. Fem., V10, P523, DOI 10.1590/S0104-026X2002000200023
   East CE, 2015, MIDWIFERY, V31, P122, DOI 10.1016/j.midw.2014.07.002
   Elliott JH, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001603
   Federacao Brasileira das Associacoes de Ginecologia e Obstetricia, 2010, MAN OR FEBRASGO ASS
   Frankman EA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.022
   Graham ID, 2005, BIRTH-ISS PERINAT C, V32, P219, DOI 10.1111/j.0730-7659.2005.00373.x
   HARRISON RF, 1984, BRIT MED J, V288, P1971, DOI 10.1136/bmj.288.6435.1971
   Hartmann K, 2005, JAMA-J AM MED ASSOC, V293, P2141, DOI 10.1001/jama.293.17.2141
   Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x
   Howden NLS, 2004, OBSTET GYNECOL, V103, P114, DOI 10.1097/01.AOG.0000103997.83468.70
   Jiang H, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000081.pub3
   Klein MC, 2011, BIRTH-ISS PERINAT C, V38, P129, DOI 10.1111/j.1523-536X.2010.00462.x
   Lago TDG, 2009, PESQUISA NACL DEMOGR, P151
   Lansky S, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00133213
   Lappen J. R., 2014, EXPERT REV OBSTET GY, V5, P301, DOI [10.1586/eog.10.21, DOI 10.5686/E0G.10.21]
   Leal MD, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00151513
   Likert R., 1932, ARCH PSYCHOL, V22, P1, DOI DOI 10.1111/J.1540
   Ministerio da Saude. Secretaria de Ciencia Tecnologia e Insumos Estrategicos. Departamento de Gestao e Incorporacao de Tecno- logias em Saude., 2017, DIR NAC ASS PART NOR
   Ministerio da Saude. Secretaria de Politicas de Saude. Area Tecnica de Saude daMulher, 2001, AR TECN SAUD MULH
   Mostofian F, 2015, AM J MANAG CARE, V21, P75
   Norman AH, 2009, CAD SAUDE PUBLICA, V25, P2012, DOI 10.1590/S0102-311X2009000900015
   Reinhold D, 2012, J GYNECOL OBST BIO R, V41, P62, DOI 10.1016/j.jgyn.2011.08.006
   Scott JR, 2005, OBSTET GYN CLIN N AM, V32, P307, DOI 10.1016/j.ogc.2004.12.001
   Seijmonsbergen-Schermers AE, 2013, BIRTH-ISS PERINAT C, V40, P247, DOI 10.1111/birt.12060
   SLEEP J, 1984, BRIT MED J, V289, P587, DOI 10.1136/bmj.289.6445.587
   Souza JP, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311XPE02S114
   Steiner N, 2012, ARCH GYNECOL OBSTET, V286, P1369, DOI 10.1007/s00404-012-2460-x
   Trinh AT, 2013, B WORLD HEALTH ORGAN, V91, P350, DOI 10.2471/BLT.12.114314
   Waldman R, 2019, OBSTET GYNECOL, V133, P185, DOI 10.1097/AOG.0000000000003041
   World Health Organization, 2018, WHO REC INTR CAR POS
   Wyatt JC, 1998, BMJ-BRIT MED J, V317, P1041
NR 42
TC 0
Z9 0
U1 0
U2 2
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD NOV
PY 2019
VL 41
IS 11
BP 636
EP 646
DI 10.1055/s-0039-3400314
PG 11
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA JP3KP
UT WOS:000498166700002
PM 31745956
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Lins, VML
   Katz, L
   Vasconcelos, FBL
   Coutinho, I
   Amorim, MM
AF Laranjeiras Lins, Vanessa Maria
   Katz, Leila
   Lima Vasconcelos, Fernanda Barros
   Coutinho, Isabela
   Amorim, Melania Maria
TI Factors associated with spontaneous perineal lacerations in deliveries
   without episiotomy in a university maternity hospital in the city of
   Recife, Brazil: a cohort study
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE Injuries and lesions; normal childbirth; perineum; risk factors
ID RISK-FACTORS; TRAUMA; CHILDBIRTH; PREVENTION; BIRTH; CARE
AB Objectives: The objective of this study is to determine factors associated with spontaneous perineal laceration in low-risk pregnant women who delivered vaginally without episiotomy in a university maternity hospital in Recife, Pernambuco, Brazil.Methods: A prospective cohort study was conducted with 222 low-risk, full-term pregnant women admitted in labor with a single fetus in cephalic presentation. Women with malformed fetuses were excluded from the study. The variables analyzed were: the frequency and severity of lacerations, the women's biological, sociodemographic, clinical and obstetrical characteristics, neonatal characteristics, and data on their deliveries and procedures. For the data analysis, risk ratios and their 95% confidence intervals were calculated. A significance level of 5% was adopted and multiple regression analysis was performed.Results: Spontaneous first-degree perineal tears were registered in 47% of the women, second-degree tears in 31%, and third degree tears in only 1.8%. There were no cases of fourth-degree tears. Having experienced normal childbirth previously constituted a protective factor against vaginal tearing (OR= 0.46; 95%CI: 0.23-0.91; p=.027).Conclusion: The principal protective factor against spontaneous lacerations was having experienced normal childbirth previously. Intrapartum strategies aimed at protecting the perineum and pelvic floor muscle training during prenatal care should be encouraged in these women.
C1 [Laranjeiras Lins, Vanessa Maria; Katz, Leila; Lima Vasconcelos, Fernanda Barros; Coutinho, Isabela; Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Katz, L (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
EM katzleila@gmail.com
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
CR Aasheim V, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006672.pub2
   Albers LL, 2006, J MIDWIFERY WOM HEAL, V51, P249, DOI 10.1016/j.jmwh.2006.03.001
   Albers LL, 2005, J MIDWIFERY WOM HEAL, V50, P365, DOI 10.1016/j.jmwh.2005.05.012
   Amorim MMR, 2010, REV SAUDE CIENCIA, V1, P80
   Amorim MMR, 2008, FEMINA, V36, P47
   Araujo NM, 2008, REV LAT-AM ENFERM, V16, P375, DOI 10.1590/S0104-11692008000300007
   Carroli G, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000081.pub2
   Caughey A, 2007, AM J OBSTET GYNECOL, V196, P155
   da Costa ADC, 2006, J MIDWIFERY WOM HEAL, V51, P106, DOI 10.1016/j.jmwh.2005.10.017
   Dahlen HG, 2007, MIDWIFERY, V23, P196, DOI 10.1016/j.midw.2006.04.004
   de Oliveira C, 2007, CLINICS, V62, P439, DOI 10.1590/S1807-59322007000400011
   Deering SH, 2004, J REPROD MED, V49, P306
   Elvander C, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0689-7
   Groutz A, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.019
   Halperin O, 2010, JOGNN-J OBST GYN NEO, V39, P292, DOI 10.1111/j.1552-6909.2010.01137.x
   Howard D, 2000, OBSTET GYNECOL, V96, P622, DOI 10.1016/S0029-7844(00)00956-X
   Kudish B, 2008, INT J GYNECOL OBSTET, V102, P165, DOI 10.1016/j.ijgo.2008.02.017
   Low Lisa Kane, 2014, Open J Obstet Gynecol, V4, P266
   Matsuo K, 2009, ARCH GYNECOL OBSTET, V280, P781, DOI 10.1007/s00404-009-1015-2
   MOUTA R. J. O, 2008, REV ENFERMAGEM UERJ, V16, P472
   Ott J, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0703-0
   Ruckhaberle E, 2009, AUST NZ J OBSTET GYN, V49, P478, DOI 10.1111/j.1479-828X.2009.01044.x
   Santos Jaqueline de Oliveira, 2008, Esc. Anna Nery, V12, P658, DOI 10.1590/S1414-81452008000400008
   SULTAN AH, 1994, BRIT MED J, V308, P887, DOI 10.1136/bmj.308.6933.887
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
NR 25
TC 3
Z9 3
U1 1
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD SEP 17
PY 2019
VL 32
IS 18
BP 3062
EP 3067
DI 10.1080/14767058.2018.1457639
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IK5AJ
UT WOS:000476597800017
PM 29577777
DA 2020-12-01
ER

PT J
AU Silva, FP
   Souza, RT
   Cecatti, JG
   Passini, R
   Tedesco, RP
   Lajos, GJ
   Nomura, ML
   Rehder, PM
   Dias, TZ
   Oliveira, PF
   Silva, CM
   Costa, ML
   Pacagnella, RC
   Haddad, SM
   Zotarelli, V
   Gurgel, LT
   Maia, NL
   Mathias, JP
   Marba, ST
   Guinsburg, R
   Martinez, FE
   Quintana, SM
   Melli, PPS
   Feitosa, FE
   Chaves, GN
   Porto, AM
   Coutinho, IC
   Lima, ACB
   Melo, EF
   Leite, DF
   Amorim, MM
   Melo, ASO
   Melo, FO
   Martins, MG
   Nunes, MV
   Paiva, CS
   Lima, MD
   Freire, DM
   Tristao, EG
   Nascimento, DJ
   Menezes, CA
   Aquino, M
   Vettorazzi, J
   Senger, CE
   Assumpcao, AMB
   Guedes, MAF
   Moreira, MEL
   Borges, VT
   Souza, E
   Zamarian, ACP
   Lotufo, FA
   Uzilin, K
   Zanette, EA
   Andreucci, CB
   Oliveira, TA
   Oliveira, LR
   Santos, MAN
   Sass, N
   Silveira, MRF
   Coutinho, PR
   Siqueira, L
AF Silva, Fabia Pigatti
   Souza, Renato T.
   Cecatti, Jose G.
   Passini, Renato, Jr.
   Tedesco, Ricardo P.
   Lajos, Giuliane J.
   Nomura, Marcelo L.
   Rehder, Patricia M.
   Dias, Tabata Z.
   Oliveira, Paulo F.
   Silva, Cleide M.
   Costa, Maria L.
   Pacagnella, Rodolfo C.
   Haddad, Samira M.
   Zotarelli, Vilma
   Gurgel, Lucio T.
   Maia Filho, Nelson L.
   Mathias, Jacinta P.
   Marba, Sergio T.
   Guinsburg, Ruth
   Martinez, Francisco E.
   Quintana, Silvana M.
   Melli, Patricia P. S.
   Feitosa, Francisco E.
   Chaves, George N.
   Porto, Ana M.
   Coutinho, Isabela C.
   Barbosa Lima, Antonio C.
   Melo, Elias F.
   Leite, Debora F.
   Amorim, Melania M.
   Melo, Adriana S. O.
   Melo, Fabiana O.
   Martins, Marilia G.
   Nunes, Marinea V.
   Paiva, Claudio S.
   Lima, Moises D.
   Freire, Djacyr M.
   Tristao, Edson G.
   Nascimento, Denis J.
   Menezes, Carlos A.
   Aquino, Marcelo
   Vettorazzi, Janete
   Senger, Cintia E.
   Assumpcao, Augusta M. B.
   Guedes, Marcela A. F.
   Moreira, Maria E. L.
   Borges, Vera T.
   Souza, Eduardo
   Zamarian, Ana C. P.
   Lotufo, Fatima A.
   Uzilin, Kaliane
   Zanette, Elvira A.
   Andreucci, Carla B.
   Oliveira, Tenilson A.
   Oliveira, Laercio R.
   Santos, Marcos A. N.
   Sass, Nelson
   Silveira, Mirian R. F.
   Coutinho, Pedro R.
   Siqueira, Luciana
CA Brazilian Multictr Study Preterm
TI Role of Body Mass Index and gestational weight gain on preterm birth and
   adverse perinatal outcomes
SO SCIENTIFIC REPORTS
LA English
DT Article
ID MATERNAL NUTRITION; OBESITY; RISK; ASSOCIATION; PREGNANCY; EPIDEMIOLOGY;
   COUNTRIES; LABOR
AB The association of body mass index (BMI) and gestational weight gain (GWG) with preterm birth (PTB) remains controversial in the literature. To evaluate different maternal BMI and GWG categories, according to the initial BMI, in relation to different PTB subtypes and perinatal outcomes, we conducted a secondary analysis of a multicentre cross-sectional study, along with a nested case-control study including PTB from 20 centers in Brazil. Pre-pregnancy underweight was associated with a lower risk of provider-initiated PTB, while overweight and obesity were associated with a higher risk of provider-initiated PTB and a lower risk of spontaneous preterm birth. Insufficient gestational weight gain was associated with a higher prevalence of spontaneous PTB and preterm premature rupture of membranes. Excessive GWG correlated with a higher prevalence of provider-initiated PTB or preterm premature rupture of membranes. Irrespective of the initial BMI, the greater the rate of GWG, the higher the predicted probability of all PTB subtypes, except for spontaneous PTB in underweight women and those with normal BMI. On multivariate analysis, the initial BMI was shown to be the only factor associated with pi-PTB. Briefly, further studies evaluating the risk for PTB should consider that GWG may have a different role depending on the initial BMI and PTB subtype.
C1 [Silva, Fabia Pigatti; Souza, Renato T.; Cecatti, Jose G.; Passini, Renato, Jr.; Lajos, Giuliane J.; Nomura, Marcelo L.; Rehder, Patricia M.; Dias, Tabata Z.; Costa, Maria L.; Pacagnella, Rodolfo C.; Haddad, Samira M.; Zotarelli, Vilma; Gurgel, Lucio T.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
   [Tedesco, Ricardo P.; Maia Filho, Nelson L.; Mathias, Jacinta P.] Jundiai Med Sch, Dept Obstet & Gynecol, Jundiai, SP, Brazil.
   [Oliveira, Paulo F.; Silva, Cleide M.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Unit Stat, Campinas, Brazil.
   [Marba, Sergio T.] Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Pediat, Campinas, SP, Brazil.
   [Guinsburg, Ruth] Univ Fed Sao Paulo, UNIFESP, EPM, Div Neonatal Med, Sao Paulo, SP, Brazil.
   [Martinez, Francisco E.; Quintana, Silvana M.; Melli, Patricia P. S.] Univ Sao Paulo, Fac Med Ribeirao Preto, Sao Paulo, Brazil.
   [Feitosa, Francisco E.; Chaves, George N.] Matern Sch, Fortaleza, Ceara, Brazil.
   [Porto, Ana M.; Coutinho, Isabela C.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Barbosa Lima, Antonio C.; Melo, Elias F.; Leite, Debora F.] Univ Fed Pernambuco, Sch Med, Dept Mother & Child Hlth, Recife, PE, Brazil.
   [Amorim, Melania M.; Melo, Adriana S. O.; Melo, Fabiana O.] Inst Saude Elpidio Almeida, Campina Grande, Paraiba, Brazil.
   [Martins, Marilia G.; Nunes, Marinea V.] Fed Univ Maranhao UFMA, Dept Gynecol & Obstet, Sao Luis, MA, Brazil.
   [Paiva, Claudio S.; Lima, Moises D.; Freire, Djacyr M.] Univ Fed Paraiba, Joao Pessoa, Paraiba, Brazil.
   [Tristao, Edson G.; Nascimento, Denis J.] Univ Fed Parana, Curitiba, Parana, Brazil.
   [Menezes, Carlos A.; Aquino, Marcelo] Univ Fed Bahia, Salvador, BA, Brazil.
   [Vettorazzi, Janete; Senger, Cintia E.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Assumpcao, Augusta M. B.; Guedes, Marcela A. F.; Moreira, Maria E. L.] Inst Fernandes Figueira Fiocruz, Rio De Janeiro, RJ, Brazil.
   [Borges, Vera T.] Sao Paulo State Univ, Dept Gynecol & Obstet, Botucatu, SP, Brazil.
   [Souza, Eduardo; Zamarian, Ana C. P.] Univ Fed Sao Paulo, EPM UNIFESP, Paulista Sch Med, Dept Obstet, Sao Paulo, SP, Brazil.
   [Lotufo, Fatima A.; Uzilin, Kaliane] Santa Casa Limeira Hosp, Limeira, SP, Brazil.
   [Zanette, Elvira A.; Andreucci, Carla B.] Santa Casa Sao Carlos Hosp, Sao Carlos, SP, Brazil.
   [Oliveira, Tenilson A.; Oliveira, Laercio R.; Santos, Marcos A. N.] Matern Casa Maternal Leonor Mendes Barros, Sao Paulo, SP, Brazil.
   [Sass, Nelson; Silveira, Mirian R. F.] Matern Escola Vila Nova Cachoeirinha, Sao Paulo, SP, Brazil.
   [Coutinho, Pedro R.; Siqueira, Luciana] Hosp Estadual Sumare, Sumare, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Andreucci, Carla B/J-4845-2015; Moreira, Maria Elisabeth
   Lopes/AAA-3775-2020; Souza, Renato Teixeira/G-4205-2017; feitosa,
   francisco e/H-8431-2014; Sass, Nelson/AAD-8259-2020; Amorim, Melania
   M/C-5807-2013; Melo, Adriana S O/H-5650-2016; BORGES, VERA/B-7363-2014
OI Andreucci, Carla B/0000-0002-5590-108X; Moreira, Maria Elisabeth
   Lopes/0000-0002-2034-0294; Souza, Renato Teixeira/0000-0002-9075-9269;
   Sass, Nelson/0000-0001-7187-1004; Amorim, Melania M/0000-0003-1047-2514;
   Cecatti, Jose Guilherme/0000-0003-1285-8445; BORGES,
   VERA/0000-0002-9347-9641
FU FAPESP (Foundation for Research Support of the State of Sao Paulo)
   BrazilFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP);
   CNPq (Brazilian National Research Council) BrazilNational Council for
   Scientific and Technological Development (CNPq); Bill and Melinda Gates
   FoundationBill & Melinda Gates Foundation [401636/2013-5, 05/2013];
   Brazilian National Research Council (CNPq)National Council for
   Scientific and Technological Development (CNPq) [401636/2013-5, 05/2013]
FX Other members of the Brazilian Multicenter Study on Preterm Birth study
   group: Maria L. Costa, Rodolfo C. Pacagnella, Samira M. Haddad, Sergio
   T. Marba, Ruth Guinsburg, Francisco E. Martinez, Vilma Zotarelli, Lucio
   T. Gurgel, Francisco E. Feitosa, George N. Chaves, Ana M. Porto, Isabela
   C. Coutinho, Antonio C. Barbosa Lima, Elias F. Melo Jr, Debora F. Leite,
   Melania M. Amorim, Adriana S. O. Melo, Fabiana O. Melo, Marilia G.
   Martins, Marynea V. Nunes, Claudio S. Paiva, Moises D. Lima, Djacyr M.
   Freire, Edson G. Tristao, Denis J. Nascimento, Carlos A. Menezes,
   Marcelo Aquino, Janete Vettorazzi, Cintia E. Senger, Augusta M. B.
   Assumpcao, Marcela A. F. Guedes, Maria E. L. Moreira, Vera T. Borges,
   Nelson L. Maia Filho, Jacinta P. Mathias, Eduardo Souza, Ana C. P.
   Zamarian, Silvana M. Quintana, Patricia P. S. Melli, Fatima A. Lotufo,
   Kaliane Uzilin, Elvira A. Zanette, Carla B. Andreucci, Tenilson A.
   Oliveira, Laercio R. Oliveira, Marcos A. N. Santos, Nelson Sass, Mirian
   R. F. Silveira, Pedro R. Coutinho, Luciana Siqueira. This study was
   supported by a grant from FAPESP (Foundation for Research Support of the
   State of Sao Paulo), and by CNPq (Brazilian National Research Council)
   Brazil. Funders played no role in study design, data collection and
   analysis, decision to publish or preparation of the manuscript. The
   current secondary analyses of EMIP data was designed and developed by
   part of the Preterm SAMBA study Group (RTS, RPJ and JGC), a
   collaborative study group on Preterm Birth Research jointly issued by
   the Brazilian National Research Council (CNPq) and the Bill and Melinda
   Gates Foundation (Award 401636/2013-5 -Grand Challenges Brazil: Reducing
   the burden of preterm birth, number 05/2013). Current findings are
   therefore, part of the range of analyses of prematurity from the Preterm
   SAMBA study group.
CR AlSaif S, 2015, LIFE SCI, V125, P2, DOI 10.1016/j.lfs.2015.02.001
   Bailey KV, 1995, B WORLD HEALTH ORGAN, V73, P673
   Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4
   Blevins JE, 2013, REV ENDOCR METAB DIS, V14, P311, DOI 10.1007/s11154-013-9260-x
   Bloomfield FH, 2011, ANNU REV NUTR, V31, P235, DOI 10.1146/annurev-nutr-072610-145141
   Brazilian Ministry of Health, 2011, SINASC NAT INF SYST
   Carlson NS, 2015, REPROD BIOL ENDOCRIN, V13, DOI 10.1186/s12958-015-0129-6
   Carnero AM, 2012, BJOG-INT J OBSTET GY, V119, P924, DOI 10.1111/j.1471-0528.2012.03345.x
   Crane JMG, 2009, J OBSTET GYNAECOL CA, V31, P28, DOI 10.1016/S1701-2163(16)34050-6
   Dekker GA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039154
   Delorme P, 2016, OBSTET GYNECOL, V127, P40, DOI 10.1097/AOG.0000000000001179
   Denison FC, 2008, BJOG-INT J OBSTET GY, V115, P720, DOI 10.1111/j.1471-0528.2008.01694.x
   Dietz PM, 2006, EPIDEMIOLOGY, V17, P170, DOI 10.1097/01.ede.0000198470.26932.9a
   El Rafei R, 2016, PAEDIATR PERINAT EP, V30, P38, DOI 10.1111/ppe.12249
   Faucher MA, 2016, BJOG-INT J OBSTET GY, V123, P199, DOI 10.1111/1471-0528.13797
   Godoy AC, 2015, CLINICS, V70, P758, DOI 10.6061/clinics/2015(11)08
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Goldstein RF, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1128-1
   Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635
   Haugen M, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-201
   Hendler I, 2005, AM J OBSTET GYNECOL, V192, P882, DOI 10.1016/j.ajog.2004.09.021
   Honest H, 2005, EUR J OBSTET GYN R B, V119, P11, DOI 10.1016/j.ejogrb.2004.07.041
   IOM (Institute of Medicine) NRC (National Research Council), 2009, WEIGHT GAIN PREGNANC
   Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03
   Kominiarek MA, 2018, OBSTET GYNECOL, V132, P875, DOI 10.1097/AOG.0000000000002854
   Lajos G. J., 2015, SCI WORLD J, V2015, DOI DOI 10.1155/2015/719104
   Luke B, 2005, J PERINAT MED, V33, P500, DOI 10.1515/JPM.2005.088
   Masho SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-120
   Neggers Y, 2003, J NUTR, V133, p1737S, DOI 10.1093/jn/133.5.1737S
   Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8
   Nohr EA, 2007, PAEDIATR PERINAT EP, V21, P5, DOI 10.1111/j.1365-3016.2007.00762.x
   Oken E, 2009, AM J EPIDEMIOL, V170, P173, DOI 10.1093/aje/kwp101
   Parker MG, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-153
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Rahman MM, 2015, OBES REV, V16, P758, DOI 10.1111/obr.12293
   Reilly JJ, 2005, BMJ-BRIT MED J, V330, P1357, DOI 10.1136/bmj.38470.670903.E0
   Salihu HM, 2009, EUR J OBSTET GYN R B, V144, P119, DOI 10.1016/j.ejogrb.2009.02.047
   Salihu HM, 2010, ARCH GYNECOL OBSTET, V282, P127, DOI 10.1007/s00404-009-1213-y
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
   Torloni MR, 2009, J MATERN-FETAL NEO M, V22, P957, DOI 10.3109/14767050903042561
   Vahratian A, 2004, OBSTET GYNECOL, V104, P943, DOI 10.1097/01.AOG.0000142713.53197.91
   von Elm E, 2007, PLOS MED, V4, P1623, DOI 10.1371/journal.pmed.0040296
   World Health Organization, 2005, ANN NUMB DEATHS CAUS
NR 43
TC 5
Z9 5
U1 2
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD SEP 11
PY 2019
VL 9
AR 13093
DI 10.1038/s41598-019-49704-x
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA IW8AR
UT WOS:000485215700003
PM 31511664
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Guendler, JA
   Katz, L
   Flamini, MEDM
   Lemos, A
   Amorim, MM
AF Guendler, Julianna Azevedo
   Katz, Leila
   Duarte Mello Flamini, Maria Eduarda
   Lemos, Andrea
   Amorim, Melania Maria
TI Prevalence of Sexual Dysfunctions and their Associated Factors in
   Pregnant Women in an Outpatient Prenatal Care Clinic
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE sexual dysfunction; sexuality; pregnancy; women's health; prevalence
ID FEMALE; LIFE; CHILDBIRTH; DELIVERY; QUALITY; IMPACT
AB Objective To determine the prevalence of sexual dysfunction and its associated factors in pregnant women.
   Methods A descriptive, cross-sectional study including 262 pregnant women aged 18years or older with gestational age between 10 and 35weeks. Women with urinary tract infections and conditions of gestational risk were excluded. The Pregnancy Sexual Response Inventory (PSRI) questionnaire was used. We performed a univariate descriptive analysis, and comparisons between the mean values of the sexual function domains were made using the Student t -test. The chi-squared test was used to determine the association between the independent and dependent variables. The prevalence ratios, with their respective 95% confidence intervals, were also estimated, and a multivariate analysis was performed.
   Results A total of 64.9% of women reported a decrease in the frequency of sexual activity during pregnancy. Slightly more than half of the women (50.8%) were satisfied, and arousal was reported as excellent/good by 30.5% of them. The frequency of sexual difficulties/dysfunctions increased with pregnancy, rising from 5.7% to 58.8%, and pain during sexual intercourse was reported by 45.8% of them. Having higher education degree decreased the chance of being sexually dissatisfied by 50%. The total PSRI score showed a significant decrease from the prepregnancy period (mean score=89.8, excellent) to the pregnancy period (mean score=59.2, good).
   Conclusion The mean sexual function score during pregnancy was classified as good, although most pregnant women reported at least one type of alteration in the sexual function domains, and the report of dissatisfaction was more frequent in women with lower schooling.
   Resumo
   Objetivo Determinar a prevalencia e fatores associados de disfuncAo sexual em gestantes.
   Metodos Estudo descritivo, transversal, incluindo 262 gestantes com idade de 18 anos ou mais, e idade gestacional entre 10 e 35 semanas. Mulheres com infeccAo de trato urinario e gestacAo de alto risco foram excluidas. O Inventario de Resposta Sexual na GestacAo (Pregnancy Sexual Response Inventory, PSRI) foi utilizado. Procedeu-se a analise univariada, e as comparacoes entre as medias dos dominios de funcAo sexual foram avaliadas pelo teste t de Student. Associacoes entre as variaveis dependentes e independentes foram determinadas por teste do qui-quadrado. Tambem estimou-se a razAo de prevalencia, com intervalo de confianca de 95%, e realizou-se analise multivariada.
   Resultados Um total de 64,9% das mulheres relataram diminuicAo na frequencia de atividade sexual durante a gravidez. Pouco mais da metade das mulheres (50,8%) estavam satisfeitas, e a excitacAo foi relatada como excelente/boa por 30,5% delas. A frequencia de dificuldades/disfuncoes sexuais aumentou com a gravidez, subindo de 5,7% para 58,8%, e dor na relacAo sexual foi relatada por 45,8% delas. Ter Ensino Superior diminuiu em 50% a chance de insatisfacAo sexual. O escore total do PSRI diminuiu significativamente entre o periodo pre-gestacional (escore medio=89,8, excelente) e o periodo gestacional (escore medio=59,2, bom).
   ConclusAo O escore medio da funcAo sexual durante a gestacAo foi classificado como bom, embora a maioria das gestantes tenha relatado pelo menos um tipo de alteracAo nos dominios da funcAo sexual. O relato de insatisfacAo foi mais frequente nas mulheres de baixa escolaridade.
C1 [Guendler, Julianna Azevedo; Katz, Leila; Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Duarte Mello Flamini, Maria Eduarda] Univ Fed Pernambuco, Hosp Clin Pernambuco, Recife, PE, Brazil.
   [Lemos, Andrea] Univ Fed Pemambuco, Recife, PE, Brazil.
RP Guendler, JA (corresponding author), Rua Prof Eduardo Wanderley Filho 293-101, BR-51020170 Recife, PE, Brazil.
EM jujuguendler@gmail.com
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917;
   Guendler, Julianna de Azevedo/0000-0002-2712-2599
CR Afshar Malihe, 2012, J Caring Sci, V1, P173, DOI 10.5681/jcs.2012.025
   Ahmed MR, 2014, J OBSTET GYNAECOL RE, V40, P1023, DOI 10.1111/jog.12313
   Asselmann E, 2016, J SEX MED, V13, P95, DOI 10.1016/j.jsxm.2015.12.005
   Aydin M, 2015, UROL J, V12, P2339
   Babazadeh R, 2013, INT J GYNECOL OBSTET, V120, P82, DOI 10.1016/j.ijgo.2012.07.021
   Bartellas E, 2000, BRIT J OBSTET GYNAEC, V107, P964, DOI 10.1111/j.1471-0528.2000.tb10397.x
   Camacho KG, 2010, REV ENFERM, V18, P32
   Rudge CVC, 2018, REV BRAS GINECOL OBS, V40, P322, DOI 10.1055/s-0038-1656536
   Bezerra IFD, 2015, REV BRAS GINECOL OBS, V37, P266, DOI 10.1590/SO100-720320150005254
   De Judicibus MA, 2002, J SEX RES, V39, P94, DOI 10.1080/00224490209552128
   de Lima AC, 2013, CAD SAUDE PUBLICA, V29, P1544, DOI [10.1590/S0102-311X2013001200007, 10.1590/0102-311X00164012]
   Dowrick AS, 2015, UROLOGY, V85, P1304, DOI 10.1016/j.urology.2015.01.046
   Eryilmaz G, 2004, GYNECOL OBSTET INVES, V57, P103, DOI 10.1159/000075582
   Esmer AC, 2013, J OBSTET GYNAECOL RE, V39, P1165, DOI 10.1111/jog.12048
   Gokyildiz S, 2005, J SEX MARITAL THER, V31, P201, DOI 10.1080/00926230590513410
   Kadri N, 2002, Arch Womens Ment Health, V5, P59, DOI 10.1007/s00737-002-0141-7
   Kahramanoglu I, 2017, ARCH GYNECOL OBSTET, V295, P907, DOI 10.1007/s00404-017-4299-7
   Latif EZ, 2013, FERTIL STERIL, V100, P898, DOI 10.1016/j.fertnstert.2013.08.006
   Malarewicz Andrzej, 2006, Ginekol Pol, V77, P733
   Olsson A, 2005, SCAND J CARING SCI, V19, P381, DOI 10.1111/j.1471-6712.2005.00357.x
   Pastore L, 2007, J SEX MED, V4, P115, DOI 10.1111/j.1743-6109.2006.00379.x
   Pauls RN, 2008, J SEX MED, V5, P1915, DOI 10.1111/j.1743-6109.2008.00884.x
   Prado DS, 2013, REV BRAS GINECOL OBS, V35, P205, DOI 10.1590/S0100-72032013000500003
   Ribeiro MC, 2011, REV BRAS GINECOL OBS, V33, P219, DOI 10.1590/S0100-72032011000500003
   Rudge Cibele V C, 2009, Reprod Health, V6, P12, DOI 10.1186/1742-4755-6-12
   Tugut N, 2017, J SEX MARITAL THER, V43, P132, DOI 10.1080/0092623X.2016.1141816
   Vannier SA, 2017, J SEX MED, V14, P387, DOI 10.1016/j.jsxm.2016.12.239
   von Sydow K, 1999, J PSYCHOSOM RES, V47, P27, DOI 10.1016/S0022-3999(98)00106-8
   Witting K, 2008, J SEX MARITAL THER, V34, P89, DOI 10.1080/00926230701636163
   Wolpe RE, 2017, EUR J OBSTET GYN R B, V211, P26, DOI 10.1016/j.ejogrb.2017.01.018
   Yeniel AO, 2014, INT UROGYNECOL J, V25, P5, DOI 10.1007/s00192-013-2118-7
   Yildiz H, 2015, J SEX MARITAL THER, V41, P49, DOI 10.1080/0092623X.2013.811452
NR 32
TC 1
Z9 1
U1 0
U2 2
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD SEP
PY 2019
VL 41
IS 9
BP 555
EP 563
DI 10.1055/s-0039-1695021
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IZ7BL
UT WOS:000487239800006
PM 31480080
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Pascoal, ACF
   Katz, L
   Pinto, MH
   Santos, CA
   Braga, LCO
   Maia, SB
   Amorim, MMR
AF Pascoal, Ana C. F.
   Katz, Leila
   Pinto, Marcela H.
   Santos, Carina A.
   Braga, Luana C. O.
   Maia, Sabina B.
   Amorim, Melania M. R.
TI Serum magnesium levels during magnesium sulfate infusion at 1gram/hour
   versus 2grams/hour as a maintenance dose to prevent eclampsia in women
   with severe preeclampsia A randomized clinical trial
SO MEDICINE
LA English
DT Article
DE controlled clinical trials; dose-response relationship; magnesium
   sulfate; magnesium; preeclampsia
ID MATERNAL MORTALITY; PREGNANCY; HYPERTENSION; PROPHYLAXIS; REGIMENS
AB Background: Magnesium sulfate is the ideal drug for the prevention and treatment of eclampsia. Nevertheless, the best regimen for protection against eclampsia with minimal side effects remains to be established. This study aimed to compare serum magnesium levels during intravenous infusion of magnesium sulfate at 1gram/hour versus 2grams/hour as a maintenance dose to prevent eclampsia in pregnant and postpartum women with severe preeclampsia.
   Methods: A randomized, triple-blind clinical trial was conducted, comparing serum magnesium levels during the intravenous infusion of magnesium sulfate at 1gram/hour versus 2grams/hour as a maintenance dose for the prevention of eclampsia in 62 pregnant and postpartum women with severe preeclampsia, 31 in each group. An intravenous loading dose of 6 grams of magnesium sulfate was administered over 30 minutes in both groups. The patients were then randomized to receive a maintenance dose of either 1 or 2grams/hour for 24 hours. Primary outcomes consisted of serum magnesium levels at the following time points: baseline, 30 minutes, every 2 hours until the end of the first 6 hours, and every 6 hours thereafter until the termination of magnesium sulfate infusion. Side effects, maternal complications, and neonatal outcomes were the secondary outcomes.
   Results: Serum magnesium levels were higher in the 2-gram/hour group, with a statistically significant difference from 2 hours after the beginning of the magnesium sulfate infusion (P < .05). Oliguria was the most common complication recorded in both groups, with no significant difference between the 2 regimens (RR 0.88; 95% CI: 0.49-1.56; P = .65). No cases of eclampsia occurred. Side effects were more common in the 2-gram/hour group (RR 1.89; 95% CI: 1.04-3.41; P = .02); however, all were mild. There were no differences between the 2 groups regarding neonatal outcomes, except for admission to neonatal intensive care, which was more frequent in the 1-gram/hour group (25% vs 6.3%; P = .04).
   Conclusion: Magnesium sulfate therapy at the maintenance dose of 1gram/hour was just as effective as the 2-gram maintenance dose, with fewer side effects.
C1 [Pascoal, Ana C. F.; Katz, Leila; Pinto, Marcela H.; Santos, Carina A.; Braga, Luana C. O.; Maia, Sabina B.; Amorim, Melania M. R.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Amorim, MMR (corresponding author), Rua Neuza Borborema de Souza 300, BR-58406120 Campina Grande, Paraiba, Brazil.
EM profmelania.amorim@gmail.com
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
CR Abbassi-Ghanavati M, 2012, AM J PERINAT, V29, P795, DOI 10.1055/s-0032-1316440
   Charoenvidhya Dhirapatara, 2013, Journal of the Medical Association of Thailand, V96, P395
   CHISSELL S, 1994, S AFR MED J, V84, P607
   Dayicioglu V, 2003, HYPERTENS PREGNANCY, V22, P257, DOI 10.1081/PRG-120024029
   Doyle LW, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004661.pub3
   Doyle LW, 2009, OBSTET GYNECOL, V113, P1327, DOI 10.1097/AOG.0b013e3181a60495
   DULEY L, 1992, BRIT J OBSTET GYNAEC, V99, P547, DOI 10.1111/j.1471-0528.1992.tb13818.x
   Duley L, 2010, COCHRANE DB SYST REV, V8
   Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Gelb DJ, 2000, INTRO CLIN NEUROLOGY
   GERRETSEN G, 1983, BRIT J OBSTET GYNAEC, V90, P34, DOI 10.1111/j.1471-0528.1983.tb06743.x
   Ghulmiyyah L, 2012, SEMIN PERINATOL, V36, P56, DOI 10.1053/j.semperi.2011.09.011
   Giordano JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097401
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Lu JF, 2000, CLIN PHARMACOKINET, V38, P305, DOI 10.2165/00003088-200038040-00002
   National Collaborating Centre for Women's and Children's Health, 2010, HYP PREGN MAN HYP DI
   Okusanya BO, 2016, BJOG-INT J OBSTET GY, V123, P356, DOI 10.1111/1471-0528.13753
   Phuapradit W, 1993, Asia Oceania J Obstet Gynaecol, V19, P387
   PRITCHARD JA, 1955, SURG GYNECOL OBSTET, V100, P131
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   Romero JP, 2003, AN FM, V64, P43
   Salinger DH, 2013, BJOG-INT J OBSTET GY, V120, P894, DOI 10.1111/1471-0528.12222
   Santos L, 2011, GESTACAO ALTO RISCO
   Sibai BM, 2004, AM J OBSTET GYNECOL, V190, P1520, DOI 10.1016/j.ajog.2003.12.057
   SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P1141, DOI 10.1016/0002-9378(90)90002-O
   Silva P., 2010, PHARMACOLOGY
   Smith JM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-34
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   Vigil-De Gracia P, 2009, INT J GYNECOL OBSTET, V104, P90, DOI 10.1016/j.ijgo.2008.09.014
   WHO, 2011, GUID APPR GUID REV C
   ZUSPAN FP, 1978, AM J OBSTET GYNECOL, V131, P591, DOI 10.1016/0002-9378(78)90816-5
NR 32
TC 4
Z9 4
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD AUG
PY 2019
VL 98
IS 32
AR e16779
DI 10.1097/MD.0000000000016779
PG 9
WC Medicine, General & Internal
SC General & Internal Medicine
GA IU0IS
UT WOS:000483262500062
PM 31393402
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Lima, THB
   Amorim, MM
   Kassar, SB
   Katz, L
AF Barbosa de Lima, Telmo Henrique
   Amorim, Melania Maria
   Kassar, Samir Buainain
   Katz, Leila
TI Maternal near miss determinants at a maternity hospital for high-risk
   pregnancy in northeastern Brazil: a prospective study
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Maternal near miss; Maternal mortality; Severe maternal morbidity
ID MORTALITY; MORBIDITY
AB BackgroundTo investigate the association between sociodemographic and obstetric variables and delays in care with maternal near misses (MNMs) and their health indicators.MethodsA prospective cohort study was conducted at a high-risk maternity hospital in northeastern Brazil from June 2015 to May 2016 that included all pregnant women seen at the maternity hospital during the data collection period and excluded those who had not been discharged at the end of the study or whom we were unable to contact after the 42nd postpartum day for MNM control. We used the MNM criteria recommended by the WHO. Risk ratios (RRs) and their 95% confidence intervals (CIs) were calculated. Hierarchical multiple logistic regression analysis was performed. The p values of all tests were two-tailed, and the significance level was set to 5%.ResultsA total of 1094 pregnant women were studied. We identified 682 (62.4%) women without adverse maternal outcomes (WOAMOs) and 412 (37.6%) with adverse maternal outcomes (WAMOs), of whom 352 had potentially life-threatening conditions (PLTCs) (85.4%), including 55 MNM cases (13.3%) and five maternal deaths (1.2%). During the study period, 1002 live births (LBs) were recorded at the maternity hospital, resulting in an MNM ratio of 54.8/1000 LB. The MNM distribution by clinical condition identified hypertension in pregnancy (67.2%), hemorrhage (42.2%) and sepsis (12.7%). In the multivariate analysis, the factors significantly associated with an increased risk of MNM were fewer than six prenatal visits (OR: 3.13; 95% CI: 1.74-5.64) and cesarean section in the current pregnancy (OR: 2.91; 95% CI: 1.45-5.82).ConclusionsThe factors significantly associated with the occurrence of MNM were fewer than six prenatal visits and cesarean section in the current pregnancy. These findings highlight the need for improved quality, an increased number of prenatal visits and the identification of innovative and viable models of labor and delivery care that value normal delivery and decrease the percentage of unnecessary cesarean sections.
C1 [Barbosa de Lima, Telmo Henrique; Kassar, Samir Buainain] Hlth Sci Univ Alagoas UNCISAL, Rua Dr Mario Nunes Vieira,149 Apto 201, Maceio, AL, Brazil.
   [Amorim, Melania Maria] Prof Fernando Figueira Inst Integral Med IMIP, Dept Obstet & Gynecol, Recife, PE, Brazil.
   [Katz, Leila] Prof Fernando Figueira Inst Integral Med IMIP, Obstetr Intens Care Unit, IMIP, Recife, PE, Brazil.
RP de Lima, THB (corresponding author), Hlth Sci Univ Alagoas UNCISAL, Rua Dr Mario Nunes Vieira,149 Apto 201, Maceio, AL, Brazil.
EM telmol@yahoo.com
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917;
   Lima, Telmo/0000-0003-2177-3208
CR Akrawi Vian Sabri, 2017, Oman Med J, V32, P386, DOI 10.5001/omj.2017.74
   [Anonymous], 2017, INF SAUD CES
   [Anonymous], 2015, TRENDS MAT MORT 1990
   [Anonymous], 2016, IBGE CID
   Dias MAB, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00154213
   Blenkinsopp A, 1996, POLICY, V328, P1070
   de Souza MAC, 2015, REV BRAS GINECOL OBS, V37, P498, DOI 10.1590/SO100-720320150005286
   Chhabra Pragti, 2014, Indian J Community Med, V39, P132, DOI 10.4103/0970-0218.137145
   Pacheco AJC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-91
   Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0
   Esteves-Pereira AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153396
   Fernandes KG, 2017, ARCH GYNECOL OBSTET, V296, P1063, DOI 10.1007/s00404-017-4530-6
   Hirshberg A, 2017, SEMIN PERINATOL, V41, P332, DOI 10.1053/j.semperi.2017.07.007
   Jaccoud Luciana, 2002, DESIGUALDADES RACIAI
   Kasahun AW, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1903-1
   Galvao LPL, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-25
   Liyew EF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179013
   Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8
   Madeiro AP, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0648-3
   Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x
   Mekango DE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183886
   Ministerio da Saude, 2017, INF SAUD MORT MAT
   Mohammadi S, 2016, ACTA OBSTET GYN SCAN, V95, P777, DOI 10.1111/aogs.12881
   Morse Márcia Lait, 2011, Rev. bras. epidemiol., V14, P310, DOI 10.1590/S1415-790X2011000200012
   Nakimuli A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0811-5
   Nelissen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061248
   Oliveira Leonam Costa, 2015, Rev. bras. ter. intensiva, V27, P220, DOI 10.5935/0103-507X.20150033
   Organization WH, 2016, MAT MORT
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Pacagnella RC, 2012, REPROD HEALTH MATTER, V20, P155, DOI 10.1016/S0968-8080(12)39601-8
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Domingues RMSM, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0232-y
   THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7
   Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x
   Viellas EF, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00126013
   World Health Organization, 2011, EV QUAL CAR SEV PREG
NR 36
TC 0
Z9 2
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD AUG 1
PY 2019
VL 19
AR 271
DI 10.1186/s12884-019-2381-9
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IN4TE
UT WOS:000478668300004
PM 31370813
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Fernandes, KG
   Costa, ML
   Haddad, SM
   Parpinelli, MA
   Sousa, MH
   Cecatti, JG
   Pacagnella, RC
   Camargo, RS
   Zotareli, V
   Gurgel, LT
   Surita, FG
   Calderon, IM
   Goncalves, SP
   Moraes, OB
   Carvalho, SA
   Feitosa, FE
   Chaves, GN
   Brum, IR
   Saint'Ynes, GC
   AMenezes, C
   Santos, PN
   MGuanabara, E
   Almeida, EJ
   Moreira, JL
   Sousa, MR
   Peret, FA
   Paula, LB
   Schmaltz, LE
   Pessoni, C
   Katz, L
   Bione, A
   Lima, ACB
   Rocha, EA
   Amorim, MM
   Leite, DF
   Radaci, I
   Martins, MG
   Barroso, F
   Oliveira, FC
   Nascimento, DJ
   Paiva, CS
   Lima, MD
   Freire, DM
   Rohloff, RD
   Rodrigues, SM
   Costa, SM
   Pfitscher, LC
   Luz, AG
   Guimaraes, D
   Lobato, G
   Nakamura-Pereira, M
   Cordioli, E
   Peterossi, A
   Perez, CD
   Peracoli, JC
   Costa, RA
   Maia, NL
   PMatias, J
   Quintana, SM
   Moises, EC
   Lotufo, FA
   Carvalho, LE
   Andreucci, CB
   Zanette, EA
   Aquino, MM
   Ohnuma, MH
   Mattar, R
   Campanharo, FF
AF Fernandes, K. G.
   Costa, M. L.
   Haddad, S. M.
   Parpinelli, M. A.
   Sousa, M. H.
   Cecatti, J. G.
   Pacagnella, Rodolfo C.
   Camargo, Rodrigo S.
   Zotareli, Vilma
   Gurgel, Lucio T.
   Surita, Fernanda G.
   Calderon, Iracema M.
   Goncalves, Simone P.
   Moraes Filho, Olimpio B.
   Carvalho, Simone A.
   Feitosa, Francisco E.
   Chaves, George N.
   Brum, Ione R.
   Saint'Ynes, Gloria C.
   AMenezes, Carlos
   Santos, Patricia N.
   MGuanabara, Everardo
   Almeida, Elson J., Jr.
   Moreira, Joaquim L.
   Sousa, Maria R.
   Peret, Frederico A.
   Paula, Liv B.
   Schmaltz, Luiza E.
   Pessoni, Cleire
   Katz, Leila
   Bione, Adriana
   Lima, Antonio C. Barbosa
   Rocha Filho, Edilberto A.
   Amorim, Melania M.
   Leite, Debora F.
   Radaci, Ivelyne
   Martins, Marilia G.
   Barroso, Frederico
   Oliveira, Fernando C., Jr.
   Nascimento, Denis J.
   Paiva, Claudio S.
   Lima, Moises D.
   Freire, Djacyr M.
   Rohloff, Roger D.
   Rodrigues, Simone M.
   Costa, Sergio M.
   Pfitscher, Lucia C.
   Luz, Adriana G.
   Guimaraes, Daniela
   Lobato, Gustavo
   Nakamura-Pereira, Marcos
   Cordioli, Eduardo
   Peterossi, Alessandra
   Perez, Cynthia D.
   Peracoli, Jose C.
   Costa, Roberto A.
   Maia Filho, Nelson L.
   PMatias, Jacinta
   Quintana, Silvana M.
   Moises, Elaine C.
   Lotufo, Fatima A.
   Carvalho, Luiz E.
   Andreucci, Carla B.
   Zanette, Elvira A.
   Aquino, Marcia M.
   Ohnuma, Maria H.
   Mattar, Rosiane
   Campanharo, Felipe F.
CA Brazilian Network Surveillance
TI Skin Color and Severe Maternal Outcomes: Evidence from the Brazilian
   Network for Surveillance of Severe Maternal Morbidity
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID PREGNANCY-RELATED MORTALITY; HEALTH; DISPARITIES; POPULATION;
   PREVALENCE; MISS; CARE; AGE
AB Background. Taking into account the probable role that race/skin color may have for determining outcomes in maternal health, the objective of this study was to assess whether maternal race/skin color is a predictor of severe maternal morbidity. Methods. This is a secondary analysis of the Brazilian Network for Surveillance of Severe Maternal Morbidity, a national multicenter cross-sectional study of 27 Brazilian referral maternity hospitals. A prospective surveillance was performed to identify cases of maternal death (MD), maternal near miss (MNM) events, and potentially life-threatening conditions (PLTC), according to standard WHO definition and criteria. Among 9,555 women with severe maternal morbidity, data on race/skin color was available for 7,139 women, who were further divided into two groups: 4,108 nonwhite women (2,253 black and 1,855 from other races/skin color) and 3,031 white women. Indicators of severe maternal morbidity according to WHO definition are shown by skin color group. Adjusted Prevalence Ratios (PRadj - 95%CI) for Severe Maternal Outcome (SMO=MNM+MD) were estimated according to sociodemographic/obstetric characteristics, pregnancy outcomes, and perinatal results considering race. Results. Among 7,139 women with severe maternal morbidity evaluated, 90.5% were classified as PLTC, 8.5% as MNM, and 1.6% as MD. There was a significantly higher prevalence of MNM and MD among white women. MNMR (maternal near miss ratio) was 9.37 per thousand live births (LB). SMOR (severe maternal outcome ratio) was 11.08 per 1000 LB, and MMR (maternal mortality ratio) was 170.4 per 100,000 LB. Maternal mortality to maternal near miss ratio was 1 to 5.2, irrespective of maternal skin color. Hypertension, the main cause of maternal complications, affected mostly nonwhite women. Hemorrhage, the second more common cause of maternal complication, predominated among white women. Nonwhite skin color was associated with a reduced risk of SMO in multivariate analysis. Conclusion. Nonwhite skin color was associated with a lower risk for severe maternal outcomes. This result could be due to confounding factors linked to a high rate of Brazilian miscegenation.
C1 [Fernandes, K. G.; Costa, M. L.; Haddad, S. M.; Parpinelli, M. A.; Cecatti, J. G.] Univ Campinas UNICAMP, Sch Med, Dept Obstet & Gynaecol, Campinas, SP, Brazil.
   [Sousa, M. H.] Jundiai Sch Med, Jundiai, SP, Brazil.
   [Brazilian Network Surveillance] Univ Estadual Campinas, Obstetr Unit, Sch Med Sci, Coordinating Inst, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Campinas UNICAMP, Sch Med, Dept Obstet & Gynaecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Katz, Leila/M-5291-2013; Andreucci, Carla B/J-4845-2015; CORDIOLI,
   EDUARDO/AAR-6100-2020; Surita, Fernanda Garanhani/H-9575-2012; Polido,
   Carla Betina Andreucci/Y-9743-2019; Cecatti, Jose Guilherme/M-5945-2013;
   Calderon, Iracema/W-4336-2019; Nakamura-Pereira, Marcos/X-1107-2019;
   Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Andreucci, Carla B/0000-0002-5590-108X;
   CORDIOLI, EDUARDO/0000-0001-5405-9380; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Polido, Carla Betina
   Andreucci/0000-0002-5590-108X; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Calderon, Iracema/0000-0003-4761-4336;
   Nakamura-Pereira, Marcos/0000-0002-4231-0205; Amorim, Melania
   M/0000-0003-1047-2514
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5]
FX This study was funded by CNPq/DECIT (The National Research Council and
   the Department of Science and Technology of the Brazilian Ministry of
   Health), grant number 402702/2008-5. We would like to thank The
   Brazilian Network for the Surveillance of Severe Maternal Morbidity
   study group that also included Rodolfo C Pacagnella, Rodrigo S. Camargo,
   Vilma Zotareli, Lucio T. Gurgel, Fernanda G Surita, Iracema M Calderon,
   Simone P Goncalves, Olimpio B Moraes Filho, Simone A Carvalho, Francisco
   E Feitosa, George N Chaves, Ione R Brum, Gloria C Saint'Ynes, Carlos A
   Menezes, Patricia N Santos, Everardo M Guanabara, Elson J Almeida Jr,
   Joaquim L Moreira, Maria R Sousa, Frederico A Peret, Liv B Paula, Luiza
   E Schmaltz, Cleire Pessoni, Leila Katz, Adriana Bione, Antonio C Barbosa
   Lima, Edilberto A Rocha Filho, Melania M Amorim, Debora F Leite, Ivelyne
   Radaci, Marilia G Martins, Frederico Barroso, Fernando C Oliveira Jr,
   Denis J Nascimento, Claudio S Paiva, Moises D Lima, Djacyr M Freire,
   Roger D Rohloff, Simone M Rodrigues, Sergio M Costa, Lucia C Pfitscher,
   Adriana G Luz, Daniela Guimaraes, Gustavo Lobato, Marcos
   Nakamura-Pereira, Eduardo Cordioli, Alessandra Peterossi, Cynthia D
   Perez, Jose C Peracoli, Roberto A Costa, Nelson L Maia Filho, Jacinta P
   Matias, Silvana M Quintana, Elaine C Moises, Fatima A Lotufo, Luiz E
   Carvalho, Carla B Andreucci, Elvira A Zanette, Marcia M Aquino, Maria H
   Ohnuma, Rosiane Mattar, and Felipe F Campanharo.
CR Bowyer L, 2007, CONFIDENTIAL ENQUIRY, DOI [10.1258/om.2008.080017, DOI 10.1258/OM.2008.080017]
   BURT VL, 1995, HYPERTENSION, V25, P305, DOI 10.1161/01.HYP.25.3.305
   Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614
   Chang Jeani, 2003, MMWR Surveill Summ, V52, P1
   Chughtai B, 2016, AM J OBSTET GYNECOL, V215, P122, DOI 10.1016/j.ajog.2016.03.046
   Creanga AA, 2012, OBSTET GYNECOL, V120, P261, DOI 10.1097/AOG.0b013e31825cb87a
   DATASUS, 2017, MATERNAL MORTALITY R
   de Oliveira FC, 2013, CLINICS, V68, P922, DOI 10.6061/clinics/2013(07)06
   Ghosh G, 2014, ETHNIC DIS, V24, P283
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Howell EA, 2017, OBSTET GYNECOL, V129, P285, DOI 10.1097/AOG.0000000000001864
   Kirmayer LJ, 2016, LANCET, V388, P105, DOI 10.1016/S0140-6736(16)30194-5
   Knight M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b542
   Laopaiboon M, 2014, BJOG-INT J OBSTET GY, V121, P49, DOI 10.1111/1471-0528.12659
   Martins AL, 2016, SAUDE SOC-SAO PAULO, V25, P573, DOI 10.1590/S0104-129020162621
   Mbachu II, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1436-z
   Nair M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095086
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Pfitscher LC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1525-z
   Rowe RE, 2008, PUBLIC HEALTH, V122, P1363, DOI 10.1016/j.puhe.2008.05.011
   Santos RV, 2015, BIOSOCIETIES, V10, P48, DOI 10.1057/biosoc.2014.21
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Small MJ, 2017, SEMIN PERINATOL, V41, P318, DOI 10.1053/j.semperi.2017.04.009
   Souza J P, 2007, BMC Pregnancy Childbirth, V7, P20, DOI 10.1186/1471-2393-7-20
   Souza JP, 2010, B WORLD HEALTH ORGAN, V88, P113, DOI 10.2471/BLT.08.057828
   THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7
   Tucker MJ, 2007, AM J PUBLIC HEALTH, V97, P247, DOI 10.2105/AJPH.2005.072975
   van Roosmalen J, 2002, BJOG-INT J OBSTET GY, V109, P212, DOI 10.1016/S1470-0328(02)01025-X
   WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1
   WHO, 2016, WHO WHO MAT MORT
   Zwart JJ, 2008, BJOG-INT J OBSTET GY, V115, P842, DOI 10.1111/j.1471-0528.2008.01713.x
NR 31
TC 0
Z9 0
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PD JUL 30
PY 2019
VL 2019
AR 2594343
DI 10.1155/2019/2594343
PG 11
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA IS1NP
UT WOS:000481920400001
PM 31467877
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Souza, RT
   Cecatti, JG
   Passini, R
   Pacagnella, RC
   Oliveira, PF
   Silva, CM
   Tedesco, RP
   Lajos, GJ
   Nomura, ML
   Rehder, PM
   Dias, TZ
   Costa, ML
   Haddad, SM
   Marba, ST
   Guinsburg, R
   Martinez, FE
   Zotarelli, V
   Gurgel, LT
   Feitosa, FE
   Chaves, GN
   Porto, AM
   Coutinho, IC
   Lima, ACB
   Melo, EF
   Leite, DF
   Amorim, MM
   Melo, ASO
   Melo, FO
   Martins, MG
   Nunes, MV
   Paiva, CS
   Lima, MD
   Freire, DM
   Tristao, EG
   Nascimento, DJ
   Menezes, CA
   Aquino, M
   Vettorazzi, J
   Senger, CE
   Assumpcao, AMB
   Guedes, MAF
   Moreira, MEL
   Borges, VT
   Maia, NL
   Mathias, JP
   Souza, E
   Zamarian, ACP
   Quintana, SM
   Melli, PPS
   Lotufo, FA
   Uzilin, K
   Zanette, EA
   Andreucci, CB
   Oliveira, TA
   Oliveira, LR
   Santos, MAN
   Sass, N
   Silveira, MRF
   Coutinho, PR
   Siqueira, L
AF Souza, Renato T.
   Cecatti, Jose G.
   Passini Jr, Renato
   Pacagnella, Rodolfo C.
   Oliveira, Paulo F.
   Silva, Cleide M.
   Tedesco, Ricardo P.
   Lajos, Giuliane J.
   Nomura, Marcelo L.
   Rehder, Patricia M.
   Dias, Tabata Z.
   Costa, Maria L.
   Haddad, Samira M.
   Marba, Sergio T.
   Guinsburg, Ruth
   Martinez, Francisco E.
   Zotarelli, Vilma
   Gurgel, Lucio T.
   Feitosa, Francisco E.
   Chaves, George N.
   Porto, Ana M.
   Coutinho, Isabela C.
   Barbosa Lima, Antonio C.
   Melo Jr, Elias F.
   Leite, Debora F.
   Amorim, Melania M.
   Melo, Adriana S. O.
   Melo, Fabiana O.
   Martins, Marilia G.
   Nunes, Marynea, V
   Paiva, Claudio S.
   Lima, Moises D.
   Freire, Djacyr M.
   Tristao, Edson G.
   Nascimento, Denis J.
   Menezes, Carlos A.
   Aquino, Marcelo
   Vettorazzi, Janete
   Senger, Cintia E.
   Assumpcao, Augusta M. B.
   Guedes, Marcela A. F.
   Moreira, Maria E. L.
   Borges, Vera T.
   Maia Filho, Nelson L.
   Mathias, Jacinta P.
   Souza, Eduardo
   Zamarian, Ana C. P.
   Quintana, Silvana M.
   Melli, Patricia P. S.
   Lotufo, Fatima A.
   Uzilin, Kaliane
   Zanette, Elvira A.
   Andreucci, Carla B.
   Oliveira, Tenilson A.
   Oliveira, Laercio R.
   Santos, Marcos A. N.
   Sass, Nelson
   Silveira, Mirian R. F.
   Coutinho, Pedro R.
   Siqueira, Luciana
CA Brazilian Multictr Study Preterm B
TI Cluster analysis identifying clinical phenotypes of preterm birth and
   related maternal and neonatal outcomes from the Brazilian Multicentre
   Study on Preterm Birth
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Cluster; k-means; Maternal outcomes; Neonatal outcomes; Phenotypes;
   Preterm birth
ID ORGANIZATION MULTICOUNTRY SURVEY; ISCHEMIC PLACENTAL DISEASE; SECONDARY
   ANALYSIS; EPIDEMIOLOGY; PREDICTION
AB Objective To explore a conceptual framework of clinical conditions associated with preterm birth (PTB) by cluster analysis, assessing determinants for different PTB subtypes and related maternal and neonatal outcomes. Methods Secondary analysis of the Brazilian Multicentre Study on Preterm Birth of 33 740 births in 20 maternity hospitals between April 2011 and July 2012. In accordance with a prototype concept based on maternal, fetal, and placental conditions, an adapted k-means model and fuzzy algorithm were used to identify clusters using predefined conditions. The mains outcomes were phenotype clusters and maternal and neonatal outcomes. Results Among 4150 PTBs, three clusters of PTB phenotypes were identified: women who had PTB without any predefined conditions; women with mixed conditions; and women who had pre-eclampsia, eclampsia, HELLP syndrome and fetal growth restriction. The prevalence of different preterm subtypes differed significantly in the three clusters, varying from 80.95% of provider-initiated PTBs in cluster 3-6.62% in cluster 1 (P<0.001). Although some maternal characteristics differed among the clusters, maternal and neonatal outcomes did not. Conclusions The analysis identified three clusters with distinct phenotypes. Women from the different clusters had different subtypes of PTB and maternal and pregnancy characteristics.
C1 [Souza, Renato T.; Cecatti, Jose G.; Passini Jr, Renato; Pacagnella, Rodolfo C.] Univ Estadual Campinas, Dept Obstet & Gynaecol, UNICAMP, Sch Med, Campinas, SP, Brazil.
   [Oliveira, Paulo F.; Silva, Cleide M.] Univ Estadual Campinas, Unit Stat, UNICAMP, Sch Med Sci, Campinas, SP, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Dept Obstet & Gynecol, Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Souza, Renato Teixeira/G-4205-2017; feitosa, francisco e/H-8431-2014;
   Andreucci, Carla B/J-4845-2015; Polido, Carla Betina
   Andreucci/Y-9743-2019; Sass, Nelson/AAD-8259-2020; BORGES, VERA
   T/B-7363-2014; Melo, Adriana S O/H-5650-2016; Amorim, Melania
   M/C-5807-2013
OI Souza, Renato Teixeira/0000-0002-9075-9269; Andreucci, Carla
   B/0000-0002-5590-108X; Polido, Carla Betina
   Andreucci/0000-0002-5590-108X; Sass, Nelson/0000-0001-7187-1004; BORGES,
   VERA T/0000-0002-9347-9641; Amorim, Melania M/0000-0003-1047-2514
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP); Bill and Melinda Gates FoundationBill & Melinda Gates
   Foundation
FX CNPq; FAPESP; Bill and Melinda Gates Foundation
CR Ananth CV, 2011, EUR J OBSTET GYN R B, V159, P77, DOI 10.1016/j.ejogrb.2011.07.025
   Barros FC, 2015, JAMA PEDIATR, V169, P220, DOI 10.1001/jamapediatrics.2014.3040
   Bartsch E, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1753
   Beckmann JS, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0388-7
   Berghella V, 2017, ULTRASOUND OBST GYN, V49, P322, DOI 10.1002/uog.17388
   Brosens I, 2011, AM J OBSTET GYNECOL, V204, P193, DOI 10.1016/j.ajog.2010.08.009
   Di Renzo GC, 2009, J MATERN-FETAL NEO M, V22, P633, DOI 10.1080/14767050902866804
   Esplin MS, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.06.011
   Goldenberg RL, 2005, AM J OBSTET GYNECOL, V192, pS36, DOI 10.1016/j.ajog.2005.02.015
   Goldenberg RL, 2012, AM J OBSTET GYNECOL, V206, P113, DOI 10.1016/j.ajog.2011.10.865
   Honest H, 2012, CURR OPIN OBSTET GYN, V24, P422, DOI 10.1097/GCO.0b013e328359823a
   IOM (Institute of Medicine) NRC (National Research Council), 2009, WEIGHT GAIN PREGNANC
   Koullali B, 2016, SEMIN FETAL NEONAT M, V21, P80, DOI 10.1016/j.siny.2016.01.005
   Lajos G. J., 2015, SCI WORLD J, V2015, DOI DOI 10.1155/2015/719104
   Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P101, DOI 10.1111/1471-0528.12631
   Morisaki N, 2014, BJOG-INT J OBSTET GY, V121, P66, DOI 10.1111/1471-0528.12632
   Oyelade J, 2016, BIOINFORM BIOL INSIG, V10, P237, DOI 10.4137/BBI.S38316
   Parker SE, 2014, SEMIN PERINATOL, V38, P133, DOI 10.1053/j.semperi.2014.03.004
   Passini R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109069
   Passini R, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-22
   Peek N, 2014, Yearb Med Inform, V9, P42, DOI 10.15265/IY-2014-0018
   Souza RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148244
   Villar J, 2012, AM J OBSTET GYNECOL, V206, P119, DOI 10.1016/j.ajog.2011.10.866
   Wang LP, 2016, METHODS, V111, P21, DOI 10.1016/j.ymeth.2016.08.014
NR 24
TC 2
Z9 2
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD JUL
PY 2019
VL 146
IS 1
BP 110
EP 117
DI 10.1002/ijgo.12839
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IK7IE
UT WOS:000476761900018
PM 31055833
OA Other Gold
DA 2020-12-01
ER

PT J
AU Amorim, M
   Mariz, R
   Macedo, L
   Neto, AHF
   Vasconcelos, D
   Katz, L
AF Amorim, Melania
   Mariz, Raiana
   Macedo, Lorena
   Franca Neto, Antonio Henriques
   Vasconcelos, Danilo
   Katz, Leila
TI Electromyographic Response of the Pelvic Floor Muscles in Female Sex
   Workers
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 03-06, 2019
CL Nashville, TN
SP Amer Coll Obstetricians & Gynecologists
C1 [Amorim, Melania] Inst Med Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2019
VL 133
SU 1
MA 23I
BP 101S
EP 101S
DI 10.1097/01.AOG.0000558800.63950.ea
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IG4YM
UT WOS:000473810000349
DA 2020-12-01
ER

PT J
AU Neto, AHF
   Amorim, M
   Marinho, AM
AF Franca Neto, Antonio Henriques
   Amorim, Melania
   Marinho, Alexandre M.
TI Does Amitriptyline Work as Preemptive Analgesia in Abdominal
   Hysterectomies?
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 03-06, 2019
CL Nashville, TN
SP Amer Coll Obstetricians & Gynecologists
C1 [Franca Neto, Antonio Henriques] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2019
VL 133
SU 1
MA 6J
BP 107S
EP 108S
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IG4YM
UT WOS:000473810000371
DA 2020-12-01
ER

PT J
AU Amorim, M
   Brandao, D
   Meneses, J
   Portela, N
   Neto, AHF
   Porto, AM
AF Amorim, Melania
   Brandao, Danielle
   Meneses, Jucille
   Portela, Nara
   Franca Neto, Antonio Henriques
   Porto, Ana Maria
TI Does the Use of Antenatal Corticosteroids Decrease Levels of Neonatal
   Hyperbilirubinemia in Preterm Infants?
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 03-06, 2019
CL Nashville, TN
SP Amer Coll Obstetricians & Gynecologists
C1 [Amorim, Melania] Inst Med Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2019
VL 133
SU 1
MA 15K
BP 121S
EP 121S
DI 10.1097/01.AOG/01.AOG.0000559209.10664.de
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IG4YM
UT WOS:000473810000416
DA 2020-12-01
ER

PT J
AU Lima, T
   Katz, L
   Kassar, S
   Amorim, M
AF Lima, Telmo
   Katz, Leila
   Kassar, Samir
   Amorim, Melania
TI Maternal Near Miss Determinants at a High-Risk Maternity Hospital in
   Northeastern Brazil: A Prospective Study
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 03-06, 2019
CL Nashville, TN
SP Amer Coll Obstetricians & Gynecologists
C1 [Lima, Telmo] UNCISAL, Maceio, Alagoas, Brazil.
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2019
VL 133
SU 1
MA 26N
BP 157S
EP 157S
DI 10.1097/01.AOG.0000559332.88273.de
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IG4YM
UT WOS:000473810000536
DA 2020-12-01
ER

PT J
AU Guendler, J
   Katz, L
   Flamini, ME
   Lemos, A
   Amorim, M
AF Guendler, Julianna
   Katz, Leila
   Flamini, Maria Eduarda
   Lemos, Andrea
   Amorim, Melania
TI Prevalence of Sexual Dysfunctions and Orientations on Sexuality in
   Postpartum Women: Cross-Sectional Study
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 03-06, 2019
CL Nashville, TN
SP Amer Coll Obstetricians & Gynecologists
C1 [Guendler, Julianna] FPS, Recife, PE, Brazil.
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
NR 0
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2019
VL 133
SU 1
MA 4T
BP 213S
EP 214S
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA IG4YM
UT WOS:000473810000737
DA 2020-12-01
ER

PT J
AU Monteiro, TM
   Katz, L
   Bento, SF
   Amorim, MM
   Moriel, PC
   Pacagnella, RC
AF Monteiro, Thais M.
   Katz, Leila
   Bento, Silvana F.
   Amorim, Melania M.
   Moriel, Patricia C.
   Pacagnella, Rodolfo C.
TI Reasons given by pregnant women for participating in a clinical trial
   aimed at preventing premature delivery: a qualitative analysis
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Pregnancy; Premature delivery; Clinical trial
ID DECISIONS; SATISFACTION
AB Background: In clinical trials, pregnant women are potentially vulnerable, and the fetus is exposed to the intervention. This study aimed to identify the reasons that led pregnant women at a high risk of premature delivery to participate in a randomized clinical trial.
   Methods: The women participating in the main trial were contacted by telephone postpartum and invited to answer an open questionnaire in a cross-sectional study. Data were collected by telephone and analyzed using thematic analysis. After the analysis categories were defined, all the answers were reviewed, categorized and grouped. A descriptive summary of the content of each category was then made.
   Results: Overall, 208 women from different geographical regions of the country agreed to participate. Four categories were identified: 1) The risk of losing the baby; 2) A previous experience of premature delivery; 3) The role of the doctor and other health professionals, and 4) The availability of quality medical care and free medication. The main reason given for agreeing to participate was to reduce the risks associated with the baby being born prematurely, particularly when the woman herself or someone close to her had already experienced premature delivery. Other reasons were having received clear guidance and explanations from the doctor regarding prematurity and about the study and being given the opportunity to receive free treatment with greater access to the public healthcare system.
   Conclusions: The decision to participate in a clinical trial is not easy, particularly when the individual is vulnerable and in a critical situation as in the case of a pregnant woman at a high risk of delivering prematurely. Fears and uncertainties regarding the pregnancy outcome, as well as the woman's previous experiences and her awareness of the actual risks she faces will affect her decision regarding whether or not to participate. Recruitment challenges could be overcome by ensuring that the research team provides adequate information and support, thus creating a bond with participants that would foster a sense of safety and trust in the study proposals.
C1 [Monteiro, Thais M.; Katz, Leila; Amorim, Melania M.; Moriel, Patricia C.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
   [Bento, Silvana F.] Univ Campinas UNICAMP, Prof Dr Jose A Pinotti Womens Hosp, Ctr Integral Serv Hlth Women CAISM, Campinas, SP, Brazil.
   [Pacagnella, Rodolfo C.] Univ Campinas UNICAMP, Sch Med Sci, Campinas, SP, Brazil.
RP Katz, L (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
EM thaisvaleriasilva@gmail.com; katzleila@gmail.com
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013; de Carvalho
   Pacagnella, Rodolfo/H-9390-2019; Silva, Thais Valeria/AAL-6949-2020
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917;
   de Carvalho Pacagnella, Rodolfo/0000-0002-5739-0009; Silva, Thais
   Valeria/0000-0002-8718-5372
FU Brazilian Ministry of Health; Brazilian National Council for Scientific
   and Technological Development (CNPq)National Council for Scientific and
   Technological Development (CNPq); Bill and Melinda Gates FoundationBill
   & Melinda Gates Foundation
FX The Brazilian Ministry of Health, the Brazilian National Council for
   Scientific and Technological Development (CNPq) and the Bill and Melinda
   Gates Foundation provided financial support for this study. The funding
   sources had no role in the design or development of the study, in the
   analysis or interpretation of the data, or in the writing of the
   manuscript.
CR Andrade SE, 2004, AM J OBSTET GYNECOL, V191, P398, DOI 10.1016/j.ajog.2004.04.025
   [Anonymous], 2004, ETH OBST GYN
   Donovan J, 2002, BMJ-BRIT MED J, V325, P766, DOI 10.1136/bmj.325.7367.766
   Ghorbani Maryam, 2014, Glob J Health Sci, V6, P65, DOI 10.5539/gjhs.v6n3p65
   Harrison MJ, 2003, BIRTH-ISS PERINAT C, V30, P109, DOI 10.1046/j.1523-536X.2003.00229.x
   Hundley V, 2004, MIDWIFERY, V20, P27, DOI 10.1016/S0266-6138(03)00050-0
   Kenyon S, 2006, QUAL SAF HEALTH CARE, V15, P98, DOI 10.1136/qshc.2005.015636
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Kurt A, 2017, WEST J EMERG MED, V18, P846, DOI 10.5811/westjem.2017.5.33827
   Lawton J, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1323-3
   Lyerly Anne Drapkin, 2008, Int J Fem Approaches Bioeth, V1, P5, DOI 10.2979/FAB.2008.1.2.5
   Matsui D, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/796590
   McKinstry B, 2006, FAM PRACT, V23, P240, DOI 10.1093/fampra/cmi111
   MERKATZ RB, 1993, NEW ENGL J MED, V329, P292, DOI 10.1056/NEJM199307223290429
   Meshaka R, 2017, HEALTH EXPECT, V20, P188, DOI 10.1111/hex.12446
   Mills N, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-323
   Mohanna K, 1999, BRIT J OBSTET GYNAEC, V106, P892, DOI 10.1111/j.1471-0528.1999.tb08426.x
   Myles S, 2018, J WOMENS HEALTH, V27, P258, DOI 10.1089/jwh.2017.6458
   Patton M., 1990, QUALITATIVE EVALUATI
   Pinnow E, 2009, WOMEN HEALTH ISS, V19, P89, DOI 10.1016/j.whi.2008.09.009
   Rengerink KO, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0641-x
   Rodger MA, 2003, AM J PERINAT, V20, P69, DOI 10.1055/s-2003-38318
   Smyth RMD, 2012, MIDWIFERY, V28, pE538, DOI 10.1016/j.midw.2011.08.006
   Strommer S, 2018, SOC SCI MED, V200, P73, DOI 10.1016/j.socscimed.2018.01.014
   Thornton Hazel, 2003, Health Expect, V6, P189, DOI 10.1046/j.1369-6513.2003.00231.x
   Wada K, 2018, QUAL HEALTH RES, V28, P2033, DOI 10.1177/1049732318773724
   Warlow C, 2003, BRIT MED J, V327, P240, DOI 10.1136/bmj.327.7409.240
   Wragg JA, 2000, SOC SCI MED, V51, P453, DOI 10.1016/S0277-9536(99)00477-3
NR 28
TC 1
Z9 1
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD MAR 20
PY 2019
VL 19
AR 97
DI 10.1186/s12884-019-2240-8
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HQ2PH
UT WOS:000462243500001
PM 30894167
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Zanardi, DM
   Parpinelli, MA
   Haddad, SM
   Costa, ML
   Sousa, MH
   Leite, DFB
   Cecatti, JG
   Pacagnella, RC
   Camargo, RS
   Santana, DS
   Zotareli, V
   Gurgel, LT
   Surita, FG
   Silva, JLP
   Amaral, EM
   Say, L
   Pattinson, RC
   Rudge, MV
   Calderon, IM
   Bahamondes, MV
   Goncalves, SP
   Moraes, OB
   Carvalho, SA
   Feitosa, FE
   Chaves, GN
   Brum, IR
   Saint'Ynes, GC
   Menezes, CA
   Santos, PN
   Guanabara, EM
   Almeida, EJ
   Moreira, JL
   Sousa, MR
   Peret, FA
   Paula, LB
   Schmaltz, LE
   Pessoni, C
   Katz, L
   Bione, A
   Lima, ACB
   Filho, EAR
   Amorim, MM
   Radaci, I
   Martins, MG
   Barroso, F
   Oliveira, FC
   Nascimento, DJ
   Paiva, CS
   Lima, MD
   Freire, DM
   Rohloff, RD
   Rodrigues, SM
   Costa, SM
   Pfitscher, LC
   Luz, AG
   Guimaraes, DI
   Lobato, G
   Nakamura-Pereira, M
   Cordioli, E
   Peterossi, A
   Perez, CD
   Peracoli, JC
   Costa, RA
   Maia, NL
   Matias, JP
   Quintana, SM
   Moises, EC
   Lotufo, FA
   Carvalho, LE
   Andreucci, CB
   Zanette, EA
   Aquino, MM
   Ohnuma, MH
   Mattar, R
   Campanharo, FF
AF Zanardi, Dulce M.
   Parpinelli, Mary A.
   Haddad, Samira M.
   Costa, Maria L.
   Sousa, Maria H.
   Leite, Debora F. B.
   Cecatti, Jose G.
   Pacagnella, Rodolfo C.
   Camargo, Rodrigo S.
   Santana, Daniely S.
   Zotareli, Vilma
   Gurgel, Lucio T.
   Surita, Fernanda G.
   Pinto e Silva, Joao L.
   Amaral, Eliana M.
   Say, Lale
   Pattinson, Robert C.
   Rudge, Marilza V.
   Calderon, Iracema M.
   Bahamondes, Maria V.
   Goncalves, Simone P.
   Moraes Filho, Olimpio B.
   Carvalho, Simone A.
   Feitosa, Francisco E.
   Chaves, George N.
   Brum, Ione R.
   Saint'Ynes, Gloria C.
   Menezes, Carlos A.
   Santos, Patricia N.
   Guanabara, Everardo M.
   Almeida, Elson J., Jr.
   Moreira, Joaquim L.
   Sousa, Maria R.
   Peret, Frederico A.
   Paula, Liv B.
   Schmaltz, Luiza E.
   Pessoni, Cleire
   Katz, Leila
   Bione, Adriana
   Barbosa Lima, Antonio C.
   Rocha Filho, Edilberto A.
   Amorim, Melania M.
   Radaci, Ivelyne
   Martins, Marilia G.
   Barroso, Frederico
   Oliveira, Fernando C., Jr.
   Nascimento, Denis J.
   Paiva, Claudio S.
   Lima, Moises D.
   Freire, Djacyr M.
   Rohloff, Roger D.
   Rodrigues, Simone M.
   Costa, Sergio M.
   Pfitscher, Lucia C.
   Luz, Adriana G.
   Guimaraes, Dan-Iela
   Lobato, Gustavo
   Nakamura-Pereira, Marcos
   Cordioli, Eduardo
   Peterossi, Alessandra
   Perez, Cynthia D.
   Peracoli, Jose C.
   Costa, Roberto A.
   Maia Filho, Nelson L.
   Matias, Jacinta P.
   Quintana, Silvana M.
   Moises, Elaine C.
   Lotufo, Fatima A.
   Carvalho, Luiz E.
   Andreucci, Carla B.
   Zanette, Elvira A.
   Aquino, Marcia M.
   Ohnuma, Maria H.
   Mattar, Rosiane
   Campanharo, Felipe F.
CA Brazilian Network Surveillance Se
TI Adverse perinatal outcomes are associated with severe maternal morbidity
   and mortality: evidence from a national multicentre cross-sectional
   study
SO ARCHIVES OF GYNECOLOGY AND OBSTETRICS
LA English
DT Article
DE Perinatal morbidity; Perinatal mortality; Severe maternal morbidity;
   Maternal near miss; Maternal mortality; Apgar score
ID HEALTH; COMPLICATIONS; SURVEILLANCE; PREGNANCY; NETWORK; BRAZIL
AB PurposeTo assess the association between maternal potentially life-threatening conditions(PLTC), maternal near miss (MNM), and maternal death (MD) with perinatal outcomes.MethodsCross-sectional study in 27 Brazilian referral centers from July, 2009 to June, 2010. All women presenting any criteria for PLTC and MNM, or MD, were included. Sociodemographic and obstetric characteristics were evaluated in each group of maternal outcomes. Childbirth and maternal morbidity data were related to perinatal adverse outcomes (5th min Apgar score<7, fetal death, neonatal death, or any of these). The Chi-squared test evaluated the differences between groups. Multiple regression analysis adjusted for the clustering design effect identified the independently associated maternal factors with the adverse perinatal outcomes (prevalence ratios; 95% confidence interval).ResultsAmong 8271 cases of severe maternal morbidity, there were 714 cases of adverse perinatal outcomes. Advanced maternal age, low level of schooling, multiparity, lack of prenatal care, delays in care, preterm birth, and adverse perinatal outcomes were more common among MNM and MD. Both MNM and MD were associated with Apgar score (2.39; 1.68-3.39); maternal hemorrhage was the most prevalent characteristic associated with fetal death (2.9, 95% CI 1.81-4.66) and anyadverseperinatal outcome (2.16; 1.59-2.94); while clinical/surgical conditions were more related to neonatal death (1.56; 1.08-2.25).ConclusionWe confirmed the association between MNM and MD with adverse perinatal outcomes. Maternal and perinatal issues should not be dissociated. Policies aiming maternal care should include social and economic development, and improvements in accessibility to specialized care. These, in turn, will definitively impact on childhood mortality rates.
C1 [Zanardi, Dulce M.; Parpinelli, Mary A.; Haddad, Samira M.; Costa, Maria L.; Leite, Debora F. B.; Cecatti, Jose G.] Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13083891 Campinas, SP, Brazil.
   [Sousa, Maria H.] Jundiai Med Sch, Dept Publ Hlth, Jundiai, SP, Brazil.
   [Leite, Debora F. B.] Univ Fed Pernambuco, Dept Life Sci, Caruaru, PE, Brazil.
RP Cecatti, JG (corresponding author), Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13083891 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Amorim, Melania M/C-5807-2013; Moises, Elaine Christine
   Dantas/N-9522-2019; Surita, Fernanda Garanhani/H-9575-2012; Leite,
   Debora F B/D-7299-2018; Calderon, Iracema/W-4336-2019; Andreucci, Carla
   B/J-4845-2015; Cordioli, Eduardo/X-1934-2019; Polido, Carla Betina
   Andreucci/Y-9743-2019; feitosa, francisco e/H-8431-2014; de Carvalho
   Pacagnella, Rodolfo/H-9390-2019; Cecatti, Jose Guilherme/M-5945-2013;
   Katz, Leila/M-5291-2013; CORDIOLI, EDUARDO/AAR-6100-2020;
   Nakamura-Pereira, Marcos/X-1107-2019
OI Amorim, Melania M/0000-0003-1047-2514; Moises, Elaine Christine
   Dantas/0000-0001-9099-4544; Surita, Fernanda
   Garanhani/0000-0003-4335-0337; Leite, Debora F B/0000-0001-8839-3934;
   Calderon, Iracema/0000-0003-4761-4336; Andreucci, Carla
   B/0000-0002-5590-108X; Polido, Carla Betina
   Andreucci/0000-0002-5590-108X; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; Katz, Leila/0000-0001-9854-7917;
   CORDIOLI, EDUARDO/0000-0001-5405-9380; Nakamura-Pereira,
   Marcos/0000-0002-4231-0205; Zanardi, Dulce/0000-0002-2993-8460
FU National Research Council (CNPq), through the Department of Science and
   Technology of the Brazilian Ministry of Health (DECIT) [402702/2008-5]
FX We would like to thank our sponsors, the National Research Council
   (CNPq), through the Department of Science and Technology of the
   Brazilian Ministry of Health (DECIT); Grant number 402702/2008-5. We are
   also grateful to all the researchers from the Brazilian Network for the
   Surveillance of Severe Maternal Morbidity Group: Rodolfo C. Pacagnella,
   Rodrigo S. Camargo, Daniely S. Santana, Vilma Zotareli, Lucio T. Gurgel,
   Fernanda G. Surita, Joao L. Pinto e Silva, Eliana M. Amaral, Lale Say,
   Robert C. Pattinson, Marilza V. Rudge, Iracema M. Calderon, Maria V.
   Bahamondes, Simone P. Goncalves, Olimpio B. Moraes Filho, Simone A.
   Carvalho, Francisco E. Feitosa, George N. Chaves, Ione R. Brum, Gloria
   C. Saint'Ynes, Carlos A. Menezes, Patricia N. Santos, Everardo M.
   Guanabara, Elson J. Almeida Jr., Joaquim L. Moreira, Maria R. Sousa,
   Frederico A. Peret, Liv B. Paula, Luiza E. Schmaltz, Cleire Pessoni,
   Leila Katz, Adriana Bione, Antonio C. Barbosa Lima, Edilberto A. Rocha
   Filho, Melania M. Amorim, Ivelyne Radaci, Marilia G. Martins, Frederico
   Barroso, Fernando C. Oliveira Jr., Denis J. Nascimento, Claudio S.
   Paiva, Moises D. Lima, Djacyr M. Freire, Roger D. Rohloff, Simone M.
   Rodrigues, Sergio M. Costa, Lucia C. Pfitscher, Adriana G. Luz, Daniela
   Guimaraes, Gustavo Lobato, Marcos Nakamura-Pereira, Eduardo Cordioli,
   Alessandra Peterossi, Cynthia D. Perez, Jose C. Peracoli, Roberto A.
   Costa, Nelson L. Maia Filho, Jacinta P. Matias, Silvana M. Quintana,
   Elaine C. Moises, Fatima A. Lotufo, Luiz E. Carvalho, Carla B.
   Andreucci, Elvira A. Zanette, Marcia M. Aquino, Maria H. Ohnuma, Rosiane
   Mattar, and Felipe F. Campanharo.
CR Allanson ER, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0472-9
   Anggondowati T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1280-1
   [Anonymous], 2015, MILL DEV GOALS REP 2
   Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   De Mucio B, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0250-9
   Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630
   Guanais FC, 2015, AM J PUBLIC HEALTH, V105, pS593, DOI 10.2105/AJPH.2013.301452r
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Hughes MM, 2017, MATERN CHILD HLTH J, V21, P283, DOI 10.1007/s10995-016-2131-9
   Kale PL, 2017, CAD SAUDE PUBLICA, V33, DOI [10.1590/0102-311X00179115, 10.1590/0102-311x00179115]
   Kassebaum NJ, 2014, LANCET, V384, P980, DOI 10.1016/S0140-6736(14)60696-6
   Kone S, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1858-2
   Lawn JE, 2012, HEALTH POLICY PLANN, V27, P6, DOI 10.1093/heapol/czs053
   Lazzerini M, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019787
   Madeiro AP, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0648-3
   Nakimuli A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0362-3
   Oladapo OT, 2016, BJOG-INT J OBSTET GY, V123, P928, DOI 10.1111/1471-0528.13450
   Pacagnella RC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-159
   Duarte CMR, 2007, CAD SAUDE PUBLICA, V23, P1511, DOI 10.1590/S0102-311X2007000700002
   Santana DS, 2017, INT J GYNECOL OBSTET, V139, P230, DOI 10.1002/ijgo.12287
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Serruya SJ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8271042
   Domingues RMSM, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0232-y
   Soma-Pillay P, 2015, SAMJ, S. Afr. med. j., V105, P578, DOI [10.7196/SAMJnew.8038, 10.7196/SAMJNEW.8038]
   Souza JP, 2016, BJOG-INT J OBSTET GY, V123, P427, DOI 10.1111/1471-0528.13509
   Souza JP, 2014, BJOG-INT J OBSTET GY, V121, P1, DOI 10.1111/1471-0528.12735
   Souza J P, 2007, BMC Pregnancy Childbirth, V7, P20, DOI 10.1186/1471-2393-7-20
   Souza JP, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-61
   Tuncalp O, 2014, BJOG-INT J OBSTET GY, V121, P57, DOI 10.1111/1471-0528.12634
   Victora CG, 2011, LANCET, V377, P2042, DOI 10.1016/S0140-6736(11)60055-X
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Vogel JP, 2014, BJOG-INT J OBSTET GY, V121, P76, DOI 10.1111/1471-0528.12633
   von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.1016/j.jclinepi.2007.11.008
   Webbe James, 2017, BMJ Paediatr Open, V1, pe000048, DOI 10.1136/bmjpo-2017-000048
   WHO, 2015, MAT MORT
   WHO UNICEF UNFPA World Bank Group & United Nations Population Division, 2015, TRENDS MAT MORT 1990
   Yoshida S, 2014, LANCET, V384, pE27, DOI 10.1016/S0140-6736(14)60263-4
   2013, WORLD MAL REP 2013, P1
NR 39
TC 4
Z9 4
U1 1
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0932-0067
EI 1432-0711
J9 ARCH GYNECOL OBSTET
JI Arch. Gynecol. Obstet.
PD MAR
PY 2019
VL 299
IS 3
BP 645
EP 654
DI 10.1007/s00404-018-5004-1
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA HM8VJ
UT WOS:000459760600005
PM 30539385
DA 2020-12-01
ER

PT J
AU Abib, S
   Duarte, A
   Souza, F
   Macedo, C
   Amorim, M
   Azevedo, R
   Lederman, H
   Alves, MT
AF Abib, S.
   Duarte, A.
   Souza, F.
   Macedo, C.
   Amorim, M.
   Azevedo, R.
   Lederman, H.
   Alves, M. T.
TI Primary Liver Germ Cell Tumor: A Rare Entity
SO PEDIATRIC BLOOD & CANCER
LA English
DT Meeting Abstract
C1 [Abib, S.; Duarte, A.; Souza, F.; Amorim, M.] Univ Fed Sao Paulo, Pediat Oncol Inst, GRAACC, Pediat Surg, Sao Paulo, Brazil.
   [Macedo, C.] Univ Fed Sao Paulo, Pediat Oncol Inst, GRAACC, Pediat Oncol, Sao Paulo, Brazil.
   [Azevedo, R.] Univ Fed Sao Paulo, Pediat Gastroenterol, Sao Paulo, Brazil.
   [Lederman, H.] Univ Fed Sao Paulo, Pediat Oncol Inst, GRAACC, Radiol, Sao Paulo, Brazil.
   [Alves, M. T.] Univ Fed Sao Paulo, Pediat Oncol Inst, GRAACC, Pathol, Sao Paulo, Brazil.
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1545-5009
EI 1545-5017
J9 PEDIATR BLOOD CANCER
JI Pediatr. Blood Cancer
PD NOV
PY 2018
VL 65
SU 2
MA PO-091
BP S463
EP S464
PG 2
WC Oncology; Hematology; Pediatrics
SC Oncology; Hematology; Pediatrics
GA GU3QT
UT WOS:000445195004055
DA 2020-12-01
ER

PT J
AU de Lima, THB
   Katz, L
   Kassar, SB
   Amorim, MM
AF Barbosa de Lima, Telmo Henrique
   Katz, Leila
   Kassar, Samir Buainain
   Amorim, Melania Maria
TI Neonatal near miss determinants at a maternity hospital for high-risk
   pregnancy in Northeastern Brazil: a prospective study
SO BMC PREGNANCY AND CHILDBIRTH
LA English
DT Article
DE Neonatal near miss; Neonatal mortality; Fetal death; Maternal near miss
ID INADEQUATE PRENATAL-CARE; CRITERIA; SYSTEM; MORTALITY; DEATHS
AB Background: To investigate the associations of maternal variables - sociodemographic, obstetrical and maternal near miss (MNM) variables - with neonatal near miss (NNM) using the new concept of NNM formulated by the Centro Latino-Americano de Perinatologia (CLAP) and the corresponding health indicators for NNM.
   Methods: An analytical prospective cohort study was performed at maternity hospital for high-risk pregnancy in Northeastern Brazil. Puerperal women whose newborn infants met the selection criteria were subjected to interviews involving pretested questionnaires.
   Statistical analysis was performed with the Epi Info 3.5.1 program using the Chi square test and Fisher's exact test when appropriate, with a level of significance of 5%. A bivariate analysis was performed to evaluate differences between the groups. All the variables evaluated in the bivariate analysis were subsequently included in the multivariate analysis. For stepwise logistic regression analysis, a hierarchical model was plotted to assess variable responses and adverse outcomes associated with MNM and NNM variables.
   Results: There were 1002 live births (LB) from June 2015 through May 2016, corresponding to 723 newborn infants (72.2%) without any neonatal adverse outcomes, 221 (22%) NNM cases, 44 (4.4%) early neonatal deaths and 14 (1.4%) late neonatal deaths. The incidence of NNM was 220/1000 LB. Following multivariate analysis, the factors that remained significantly associated with increased risk of NNM were fewer than 6 prenatal care visits (odds ratio (OR): 3.57; 95% confidence interval (CI): 2.57-4.94) and fetal malformations (OR: 8.78; 95% CI: 3.69-20.90). Maternal age older than 35 years (OR: 0.43; 95% CI: 0.23-0.83) and previous cesarean section (OR: 0.45; 95% CI: 0.29-0.68) protected against NNM.
   Conclusion: Based on the large differences between the NNM and neonatal mortality rates found in the present study and the fact that NNM seems to be a preventable precursor of neonatal death, we suggest that all cases of NNM should be audited. Inadequate prenatal care and fetal malformations increased the risk of NNM, while older maternal age and a history of a previous cesarean section were protective factors.
C1 [Barbosa de Lima, Telmo Henrique; Kassar, Samir Buainain] Univ Alagoas UNCISAL, Hlth Sci, Maceio, Brazil.
   [Barbosa de Lima, Telmo Henrique] Fed Univ Sao Paulo UNIFESP, Hlth Sci, Sao Paulo, Brazil.
   [Katz, Leila; Amorim, Melania Maria] Inst Materno Infantil Pernambuco, Postgrad Program, Fernando Figueira Inst Integral Med IMIP, Obstetr Intens Care Unit, Recife, PE, Brazil.
   [Amorim, Melania Maria] Univ Fed Campina Grande, Campina Grande, Brazil.
   [Barbosa de Lima, Telmo Henrique] Maternidade Santa Monica, Maceio, Brazil.
RP de Lima, THB (corresponding author), Univ Alagoas UNCISAL, Hlth Sci, Maceio, Brazil.; de Lima, THB (corresponding author), Fed Univ Sao Paulo UNIFESP, Hlth Sci, Sao Paulo, Brazil.
EM thbl@uol.com.br
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
CR Anggondowati T, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1280-1
   Avenant T, 2009, BEST PRACT RES CL OB, V23, P369, DOI 10.1016/j.bpobgyn.2008.12.005
   Brasil Ministerio da Saude, 2016, RED MORT PER
   Lansky S, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00133213
   Morcillo André Moreno, 2010, Rev. paul. pediatr., V28, P269, DOI 10.1590/S0103-05822010000300003
   da Silva AAM, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00129613
   Nair M, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007434
   Nardello DM, 2017, REV BRAS ENFERM, V70, P98, DOI 10.1590/0034-7167-2016-0405
   Nunes Juliana Teixeira, 2016, Cad. saúde colet., V24, P252, DOI 10.1590/1414-462X201600020171
   Oliveira LC, 2013, REV ASSOC MED BRAS, V59, P487, DOI [10.1016/j.ramb.2013.08.004, 10.1016/S2255-4823(13)70508-3]
   Partridge S, 2012, AM J PERINAT, V29, P787, DOI 10.1055/s-0032-1316439
   Pedrosa LDCO, 2007, CAD SAUDE PUBLICA, V23, P2385, DOI 10.1590/S0102-311X2007001000013
   Pileggi C, 2010, J PEDIAT-BRAZIL, V86, P21, DOI 10.2223/JPED.1965
   Pileggi-Castro C, 2014, BJOG-INT J OBSTET GY, V121, P110, DOI 10.1111/1471-0528.12637
   Saavedra JS, 2015, CAD SAUDE PUBLICA, V31, P1003, DOI 10.1590/0201-311X00085014
   Santos JP, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0758-y
   Santos JP, 2015, CLINICS, V70, P820, DOI 10.6061/clinics/2015(12)10
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Domingues RMSM, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0232-y
   Domingues RMSM, 2012, CAD SAUDE PUBLICA, V28, P425, DOI 10.1590/S0102-311X2012000300003
   Takagi MM, 2010, ARQ MED HOSP FAC CIE, V55, P108
   Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x
   Ugwumadu A, 2005, PLOS MED, V2, P837, DOI 10.1371/journal.pmed.0020305
   Viellas EF, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00126013
   World Health Organization, 2015, MAT MORT
NR 25
TC 6
Z9 8
U1 0
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2393
J9 BMC PREGNANCY CHILDB
JI BMC Pregnancy Childbirth
PD OCT 12
PY 2018
VL 18
AR 401
DI 10.1186/s12884-018-2020-x
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GY2MQ
UT WOS:000448377500001
PM 30314456
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Pordeus, ACB
   Katz, L
   Soares, MC
   Maia, SB
   Amorim, MMR
AF Pordeus, Ana Carolina B.
   Katz, Leila
   Soares, Mariana C.
   Maia, Sabina B.
   Amorim, Melania M. R.
TI Acute pulmonary edema in an obstetric intensive care unit A case series
   study
SO MEDICINE
LA English
DT Article
DE complications of pregnancy; echocardiography; intensive care unit;
   obstetrics; pulmonary edema
ID MAGNESIUM-SULFATE; NEAR-MISS; PREGNANCY; PREECLAMPSIA; COMPLICATIONS;
   GUIDELINES; DELIVERY; WOMEN; RISK
AB Acute pulmonary edema (PE) affects 0.08% to 1.5% of women during pregnancy and in the postpartum. At the Instituto de Medicina Integral Prof. Fernando Figueira (IMIP), acute PE accounts for 1.5% of admissions to the obstetric intensive care unit (ICU) and occurs in 9.3% of the patients admitted with near miss criteria. This study was conducted to describe the clinical/epidemiological profile of patients with acute PE in IMIP's obstetric ICU.
   A case series of 50 patients with acute PE in an obstetric ICU in northeastern Brazil between August 2012 and March 2015. Frequency distribution and measures of central tendency/dispersion were calculated using Epi Info, version 7.1.5.
   The mean age of the women was 27.2 years; 60% were from Recife; 50% had 8 to 11 years of schooling; 54.0% were primigravidas. Acute PE occurred antepartum (58%), postpartum (38%), or intrapartum (4.0%). Overall, 8% had had previous episodes; 6% relapsed during hospitalization; 4% died. Caesarean sections were common (78.0%), with 73.3% delivering at <37 weeks and 39.0% at <34 weeks. Etiologies were hypertensive (62%), cardiogenic (16.0%), both hypertensive and cardiogenic (20.0%) or due to fluid overload (2.0%). Irrespective of etiology, in the 24 hours preceding acute PE, fluid overload was present in 34.0%. Median time from diagnosis until resuscitation maneuvers was 5 minutes (within 30 minutes of diagnosis in 75.0% of patients). Mean ICU time was 5 days and mean hospitalization time 11 days.
   Acute PE is a severe disease resulting in high maternal/perinatal morbidity/mortality rates. Most commonly, it occurred antepartum and associated with hypertension. Fluid overload appears to constitute an important trigger.
C1 [Pordeus, Ana Carolina B.; Katz, Leila; Maia, Sabina B.; Amorim, Melania M. R.] Inst Med Integral Prof Fernando Figueira, Postgrad Program Maternal & Child Hlth, Recife, PE, Brazil.
   [Soares, Mariana C.] FPS, Recife, PE, Brazil.
RP Amorim, MMR (corresponding author), Rua Neuza Borborema de Souza 300, BR-58406120 Campine Grande, Paraiba, Brazil.
EM profmelania.amorim@gmail.com
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
CR Amorim Melania Maria Ramos de, 2006, Rev. Bras. Saude Mater. Infant., V6, ps55, DOI 10.1590/S1519-38292006000500008
   Bauer ST, 2009, SEMIN PERINATOL, V33, P158, DOI 10.1053/j.semperi.2009.02.008
   Dennis AT, 2012, ANAESTHESIA, V67, P646, DOI 10.1111/j.1365-2044.2012.07055.x
   Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0
   Gandhi S, 2014, J OBSTET GYNAECOL CA, V36, P1065, DOI 10.1016/S1701-2163(15)30383-2
   Helve Otto, 2009, Neonatology, V95, P347, DOI 10.1159/000209300
   Kuklina EV, 2010, OBSTET GYNECOL, V115, P93, DOI 10.1097/AOG.0b013e3181c4ee8c
   Linhares JJ, 2014, REV BRAS GINECOL OBS, V36, P259, DOI 10.1590/S0100-720320140004812
   Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x
   Montera MW, 2009, ARQ BRAS CARDIOL, V93, P1
   Ogunyemi D, 2007, EUR J OBSTET GYN R B, V133, P143, DOI 10.1016/j.ejogrb.2006.09.001
   Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001
   Pereira A, 2004, CLIN CHEST MED, V25, P299, DOI 10.1016/j.ccm.2004.01.010
   Poole JH, 2005, J PERINAT NEONAT NUR, V19, P316, DOI 10.1097/00005237-200510000-00007
   Souza ASR, 2008, REV ASSOC MED BRAS, V54, P232, DOI 10.1590/S0104-42302008000300016
   Sciscione AC, 2003, OBSTET GYNECOL, V101, P511, DOI 10.1016/S0029-7844(02)02733-3
   Sociedade Brasileira de cardiologia, 2009, Arq Bras Cardiol, V93, pe110
   Sweet DG, 2013, NEONATOLOGY, V103, P353, DOI 10.1159/000349928
   Thornton CE, 2011, HYPERTENS PREGNANCY, V30, P169, DOI 10.3109/10641950902972140
   YEAST JD, 1993, AM J OBSTET GYNECOL, V169, P1566, DOI 10.1016/0002-9378(93)90438-O
   Zlatnik MG, 1997, SEMIN PERINATOL, V21, P298, DOI 10.1016/S0146-0005(97)80072-9
NR 21
TC 2
Z9 2
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0025-7974
EI 1536-5964
J9 MEDICINE
JI Medicine (Baltimore)
PD JUL
PY 2018
VL 97
IS 28
AR e11508
DI 10.1097/MD.0000000000011508
PG 5
WC Medicine, General & Internal
SC General & Internal Medicine
GA GO0AE
UT WOS:000439577500069
PM 29995818
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Macedo, LC
   Lemos, A
   Vasconcelos, DA
   Katz, L
   Amorim, MMR
AF Macedo, Lorena C.
   Lemos, Andrea
   Vasconcelos, Danilo A.
   Katz, Leila
   Amorim, Melania M. R.
TI Correlation between electromyography and perineometry in evaluating
   pelvic floor muscle function in nulligravidas: A cross-sectional study
SO NEUROUROLOGY AND URODYNAMICS
LA English
DT Article
DE electromyography; manometer; nulliparous women; pelvic floor muscles
ID VAGINAL PALPATION; STRENGTH; STANDARDIZATION; RELIABILITY; TERMINOLOGY;
   PRESSURE; WOMEN
AB ObjectiveTo correlate the results of electromyography and perineometry in the assessment of PFM function in nulligravidas.
   MethodsThe cross-sectional observational study was approved by the internal review board of the Instituto de Medicina Integral Prof. Fernando Figueira (IMIP) and was conducted in the Instituto Paraibano de Pesquisa Professor Joaquim Amorim Neto (IPESQ). Thirty-eight nulligravidas aged 18-39 years of age, who had already initiated their sexual life, participated in the study. Exclusion criteria consisted of the presence of genital prolapse, a history of pelvic or urogenital surgery and the presence of neurological disease producing muscle disorders. For the evaluation procedure, the women were submitted to a clinical evaluation of the pelvic floor muscles followed by electromyography. Perineometry was performed 72h later. Prior to electromyography and perineometry, the women were given standardized training with electromyographic biofeedback to teach them to contract only their pelvic floor muscles.
   ResultsA highly positive, statistically significant correlation (r=0.968; P<0.001) was found between the electromyographic and perineometric findings.
   ConclusionsA strong correlation was found between perineometric and electromyographic findings of pelvic floor muscle function.
C1 [Macedo, Lorena C.; Katz, Leila] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
   [Macedo, Lorena C.] Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
   [Lemos, Andrea] Fed Univ Pernambuco UFPE, Recife, PE, Brazil.
   [Vasconcelos, Danilo A.] State Univ Paraiba UEPB, Campina Grande, Paraiba, Brazil.
   [Amorim, Melania M. R.] Fed Univ Campina Grande UFCG, Inst Paraibano Pesquisa Prof Joaquim Amorim Neto, Neuza Borborema de Souza 300, Campina Grande, Paraiba, Brazil.
RP Amorim, MMR (corresponding author), Fed Univ Campina Grande UFCG, Inst Paraibano Pesquisa Prof Joaquim Amorim Neto, Neuza Borborema de Souza 300, Campina Grande, Paraiba, Brazil.
EM profmelania.amorim@gmail.com
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514;
   Lemos, Andrea/0000-0003-0631-0512
FU Fundo de Apoio a Pesquisa e Ensino do Instituto de Medicina Integral
   Prof. Fernando Figueira (FAPE/IMIP); Conselho Nacional de
   Desenvolvimento Cietifico e Tecnologico (CNPq)National Council for
   Scientific and Technological Development (CNPq)
FX Fundo de Apoio a Pesquisa e Ensino do Instituto de Medicina Integral
   Prof. Fernando Figueira (FAPE/IMIP); Conselho Nacional de
   Desenvolvimento Cietifico e Tecnologico (CNPq)
CR [Anonymous], 1999, J ELECTROMYOGR KINES, V9, pIII
   Bo K, 2005, PHYS THER, V85, P269
   Bo K, 2001, ACTA OBSTET GYN SCAN, V80, P883, DOI 10.1034/j.1600-0412.2001.801003.x
   Botelho S, 2013, NEUROUROL URODYNAM, V32, P420, DOI 10.1002/nau.22321
   Bump RC, 1996, AM J OBSTET GYNECOL, V175, P10, DOI 10.1016/S0002-9378(96)70243-0
   Criswell E., 2011, CRAMS INTRO SURFACE, P17
   Da Roza T, 2013, PHYSIOTHERAPY, V99, P207, DOI 10.1016/j.physio.2012.05.014
   Dietz HP, 2003, INT UROGYNECOL J, V14, P24, DOI 10.1007/s00192-002-1001-8
   Farina D, 2010, CLIN NEUROPHYSIOL, V121, P1616, DOI 10.1016/j.clinph.2009.10.040
   Frawley HC, 2006, NEUROUROL URODYNAM, V25, P236, DOI 10.1002/nau.20201
   Grape HH, 2009, NEUROUROL URODYNAM, V28, P395, DOI 10.1002/nau.20648
   Hundley AF, 2005, AM J OBSTET GYNECOL, V192, P1583, DOI 10.1016/j.ajog.2004.11.015
   Isherwood PJ, 2000, BRIT J OBSTET GYNAEC, V107, P1007, DOI 10.1111/j.1471-0528.2000.tb10404.x
   Ferreira CHJ, 2011, PHYSIOTHERAPY, V97, P132, DOI 10.1016/j.physio.2010.06.007
   Kamen G, 2010, ESSSENTIALS ELECTROM
   Madill SJ, 2006, NEUROUROL URODYNAM, V25, P722, DOI 10.1002/nau.20285
   Madill SJ, 2009, INT UROGYNECOL J, V20, P447, DOI 10.1007/s00192-008-0800-y
   Messelink B, 2005, NEUROUROL URODYNAM, V24, P374, DOI 10.1002/nau.20144
   Moen MD, 2009, INT UROGYNECOL J, V20, P843, DOI 10.1007/s00192-009-0853-6
   Moreno AL., 2009, FISIOTERAPIA UROGINE
   Barbosa AMP, 2005, REV BRAS GINECOL OBS, V27, P677, DOI 10.1590/S0100-72032005001100008
   Pereira VS, 2014, BRAZ J PHYS THER, V18, P428, DOI 10.1590/bjpt-rbf.2014.0038
   Peschers UM, 2001, INT UROGYNECOL J PEL, V12, P27, DOI 10.1007/s001920170090
   Rahmani N, 2011, J BODYW MOV THER, V15, P209, DOI 10.1016/j.jbmt.2009.07.007
   Resende Ana Paula Magalhães, 2011, Fisioter. Pesqui., V18, P292, DOI 10.1590/S1809-29502011000300016
   Rett Mariana Tirolli, 2005, Rev. Bras. Ginecol. Obstet., V27, P12, DOI 10.1590/S0100-72032005000100005
   Riesco MLG, 2010, REV LAT-AM ENFERM, V19, P2424
   Sapsford RR, 2001, ARCH PHYS MED REHAB, V82, P1081, DOI 10.1053/apmr.2001.24297
   SENIAN, 2015, SENIAM GROUP REC
   TURKER KS, 1993, PHYS THER, V73, P698
NR 30
TC 1
Z9 1
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0733-2467
EI 1520-6777
J9 NEUROUROL URODYNAM
JI Neurourol. Urodyn.
PD JUN
PY 2018
VL 37
IS 5
BP 1658
EP 1666
DI 10.1002/nau.23402
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA GO4SH
UT WOS:000440003700017
PM 29572913
DA 2020-12-01
ER

PT J
AU Heraclio, SA
   de Souza, ASR
   de Souza, PRE
   Katz, L
   Lima, SF
   Amorim, MMR
AF Heraclio, Sandra A.
   de Souza, Alex S. R.
   de Souza, Paulo R. E.
   Katz, Leila
   Lima Junior, Sergio F.
   Amorim, Melania M. R.
TI Cross-sectional study of anal intraepithelial lesions in women with
   cervical neoplasia without HIV
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Anal canal; Anal cancer; Cervical intraepithelial neoplasia; Molecular
   biology; Papillomaviridae; Polymerase chain reaction; Screening; Uterine
   cervical neoplasms
ID HIGH-RESOLUTION ANOSCOPY; HUMAN-PAPILLOMAVIRUS; CANCER; PREVALENCE;
   COLPOSCOPY; INFECTION; AGREEMENT; ANUS
AB Objective To evaluate the prevalence of anal intraepithelial lesions and associated risk factors in women with cervical neoplasia.
   Methods The present cross-sectional study enrolled patients with intraepithelial or invasive cervical neoplasia who had been referred to the lower genital tract pathology outpatient department of the Instituto de Medicina Integral Prof. Fernando Figueira, Recife, Brazil, between December 1, 2008, and December 31, 2009; patients with HIV infections were excluded. All participants underwent anal cytology and high-resolution anoscopy; sociodemographic and clinical risk factors were identified using multivariate analysis.
   Results There were 324 patients included and 37 (11.4%) had anal intraepithelial neoplasia. Factors associated with anal intraepithelial neoplasia in the multivariate analysis were being older than 35years of age (P=0.002), having completed no more than 4years of education (P=0.012), anomalous anal cytology (P=0.003), and anomalous high-resolution anoscopy findings (P<0.001); subclinical HPV lesions on vulvoscopy (P=0.057) were not associated with anal intraepithelial neoplasia.
   Conclusion The prevalence of anal intraepithelial neoplasia was high among patients with cervical neoplasia who did not have HIV, particularly patients older than 35years.
C1 [Heraclio, Sandra A.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Pathol Lower Genital Tract, Recife, PE, Brazil.
   [de Souza, Alex S. R.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Fetal Med & Ultrasonog, Recife, PE, Brazil.
   [de Souza, Paulo R. E.; Lima Junior, Sergio F.] Univ Fed Rural Pernambuco, Dept Biol, Recife, PE, Brazil.
   [Katz, Leila; Amorim, Melania M. R.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Womens Hlth, Recife, PE, Brazil.
RP Heraclio, SA (corresponding author), Rua Gen Artur Oscar 30,Apt 1401, BR-52050430 Recife, PE, Brazil.
EM sandraheraclio@gmail.com
RI Souza, Alex Sandro Rolland/AAG-2471-2019; Katz, Leila/M-5291-2013;
   Amorim, Melania M/C-5807-2013
OI Souza, Alex Sandro Rolland/0000-0001-7039-2052; Katz,
   Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
FU Instituto de Medicina Integral Prof. Fernando Figueira- IMIP
FX The present study was supported by Instituto de Medicina Integral Prof.
   Fernando Figueira- IMIP.
CR Darragh TM, 2012, J LOW GENIT TRACT DI, V16, P205, DOI 10.1097/LGT.0b013e31825c31dd
   De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116
   Durdi GS, 2009, J TURK-GER GYNECOL A, V10, P205
   ElNaggar AC, 2013, OBSTET GYNECOL, V122, P218, DOI 10.1097/AOG.0b013e31829a2ace
   Fernandes A M, 2000, Cad Saude Publica, V16, P103
   Goodman MT, 2010, J INFECT DIS, V201, P1331, DOI 10.1086/651620
   Hampl M, 2008, GYNECOL ONCOL, V109, P340, DOI 10.1016/j.ygyno.2008.01.041
   Heraclio SA, 2015, INT J GYNECOL OBSTET, V128, P216, DOI 10.1016/j.ijgo.2014.09.014
   Heraclio SD, 2011, ACTA CYTOL, V55, P218, DOI 10.1159/000320922
   Jacyntho CMA, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.03.011
   Jimenez W, 2009, GYNECOL ONCOL, V114, P395, DOI 10.1016/j.ygyno.2009.05.006
   Koppe DC, 2011, DIS COLON RECTUM, V54, P442, DOI 10.1007/DCR.0b013e3182061b34
   Macdowall W, 2013, LANCET, V382, P1845, DOI 10.1016/S0140-6736(13)62300-4
   Nahas CSR, 2009, DIS COLON RECTUM, V52, P1854, DOI 10.1007/DCR.0b013e3181b98f36
   Nayar R, 2015, CANCER CYTOPATHOL, V123, P271, DOI 10.1002/cncy.21521
   Park IU, 2009, GYNECOL ONCOL, V114, P399, DOI 10.1016/j.ygyno.2009.05.008
   Santoso JT, 2010, OBSTET GYNECOL, V116, P578, DOI 10.1097/AOG.0b013e3181ea1834
   Stier EA, 2015, AM J OBSTET GYNECOL, V213, P278, DOI 10.1016/j.ajog.2015.03.034
   Tatti S, 2013, OBSTET GYN CLIN N AM, V40, P235, DOI 10.1016/j.ogc.2013.02.002
   Ueda Y, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/951250
   van der Zee RP, 2013, NETH J MED, V71, P401
   Wilkinson JR, 2014, COLORECTAL DIS, V16, pO234, DOI 10.1111/codi.12553
NR 22
TC 1
Z9 1
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD FEB
PY 2018
VL 140
IS 2
BP 233
EP 240
DI 10.1002/ijgo.12367
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FR8CA
UT WOS:000419300300017
PM 29080327
DA 2020-12-01
ER

PT J
AU Knobel, R
   Takemoto, MLS
   Menezes, MO
   Magalhaes, CG
   Andreucci, CB
   Katz, L
   Amorim, MMR
AF Knobel, Roxana
   Takemoto, Maira L. S.
   Menezes, Mariane O.
   Magalhaes, Claudia G.
   Andreucci, Carla B.
   Katz, Leila
   Amorim, Melania M. R.
TI Concerning the Article by Bodner-Adler et al: "Management of the
   Perineum during Delivery with the Kiwi Omnicup: Effects of Mediolateral
   Episiotomy on Anal Sphincter Tears in Nulliparous Women"
SO GYNECOLOGIC AND OBSTETRIC INVESTIGATION
LA English
DT Letter
C1 [Knobel, Roxana] Univ Fed Santa Catarina, Ctr Ciencias Saude, Dept Ginecol & Obstet, Florianopolis, SC, Brazil.
   [Takemoto, Maira L. S.; Menezes, Mariane O.] Levatrice Cursos, Rua Senador Dantas 117,Cobertura 1A Ctr, BR-20031911 Rio De Janeiro, RJ, Brazil.
   [Magalhaes, Claudia G.] Univ Estadual Paulista, Fac Med, Botucatu, SP, Brazil.
   [Andreucci, Carla B.] Univ Fed Sao Carlo, Dept Med, Sao Carlos, SP, Brazil.
   [Katz, Leila] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Amorim, Melania M. R.] Inst Paraibano Pesquisa Prof Joaquim Amorim Neto, Campina Grande, Brazil.
RP Takemoto, MLS (corresponding author), Levatrice Cursos, Rua Senador Dantas 117,Cobertura 1A Ctr, BR-20031911 Rio De Janeiro, RJ, Brazil.
EM mlibertad@gmail.com
RI TAKEMOTO, MAIRA LS/G-7889-2018; Amorim, Melania M/C-5807-2013; Knobel,
   Roxana/S-4550-2019; Polido, Carla Betina Andreucci/Y-9743-2019; Katz,
   Leila/M-5291-2013; de Oliveira Menezes, Mariane/F-1627-2013; Menezes,
   Mariane/P-4688-2019; Andreucci, Carla B/J-4845-2015
OI TAKEMOTO, MAIRA LS/0000-0002-7016-2879; Amorim, Melania
   M/0000-0003-1047-2514; Knobel, Roxana/0000-0001-9180-4685; Polido, Carla
   Betina Andreucci/0000-0002-5590-108X; Katz, Leila/0000-0001-9854-7917;
   de Oliveira Menezes, Mariane/0000-0002-8525-0521; Menezes,
   Mariane/0000-0002-8525-0521; Andreucci, Carla B/0000-0002-5590-108X
CR Bodner-Adler B, 2017, GYNECOL OBSTET INVES
   Jiang H, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000081.pub3
   Lund NS, 2016, EUR J OBSTET GYN R B, V207, P193, DOI 10.1016/j.ejogrb.2016.10.013
   Sagi-Dain L, 2015, BJOG-INT J OBSTET GY, V122, P1073, DOI 10.1111/1471-0528.13439
NR 4
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0378-7346
EI 1423-002X
J9 GYNECOL OBSTET INVES
JI Gynecol.Obstet.Invest.
PY 2018
VL 83
IS 4
BP 415
EP 416
DI 10.1159/000487594
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA GN7PJ
UT WOS:000439336500013
PM 29860263
DA 2020-12-01
ER

PT J
AU Amorim, MM
   Coutinho, IC
   Melo, I
   Katz, L
AF Amorim, Melania M.
   Coutinho, Isabela Cristina
   Melo, IneS
   Katz, Leila
TI Selective episiotomy vs. implementation of a non-episiotomy protocol: a
   randomized clinical trial (vol 14, 55, 2017)
SO REPRODUCTIVE HEALTH
LA English
DT Correction
C1 [Amorim, Melania M.; Coutinho, Isabela Cristina; Melo, IneS; Katz, Leila] Womens Healthcare Ctr, Inst Med Integral Prof Fernando Figueira, BR-50070550 Recife, PE, Brazil.
   [Amorim, Melania M.] Inst Paraibano Pesquisa Prof Joaquim Amorim Neto, Rua Neusa Borborema 300, BR-58406120 Santo Antonio, Campina Grande, Brazil.
RP Amorim, MM (corresponding author), Womens Healthcare Ctr, Inst Med Integral Prof Fernando Figueira, BR-50070550 Recife, PE, Brazil.; Amorim, MM (corresponding author), Inst Paraibano Pesquisa Prof Joaquim Amorim Neto, Rua Neusa Borborema 300, BR-58406120 Santo Antonio, Campina Grande, Brazil.
EM melania.amorim@gmail.com
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
CR Amorim MM, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0315-4
NR 1
TC 2
Z9 2
U1 0
U2 1
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD OCT 24
PY 2017
VL 14
AR 135
DI 10.1186/s12978-017-0399-x
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA FK4VN
UT WOS:000413495000001
PM 29065891
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Almeida, ST
   Katz, L
   Coutinho, I
   Amorim, MMR
AF Almeida, Silvana T.
   Katz, Leila
   Coutinho, Isabela
   Amorim, Melania M. R.
TI Validation of fullPIERS model for prediction of adverse outcomes among
   women with severe pre-eclampsia
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Morbidity; Pre-eclampsia; Pregnancy complications; Prognosis; Severe
   pre-eclampsia
ID MATERNAL OUTCOMES; COHORT; COMPLICATIONS; PREGNANCY
AB Objective: To evaluate the accuracy of the Pre-eclampsia Integrated Estimate of RiSk (fullPIERS) model for the prediction of complications among patients with severe pre-eclampsia in northeastern Brazil.
   Methods: A retrospective study was conducted of data for all patients with severe pre-eclampsia admitted to a center in Recife in 2014. The fullPIERS model was applied to calculate the predicted probability of complications. A receiver operating characteristic curve was constructed to determine the accuracy of the model, and the area under the curve was calculated. Multiple logistic regression analysis was performed.
   Results: Among 325 included women, 55 (16.9%) had one or more complication before discharge. The area under the curve was 0.72 (P<0.001), determining a cutoff point for fullPIERS probability of 1.7%. Sensitivity was 60.0% and specificity was 65.1%; the positive likelihood ratio was 1.72 and the negative likelihood ratio was 0.61. In multivariate analysis, the only variable that remained significantly associated with complications was a fullPIERS probability of more than 1.7% (odds ratio 5.87, 95% confidence interval 3.16-10.89; P<0.001).
   Conclusion: The fullPIERS model is a useful tool for predicting complications in women with severe pre-eclampsia, with the cutoff point of 1.7%.
C1 [Almeida, Silvana T.; Katz, Leila; Coutinho, Isabela; Amorim, Melania M. R.] Inst Med Integral Prof Fernando Figueira, Maternal & Child Healthcare, Recife, PE, Brazil.
RP Katz, L (corresponding author), Inst Med Integral Prof Fernando Figueira, Maternal & Child Healthcare, Recife, PE, Brazil.
EM katzleila@gmail.com
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
CR Abalos E, 2014, BJOG-INT J OBSTET GY, V121, P14, DOI 10.1111/1471-0528.12629
   Agrawal S, 2016, J OBSTET GYN INDIA, V66, P104, DOI 10.1007/s13224-015-0779-5
   Akkermans J, 2014, EUR J OBSTET GYN R B, V179, P58, DOI 10.1016/j.ejogrb.2014.05.021
   [Anonymous], 2014, PREGNANCY HYPERTENS, V4, P97
   Bossuyt PM, 2003, CROAT MED J, V44, P639
   CHURCHILL D, 2002, COCHRANE DB SYST REV
   Churchill D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003106.pub2
   Department of Health Surveillance, 2012, MAT MORT BRAZ MAIN C
   Godara SM, 2014, SAUDI J KIDNEY DIS T, V25, P906, DOI 10.4103/1319-2442.135215
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Mehrabadi A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4731
   Millman AL, 2011, J OBSTET GYNAECOL CA, V33, P705, DOI 10.1016/S1701-2163(16)34955-6
   Nakimuli A, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0362-3
   Nankali A, 2013, J OBSTET GYN INDIA, V63, P112, DOI 10.1007/s13224-012-0283-0
   Payne B, 2013, BJOG-INT J OBSTET GY, V120, P113, DOI 10.1111/j.1471-0528.2012.03496.x
   Payne BA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001589
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X
   Seyom E, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0135-5
   vonsDadelszen P, 2011, LANCET, V377, P219
   Wynn A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116102
NR 21
TC 5
Z9 7
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD AUG
PY 2017
VL 138
IS 2
BP 142
EP 147
DI 10.1002/ijgo.12197
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FA0AQ
UT WOS:000405093300003
PM 28475234
DA 2020-12-01
ER

PT J
AU Chimelli, L
   Melo, ASO
   Avvad-Portari, E
   Wiley, CA
   Camacho, AHS
   Lopes, VS
   Machado, HN
   Andrade, CV
   Dock, DCA
   Moreira, ME
   Tovar-Moll, F
   Oliveira-Szejnfeld, PS
   Carvalho, ACG
   Ugarte, ON
   Batista, AGM
   Amorim, MMR
   Melo, FO
   Ferreira, TA
   Marinho, JRL
   Azevedo, GS
   Leal, JIBF
   da Costa, RFM
   Rehen, S
   Arruda, MB
   Brindeiro, RM
   Delvechio, R
   Aguiar, RS
   Tanuri, A
AF Chimelli, Leila
   Melo, Adriana S. O.
   Avvad-Portari, Elyzabeth
   Wiley, Clayton A.
   Camacho, Aline H. S.
   Lopes, Vania S.
   Machado, Heloisa N.
   Andrade, Cecilia V.
   Dock, Dione C. A.
   Moreira, Maria Elisabeth
   Tovar-Moll, Fernanda
   Oliveira-Szejnfeld, Patricia S.
   Carvalho, Angela C. G.
   Ugarte, Odile N.
   Batista, Alba G. M.
   Amorim, Melania M. R.
   Melo, Fabiana O.
   Ferreira, Thales A.
   Marinho, Jacqueline R. L.
   Azevedo, Girlene S.
   Leal, Jeime I. B. F.
   Madeiro da Costa, Rodrigo F.
   Rehen, Stevens
   Arruda, Monica B.
   Brindeiro, Rodrigo M.
   Delvechio, Rodrigo
   Aguiar, Renato S.
   Tanuri, Amilcar
TI The spectrum of neuropathological changes associated with congenital
   Zika virus infection
SO ACTA NEUROPATHOLOGICA
LA English
DT Article
DE Zika virus; Congenital ZIKV infection; Microcephaly; Calcification; In
   situ hybridization; Neuropathology
ID TRANSMISSION; OUTBREAK; BRAZIL
AB A major concern associated with ZIKV infection is the increased incidence of microcephaly with frequent calcifications in infants born from infected mothers. To date, postmortem analysis of the central nervous system (CNS) in congenital infection is limited to individual reports or small series. We report a comprehensive neuropathological study in ten newborn babies infected with ZIKV during pregnancy, including the spinal cords and dorsal root ganglia (DRG), and also muscle, pituitaries, eye, systemic organs, and placentas. Using in situ hybridization (ISH) and electron microscopy, we investigated the role of direct viral infection in the pathogenesis of the lesions. Nine women had Zika symptoms between the 4th and 18th and one in the 28th gestational week. Two babies were born at 32, one at 34 and 36 weeks each and six at term. The cephalic perimeter was reduced in four, and normal or enlarged in six patients, although the brain weights were lower than expected. All had arthrogryposis, except the patient infected at 28 weeks gestation. We defined three patterns of CNS lesions, with different patterns of destructive, calcification, hypoplasia, and migration disturbances. Ventriculomegaly was severe in the first pattern due to midbrain damage with aqueduct stenosis/distortion. The second pattern had small brains and mild/moderate (ex-vacuo) ventriculomegaly. The third pattern, a well-formed brain with mild calcification, coincided with late infection. The absence of descending fibres resulted in hypoplastic basis pontis, pyramids, and cortico-spinal tracts. Spinal motor cell loss explained the intrauterine akinesia, arthrogryposis, and neurogenic muscle atrophy. DRG, dorsal nerve roots, and columns were normal. Lymphohistiocytic inflammation was mild. ISH showed meningeal, germinal matrix, and neocortical infection, consistent with neural progenitors death leading to proliferation and migration disorders. A secondary ischemic process may explain the destructive lesions. In conclusion, we characterized the destructive and malformative consequences of ZIKV in the nervous system, as reflected in the topography and severity of lesions, anatomic localization of the virus, and timing of infection during gestation. Our findings indicate a developmental vulnerability of the immature CNS, and shed light on possible mechanisms of brain injury of this newly recognized public health threat.
C1 [Chimelli, Leila; Camacho, Aline H. S.] State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Chimelli, Leila; Camacho, Aline H. S.] Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
   [Melo, Adriana S. O.; Amorim, Melania M. R.; Melo, Fabiana O.; Ferreira, Thales A.; Azevedo, Girlene S.] Res Inst Prof Amorim Neto, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Melo, Adriana S. O.; Batista, Alba G. M.; Marinho, Jacqueline R. L.; Leal, Jeime I. B. F.] Hlth Secretary Campina Grande, Rua Duque Caxias 330, BR-58400506 Campina Grande, PB, Brazil.
   [Avvad-Portari, Elyzabeth; Machado, Heloisa N.; Andrade, Cecilia V.; Dock, Dione C. A.; Moreira, Maria Elisabeth] Fiocruz MS, Fernandes Figueira Inst, Ave Rui Barbosa 716, BR-22250020 Rio De Janeiro, RJ, Brazil.
   [Wiley, Clayton A.] UPMC Presbiterian Hosp, Div Neuropathol, S701 Scaife Hall 200 Lothrop St, Pittsburgh, PA 15213 USA.
   [Lopes, Vania S.; Carvalho, Angela C. G.; Ugarte, Odile N.] Univ Fed Fluminense, Antonio Pedro Univ Hosp, Dept Pathol, Rua Marques Parana 303, BR-24033900 Niteroi, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] DOr Inst Res & Educ IDOR, Rua Diniz Cordeiro 30, BR-22281100 Rio De Janeiro, RJ, Brazil.
   [Tovar-Moll, Fernanda; Madeiro da Costa, Rodrigo F.; Rehen, Stevens] Univ Fed Rio de Janeiro, Rua Diniz Cordeiro 30, BR-22281100 Rio de Janeiro, RJ, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Fdn Inst Educ & Res Diagnost Imaging FIDI, Fetal Med Res, Rua Napoleao Barros 800, BR-04024002 Sao Paulo, SP, Brazil.
   [Arruda, Monica B.; Brindeiro, Rodrigo M.; Delvechio, Rodrigo; Aguiar, Renato S.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, CCS, Inst Biol, Lab Med Virol,Dept Genet, Bloco A,Sala 121, BR-21941902 Rio de Janeiro, RJ, Brazil.
RP Chimelli, L (corresponding author), State Inst Brain Paulo Niemeyer, Neuropathol Lab, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.; Chimelli, L (corresponding author), Univ Fed Rio de Janeiro, Rua Resende 156, BR-20231092 Rio De Janeiro, RJ, Brazil.
EM chimelli@hucff.ufrj.br
RI Aguiar, Renato S/G-3542-2015; Amorim, Melania M/C-5807-2013; Ferreira,
   Thales Araujo/AAA-6252-2019; Moll, Fernanda Tovar/N-3320-2018; Melo,
   Adriana S O/H-5650-2016; Rehen, Stevens K/J-5874-2012; ANDRADE,
   CECILIA/B-5916-2017
OI Aguiar, Renato S/0000-0001-5180-3717; Amorim, Melania
   M/0000-0003-1047-2514; Moll, Fernanda Tovar/0000-0002-0292-5985; Rehen,
   Stevens K/0000-0003-4216-9501; FERREIRA, THALES/0000-0002-6699-5886;
   Soares de Oliveira Szejnfeld, Patricia/0000-0002-3780-5182; ANDRADE,
   CECILIA/0000-0001-7980-4367
FU National Institute of Health (NIH) IH NIAID grant [U01 AI 111598];
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   [CNPq]National Council for Scientific and Technological Development
   (CNPq); Fundacao de Amparo a Pesquisa do Rio de Janeiro [FAPERJ]Carlos
   Chagas Filho Foundation for Research Support of the State of Rio de
   Janeiro (FAPERJ); Medical Research CouncilMedical Research Council UK
   (MRC) [MC_PC_15102] Funding Source: researchfish; NATIONAL INSTITUTE OF
   ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U01AI111598,
   U01AI111598, U01AI111598, U01AI111598, U01AI111598, U01AI111598] Funding
   Source: NIH RePORTER
FX We thank DEbora Silva, Diego Santos, and Luciana Bitana for technical
   assistance in histological and immunohistochemical preparations, and
   Centro Nacional de Biologia Estrutural e Bioimagem (CENABIO) for
   technical assistance in transmission electron microscopy. These studies
   received partial support from the National Institute of Health (NIH) IH
   NIAID grant U01 AI 111598 (C.A.W.) and from Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico [CNPq] and Fundacao de Amparo a
   Pesquisa do Rio de Janeiro [FAPERJ] (A.T).
CR Alpert SG, 2003, AM J OPHTHALMOL, V136, P733, DOI 10.1016/S0002-9394(03)00452-5
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brien JD, 2009, J EXP MED, V206, P2735, DOI 10.1084/jem.20090222
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Silva SR, 2016, J MED VIROL, V88, P1291, DOI 10.1002/jmv.24563
   Dasti JI, 2016, ASIAN PAC J TROP MED, V9, P601, DOI 10.1016/j.apjtm.2016.05.010
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellison D, 2012, NEUROPATHOLOGY REFER
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Larroche J-C, 1977, DEV PATHOLOGY NEONAT, P1
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Love S, 2015, GREENFIELD'S NEUROPATHOLOGY, 9TH EDITION, VOLS 1AND 2, P1087
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Mecharles S, 2016, LANCET, V8, P6736, DOI DOI 10.1136/BCR-2012-007094.4
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P68, DOI 10.5858/arpa.2016-0343-OA
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   SNIJDERS RJM, 1994, ULTRASOUND OBST GYN, V4, P34, DOI 10.1046/j.1469-0705.1994.04010034.x
   Solomon IH, 2016, J NEUROINFECT DIS, V7, P220
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Strafela P, 2017, ARCH PATHOL LAB MED, V141, P73, DOI 10.5858/arpa.2016-0341-SA
   Tadros MA, 2015, J NEUROPHYSIOL, V114, P2661, DOI 10.1152/jn.00682.2015
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 49
TC 73
Z9 76
U1 1
U2 30
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0001-6322
EI 1432-0533
J9 ACTA NEUROPATHOL
JI Acta Neuropathol.
PD JUN
PY 2017
VL 133
IS 6
BP 983
EP 999
DI 10.1007/s00401-017-1699-5
PG 17
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA EU6HB
UT WOS:000401134000008
PM 28332092
DA 2020-12-01
ER

PT J
AU Melo, ASD
   Reis, BLFS
   Azevedo, GS
   Tavares, JD
   Marinho, JRL
   Amorim, MM
AF de Oliveira Melo, Adriana Suely
   Fonseca Schamber Reis, Bruno Luiz
   Azevedo, Girlene Souza
   Tavares, Jousilene de Sales
   Loureiro Marinho, Jacqueline Ramos
   Amorim, Melania M.
TI N Fetal Damage in Congenital Zika Virus Infection: Cohort Study
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [de Oliveira Melo, Adriana Suely; Fonseca Schamber Reis, Bruno Luiz; Azevedo, Girlene Souza; Tavares, Jousilene de Sales; Loureiro Marinho, Jacqueline Ramos; Amorim, Melania M.] Inst Pesquisa Prof Joaquim Amorim Neto, Campina Grande, PB, Brazil.
RI Amorim, Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016
OI Amorim, Melania M/0000-0003-1047-2514; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 3P
BP 164S
EP 164S
DI 10.1097/01.AOG.0000514076.77258.39
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800590
DA 2020-12-01
ER

PT J
AU Melo, ASD
   Carneiro, JG
   Melo, FD
   Manhaes, CBD
   Silva, MB
   Amorim, MM
AF de Oliveira Melo, Adriana Suely
   Carneiro, Juliana Garcia
   Melo, Fabiana de Oliveira
   de Souza Manhaes, Claudia Bianka
   Silva, Mariana Balbino
   Amorim, Melania M.
TI Sonographic Findings in Congenital Zika Virus Infection: Cohort Study
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [de Oliveira Melo, Adriana Suely; Carneiro, Juliana Garcia; Melo, Fabiana de Oliveira; de Souza Manhaes, Claudia Bianka; Silva, Mariana Balbino; Amorim, Melania M.] Inst Pesquisa Prof Joaquim Amorim Neto, Campina Grande, PB, Brazil.
RI Amorim, Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016
OI Amorim, Melania M/0000-0003-1047-2514; 
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 4P
BP 164S
EP 165S
DI 10.1097/01.AOG.0000514077.54388.3c
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800591
DA 2020-12-01
ER

PT J
AU Amorim, M
   Heraclio, S
   de Souza, ASR
   Katz, L
AF Amorim, Melania
   Heraclio, Sandra
   Rolland de Souza, Alex Sandro
   Katz, Leila
TI Prevalence and Genotyping of HPV in Women With Cervical and Anal
   Neoplasia
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Amorim, Melania; Heraclio, Sandra; Rolland de Souza, Alex Sandro; Katz, Leila] Inst Med Integral Prof Fernando Figueira IMIP, Campina Grande, PB, Brazil.
RI Souza, Alex Sandro Rolland/AAG-2471-2019; Amorim, Melania M/C-5807-2013;
   Katz, Leila/M-5291-2013
OI Souza, Alex Sandro Rolland/0000-0001-7039-2052; Amorim, Melania
   M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 32E
BP 60S
EP 60S
DI 10.1097/01.AOG.0000514823.41453.36
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800211
DA 2020-12-01
ER

PT J
AU Carvalho, HB
   Macedo, LC
   Danilo, A
   Amorim, MM
   Katz, L
AF Carvalho, Hellen B.
   Macedo, Lorena C.
   Vasconcelos, Danilo A.
   Amorim, Melania M.
   Katz, Leila
TI Correlation Between Sexual Function and Strength of the Pelvic Floor
   Muscles in Women With Dyspareunia
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Carvalho, Hellen B.; Macedo, Lorena C.; Vasconcelos, Danilo A.; Amorim, Melania M.; Katz, Leila] Inst Med Integral Prof Fernando Figueira IMIP, Campina Grande, PB, Brazil.
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 6G
BP 73S
EP 73S
DI 10.1097/01.AOG.0000514871.98870.19
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800258
DA 2020-12-01
ER

PT J
AU Amorim, M
   Heraclio, S
   Souza, AR
   Katz, L
   Souza, PR
   Lima, S
AF Amorim, Melania
   Heraclio, Sandra
   Souza, Alex Rolland
   Katz, Leila
   Souza, Paulo Roberto
   Lima Junior, Sergio
TI Anal Intraepithelial Lesions in HIV-Negative Women With Cervical
   Neoplasia: A Cross-Sectional Study
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Amorim, Melania; Heraclio, Sandra; Souza, Alex Rolland; Katz, Leila; Souza, Paulo Roberto; Lima Junior, Sergio] Inst Med Integral Prof Fernando Figueira IMIP, Campina Grande, PB, Brazil.
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 12J
BP 105S
EP 106S
DI 10.1097/01.AOG.0000514987.54434.ff
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800377
DA 2020-12-01
ER

PT J
AU Amorim, M
   Brandao, AC
   Tavares, JD
   de Souza, ASR
AF Amorim, Melania
   Brandao, Andrea Carla
   Tavares, Jousilene de Sales
   Rolland de Souza, Alex Sandro
TI Pulmonary Function and Body Composition in Pregnant Women: A Transversal
   Study
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 06-09, 2017
CL San Diego, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Amorim, Melania; Brandao, Andrea Carla; Tavares, Jousilene de Sales; Rolland de Souza, Alex Sandro] Inst Med Integral Prof Fernando Figueira IMIP, Campina Grande, PB, Brazil.
RI Souza, Alex Sandro Rolland/AAG-2471-2019; Amorim, Melania M/C-5807-2013
OI Souza, Alex Sandro Rolland/0000-0001-7039-2052; Amorim, Melania
   M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2017
VL 129
SU 1
MA 26N
BP 149S
EP 149S
DI 10.1097/01.AOG.0000514736.32199.fa
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA EW7PD
UT WOS:000402705800535
DA 2020-12-01
ER

PT J
AU Amorim, MM
   Coutinho, IC
   Melo, I
   Katz, L
AF Amorim, M. M.
   Coutinho, Isabela Cristina
   Melo, Ines
   Katz, Leila
TI Selective episiotomy vs. implementation of a non-episiotomy protocol: a
   randomized clinical trial
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Episiotomy; Vaginal delivery; Perineum; Randomized controlled trial
ID PERINEAL LACERATIONS; VAGINAL BIRTHS; MANAGEMENT; TRAUMA
AB Background: Despite all the evidence corroborating the selective use of episiotomy and although routine use of the procedure is contraindicated, there are no evidences corroborating if episiotomy is necessary in any circumstance. The present clinical randomized trial was performed to compare maternal and perinatal outcomes in women submitted to a non-episiotomy protocol versus one of selective episiotomy.
   Methods: An open-labelled, randomized clinical trial was carried out in a tertiary teaching hospital in Recife, Northeastern Brazil. Women in labor with a full-term live foetus, dilatation of 6 to 8 cm and cephalic presentation (vertex position) were included. Exclusion criteria consisted of bleeding disorders and an indication for a caesarean section. After signing the consent form, 241 women were randomized to a non-episiotomy protocol (the experimental group) or to a selective episiotomy group (the control group). No episiotomies were to be performed in the experimental group except under exceptional circumstances. In the control group, selective episiotomies were to be performed in accordance with the healthcare professionals' clinical judgement. Maternal and perinatal outcomes were evaluated. Ratio Risk (RR) and the 95% confidence interval (95% CI) were calculated for our outcomes.
   Results: The analysis include 115 women assigned to a non-episiotomy protocol and 122 to selective episiotomy. There was no difference between the two groups with respect to maternal or perinatal outcomes. The episiotomy rate was similar (two cases in each group, about 1.7%), as was the duration of the second stage of labor, the frequency of perineal tears, severe perineal trauma, need for perineal suturing and blood loss at delivery.
   Conclusions: A non-episiotomy protocol appears to be safe for mother and child, and highlights the need to investigate whether there is, in fact, any indication for this procedure.
C1 [Amorim, M. M.; Coutinho, Isabela Cristina; Melo, Ines; Katz, Leila] Womens Healthcare Ctr, Inst Med Integral Prof Fernando Figueira, BR-50070550 Recife, PE, Brazil.
   [Amorim, M. M.] Inst Paraibano Pesquisa Prof Joaquim Amorim Neto, Rua Neusa Borborema 300, BR-58406120 Santo Antonio, Campina Grande, Brazil.
RP Amorim, MM (corresponding author), Womens Healthcare Ctr, Inst Med Integral Prof Fernando Figueira, BR-50070550 Recife, PE, Brazil.; Amorim, MM (corresponding author), Inst Paraibano Pesquisa Prof Joaquim Amorim Neto, Rua Neusa Borborema 300, BR-58406120 Santo Antonio, Campina Grande, Brazil.
EM melania.amorim@gmail.com
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
FU CNPq (National Counsel of Technological and Scientific
   Development)National Council for Scientific and Technological
   Development (CNPq) [482010/2012-6]
FX CNPq (National Counsel of Technological and Scientific Development) -
   Grant by Universal Edital Number 482010/2012-6 for elaboration of the
   protocol.
CR Albers LL, 2006, BIRTH-ISS PERINAT C, V33, P94, DOI 10.1111/j.0730-7659.2006.00085.x
   American College of Obstetricians-Gynecologists, 2016, ACOG PRACT B PRACT B, V128, pe1
   Amorim MM, 2014, OBSTET GYNECOL, V123, p38S, DOI 10.1097/01.AOG.0000447314.51968.54
   [Anonymous], 1993, Lancet, V342, P1517
   Belizan JM, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0131-2
   Blondel B, 2016, ACTA OBSTET GYN SCAN, V95, P746, DOI 10.1111/aogs.12894
   Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847
   CARROLI G, 2000, COCHRANE DB SYST REV, V2
   Carroli G, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000081.pub2
   Caughey AB, 2014, AM J OBSTET GYNECOL, V210, P179, DOI 10.1016/j.ajog.2014.01.026
   CHAPMAN CR, 1990, MANAGEMENT PAIN, P580
   Cochrane AL, 1972, EFFECTIVENESS EFFICI
   Davis-Floyd R, 1993, BIRTH AM RITE PASSAG, P382
   Eason E, 2000, OBSTET GYNECOL, V95, P616, DOI 10.1016/S0029-7844(99)00609-2
   El-Sayed YY, 2012, SEMIN PERINATOL, V36, P374, DOI 10.1053/j.semperi.2012.04.022
   Gabbe SG, 2002, AM J OBSTET GYNECOL, V187, P255, DOI 10.1067/mob.2002.123205
   Hicks CL, 2001, PAIN, V93, P173, DOI 10.1016/S0304-3959(01)00314-1
   Lappen J. R., 2014, EXPERT REV OBSTET GY, V5, P301, DOI [10.1586/eog.10.21, DOI 10.5686/E0G.10.21]
   Leal MD, 2014, CAD SAUDE PUBLICA, V30, DOI 10.1590/0102-311X00151513
   Leal NV, 2014, OBSTET GYNECOL, V123, p63S, DOI 10.1097/01.AOG.0000447369.00977.4c
   Melo I, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-66
   Myers-Helfgott MG, 1999, OBSTET GYN CLIN N AM, V26, P305, DOI 10.1016/S0889-8545(05)70077-2
   D'Gregorio RP, 2010, INT J GYNECOL OBSTET, V111, P201, DOI 10.1016/j.ijgo.2010.09.002
   Sagi-Dain L, 2015, OBSTET GYNECOL SURV, V70, P354, DOI 10.1097/OGX.0000000000000179
   Scott JR, 2005, OBSTET GYN CLIN N AM, V32, P307, DOI 10.1016/j.ogc.2004.12.001
   SLEEP J, 1984, BRIT MED J, V289, P587, DOI 10.1136/bmj.289.6445.587
   Steiner N, 2012, ARCH GYNECOL OBSTET, V286, P1369, DOI 10.1007/s00404-012-2460-x
   Suto M, 2015, J MIDWIFERY WOM HEAL, V60, P419, DOI 10.1111/jmwh.12324
   Thacker S B, 1983, Obstet Gynecol Surv, V38, P322, DOI 10.1097/00006254-198306000-00003
   THORP JM, 1987, OBSTET GYNECOL, V70, P260
   World Health Organization, 1996, CAR NORM BIRTH PRACT
   Zhang J, 2010, OBSTET GYNECOL, V116, P1281, DOI 10.1097/AOG.0b013e3181fdef6e
NR 32
TC 7
Z9 8
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD APR 24
PY 2017
VL 14
AR 55
DI 10.1186/s12978-017-0315-4
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA ES9KL
UT WOS:000399875800001
PM 28438209
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Marques, RMCD
   Souza, ASR
   Feitosa, FED
   da Costa, AAR
   Amorim, MMR
AF Carvalho de Paiva Marques, Rossana Mariana
   Rolland Souza, Alex Sandro
   de Lucena Feitosa, Francisco Edson
   Ribeiro da Costa, Aurelio Antonio
   Ramos Amorim, Melania Maria
TI Maternal and perinatal outcomes in women with and without hypertensive
   syndromes submitted to induction of labor with misoprostol
SO HYPERTENSION IN PREGNANCY
LA English
DT Article
DE Childbirth; hypertensive syndromes; induction of labor; labor;
   misoprostol
ID CESAREAN-SECTION; ELECTIVE INDUCTION; DELIVERY; RISK; PREECLAMPSIA
AB Objectives: To determine maternal and perinatal outcomes according to the mode of delivery in normotensive and hypertensive women bearing a live, full-term fetus, who were submitted to labor induction with misoprostol. Methods: Retrospective cohort study. The endpoints were tachysystole, uterine hyperstimulation, indications for cesarean section, severe maternal morbidity, side effects, maternal death, 1st/5th minute Apgar, neonatal death, requirement for neonatal intensive care, and birth weight (grams). The chi-square or Fisher's exact test was applied at a significance level of 5%. Risk ratios (RRs) and their 95% confidence intervals (95% CI) were calculated. Results: No significant differences were found in maternal outcome as a function of mode of delivery. First-minute Apgar score <7 was less common with vaginal deliveries in normotensive women (RR = 0.41; 95% CI: 0.18-0.90), this being the only significant difference in perinatal outcome. Conclusion: Maternal and perinatal outcomes were similar in hypertensive and normotensive women submitted to labor induction with misoprostol.
C1 [Carvalho de Paiva Marques, Rossana Mariana] Inst Med Integral Prof Fernando Figueira, Med Resident Obstet & Gynecol, Recife, PE, Brazil.
   [Rolland Souza, Alex Sandro; Ribeiro da Costa, Aurelio Antonio; Ramos Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira, Dept Obstet & Gynecol, Recife, PE, Brazil.
   [Rolland Souza, Alex Sandro] Univ Fed Pernambuco, Dept Maternal & Child Healthcare, Recife, PE, Brazil.
   [Rolland Souza, Alex Sandro; Ribeiro da Costa, Aurelio Antonio] Barao de Lucena Hosp, Dept Obstet, Recife, PE, Brazil.
   [Rolland Souza, Alex Sandro] Arnaldo Marques Polyclin & Matern Hosp, Dept Obstet, Recife, PE, Brazil.
   [de Lucena Feitosa, Francisco Edson] Univ Fed Ceara, Dept Maternal & Child Healthcare, Fortaleza, Ceara, Brazil.
   [Ramos Amorim, Melania Maria] Univ Fed Campina Grande, Dept Maternal & Child Healthcare, Campina Grande, Paraiba, Brazil.
RP Souza, ASR (corresponding author), Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM alexrolland@uol.com.br
RI feitosa, francisco e/H-8431-2014; Amorim, Melania M/C-5807-2013; Souza,
   Alex Sandro Rolland/AAG-2471-2019
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052
CR Abdul M A, 2007, West Afr J Med, V26, P213
   ACOG Committee on Practice Bulletins -- Obstetrics, 2009, Obstet Gynecol, V114, P386, DOI 10.1097/AOG.0b013e3181b48ef5
   Amorim MM, 2010, FEMINA, V38, P415
   BISHOP EH, 1964, OBSTET GYNECOL, V24, P266
   Brasil. Ministerio da Saude, 2010, GEST ALT RISC MAN TE, P257
   Marques RMCD, 2015, HYPERTENS PREGNANCY, V34, P153, DOI 10.3109/10641955.2014.988351
   Cecatti J G, 2000, Cad Saude Publica, V16, P1083, DOI 10.1590/S0102-311X2000000400026
   Cecatti JG, 1998, REV BRAS GINECOL OBS, V20, P389
   Gattas DSDB, 2012, REV BRAS GINECOL OBS, V34, P164, DOI 10.1590/S0100-72032012000400005
   Edwards C, 1997, INT J GYNECOL OBSTET, V57, P39, DOI 10.1016/S0020-7292(97)02854-3
   Faundes A, 1991, Cad Saude Publica, V7, P150, DOI 10.1590/S0102-311X1991000200003
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Fettosa FEL, 2006, INT J GYNECOL OBSTET, V94, P91, DOI 10.1016/j.ijgo.2006.04.031
   FILHO O, 2005, REV BRAS GINECOL OBS, V27, P24
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Guerra GV, 2009, BJOG-INT J OBSTET GY, V116, P1762, DOI 10.1111/j.1471-0528.2009.02348.x
   Guerra GV, 2011, B WORLD HEALTH ORGAN, V89, P657, DOI 10.2471/BLT.08.061226
   Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087
   Hofmeyr GJ, 2010, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000941
   Kim LH, 2010, J MATERN-FETAL NEO M, V23, P383, DOI 10.3109/14767050903168432
   Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4
   Lin C, 2004, AM J OBSTET GYNECOL, V190, P1476, DOI 10.1016/j.ajog.2004.02.035
   Lin MG, 2006, CLIN OBSTET GYNECOL, V49, P585, DOI 10.1097/00003081-200609000-00018
   Lydon-Rochelle MT, 2007, MED CARE, V45, P505, DOI 10.1097/MLR.0b013e3180330e26
   Patah LEM, 2011, REV SAUDE PUBL, V45, P185, DOI 10.1590/s0034-89102011000100021
   Mann T., 1996, CLIN GUIDELINES USIN
   NOTZON FC, 1994, AM J OBSTET GYNECOL, V170, P495, DOI 10.1016/S0002-9378(94)70217-9
   Pevzner L, 2009, OBSTET GYNECOL, V114, P261, DOI 10.1097/AOG.0b013e3181ad9377
   Royal College of Obstetricians and Gynaecologists, 2001, RCOG CLIN EFF SUPP U
   Sampaio ZS, 2004, REV BRAS GINECOL OBS, V26, P21
   Sanchez-Ramos L, 2002, OBSTET GYNECOL, V99, P145, DOI 10.1016/S0029-7844(01)01644-1
   Seyb ST, 1999, OBSTET GYNECOL, V94, P600, DOI 10.1016/S0029-7844(99)00377-4
   Souza ASR, 2013, INT J GYNECOL OBSTET, V123, P207, DOI 10.1016/j.ijgo.2013.06.028
   Souza AS, 2010, FEMINA, V38, P185
   Vause S, 1999, BRIT MED J, V318, P1056, DOI 10.1136/bmj.318.7190.1056
   WHO, 2011, WHO REC IND LAB
   Wing DA, 1998, OBSTET GYNECOL, V91, P828, DOI 10.1016/S0029-7844(97)00553-X
   Xiong X, 1999, AM J OBSTET GYNECOL, V180, P207, DOI 10.1016/S0002-9378(99)70176-6
NR 38
TC 2
Z9 3
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1064-1955
EI 1525-6065
J9 HYPERTENS PREGNANCY
JI Hypertens. Pregnancy
PD FEB
PY 2017
VL 36
IS 1
BP 1
EP 7
DI 10.1080/10641955.2016.1197935
PG 7
WC Obstetrics & Gynecology; Physiology; Peripheral Vascular Disease
SC Obstetrics & Gynecology; Physiology; Cardiovascular System & Cardiology
GA EM2XJ
UT WOS:000395178800001
PM 27420285
DA 2020-12-01
ER

PT J
AU Neto, CN
   Maia, SSB
   Katz, L
   Coutinho, IC
   Souza, AR
   Amorim, MM
AF Neto C, Carlos Noronha
   Maia, Sabina S. B.
   Katz, Leila
   Coutinho, Isabela C.
   Souza, Alex R.
   Amorim, Melania M.
TI Clonidine versus Captopril for Severe Postpartum Hypertension: A
   Randomized Controlled Trial
SO PLOS ONE
LA English
DT Article
ID PREGNANCY; PREECLAMPSIA; MANAGEMENT
AB Background
   Changes during the puerperium are still unclear, particularly in women with hypertension. The choice of antihypertensives, both to control very high blood pressure episodes and to keep blood pressure stable, also requires further elucidation. Currently, there are no clear data to guide the decision for the choice of postpartum antihypertensives. Captopril plays an important role in the treatment of very high blood pressure episodes and may be used postpartum. Clonidine has been used as an alternative in pregnant or postpartum women with contraindications to captopril, with satisfactory effect. The objective of the present study was to evaluate the effectiveness and safety of clonidine compared to captopril for treating severe postpartum hypertension.
   Methods and findings
   A randomized, drug-controlled, triple-blind clinical trial evaluating postpartum women receiving captopril or clonidine. Inclusion criteria consisted of: women with hypertensive disorders ;of pregnancy systolic blood pressure (SBP) >= 180 mmHg and/or diastolic blood pressure (DBP) >= 110 mmHg], requiring magnesium sulfate. Exclusion criteria were: heart disease, smoking, illicit drug use, contraindications to captopril, clonidine or oral medication, and having used captopril/clonidine previously. The primary outcome was the frequency of very high blood pressure episodes while in the obstetric intensive care unit. A total of 90 postpartum women met the study inclusion criteria, with 45 randomized to each group. There were fewer very high blood pressure episodes during hospitalization (2.1 +/- 2.1 vs. 3.5 +/- 4.7, p = 0.08), greater percentage reduction in SBP (14.0% +/- 8.6% vs. 10.8% +/- 8.8%, p = 0.08) and fewer women requiring sodium nitroprusside (2.3% vs. 13.3%; RR: 0.17; 95% CI: 0.02 +/- 1.39; p = 0.06) in the clonidine group compared to the captopril group; however, these differences were not significant. The groups were similar regarding daily mean SBP or DBP; however, on the third postpartum day, mean SBP was lower in the clonidine compared to the captopril group (151.9 +/- 11.8 mmHg vs. 158.1 +/- 13.6 mmHg, p = 0.02). Although not statistically significant, adverse reactions were more common in the captopril group (28.8%) compared to the clonidine group (18.6%).
   Conclusion
   Clonidine and captopril represent safe, effective treatments for severe postpartum hypertension.
C1 [Neto C, Carlos Noronha; Maia, Sabina S. B.; Katz, Leila; Coutinho, Isabela C.; Souza, Alex R.; Amorim, Melania M.] Inst Med Integral Prof Fernando Figueira, Post Grad Program Maternal & Child Hlth, Recife, PE, Brazil.
RP Amorim, MM (corresponding author), Inst Med Integral Prof Fernando Figueira, Post Grad Program Maternal & Child Hlth, Recife, PE, Brazil.
EM profmelania.amorim@gmail.com
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013; Souza, Alex
   Sandro Rolland/G-3446-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514;
   maia, sabina/0000-0003-4974-5073; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052
CR [Anonymous], 7 REP JOINT NAT COM
   Barrilleaux PS, 2002, CLIN OBSTET GYNECOL, V45, P22, DOI 10.1097/00003081-200203000-00005
   Fujitani Shigeki, 2005, Crit Care Med, V33, pS354, DOI 10.1097/01.CCM.0000183156.73560.0C
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   HARTIKAINENSORRI AL, 1987, OBSTET GYNECOL, V69, P598
   Magee L, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004351.pub3
   Marchioli Milton, 2004, Rev. Bras. Ginecol. Obstet., V26, P391, DOI 10.1590/S0100-72032004000500008
   MCMAHON FG, 1990, CLIN THER, V12, P88
   Neto C Noronha, 2013, REPROD HLTH, V10, P37, DOI [10.1186/1742-4755-10-37, DOI 10.1186/1742-4755-10-37]
   Neto CN, 2010, REV BRAS GINECOL OBS, V32, P459, DOI 10.1590/S0100-72032010000900008
   Patil PM, 2012, J ORAL MAXIL SURG, V70, P257, DOI 10.1016/j.joms.2011.07.011
   de Melo BCP, 2009, REV ASSOC MED BRAS, V55, P175, DOI 10.1590/S0104-42302009000200022
   Podymow T, 2011, SEMIN NEPHROL, V31, P70, DOI 10.1016/j.semnephrol.2010.10.007
   Souza ASR, 2008, REV ASSOC MED BRAS, V54, P232, DOI 10.1590/S0104-42302008000300016
   Serreau R, 2010, Ann Fr Anesth Reanim, V29, pe37, DOI 10.1016/j.annfar.2010.02.016
   Sevrez C, 2014, ARCH PEDIATRIE, V21, P198, DOI 10.1016/j.arcped.2013.11.004
   Sibai BM, 2012, AM J OBSTET GYNECOL, V206, P470, DOI 10.1016/j.ajog.2011.09.002
   Stocche Renato Mestriner, 2002, Rev. Bras. Anestesiol., V52, P426, DOI 10.1590/S0034-70942002000400006
   TUIMALA R, 1985, ANN CHIR GYNAECOL FE, V74, P47
   van den Born BJH, 2011, NETH J MED, V69, P248
   Yilmaz S, 2011, BLOOD PRESSURE, V20, P239, DOI 10.3109/08037051.2011.553934
   ZUSPAN FP, 1978, AM J OBSTET GYNECOL, V131, P591, DOI 10.1016/0002-9378(78)90816-5
NR 22
TC 2
Z9 2
U1 0
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 26
PY 2017
VL 12
IS 1
AR e0168124
DI 10.1371/journal.pone.0168124
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA EN7IT
UT WOS:000396176100151
PM 28125624
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Amorim, MMR
   Souza, ASR
   Katz, L
AF Amorim, Melania M. R.
   Souza, Alex Sandro R.
   Katz, Leila
TI Planned caesarean section versus planned vaginal birth for severe
   pre-eclampsia
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID HYPERTENSIVE DISORDERS; DIAGNOSIS; INDUCTION; DELIVERY; LABOR;
   MANAGEMENT; OUTCOMES; WOMEN
AB Background
   Pre-eclampsia is a very frequent complication of pregnancy, and anticipation of birth is often necessary. However, the best mode of giving birth remains to be established, although observational studies suggest better maternal and perinatal outcomes with vaginal birth.
   Objectives
   To assess the effects of a policy of planned caesarean section versus planned vaginal birth for women with severe pre-eclampsia on mortality and morbidity for mother and baby.
   Search methods
   We searched Cochrane Pregnancy and Childbirth's Trials Register, ClinicalTrials. gov, the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) (6 September 2017) and reference lists of retrieved studies.
   Selection criteria
   We planned to include all randomised trials of planned caesarean section versus planned vaginal birth for pregnant women with severe pre-eclampsia. Quasi-randomised and non-randomised studies are not eligible for inclusion in this review. The focus of this review is severe pre- eclampsia; studies of planned caesarean section versus planned vaginal birth in pregnant women with eclampsia are not eligible for inclusion.
   Data collection and analysis
   We identified no studies that met the inclusion criteria. We excluded two studies.
   Main results
   There are no included studies in this review.
   Authors' conclusions
   There is a lack of robust evidence from randomised controlled trials that can inform practice regarding planned caesarean section versus planned vaginal birth for women with severe pre-eclampsia. There is a need for high-quality randomised controlled trials to assess the short-and long-term effects of caesarean section and vaginal birth for these women and their babies.
C1 [Amorim, Melania M. R.; Souza, Alex Sandro R.; Katz, Leila] Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos 300, BR-50070050 Recife, PE, Brazil.
RP Amorim, MMR (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos 300, BR-50070050 Recife, PE, Brazil.
EM profmelania.amorim@gmail.com
RI Souza, Alex Sandro Rolland/AAG-2471-2019; Amorim, Melania M/C-5807-2013;
   Katz, Leila/M-5291-2013
OI Souza, Alex Sandro Rolland/0000-0001-7039-2052; Amorim, Melania
   M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
FU Instituto de Medicina Integral Professor Fernando Figueira, Brazil
FX Instituto de Medicina Integral Professor Fernando Figueira, Brazil.
CR ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67
   Alanis MC, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.076
   Amorim MMR, 2015, J MATERN-FETAL NEO M, V28, P654, DOI 10.3109/14767058.2014.928689
   Amorim MMR, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009430, DOI 10.1002/14651858.CD009430]
   Blackwell S C, 2001, J Matern Fetal Med, V10, P305
   Broekhuijsen K, 2015, LANCET, V385, P2492, DOI 10.1016/S0140-6736(14)61998-X
   CATANZARITE V, 1991, AM J PERINAT, V8, P7, DOI 10.1055/s-2007-999327
   Coppage KH, 2002, AM J OBSTET GYNECOL, V186, P921, DOI 10.1067/mob.2002.124041
   Drife J, 2006, BJOG-INT J OBSTET GY, V113, P81, DOI 10.1111/j.1471-0528.2006.01129.x
   Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2
   Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000127.pub2
   Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000128.pub2
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Esteves-Pereira AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153396
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Gruslin A, 2008, J OBSTET GYNAECOL CA, V30, P1000, DOI 10.1016/S1701-2163(16)32993-0
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Jauniaux E, 2017, AM J OBSTET GYNECOL, V217, P27, DOI 10.1016/j.ajog.2017.02.050
   Kawakita T, 2018, AM J PERINAT, V35, P95, DOI 10.1055/s-0037-1606185
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4
   Kuklina EV, 2009, OBSTET GYNECOL, V113, P1299, DOI 10.1097/AOG.0b013e3181a45b25
   Mozurkewich E, 2009, BJOG-INT J OBSTET GY, V116, P626, DOI 10.1111/j.1471-0528.2008.02065.x
   Nassar AH, 1998, AM J OBSTET GYNECOL, V179, P1210, DOI 10.1016/S0002-9378(98)70133-4
   National Collaborating Centre for Women's and Children's Health, 2011, HYP PREGN DIAGN MAN
   Neto CN, 2010, REV BRAS GINECOL OBS, V32, P459, DOI 10.1590/S0100-72032010000900008
   Norwitz ER, PREECLAMPSIA MANAGEM
   Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   Ronsmans C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S8
   Seal SL, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2012.04.009
   Sibai BM, 2005, OBSTET GYNECOL, V105, P402, DOI 10.1097/01.AOG.0000152351.13671.99
   Sibai BM, 2004, OBSTET GYNECOL, V103, P981, DOI 10.1097/01.AOG.0000126245.35811.2a
   Sibai BM, 2007, JAMA-J AM MED ASSOC, V298, P1548
   The Nordic Cochrane Centre, 2014, REV MAN REVMAN VERS
   Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]
   Tukur J, 2007, Niger J Med, V16, P364
   [WHO] World Health Organization, 2011, WHO REC PREV TREATM
   World Health Organization, 2009, REP WORLD HLTH ORG W
   Xenakis EMJ, 1997, OBSTET GYNECOL, V89, P600, DOI 10.1016/S0029-7844(97)00043-4
NR 41
TC 3
Z9 3
U1 1
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2017
IS 10
AR CD009430
DI 10.1002/14651858.CD009430.pub2
PG 19
WC Medicine, General & Internal
SC General & Internal Medicine
GA FL6YD
UT WOS:000414391500005
PM 29058762
OA Green Published
DA 2020-12-01
ER

PT J
AU Lemos, A
   Amorim, MMR
   de Andrade, AD
   de Souza, AI
   Cabral, JE
   Correia, JB
AF Lemos, Andrea
   Amorim, Melania M. R.
   de Andrade, Armele Dornelas
   de Souza, Ariani I.
   Cabral Filho, Jose Eulalio
   Correia, Jailson B.
TI Pushing/bearing down methods for the second stage of labour (Review)
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
DE Analgesia, Epidural [methods]; Analgesia, Obstetrical [methods]; Breath
   Holding; Delivery, Obstetric [*methods]; Labor Stage, Second
   [*physiology]; Randomized Controlled Trials as Topic; Respiration; Time
   Factors; Uterine Contraction [*physiology]; Valsalva Maneuver; Adult;
   Female; Humans; Infant; Newborn; Pregnancy
ID RANDOMIZED CONTROLLED-TRIAL; LUMBAR EPIDURAL ANALGESIA; 2ND STAGE;
   NULLIPAROUS WOMEN; PUSHING TECHNIQUES; IMMEDIATE; DELIVERY; BEARING;
   MANAGEMENT; DURATION
AB Background
   Maternal pushing during the second stage of labour is an important and indispensable contributor to the involuntary expulsive force developed by uterus contraction. Currently, there is no consensus on an ideal strategy to facilitate these expulsive efforts and there are contradictory results about the influence on mother and fetus.
   Objectives
   To evaluate the benefits and possible disadvantages of different kinds of techniques regarding maternal pushing/breathing during the expulsive stage of labour on maternal and fetal outcomes.
   Search methods
   We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (28 January 2015) and reference lists of retrieved studies.
   Selection criteria
   Randomised and quasi-randomised assessing the effects of pushing/bearing down techniques (type and/or timing) performed during the second stage of labour on maternal and neonatal outcomes. Cluster-RCTs were eligible for inclusion but none were identified. Studies using a cross-over design and those published in abstract form only were not eligible for inclusion.We considered the following comparisons.Timing of pushing: to compare pushing, which begins as soon as full dilatation has been determined versus pushing which begins after the urge to push is felt.Type of pushing: to compare pushing techniques that involve the 'Valsalva Manoeuvre' versus all other pushing techniques.
   Data collection and analysis
   Two review authors independently assessed trials for inclusion and risk of bias. Two review authors independently extracted data. Data were checked for accuracy.
   Main results
   In this updated review, we included 21 studies in total, eight ( 884 women) comparing spontaneous pushing versus directed pushing, with or without epidural analgesia and 13 ( 2879 women) comparing delayed pushing versus immediate pushing with epidural analgesia. Our GRADE assessments of evidence ranged from moderate to very low quality; the main reasons for downgrading were study design limitations and imprecision of effect estimates. Overall, the included studies varied in their risk of bias; most were judged to be at unclear risk of bias.
   Comparison 1: types of pushing: spontaneous pushing versus directed pushing
   There was no clear difference in the duration of the second stage of labour (mean difference (MD) 10.26 minutes; 95% confidence interval (CI) -1.12 to 21.64 minutes, six studies, 667 women, random- effects, I-2 = 81%) (very low-quality evidence). There was no clear difference in 3rd or 4th degree perineal laceration (risk ratio (RR) 0.87; 95% CI 0.45 to 1.66, one study, 320 women) (low-quality evidence), episiotomy (average RR 1.05; 95% CI 0.60 to 1.85, two studies, 420 women, random- effects, I (2) = 81%), duration of pushing (MD -9.76 minutes, 95% CI -19.54 to 0.02; two studies; 169 women; I-2 = 88%) (very low-quality evidence), or rate of spontaneous vaginal delivery (RR 1.01, 95% CI 0.97 to 1.05; five studies; 688 women; I-2 = 2%) (moderate-quality evidence). For primary neonatal outcomes such as five-minute Apgar score less than seven, there was no clear difference between groups (RR 0.35; 95% CI 0.01 to 8.43, one study, 320 infants) (very low-quality evidence), and the number of admissions to neonatal intensive care (RR 1.08; 95% CI 0.30 to 3.79, two studies, 393 infants) (very low-quality evidence) also showed no clear difference between spontaneous and directed pushing. No data were available on hypoxic ischaemic encephalopathy.
   Comparison 2: timing of pushing: delayed pushing versus immediate pushing (all women with epidural)
   For the primary maternal outcomes, delayed pushing was associated with an increase of 56 minutes in the duration of the second stage of labour (MD 56.40, 95% CI 42.05 to 70.76; 11 studies; 3049 women; I-2 = 91%) (very low-quality evidence), but no clear difference in third or 4th degree perineal laceration (RR 0.94; 95% CI 0.78 to 1.14, seven studies. 2775 women) (moderate-quality evidence) or episiotomy (RR 0.95; 95% CI 0.87 to 1.04, five studies, 2320 women). Delayed pushing was also associated with a 19-minute decrease in the duration of pushing (MD -19.05, 95% CI -32.27 to -5.83; 11 studies; 2932 women; I-2 = 95%) (very low-quality evidence) and an increase in spontaneous vaginal delivery (RR 1.07; 95% CI 1.02 to 1.11, 12 studies, 3114 women) (moderate-quality evidence). For the primary neonatal outcomes, there was no clear difference between groups in admission to neonatal intensive care (RR 0.98; 95% CI 0.67 to 1.41, three studies, n = 2197) (low-quality evidence) and five-minute Apgar score less than seven (RR 0.15; 95% CI 0.01 to 3.00; three studies; 413 infants) (very low-quality evidence). There were no data on hypoxic ischaemic encephalopathy. Delayed pushing was associated with a greater incidence of low umbilical cord blood pH (RR 2.24; 95% CI 1.37 to 3.68, 4 studies, 2145 infants) and increased the cost of intrapartum care by CDN$ 68.22 (MD 68.22, 95% CI 55.37, 81.07, one study, 1862 women).
   Authors' conclusions
   This updated review is based on 21 included studies of moderate to very low quality of evidence ( with evidence mainly downgraded due to study design limitations and imprecision of effect estimates).
   Timing of pushing with epidural is consistent in that delayed pushing leads to a shortening of the actual time pushing and increase of spontaneous vaginal delivery at the expense of an overall longer duration of the second stage of labour and an increased risk of a low umbilical cord pH (based only on one study). Nevertheless, there was no clear difference in serious perineal laceration and episiotomy, and in other neonatal outcomes (admission to neonatal intensive care, five-minute Apgar score less than seven and delivery room resuscitation) between delayed and immediate pushing.
   Therefore, for the type of pushing, with or without epidural, there is no conclusive evidence to support or refute any specific style as part of routine clinical practice, and in the absence of strong evidence supporting a specific method or timing of pushing, the woman's preference and comfort and clinical context should guide decisions. Further properly well-designed RCTs, addressing clinically important maternal and neonatal outcomes are required to add evidence-based information to the current knowledge. Such trials will provide more complete data to be incorporated into a future update of this review.
C1 [Lemos, Andrea; de Andrade, Armele Dornelas] Univ Fed Pernambuco, Phys Therapy, Recife, PE, Brazil.
   [Amorim, Melania M. R.; de Souza, Ariani I.; Cabral Filho, Jose Eulalio; Correia, Jailson B.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Lemos, A (corresponding author), Univ Fed Pernambuco, Phys Therapy, Dept Fisioterapia, Av Prof Moraes Rego 1235,Cidade Univ, BR-50670901 Recife, PE, Brazil.
EM andrealemos4@gmail.com
RI Souza, Ariani I/C-1568-2015; de Souza, Ariani Impieri/AAR-6884-2020;
   Amorim, Melania M/C-5807-2013
OI Souza, Ariani I/0000-0002-7917-5983; de Souza, Ariani
   Impieri/0000-0002-7917-5983; Amorim, Melania M/0000-0003-1047-2514
FU National Institute for Health Research, via Cochrane Infrastructure -
   Cochrane Pregnancy and Child birth
FX This project was supported by the National Institute for Health
   Research, via Cochrane Infrastructure funding to Cochrane Pregnancy and
   Child birth. The views and opinions expressed therein are those of the
   authors and do not necessarily reflect those of the Systematic Reviews
   Programme, NIHR, NHS or the Department of Health.
CR ADERHOLD KJ, 1991, J NURSE-MIDWIFERY, V36, P267, DOI 10.1016/0091-2182(91)90041-M
   Albers LL, 2007, J MIDWIFERY WOM HEAL, V52, P246, DOI 10.1016/j.jmwh.2006.12.008
   ALDRICH CJ, 1995, BRIT J OBSTET GYNAEC, V102, P448, DOI 10.1111/j.1471-0528.1995.tb11316.x
   Aviram A, 2016, J MATERN-FETAL NEO M, V29, P868, DOI 10.3109/14767058.2015.1024648
   BARNETT MM, 1982, BIRTH-ISS PERINAT C, V9, P221, DOI 10.1111/j.1523-536X.1982.tb01667.x
   BATES RG, 1985, BRIT J OBSTET GYNAEC, V92, P1246, DOI 10.1111/j.1471-0528.1985.tb04870.x
   BEYNON CL, 1957, J OBSTET GYNAECOL, V64, P815
   Bloom SL, 2006, AM J OBSTET GYNECOL, V194, P10, DOI 10.1016/j.ajog.2005.06.022
   Boulvain M, 1998, 21 C SWISS SOC GYN O, P5
   Brancato RM, 2008, JOGNN-J OBST GYN NEO, V37, P4, DOI [10.1111/J.1552-6909.2007.00205.x, 10.1111/j.1552-6909.2007.00205.x]
   Brincat C, 2009, INT J GYNECOL OBSTET, V106, P236, DOI 10.1016/j.ijgo.2009.04.018
   Buhimschi CS, 2002, AM J OBSTET GYNECOL, V186, P1339, DOI 10.1067/mob.2002.122402
   BUXTON EJ, 1988, J OBSTET GYNAECOL, V8, P258, DOI 10.3109/01443618809012295
   Buxton EJ, 1989, P SILV JUBL BRIT C O, P80
   Caldeyro-Barcia R., 1990, COMMUNICATION
   CALDEYROBARCIA R, 1981, J PERINAT MED, V9, P63, DOI 10.1515/jpme.1981.9.s1.63
   Chang SC, 2011, MIDWIFERY, V27, P825, DOI 10.1016/j.midw.2010.08.009
   Cunningham FG, 2001, WILLIAMS OBSTET
   Fitzpatrick M, 2002, BJOG-INT J OBSTET GY, V109, P1359, DOI 10.1046/j.1471-0528.2002.02109.x
   Fitzpatrick M., 2000, American Journal of Obstetrics and Gynecology, V182, pS37
   Fraser WD, 2000, AM J OBSTET GYNECOL, V182, P1165, DOI 10.1067/mob.2000.105197
   Fraser WD, 1997, ACTA OBSTET GYNECO S, V76, P45
   Fraser WD, 1998, SOC OBST GYN CAN 54, P36
   Gillesby E, 2010, JOGNN-J OBST GYN NEO, V39, P635, DOI 10.1111/j.1552-6909.2010.01195.x
   Gillesby EJ, 2010, JOGNN-J OBST GYN NEO, V39, pS87, DOI 10.1111/j.1552-6909.2010.01123_1.x
   GLEESON NC, 1991, BRIT J CLIN PRACT, V45, P90
   GOODFELLOW CF, 1979, BRIT J CLIN PRACT, V33, P287
   Gupta JK, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002006.pub3, DOI 10.1002/14651858.CD002006.PUB3]]
   Hansen SL, 2002, OBSTET GYNECOL, V99, P29, DOI 10.1016/S0029-7844(01)01642-8
   Hanson L, 2009, J PERINAT NEONAT NUR, V23, P31, DOI 10.1097/JPN.0b013e318196526b
   Haseeb YA, 2014, SAUDI J MED MED SCI, V2, P101, DOI 10.4103/1658-631X.137000
   Hauspurg A, 2014, PASSIVE DESCENT OBES
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   Jahdi F, 2011, INT J NURS MIDWIFERY, V3, P55
   Jahdi F, 2011, INT J COLLAB RES INT, V3, P159
   Kelly M, 2010, MCN-AM J MATERN-CHIL, V35, P81, DOI 10.1097/NMC.0b013e3181cae7ad
   KNAUTH DG, 1986, NURS RES, V35, P49
   Lai ML, 2009, J NURS RES, V17, P62, DOI 10.1097/JNR.0b013e3181999e78
   Lam C. W, 2006, THESIS
   Lam CCO, 2010, HONG KONG J GYNAECOL, V10, P13
   Le Ray C, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.002
   Le Ray C, 2008, AM J OBSTET GYNECOL, V199, pS37, DOI 10.1016/j.ajog.2008.09.111
   Lemos A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009124, DOI 10.1002/14651858.CD009124]]
   Lemos A, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009124.pub2
   Lin P, 2000, J Fam Pract, V49, P783
   Liston RM, 1996, COMMUNICATION
   Liston RM, 1987, P 19 ANN M SOC OBST, P94
   Low LK, 2013, INT UROGYNECOL J, V24, P453, DOI 10.1007/s00192-012-1884-y
   Low LK, 2013, FEMALE PELVIC MED RE, V19
   Low LK, 2010, FEMALE PELVIC MED S2, V16, pS70
   MARESH M, 1983, BRIT J OBSTET GYNAEC, V90, P623, DOI 10.1111/j.1471-0528.1983.tb09278.x
   Martinez-Lopez V, 1984, P 31 M SOC GYN INV 1
   Matsuo K, 2009, J OBSTET GYNAECOL RE, V35, P672, DOI 10.1111/j.1447-0756.2008.01010.x
   Mayberry L J, 1999, J Perinatol, V19, P26, DOI 10.1038/sj.jp.7200076
   MCQUEEN J, 1977, BRIT MED J, V1, P640
   Menez-Orieux C, 2005, J Gynecol Obstet Biol Reprod (Paris), V34, P440
   Minato JF, 2001, AWHONN LIFELINES, V4, P20
   Moraloglu O, 2016, J MATERNAL FETAL NEO
   Mulvey SF., MCROBERTS MANOEUVRE
   PARNELL C, 1993, ACTA OBSTET GYN SCAN, V72, P31, DOI 10.3109/00016349309013345
   Parnell C, 1993, UGESKRIFT LAEGER, V155, P2259
   Parnell C, 1992, ACTA PAEDIATR, P17
   Petrou S, 2000, AM J OBSTET GYNECOL, V182, P1158, DOI 10.1067/mob.2000.104213
   Phipps H, 2007, J PAEDIAT CHILD H S1, V43, pA67
   Phipps H, 2009, AUST NZ J OBSTET GYN, V49, P274, DOI 10.1111/j.1479-828X.2009.00984.x
   Pickrell MD, 1989, P SILV JUB BRIT C OB, P128
   Plunkett BA, 2003, OBSTET GYNECOL, V102, P109, DOI 10.1016/S0029-7844(03)00479-4
   Plunkett Beth, 2001, American Journal of Obstetrics and Gynecology, V184, pS119
   Prins M, 2011, BJOG-INT J OBSTET GY, V118, P662, DOI 10.1111/j.1471-0528.2011.02910.x
   RAVINDRAN RS, 1981, ANESTH ANALG, V60, P524
   Roberts CL, 2004, BJOG-INT J OBSTET GY, V111, P1333, DOI 10.1111/j.1471-0528.2004.00282.x
   Roberts J, 1996, J Obstet Gynecol Neonatal Nurs, V25, P415, DOI 10.1111/j.1552-6909.1996.tb02446.x
   Roberts J E, 1987, J Obstet Gynecol Neonatal Nurs, V16, P48, DOI 10.1111/j.1552-6909.1987.tb01438.x
   Roberts JE, 2002, J MIDWIFERY WOM HEAL, V47, P2, DOI 10.1016/S1526-9523(01)00233-1
   Roberts J, 2007, J MIDWIFERY WOM HEAL, V52, P238, DOI 10.1016/j.jmwh.2006.12.011
   Schaffer J, 2005, AM J OBSTET GYNECOL, V192, P1692, DOI 10.1016/j.ajog.2004.11.043
   Simpson KR, 2005, NURS RES, V54, P149
   Snyder S, 1996, COMMUNICATION
   Spiby H, 1990, COMMUNICATION
   The Nordic Cochrane Centre, 2014, REV MAN REVMAN VERS
   THOMSON AM, 1995, J ADV NURS, V22, P1027
   THOMSON AM, 1993, J ADV NURS, V18, P171, DOI 10.1046/j.1365-2648.1993.18020171.x
   Thomson AM., 1990, THESIS
   Thomson AM., 1991, P 22 INT C CONF MIDW, P76
   Thorp JA, 1996, BIRTH-ISS PERINAT C, V23, P63, DOI 10.1111/j.1523-536X.1996.tb00833.x
   Tuuli MG, 2012, OBSTET GYNECOL, V120, P660, DOI 10.1097/AOG.0b013e3182639fae
   Vause S, 1998, BRIT J OBSTET GYNAEC, V105, P186, DOI 10.1111/j.1471-0528.1998.tb10050.x
   Vause S, 1998, BRIT J OBSTET GYNAEC, V105, P85
   Vaziri F, 2016, IRANIAN RED IN PRESS
   Wai CY, 2011, INT UROGYNECOL J, V22, P1293, DOI 10.1007/s00192-011-1438-8
   Walker C, 2012, INT UROGYNECOL J, V23, P1249, DOI 10.1007/s00192-012-1675-5
   YEATES DA, 1984, J NURSE-MIDWIFERY, V29, P3, DOI 10.1016/0091-2182(84)90324-0
   Yildirim G, 2008, BIRTH-ISS PERINAT C, V35, P25, DOI 10.1111/j.1523-536X.2007.00208.x
NR 94
TC 6
Z9 7
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2017
IS 3
AR CD009124
DI 10.1002/14651858.CD009124.pub3
PG 111
WC Medicine, General & Internal
SC General & Internal Medicine
GA EU1FX
UT WOS:000400761200025
PM 28349526
OA Green Published
DA 2020-12-01
ER

PT J
AU Ornelas, AMM
   Pezzuto, P
   Silveira, PP
   Melo, FO
   Ferreira, TA
   Oliveira-Szejnfeld, PS
   Leal, JI
   Amorim, MMR
   Hamilton, S
   Rawlinson, WD
   Cardoso, CC
   Nixon, DF
   Tanuri, A
   Melo, AS
   Aguiar, RS
AF Ornelas, Alice M. M.
   Pezzuto, Paula
   Silveira, Paola P.
   Melo, Fabiana O.
   Ferreira, Thales A.
   Oliveira-Szejnfeld, Patricia S.
   Leal, Jeime I.
   Amorim, Melania M. R.
   Hamilton, Stuart
   Rawlinson, William D.
   Cardoso, Cynthia C.
   Nixon, Douglas F.
   Tanuri, Amilcar
   Melo, Adriana S.
   Aguiar, Renato S.
TI Immune activation in amniotic fluid from Zika virus-associated
   microcephaly
SO ANNALS OF NEUROLOGY
LA English
DT Article
ID INFECTION; CYTOKINES; GROWTH; BRAIN; WOMEN
AB Recent advances in the understanding of neuropathogenesis associated with Zika virus (ZIKV) infection has led to descriptions of neonatal microcephaly cases. However, none of these reports have evaluated the humoral response during ZIKV infection. We report here polyfunctional immune activation associated with increased interferon-gamma-inducible protein 10, interleukin (IL)-6, IL-8, vascular endothelial growth factor (VEGF), monocyte chemoattractive protein 1 (MCP-1), and granulocyte colony-stimulating factor (G-CSF) levels in the amniotic fluid of ZIKV-positive pregnant women with neonatal microcephaly. These cytokines have been associated not only with neuronal damage, but also with differentiation and proliferation of neural progenitor cells. Our results suggested that the immune activation caused by ZIKV infection in the uterine environment could also interfere with fetal development. ANN NEUROL 2017;81:152-156
C1 [Ornelas, Alice M. M.; Pezzuto, Paula; Silveira, Paola P.; Cardoso, Cynthia C.; Tanuri, Amilcar; Aguiar, Renato S.] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
   [Melo, Fabiana O.; Ferreira, Thales A.; Leal, Jeime I.; Amorim, Melania M. R.; Melo, Adriana S.] Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
   [Oliveira-Szejnfeld, Patricia S.] Univ Fed Sao Paulo, Fundacao Inst Ensino & Pesquisa Diagnost Imagem F, Dept Diagnost Imagem, Sao Paulo, Brazil.
   [Hamilton, Stuart; Rawlinson, William D.] Prince Wales Hosp, POWH & UNSW Res Labs, Virol Res, Randwick, NSW, Australia.
   [Nixon, Douglas F.] George Washington Univ, Dept Microbiol Immunol & Trop Med, Washington, DC USA.
RP Aguiar, RS (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Ave Carlos Chagas Filho 373, BR-21941902 Rio De Janeiro, Brazil.
EM santanarnt@gmail.com
RI Cardoso, Cynthia/K-5824-2012; Aguiar, Renato S/G-3542-2015; Nixon,
   Douglas/AAU-5734-2020; Ferreira, Thales Araujo/AAA-6252-2019; Melo,
   Adriana S O/H-5650-2016; Amorim, Melania M/C-5807-2013
OI Cardoso, Cynthia/0000-0003-0565-7047; Aguiar, Renato
   S/0000-0001-5180-3717; Nixon, Douglas/0000-0002-2801-1786; Amorim,
   Melania M/0000-0003-1047-2514; Soares de Oliveira Szejnfeld,
   Patricia/0000-0002-3780-5182; FERREIRA, THALES/0000-0002-6699-5886
FU Consellho Nacional de Desenvolvimento e Pesquisa (CNPq); Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)Carlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ); CAPESCAPES; Brazilian Ministry of Education (CAPES)CAPES
FX This work was funded by Consellho Nacional de Desenvolvimento e Pesquisa
   (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro
   (FAPERJ).; We thank CAPES for student's fellowship. A.M.M.O. has been
   sponsored by a Ph.D. scholarship from the Brazilian Ministry of
   Education (CAPES) and this work is part of her requirements for
   obtaining a Ph.D. degree by the Graduate Program in Genetics at the
   Federal University of rio de janeiro, Brazil.
CR Ashdown H, 2006, MOL PSYCHIATR, V11, P47, DOI 10.1038/sj.mp.4001748
   Breton J, 2011, J NEUROL NEUROPHYSIO, pS4, DOI DOI 10.4172/2155-9562.S4-001
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chow SSW, 2008, CYTOKINE, V44, P78, DOI 10.1016/j.cyto.2008.06.009
   Fortunato SJ, 1998, AM J REPROD IMMUNOL, V39, P16
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   GREIG PC, 1995, AM J OBSTET GYNECOL, V173, P1223, DOI 10.1016/0002-9378(95)91358-0
   Hui L, 2012, OBSTET GYNECOL, V119, P111, DOI 10.1097/AOG.0b013e31823d4150
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Meyer U, 2006, J NEUROSCI, V26, P4752, DOI 10.1523/JNEUROSCI.0099-06.2006
   Meyer U, 2009, SCHIZOPHRENIA BULL, V35, P959, DOI 10.1093/schbul/sbn022
   Miceli M, 2016, PROTEOMICS, V16, P674, DOI 10.1002/pmic.201500223
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Onis M., 2007, WHO CHILD GROWTH STA
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Suzuki Y, 2006, FETAL DIAGN THER, V21, P45, DOI 10.1159/000089047
   Urakubo A, 2001, SCHIZOPHR RES, V47, P27, DOI 10.1016/S0920-9964(00)00032-3
   Wallner Stephanie, 2015, Front Cell Dev Biol, V3, P48, DOI 10.3389/fcell.2015.00048
   Watanabe Y, 2010, PSYCHIAT CLIN NEUROS, V64, P217, DOI 10.1111/j.1440-1819.2010.02094.x
NR 20
TC 20
Z9 20
U1 0
U2 10
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0364-5134
EI 1531-8249
J9 ANN NEUROL
JI Ann. Neurol.
PD JAN
PY 2017
VL 81
IS 1
BP 152
EP 156
DI 10.1002/ana.24839
PG 5
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA EJ9QV
UT WOS:000393562300015
PM 27977881
DA 2020-12-01
ER

PT J
AU Melo, ASD
   Aguiar, RS
   Amorim, MMR
   Arruda, MB
   Melo, FD
   Ribeiro, STC
   Batista, AGM
   Ferreira, T
   dos Santos, MP
   Sampaio, VV
   Moura, SRM
   Rabello, LP
   Gonzaga, CE
   Malinger, G
   Ximenes, R
   de Oliveira-Szejnfeld, PS
   Tovar-Moll, F
   Chimelli, L
   Silveira, PP
   Delvechio, R
   Higa, L
   Campanati, L
   Nogueira, RMR
   Filippis, AMB
   Szejnfeld, J
   Voloch, CM
   Ferreira, OC
   Brindeiro, RM
   Tanuri, A
AF de Oliveira Melo, Adriana Suely
   Aguiar, Renato Santana
   Ramos Amorim, Melania Maria
   Arruda, Monica B.
   Melo, Fabiana de Oliveira
   Clementino Ribeiro, Suelem Tais
   Medeiros Batista, Alba Gean
   Ferreira, Thales
   dos Santos, Mayra Pereira
   Sampaio, Virginia Vilar
   Martins Moura, Sarah Rogeria
   Rabello, Luciana Portela
   Gonzaga, Clarissa Emanuelle
   Malinger, Gustavo
   Ximenes, Renato
   de Oliveira-Szejnfeld, Patricia Soares
   Tovar-Moll, Fernanda
   Chimelli, Leila
   Silveira, Paola Paz
   Delvechio, Rodrigo
   Higa, Luiza
   Campanati, Loraine
   Nogueira, Rita M. R.
   Bispo Filippis, Ana Maria
   Szejnfeld, Jacob
   Voloch, Carolina Moreira
   Ferreira, Orlando C., Jr.
   Brindeiro, Rodrigo M.
   Tanuri, Amilcar
TI Congenital Zika Virus Infection Beyond Neonatal Microcephaly
SO JAMA NEUROLOGY
LA English
DT Article
ID CYTOMEGALOVIRUS-INFECTION; DIAGNOSTIC-APPROACH; TRANSMISSION; CHILDREN
AB IMPORTANCE Recent studies have reported an increase in the number of fetuses and neonates with microcephaly whose mothers were infected with the Zika virus (ZIKV) during pregnancy. To our knowledge, most reports to date have focused on select aspects of the maternal or fetal infection and fetal effects.
   OBJECTIVE To describe the prenatal evolution and perinatal outcomes of 11 neonates who had developmental abnormalities and neurological damage associated with ZIKV infection in Brazil.
   DESIGN, SETTING, AND PARTICIPANTS We observed 11 infants with congenital ZIKV infection from gestation to 6 monthus in the state of Paraba, Brazil. Ten of 11 women included in this study presented with symptoms of ZIKV infection during the first half of pregnancy, and all 11 had laboratory evidence of the infection in several tissues by serology or polymerase chain reaction. Brain damage was confirmed through intrauterine ultrasonography and was complemented by magnetic resonance imaging. Histopathological analysis was performed on the placenta and brain tissue from infants who died. The ZIKV genome was investigated in several tissues and sequenced for further phylogenetic analysis.
   MAIN OUTCOMES AND MEASURES Description of the major lesions caused by ZIKV congenital infection.
   RESULTS Of the 11 infants, 7 (63.6%) were female, and the median (SD) maternal age at delivery was 25 (6) years. Three of 11 neonates died, giving a perinatal mortality rate of 27.3%. The median (SD) cephalic perimeter at birth was 31 (3) cm, a value lower than the limit to consider a microcephaly case. In all patients, neurological impairments were identified, including microcephaly, a reduction in cerebral volume, ventriculomegaly, cerebellar hypoplasia, lissencephaly with hydrocephalus, and fetal akinesia deformation sequence (ie, arthrogryposis). Results of limited testing for other causes of microcephaly, such as genetic disorders and viral and bacterial infections, were negative, and the ZIKV genome was found in both maternal and neonatal tissues (eg, amniotic fluid, cord blood, placenta, and brain). Phylogenetic analyses showed an intrahost virus variation with some polymorphisms in envelope genes associated with different tissues.
   CONCLUSIONS AND RELEVANCE Combined findings from clinical, laboratory, imaging, and pathological examinations provided a more complete picture of the severe damage and developmental abnormalities caused by ZIKV infection than has been previously reported. The term congenital Zika syndrome is preferable to refer to these cases, as microcephaly is just one of the clinical signs of this congenital malformation disorder.
C1 [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Melo, Fabiana de Oliveira] Inst Pesquisa Prof Amorim Neto IPESQ, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Melo, Fabiana de Oliveira; Clementino Ribeiro, Suelem Tais; dos Santos, Mayra Pereira] Inst Saude Elpidio de Almeida, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria; Clementino Ribeiro, Suelem Tais; Sampaio, Virginia Vilar; Martins Moura, Sarah Rogeria; Rabello, Luciana Portela] Fac Ciencias Med Campina Grande, Campina Grande, Paraiba, Brazil.
   [de Oliveira Melo, Adriana Suely; Medeiros Batista, Alba Gean; Sampaio, Virginia Vilar; Martins Moura, Sarah Rogeria; Rabello, Luciana Portela; Gonzaga, Clarissa Emanuelle] Hosp Municipal Pedro I, Campina Grande, Paraiba, Brazil.
   [Aguiar, Renato Santana; Arruda, Monica B.; Silveira, Paola Paz; Delvechio, Rodrigo; Higa, Luiza; Voloch, Carolina Moreira; Ferreira, Orlando C., Jr.; Brindeiro, Rodrigo M.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Ramos Amorim, Melania Maria; Ferreira, Thales] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Div Ultrasound Obstet & Gynecol, Lis Matern Hosp, Tel Aviv Sourasky Med Ctr,Sackler Fac Med, Tel Aviv, Israel.
   [Ximenes, Renato] Fundacao Med Fetal Latino Amer, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Fed Sao Paulo, Fundacao Inst Pesquisa & Ensino Diagnost Imagem, Sao Paulo, Brazil.
   [Tovar-Moll, Fernanda; Campanati, Loraine] Univ Fed Rio de Janeiro, Inst Ciencias Biomed, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Inst DOr Pesquisa & Ensino, Rio De Janeiro, Brazil.
   [Chimelli, Leila] Inst Estadual Cerebro Paulo Niemeyer, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nogueira, Rita M. R.; Bispo Filippis, Ana Maria] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imagem, Sao Paulo, Brazil.
RP Tanuri, A (corresponding author), Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Lab Virol Mol, CCS Bloco Sala 121, BR-21941902 Rio De Janeiro, Brazil.
EM atanuri1@gmail.com
RI Campanati, Loraine/V-2632-2018; Amorim, Melania M/C-5807-2013; Higa,
   Luiza/W-2698-2019; Aguiar, Renato S/G-3542-2015; Moll, Fernanda
   Tovar/N-3320-2018; Melo, Adriana S O/H-5650-2016; Voloch, Carolina
   M/F-8874-2013; Ferreira, Thales Araujo/AAA-6252-2019
OI Campanati, Loraine/0000-0001-9172-1951; Amorim, Melania
   M/0000-0003-1047-2514; Aguiar, Renato S/0000-0001-5180-3717; Moll,
   Fernanda Tovar/0000-0002-0292-5985; Voloch, Carolina
   M/0000-0001-5182-4366; Malinger, Gustavo/0000-0003-0864-206X
FU Consellho Nacional de Desenvolvimento e Pesquisa; Fundacao de Amparo a
   Pesquisa do Estado do Rio de JaneiroCarlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Prefeitura Municipal
   de Campina Grande; Medical Research CouncilMedical Research Council UK
   (MRC) [MC_PC_15102] Funding Source: researchfish
FX This study was supported by Consellho Nacional de Desenvolvimento e
   Pesquisa, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro,
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, and
   Prefeitura Municipal de Campina Grande.
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Besnard M., 2014, EURO SURVEILL, V19
   Bosnjak VM, 2011, COLLEGIUM ANTROPOL, V35, P229
   Brasil P, 2016, N ENGL J MED
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Hall JG, 1997, J PEDIATR ORTHOP B, V6, P159, DOI 10.1097/01202412-199707000-00002
   Jaglin XH, 2009, TRENDS GENET, V25, P555, DOI 10.1016/j.tig.2009.10.003
   Kouame N, 2013, Diagn Interv Imaging, V94, P433, DOI 10.1016/j.diii.2013.01.002
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muller-Oehring EM, 2010, NEUROPSYCHOLOGIA, V48, P1133, DOI 10.1016/j.neuropsychologia.2009.12.015
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Romaniello R, 2015, BRAIN DEV-JPN, V37, P273, DOI 10.1016/j.braindev.2014.06.002
   Stadlbauer A, 2012, EUR RADIOL, V22, P232, DOI 10.1007/s00330-011-2247-7
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Woods CG, 2013, ARCH DIS CHILD, V98, P707, DOI 10.1136/archdischild-2012-302882
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zucca C, 2003, NEUROLOGY, V61, P710, DOI 10.1212/WNL.61.5.710
NR 33
TC 185
Z9 185
U1 0
U2 47
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6149
EI 2168-6157
J9 JAMA NEUROL
JI JAMA Neurol.
PD DEC 1
PY 2016
VL 73
IS 12
BP 1407
EP 1416
DI 10.1001/jamaneurol.2016.3720
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA EG5ZB
UT WOS:000391122200011
PM 27695855
OA Bronze
DA 2020-12-01
ER

PT J
AU de Oliveira-Szejnfeld, PS
   Levine, D
   Melo, ASD
   Amorim, MMR
   Batista, AGM
   Chimelli, L
   Tanuri, A
   Aguiar, RS
   Malinger, G
   Ximenes, R
   Robertson, R
   Szejnfeld, J
   Tovar-Moll, F
AF de Oliveira-Szejnfeld, Patricia Soares
   Levine, Deborah
   de Oliveira Melo, Adriana Suely
   Ramos Amorim, Melania Maria
   Batista, Alba Gean M.
   Chimelli, Leila
   Tanuri, Amilcar
   Aguiar, Renato Santana
   Malinger, Gustavo
   Ximenes, Renato
   Robertson, Richard
   Szejnfeld, Jacob
   Tovar-Moll, Fernanda
TI Congenital Brain Abnormalities and Zika Virus: What the Radiologist Can
   Expect to See Prenatally and Postnatally
SO RADIOLOGY
LA English
DT Article
ID INFECTION; ULTRASOUND; OUTBREAK; GROWTH; BRAZIL
AB Purpose: To document the imaging findings associated with congenital Zika virus infection as found in the Instituto de Pesquisa in Campina Grande State Paraiba (IPESQ) in northeastern Brazil, where the congenital infection has been particularly severe.
   Materials and Methods: From June 2015 to May 2016, 438 patients were referred to the IPESQ for rash occurring during pregnancy or for suspected fetal central nervous system abnormality. Patients who underwent imaging at IPESQ were included, as well as those with documented Zika virus infection in fluid or tissue (n = 17, confirmed infection cohort) or those with brain findings suspicious for Zika virus infection, with intracranial calcifications (n = 28, presumed infection cohort). Imaging examinations included 12 fetal magnetic resonance (MR) examinations, 42 postnatal brain computed tomographic examinations, and 11 postnatal brain MR examinations. Images were reviewed by four radiologists, with final opinion achieved by means of consensus.
   Results: Brain abnormalities seen in confirmed (n = 17) and presumed (n = 28) congenital Zika virus infections were similar, with ventriculomegaly in 16 of 17 (94%) and 27 of 28 (96%) infections, respectively; abnormalities of the corpus callosum in 16 of 17 (94%) and 22 of 28 (78%) infections, respectively; and cortical migrational abnormalities in 16 of 17 (94%) and 28 of 28 (100%) infections, respectively. Although most fetuses underwent at least one examination that showed head circumference below the 5th percentile, head circumference could be normal in the presence of severe ventriculomegaly (seen in three fetuses). Intracranial calcifications were most commonly seen at the gray matter-white matter junction, in 15 of 17 (88%) and 28 of 28 (100%) confirmed and presumed infections, respectively. The basal ganglia and/or thalamus were also commonly involved with calcifications in 11 of 17 (65%) and 18 of 28 (64%) infections, respectively. The skull frequently had a collapsed appearance with overlapping sutures and redundant skin folds and, occasionally, intracranial herniation of orbital fat and clot in the confluence of sinuses.
   Conclusion: The spectrum of findings associated with congenital Zika virus infection in the IPESQ in northeastern Brazil is illustrated to aid the radiologist in identifying Zika virus infection at imaging. (C) RSNA, 2016
C1 [de Oliveira-Szejnfeld, Patricia Soares; Ximenes, Renato; Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares; Szejnfeld, Jacob] Univ Fed Sao Paulo, Dept Diagnost Imaging, Fdn Inst Educ & Res Diagnost Imaging, Sao Paulo, Brazil.
   [Levine, Deborah] Harvard Med Sch, Dept Radiol, Beth Israel Deaconess Med Ctr, Boston, MA USA.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria] Inst Pesquisa Prof Amorim Neto, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely; Ramos Amorim, Melania Maria] Inst Saude Elpidio Almeida, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely] Fac Ciencias Med Campina Grande, Campina Grande, PB, Brazil.
   [de Oliveira Melo, Adriana Suely; Batista, Alba Gean M.] Hosp Municipal Pedro I, Serv Municipal Atendimento Transdisciplinar Gesta, Campina Grande, PB, Brazil.
   [Ramos Amorim, Melania Maria] Univ Fed Campina Grande, Campina Grande, PB, Brazil.
   [Chimelli, Leila] State Inst Brain, Neuropathol Lab, Rio De Janeiro, Brazil.
   [Tanuri, Amilcar; Aguiar, Renato Santana] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Malinger, Gustavo] Tel Aviv Univ, Sackler Fac Med, Div Ultrasound Obstet & Gynecol, Tel Aviv Sourasky Med Ctr,Lis Matern Hosp, Tel Aviv, Israel.
   [Ximenes, Renato] Fetal Med Fdn Latinamerica FMFLA, Centrus Fetal Med, Campinas, SP, Brazil.
   [Robertson, Richard] Boston Childrens Hosp, Boston, MA USA.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
RP Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), Univ Fed Rio de Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.; Tovar-Moll, F (corresponding author), DOr Inst Res & Educ, Rua Diniz Cordeiro 30, BR-22881100 Rio De Janeiro, RJ, Brazil.
EM Fernanda.tovarmoll@idor.org
RI Melo, Adriana S O/H-5650-2016; Amorim, Melania M/C-5807-2013; Moll,
   Fernanda Tovar/N-3320-2018; Aguiar, Renato S/G-3542-2015
OI Amorim, Melania M/0000-0003-1047-2514; Moll, Fernanda
   Tovar/0000-0002-0292-5985; Aguiar, Renato S/0000-0001-5180-3717;
   Malinger, Gustavo/0000-0003-0864-206X; Robertson,
   Richard/0000-0001-8811-4405; Soares de Oliveira Szejnfeld,
   Patricia/0000-0002-3780-5182
FU Medical Research CouncilMedical Research Council UK (MRC) [MC_PC_15102]
   Funding Source: Medline
CR [Anonymous], 2016, HEAD CIRC FOR AG
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Brasil P, 2016, N ENGL J MED
   Brazilian Ministry of Health, 2016, MIN SAUD CONF 1656 C
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Centers for Disease Control and Prevention, ALL COUNTR TERR ACT
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ESTROFF JA, 1992, J ULTRAS MED, V11, P686
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GV, 2016, LANCET
   Freitas B de Paula, 2016, JAMA OPHTHALMOL
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Melo A, JAMA NEUROL IN PRESS
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moinuddin A, 2003, PRENATAL DIAG, V23, P797, DOI 10.1002/pd.688
   Nonaka H, 2003, J NEUROPATH EXP NEUR, V62, P154, DOI 10.1093/jnen/62.2.154
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Picone O, 2008, PRENATAL DIAG, V28, P753, DOI 10.1002/pd.2037
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
NR 32
TC 126
Z9 132
U1 0
U2 13
PU RADIOLOGICAL SOC NORTH AMERICA
PI OAK BROOK
PA 820 JORIE BLVD, OAK BROOK, IL 60523 USA
SN 0033-8419
J9 RADIOLOGY
JI Radiology
PD OCT
PY 2016
VL 281
IS 1
BP 203
EP 218
DI 10.1148/radiol.2016161584
PG 16
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA EG8NJ
UT WOS:000391313600023
PM 27552432
OA Bronze
DA 2020-12-01
ER

PT J
AU Barros, VO
   Amorim, MR
   Melo, AO
   Tavares, JS
   Silva, AC
   Alves, JG
AF Barros, Vivianne O.
   Amorim, Melania R.
   Melo, Adriana O.
   Tavares, Jousilene S.
   Silva, Andreza C.
   Alves, Joao G.
TI Abdominal Fat Distribution Among Breastfed and Formula-Fed Infants
SO BREASTFEEDING MEDICINE
LA English
DT Article
ID ANTHROPOMETRIC INDEXES; CHILDREN; COHORT; ACCUMULATION; METAANALYSIS;
   OVERWEIGHT; THICKNESS; GROWTH; RISK
AB Objectives: To compare abdominal subcutaneous and preperitoneal fat thickness among breastfed, mixed-fed, and formula-fed infants during the first 6 months of life.
   Study Design: A cohort study started with 94 healthy newborns and 76 were followed during the whole first semester of life. Breastfeeding status was assessed by a personal interview. Abdominal subcutaneous and preperitoneal fat thickness was measured by ultrasound at the first, third, and sixth month of life.
   Results: Subcutaneous and preperitoneal fat thickness showed no differences from the first to the sixth month of life among breastfed, mixed-fed,s and formula-fed infants, respectively; subcutaneous: 26.1 +/- 10.2 to 57.4 +/- 10.3 cm, 27.7 +/- 10.5 to 55.4 +/- 1.4, and 28.1 +/- 10.9 to 52.7 +/- 10.6; p = 0.344; preperitoneal: 10.6 +/- 2.0 to 15.2 +/- 1.7, 10.3 +/- 2.8 to 15.5 +/- 1.7, and 9.7 +/- 2.6 to 15.6 +/- 1.6; p = 0.623). No differences were observed among male and female infants.
   Conclusion: Abdominal fat distribution measured by ultrasound seems not to be different among breastfed and formula-fed infants during the first semester of life.
C1 [Barros, Vivianne O.; Amorim, Melania R.; Melo, Adriana O.; Tavares, Jousilene S.; Silva, Andreza C.] Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Dept Mother & Child Care, Campina Grande, Brazil.
   [Alves, Joao G.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Mother & Child Care, Rua Coelhos 300 Boa Vista, BR-50070550 Recife, PE, Brazil.
RP Alves, JG (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Dept Mother & Child Care, Rua Coelhos 300 Boa Vista, BR-50070550 Recife, PE, Brazil.
EM joaoguilherme@imip.org.br
RI Melo, Adriana S O/H-5650-2016; Alves, Joao G/J-6483-2013; Amorim,
   Melania M/C-5807-2013
OI Alves, Joao G/0000-0002-9170-0808; Amorim, Melania M/0000-0003-1047-2514
FU CNPq, Brazilian governmentNational Council for Scientific and
   Technological Development (CNPq) [480761/20086]
FX This work was supported by CNPq (no 480761/20086), Brazilian government.
CR Alves JG, 2015, J PEDIATR ENDOCR MET, V28, P153, DOI 10.1515/jpem-2014-0191
   Arenz S, 2004, INT J OBESITY, V28, P1247, DOI 10.1038/sj.ijo.0802758
   Brei C, 2015, PEDIATR RES, V78, P342, DOI 10.1038/pr.2015.108
   DEBRUIN NC, 1995, AM J CLIN NUTR, V61, P1195
   Dewey KG, 1998, BIOL NEONATE, V74, P94, DOI 10.1159/000014016
   Ferreira APA, 2014, J PERINATOL, V34, P932, DOI 10.1038/jp.2014.110
   Gale C, 2012, AM J CLIN NUTR, V95, P656, DOI 10.3945/ajcn.111.027284
   Gale C, 2014, AM J CLIN NUTR, V99, P1034, DOI 10.3945/ajcn.113.080200
   Harder T, 2005, AM J EPIDEMIOL, V162, P397, DOI 10.1093/aje/kwi222
   Holzhauer S, 2009, EUR J EPIDEMIOL, V24, P521, DOI 10.1007/s10654-009-9368-1
   Liu KH, 2003, INT J OBESITY, V27, P1267, DOI 10.1038/sj.ijo.0802398
   Medina-Bravo P, 2011, ARCH MED RES, V42, P115, DOI 10.1016/j.arcmed.2011.03.002
   Mook-Kanamori DO, 2009, ULTRASOUND MED BIOL, V35, P1938, DOI 10.1016/j.ultrasmedbio.2009.07.002
   OAKLEY JR, 1977, ARCH DIS CHILD, V52, P79, DOI 10.1136/adc.52.1.79
   Polat TB, 2008, J PEDIATR ENDOCR MET, V21, P1031
   Stettler N, 2005, CIRCULATION, V111, P1897, DOI 10.1161/01.CIR.0000161797.67671.A7
   White UA, 2014, BBA-MOL BASIS DIS, V1842, P377, DOI 10.1016/j.bbadis.2013.05.006
NR 17
TC 4
Z9 4
U1 0
U2 2
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1556-8253
EI 1556-8342
J9 BREASTFEED MED
JI Breastfeed. Med.
PD JUN
PY 2016
VL 11
IS 5
BP 231
EP 234
DI 10.1089/bfm.2016.0033
PG 4
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA DO9GF
UT WOS:000378092300005
PM 27104359
DA 2020-12-01
ER

PT J
AU Vasconcelos, DD
   Amorim, MM
   de Macedo, LC
   Medeiros, MD
   da Silva, JR
   Alves, JGB
AF Vasconcelos, Danilo de Ameida
   Amorim, Melania M.
   de Macedo, Lorena Carneiro
   Medeiros, Marina de Sousa
   da Silva, Jose Roberto, Jr.
   Bezerra Alves, Joao Guilherme
TI Electromyographic Threshold and Microvascular Reactivity for Assessment
   of Muscle Fatigue in Elderly Women
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 14-17, 2016
CL Washington, DC
SP Amer Coll Obstetricians & Gynecologists
C1 [Vasconcelos, Danilo de Ameida; Amorim, Melania M.; de Macedo, Lorena Carneiro; Medeiros, Marina de Sousa; da Silva, Jose Roberto, Jr.; Bezerra Alves, Joao Guilherme] Inst Integrat Med Prof Fernando Figueira, Campina Grande, Brazil.
RI Amorim, Melania M/C-5807-2013; Alves, Joao G/J-6483-2013
OI Amorim, Melania M/0000-0003-1047-2514; Alves, Joao G/0000-0002-9170-0808
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2016
VL 127
SU 1
MA 1
BP 1S
EP 1S
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ER6RO
UT WOS:000398934900002
DA 2020-12-01
ER

PT J
AU Vasconcelos, DD
   Amorim, MM
   de Macedo, LC
   Silva, EKR
   da Silva, JR
   Alves, JGB
AF Vasconcelos, Danilo de Ameida
   Amorim, Melania M.
   de Macedo, Lorena Carneiro
   Rodrigues Silva, Eujessika Katielly
   da Silva, Jose Roberto, Jr.
   Bezerra Alves, Joao Guilherme
TI Effects of Strength Training on Microcirculation, Muscle Performance and
   Functional Independence in Elderly Women
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 14-17, 2016
CL Washington, DC
SP Amer Coll Obstetricians & Gynecologists
C1 [Vasconcelos, Danilo de Ameida; Amorim, Melania M.; de Macedo, Lorena Carneiro; Rodrigues Silva, Eujessika Katielly; da Silva, Jose Roberto, Jr.; Bezerra Alves, Joao Guilherme] Inst Integrat Med Prof Fernando Figueira, Campina Grande, Brazil.
RI Alves, Joao G/J-6483-2013; Amorim, Melania M/C-5807-2013
OI Alves, Joao G/0000-0002-9170-0808; Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2016
VL 127
SU 1
MA 3A
BP 12S
EP 12S
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ER6RO
UT WOS:000398934900031
DA 2020-12-01
ER

PT J
AU Pordeus, ACB
   Truta, ACL
   Soares, MC
   Maia, SB
   Katz, L
   Amorim, MM
AF Barbosa Pordeus, Ana Carolina
   Lyra Truta, Amanda Carla
   Soares, Mariana Carvalho
   Maia, Sabina B.
   Katz, Leila
   Amorim, Melania M.
TI Maternal and Perinatal Outcomes in Patients With Acute Pulmonary Edema
   Hospitalized in an Intensive Care Unit
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 14-17, 2016
CL Washington, DC
SP Amer Coll Obstetricians & Gynecologists
C1 [Barbosa Pordeus, Ana Carolina; Lyra Truta, Amanda Carla; Soares, Mariana Carvalho; Maia, Sabina B.; Katz, Leila; Amorim, Melania M.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2016
VL 127
SU 1
MA 11A
BP 14S
EP 15S
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ER6RO
UT WOS:000398934900039
DA 2020-12-01
ER

PT J
AU Belo, B
   Prata, A
   Moura, A
   Nobrega, L
   Amorim, MM
   Katz, L
AF Belo, Bruna
   Prata, Analice
   Moura, Adriana
   Nobrega, Leandro
   Amorim, Melania M.
   Katz, Leila
TI Seroprevalence of Chagas' Disease in Pregnancy and Congenital
   Transmission of Trypanosoma cruzi in Maceio, Brazil
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 14-17, 2016
CL Washington, DC
SP Amer Coll Obstetricians & Gynecologists
C1 [Belo, Bruna; Prata, Analice; Moura, Adriana; Nobrega, Leandro; Amorim, Melania M.; Katz, Leila] Inst Materno Infantil Pernambuco, Recife, PE, Brazil.
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
NR 0
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2016
VL 127
SU 1
MA 28I
BP 80S
EP 80S
DI 10.1097/01.AOG.0000483732.19468.1b
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ER6RO
UT WOS:000398934900279
DA 2020-12-01
ER

PT J
AU Cavalcanti, G
   Nunes, F
   Alves, W
   Nobrega, L
   Amorim, MM
   Katz, L
AF Cavalcanti, Gabriela
   Nunes, Fernanda
   Alves, Waneska
   Nobrega, Leandro
   Amorim, Melania M.
   Katz, Leila
TI Congenital Syphilis Epidemiology in Alagoas-Brazil
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 14-17, 2016
CL Washington, DC
SP Amer Coll Obstetricians & Gynecologists
C1 [Cavalcanti, Gabriela; Nunes, Fernanda; Alves, Waneska; Nobrega, Leandro; Amorim, Melania M.; Katz, Leila] Inst Materno Infantil Pernambuco, Recife, PE, Brazil.
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
NR 0
TC 0
Z9 0
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2016
VL 127
SU 1
MA 22J
BP 87S
EP 87S
DI 10.1097/01.AOG.0000483791.08301.b6
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ER6RO
UT WOS:000398934900301
DA 2020-12-01
ER

PT J
AU Ferro, F
   Rocha, E
   Nobrega, L
   Amorim, MM
   Katz, L
AF Ferro, Felipe
   Rocha, Edilberto
   Nobrega, Leandro
   Amorim, Melania M.
   Katz, Leila
TI Transorbital Ultrasonographic Measurement of the Optic Nerve Sheath
   Diameter in Preeclampsia
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 14-17, 2016
CL Washington, DC
SP Amer Coll Obstetricians & Gynecologists
C1 [Ferro, Felipe; Rocha, Edilberto; Nobrega, Leandro; Amorim, Melania M.; Katz, Leila] Hosp Barao de Lucena, Recife, PE, Brazil.
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2016
VL 127
SU 1
MA 24J
BP 87S
EP 87S
DI 10.1097/01.AOG.0000483793.93053.f9
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ER6RO
UT WOS:000398934900303
DA 2020-12-01
ER

PT J
AU Neto, AHF
   Amorim, MM
   Melo, AS
   Lima, MDP
   Sena, A
   Azevedo, G
AF Franca Neto, Antonio H.
   Amorim, Melania M.
   Melo, Adriana S.
   Lima, Maria do Carmo P.
   Sena, Aline
   Azevedo, Girlene
TI Correlation Between Maternal Abdominal Adiposity and Anthropometric and
   Metabolic Profile During Pregnancy
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 14-17, 2016
CL Washington, DC
SP Amer Coll Obstetricians & Gynecologists
C1 [Franca Neto, Antonio H.; Amorim, Melania M.; Melo, Adriana S.; Lima, Maria do Carmo P.; Sena, Aline; Azevedo, Girlene] Fac Ciencias Med Campina Grande, Campina Grande, Brazil.
RI Amorim, Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016
OI Amorim, Melania M/0000-0003-1047-2514; 
NR 0
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2016
VL 127
SU 1
MA 29O
BP 130S
EP 131S
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ER6RO
UT WOS:000398934900457
DA 2020-12-01
ER

PT J
AU Neto, AHF
   Amorim, MM
   Melo, AS
   Lima, MDP
   Sena, A
   Dantas, L
AF Franca Neto, Antonio H.
   Amorim, Melania M.
   Melo, Adriana S.
   Lima, Maria do Carmo P.
   Sena, Aline
   Dantas, Livia
TI Accumulation of Adiposity Fetal During Pregnancy: A Cohort Study
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 14-17, 2016
CL Washington, DC
SP Amer Coll Obstetricians & Gynecologists
C1 [Franca Neto, Antonio H.; Amorim, Melania M.; Melo, Adriana S.; Lima, Maria do Carmo P.; Sena, Aline; Dantas, Livia] Fac Ciencias Med Campina Grande, Campina Grande, Brazil.
RI Amorim, Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016
OI Amorim, Melania M/0000-0003-1047-2514; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2016
VL 127
SU 1
MA 5P
BP 132S
EP 133S
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ER6RO
UT WOS:000398934900464
DA 2020-12-01
ER

PT J
AU Amorim, MM
   Katz, L
   Coutinho, I
   Chang, TM
   Rameri, C
   Silva, RME
AF Amorim, Melania M.
   Katz, Leila
   Coutinho, Isabela
   Chang, Tien-Man
   Rameri, Carla
   Machado e Silva, Ricardo
TI Staging Locally Advanced Uterine Cervical Carcinoma With Positron
   Emission Tomography - Computed Tomography
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 14-17, 2016
CL Washington, DC
SP Amer Coll Obstetricians & Gynecologists
C1 [Amorim, Melania M.; Katz, Leila; Coutinho, Isabela; Chang, Tien-Man; Rameri, Carla; Machado e Silva, Ricardo] Inst Med Integral Prof Fernando Figueira IMIP, Campina Grande, Brazil.
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2016
VL 127
SU 1
MA 9P
BP 133S
EP 134S
DI 10.1097/01.AOG.0000483539.79207.88
PG 3
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ER6RO
UT WOS:000398934900468
DA 2020-12-01
ER

PT J
AU Neto, AHF
   Amorim, MM
   Melo, AS
   Sena, A
   Lima, MDP
   Silva, JV
AF Franca Neto, Antonio H.
   Amorim, Melania M.
   Melo, Adriana S.
   Sena, Aline
   Lima, Maria do Carmo P.
   Silva, Jamila V.
TI Thigh Measurement and Adiposity Fetal Accumulation: A Cohort Study
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 14-17, 2016
CL Washington, DC
SP Amer Coll Obstetricians & Gynecologists
C1 [Franca Neto, Antonio H.; Amorim, Melania M.; Melo, Adriana S.; Sena, Aline; Lima, Maria do Carmo P.; Silva, Jamila V.] Fac Ciencias Med Campina Grande, Campina Grande, Brazil.
RI Melo, Adriana S O/H-5650-2016; Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2016
VL 127
SU 1
MA 7R
BP 149S
EP 149S
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA ER6RO
UT WOS:000398934900524
DA 2020-12-01
ER

PT J
AU Scavuzzi, A
   Souza, ASR
   Amorim, MMR
AF Scavuzzi, Adriana
   Rolland Souza, Alex Sandro
   Ramos Amorim, Melania Maria
TI Continued Compliance and Degree of Satisfaction in Nulligravida and
   Parous Women with Intrauterine Contraceptive Devices
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA English
DT Article
DE intrauterine devices; family planning; contraception; patient
   satisfaction; gravidity
ID NULLIPAROUS WOMEN; CHALLENGES; EXPERIENCE; PLACEMENT
AB Purpose To evaluate the compliance and degree of satisfaction of nulligravida (has not given birth) and parous (had already given birth) women who are using intrauterine devices (IUDs).
   Methods A cross-sectional cohort study was conducted comparing nulligravida and parous women who had had an IUD inserted between July 2009 and November 2011. A total of 84 nulligravida women and 73 parous women were included. Interviews were conducted with women who agreed to participate through telephone contact. Statistical analysis was performed with Student's t-test and Mann-Whitney test for numeric variables; Pearson's chi-square test to test associations; and, whenever pertinent, Fisher's exact test for categorical variables. A survival curve was constructed to estimate the likelihood of each woman continuing the use of the IUD. A significance level of 5% was established.
   Results When compared with parous women, nulligravida women had a higher education level (median: 12 vs. 10 years). No statistically significant differences were found between the nulligravida and parous women with respect to information on the use of the IUD, prior use of other contraceptive methods, the reason for having chosen the IUD as the current contraceptive method, reasons for discontinuing the use and adverse effects, compliance, and degree of satisfaction. The two groups did not show any difference in terms of continued use of the IUD (p = 0.4).
   Conclusion There was no difference in compliance or the degree of satisfaction or continued use of IUDs between nulligravida and parous women, suggesting that IUD use may be recommended for women who have never been pregnant.
C1 [Scavuzzi, Adriana; Rolland Souza, Alex Sandro; Ramos Amorim, Melania Maria] Inst Materno Infantil Pernambuco, Inst Med Integral Prof Fernando Figueira, Postgrad Program Mother Child Dept, Recife, PE, Brazil.
   [Rolland Souza, Alex Sandro] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Ramos Amorim, Melania Maria] Univ Fed Campina Grande, Dept ObGyn, Campina Grande, PB, Brazil.
RP Souza, ASR (corresponding author), Inst Med Integral Prof Fernando Figueira, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM alexrolland@uol.com.br
RI Souza, Alex Sandro Rolland/AAG-2471-2019; Amorim, Melania M/C-5807-2013
OI Souza, Alex Sandro Rolland/0000-0001-7039-2052; Amorim, Melania
   M/0000-0003-1047-2514
CR Allen RH, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007373.pub2
   Bahamondes M Valeria, 2011, Contraception, V84, pe11, DOI 10.1016/j.contraception.2011.05.012
   Brockmeyer A, 2008, EUR J CONTRACEP REPR, V13, P248, DOI 10.1080/02699200802253706
   Soriano LC, 2015, PHARMACOEPIDEM DR S, V24, P52, DOI 10.1002/pds.3710
   Committee on Adolescent Health Care Long-Acting Reversible Contraception Working Group The American College of Obstetricians and Gynecologists, 2012, Obstet Gynecol, V120, P983
   Committee on Gynecologic Practice Long-Acting Reversible Contraception Working Group, 2015, Obstet Gynecol, V126, pe44, DOI 10.1097/AOG.0000000000001106
   Crosignani PG, 2008, HUM REPROD UPDATE, V14, P197, DOI 10.1093/humupd/dmn003
   d'Arcangues C, 2007, CONTRACEPTION, V75, pS2, DOI 10.1016/j.contraception.2006.12.024
   de Araujo FF, 2008, CONTRACEPTION, V78, P474, DOI 10.1016/j.contraception.2008.07.006
   Diedrich JT, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.07.025
   Fleming KL, 2010, CONTRACEPTION, V82, P178, DOI 10.1016/j.contraception.2010.02.020
   Grimes DA, 2000, LANCET, V356, P1013, DOI 10.1016/S0140-6736(00)02699-4
   GRIMES DA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001327
   Grimes DA, 2008, CONTRACEPTION, V77, P6, DOI 10.1016/j.contraception.2007.09.012
   Harper CC, 2008, OBSTET GYNECOL, V111, P1359, DOI 10.1097/AOG.0b013e318173fd83
   Hauck B, 2015, J OBSTET GYNAECOL CA, V37, P606, DOI 10.1016/S1701-2163(15)30198-5
   Hubacher D, 2002, PERSPECT SEX REPRO H, V34, P98, DOI 10.2307/3030213
   Hubacher D, 2007, CONTRACEPTION, V75, pS8, DOI 10.1016/j.contraception.2006.12.005
   Hubacher D, 2009, CONTRACEPTION, V79, P356, DOI 10.1016/j.contraception.2008.11.012
   Kulier R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005347.pub3
   Lassner K J, 1995, Bull Pan Am Health Organ, V29, P206
   Madden T, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.01.051
   Mosher William D, 2004, Adv Data, P1
   National Institute for Health and Clinical Excellence, 2014, NICE CLIN GUID 30
   Ngo LL, 2015, OBSTET GYNECOL, V126, P29, DOI 10.1097/AOG.0000000000000912
   Papic M, 2015, WOMEN HEALTH ISS, V25, P22, DOI 10.1016/j.whi.2014.09.006
   Potter J, 2015, JAMA PEDIATR, V169, P103, DOI 10.1001/jamapediatrics.2014.2812
   Romero L, 2015, MMWR-MORBID MORTAL W, V64, P363
   Sridhar Aparna, 2015, J Grad Med Educ, V7, P9, DOI 10.4300/JGME-D-14-00010.1
   Stanwood NL, 2006, OBSTET GYNECOL, V108, P1417, DOI 10.1097/01.AOG.0000245447.56585.a0
   Trussell J, 2011, CONTRACEPTION, V83, P397, DOI 10.1016/j.contraception.2011.01.021
   Wiebe ER, 2010, J OBSTET GYNAECOL CA, V32, P335, DOI 10.1016/S1701-2163(16)34477-2
   World Health Organization, 2015, MED EL CRIT CONTR US
   Xu X, 2011, FERTIL STERIL, V96, P1138, DOI 10.1016/j.fertnstert.2011.08.019
   Zibners A, 1999, J Pediatr Adolesc Gynecol, V12, P90, DOI 10.1016/S1083-3188(00)86633-4
NR 35
TC 0
Z9 1
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD MAR
PY 2016
VL 38
IS 3
BP 132
EP 139
DI 10.1055/s-0036-1580709
PG 8
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA FG4OT
UT WOS:000410243300004
PM 27022785
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Tavares, MCM
   de Lima, SF
   Coelho, AVC
   Marques, TRNM
   de Araujo, DHT
   Heraclio, SD
   Amorim, MMR
   de Souza, PRE
   Crovella, S
AF Mansur Tavares, Mayara C.
   de Lima Junior, Sergio F.
   Coelho, Antonio V. C.
   Marques, Tricia Ruschelle N. M.
   de Araujo, Diego Henrique T.
   Heraclio, Sandra de A.
   Ramos Amorim, Melania M.
   de Souza, Paulo Roberto E.
   Crovella, Sergio
TI Tumor necrosis factor (TNF) alpha and interleukin (IL) 18 genes
   polymorphisms are correlated with susceptibility to HPV infection in
   patients with and without cervical intraepithelial lesion
SO ANNALS OF HUMAN BIOLOGY
LA English
DT Article
DE Cytokine; invasive cervical cancer; single nucleotide polymorphism
ID HUMAN-PAPILLOMAVIRUS; PROMOTER POLYMORPHISM; BRAZILIAN WOMEN; RISK;
   ASSOCIATION; EXPRESSION; SMOKING; IL-18; CANCER; CARCINOGENESIS
AB Background: The Human Papillomavirus (HPV) predisposes 500 000 women to cervical cancer. Host genetic background may facilitate virus persistence in the uterine cervix. Polymorphisms in regulatory and coding regions of cytokine genes have been associated with susceptibility to some human diseases.
   Aim: This study aims at investigating whether TNFA -308 G/A and IL18 -137 G/C and -607 C/A polymorphisms are associated with susceptibility to HPV infection/progression to high-grade squamous intraepithelial lesion (HSIL).
   Subjects and methods: One hundred and twenty-two HPV infected and 132 HPV negative women (the latter used as healthy controls) were analysed. TNFA -308 G/A and IL18 (-137G/C and -607 C/A) polymorphisms were analysed using specific sequence polymorphism PCR (SSP-PCR). Univariate statistical analysis and a logistic regression were performed.
   Results: The TNFA -308A allele was associated with susceptibility to HPV infection (p = 0.0008), while the IL18 -607A allele conferred protection against HPV infection (p = 0.0043). TNFA -308 G/A and IL18 (-137G/C and -607 C/A) polymorphisms were not associated with development of cervical lesions (p > 0.05). An association was also observed between smoking and susceptibility to the development of HSIL.
   Conclusion: The findings suggest an association between two TNFA SNPs and susceptibility to HPV infection in women from Northeast Brazil. The results need to be functionally validated and replicated in other populations with different ethnic backgrounds.
C1 [Mansur Tavares, Mayara C.; de Lima Junior, Sergio F.] Univ Fed Pernambuco UFPE, Appl Mol Biol, Recife, PE, Brazil.
   [Coelho, Antonio V. C.; Crovella, Sergio] Univ Fed Pernambuco UFPE, Dept Genet, Recife, PE, Brazil.
   [Marques, Tricia Ruschelle N. M.; de Araujo, Diego Henrique T.] Univ Fed Rural Pernambuco UFRPE, Biol Sci, Recife, PE, Brazil.
   [Heraclio, Sandra de A.] Womens Healthcare Ctr, Dept Lower Genital Tract Pathol, Recife, PE, Brazil.
   [Ramos Amorim, Melania M.] Inst Med Integral Prof Fernando Figueira IMIP, Maternal & Child Healthcare Dept, Recife, PE, Brazil.
   [de Souza, Paulo Roberto E.] Univ Fed Rural Pernambuco UFRPE, Dept Biol, Recife, PE, Brazil.
RP Tavares, MCM (corresponding author), Univ Fed Pernambuco UFPE, Biol Appl Hlth Appl Mol Biol, Recife, PE, Brazil.
EM mayaramansur@gmail.com
RI Coelho, Antonio Victor C/E-6795-2015; Crovella, Sergio/K-5050-2016;
   Amorim, Melania M/C-5807-2013
OI Coelho, Antonio Victor C/0000-0003-2143-9701; Crovella,
   Sergio/0000-0001-8493-1168; Amorim, Melania M/0000-0003-1047-2514
CR Arimitsu J, 2006, BIOCHEM BIOPH RES CO, V342, P1413, DOI 10.1016/j.bbrc.2006.02.096
   Associacao Brasileira de Genitoscopia, 2002, NOM LAUD COLP
   Ayres Andréia Rodrigues Gonçalves, 2010, Rev. Saúde Pública, V44, P963
   Barth RJ, 1996, CANCER, V78, P1168, DOI 10.1002/(SICI)1097-0142(19960915)78:6<1168::AID-CNCR2>3.0.CO;2-6
   Basile JR, 2001, J BIOL CHEM, V276, P22522, DOI 10.1074/jbc.M010505200
   Bequet-Romero M, 2000, BIOCHEM BIOPH RES CO, V277, P55, DOI 10.1006/bbrc.2000.3628
   Bouma G, 1996, SCAND J IMMUNOL, V43, P456, DOI 10.1046/j.1365-3083.1996.d01-65.x
   BRASIL. INCA, 2014, CANC PREV EST 2014
   CABRERA M, 1995, J EXP MED, V182, P1259, DOI 10.1084/jem.182.5.1259
   Castelar L, 2010, TISSUE ANTIGENS, V76, P126, DOI 10.1111/j.1399-0039.2010.01471.x
   Corchado S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066619
   Deacon JM, 2000, BRIT J CANCER, V83, P1565, DOI 10.1054/bjoc.2000.1523
   Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369
   Duarte I, 2005, BIOCHEM BIOPH RES CO, V334, P588, DOI 10.1016/j.bbrc.2005.06.137
   Elahi MM, 2009, BBA-MOL BASIS DIS, V1792, P163, DOI 10.1016/j.bbadis.2009.01.007
   Esfandiari E, 2001, J IMMUNOL, V167, P5338, DOI 10.4049/jimmunol.167.9.5338
   Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146
   Fernandes APM, 2008, EUR J OBSTET GYN R B, V140, P241, DOI 10.1016/j.ejogrb.2008.04.007
   Fernandes JV, 2013, ANN MED HEALTH SCI R, V3, P504, DOI 10.4103/2141-9248.122060
   Fernandes JV, 2009, INT J GYNECOL OBSTET, V105, P21, DOI 10.1016/j.ijgo.2008.12.004
   Giedraitis V, 2001, J NEUROIMMUNOL, V112, P146, DOI 10.1016/S0165-5728(00)00407-0
   Gosmann C, 2014, J INVEST DERMATOL, V134, P2562, DOI 10.1038/jid.2014.201
   Govan VA, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-24
   Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313
   Hajeer AH, 2001, HUM IMMUNOL, V62, P1191, DOI 10.1016/S0198-8859(01)00322-6
   Hallermalm K, 2001, BLOOD, V98, P1108, DOI 10.1182/blood.V98.4.1108
   Haukim N, 2002, GENES IMMUN, V3, P313, DOI 10.1038/sj.gene.6363881
   HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057
   Johnson GCL, 2000, CURR OPIN GENET DEV, V10, P330, DOI 10.1016/S0959-437X(00)00075-7
   Karlsen F, 1996, J CLIN MICROBIOL, V34, P2095, DOI 10.1128/JCM.34.9.2095-2100.1996
   Kirkpatrick A, 2004, GYNECOL ONCOL, V92, P675, DOI 10.1016/j.ygyno.2003.11.025
   Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822
   Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7
   Laing KJ, 2001, EUR J BIOCHEM, V268, P1315, DOI 10.1046/j.1432-1327.2001.01996.x
   Lamb J, 2013, Nurs Prax N Z, V29, P24
   Lippman SA, 2010, INT J STD AIDS, V21, P105, DOI 10.1258/ijsa.2009.008436
   Lizano M, 2009, ARCH MED RES, V40, P428, DOI 10.1016/j.arcmed.2009.06.001
   LOWY DR, 2001, PAPILLOMAVIRUSES, P2231
   Mammas IN, 2014, INFECT GENET EVOL, V21, P220, DOI 10.1016/j.meegid.2013.11.002
   MANOS MM, 1989, CANCER CEL, V7, P209
   Tavares MCM, 2014, MOL BIOL REP, V41, P865, DOI 10.1007/s11033-013-2927-2
   Matsumoto K, 2010, CANCER SCI, V101, P2065, DOI 10.1111/j.1349-7006.2010.01642.x
   Min KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072142
   Nakanishi K, 2001, ANNU REV IMMUNOL, V19, P423, DOI 10.1146/annurev.immunol.19.1.423
   Oliveira-Silva M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-4
   Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74
   Perrey C, 1999, TRANSPL IMMUNOL, V7, P127, DOI 10.1016/S0966-3274(99)80030-6
   Piskin IE, 2013, DNA CELL BIOL, V32, P336, DOI 10.1089/dna.2013.1997
   Ribeiro AA, 2011, INT J GYNECOL PATHOL, V30, P288, DOI 10.1097/PGP.0b013e3181fde259
   Santos AM, 2005, CANCER GENET CYTOGEN, V159, P143, DOI 10.1016/j.cancergencyto.2004.10.005
   Sobti RC, 2008, ONCOL RES, V17, P159, DOI 10.3727/096504008785114156
   Solomon M., 2002, CONSUMER BEHAV EUROP
   Stanczuk GA, 2003, INT J GYNECOL CANCER, V13, P148, DOI 10.1046/j.1525-1438.2003.13046.x
   Szarewski A, 1996, LANCET, V347, P941, DOI 10.1016/S0140-6736(96)91417-8
   Tjiong MY, 2001, CYTOKINE, V14, P357, DOI 10.1006/cyto.2001.0909
   Tommasino M, 2014, SEMIN CANCER BIOL, V26, P13, DOI 10.1016/j.semcancer.2013.11.002
   Trimble CL, 2005, OBSTET GYNECOL, V105, P174, DOI 10.1097/01.AOG.0000148268.43584.03
   von Linsingen R, 2009, J INTERF CYTOK RES, V29, P285, DOI 10.1089/jir.2008.0081
   WHO, 2013, HUM PAP HPV CERV CAN
   Wilkerson M, 2010, AIDS CARE, V22, P1115, DOI 10.1080/09540121003599240
   Wilson AG, 1997, P NATL ACAD SCI USA, V94, P3195, DOI 10.1073/pnas.94.7.3195
   Yang YC, 2013, HUM IMMUNOL, V74, P882, DOI 10.1016/j.humimm.2013.04.001
   Ylitalo N, 2000, CANCER RES, V60, P6027
   Yu JT, 2009, BRAIN RES, V1253, P169, DOI 10.1016/j.brainres.2008.11.083
   Yue M, 2013, IMMUNOL LETT, V154, P54, DOI 10.1016/j.imlet.2013.08.007
NR 65
TC 7
Z9 8
U1 0
U2 10
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0301-4460
EI 1464-5033
J9 ANN HUM BIOL
JI Ann. Hum. Biol.
PY 2016
VL 43
IS 3
BP 261
EP 268
DI 10.3109/03014460.2014.1001436
PG 8
WC Anthropology; Biology; Public, Environmental & Occupational Health
SC Anthropology; Life Sciences & Biomedicine - Other Topics; Public,
   Environmental & Occupational Health
GA DO2EM
UT WOS:000377592700010
PM 26079218
DA 2020-12-01
ER

PT J
AU Silva, LTR
   Santos, SB
   Rameh-de-Albuquerque, LC
   Siqueira, DB
   Amorim, MMR
   Almeida, JC
   Oliveira, AAF
   Mota, RA
AF Silva, L. T. R.
   Santos, S. B.
   Rameh-de-Albuquerque, L. C.
   Siqueira, D. B.
   Amorim, M. M. R.
   Almeida, J. C.
   Oliveira, A. A. F.
   Mota, R. A.
TI Molecular detection and isolation of Mycoplasma spp. in psittacines in
   Pernambuco state, Brazil
SO ARQUIVO BRASILEIRO DE MEDICINA VETERINARIA E ZOOTECNIA
LA Portuguese
DT Article
DE molecular diagnosis; mycoplasmosis; psittaciformes
ID GALLISEPTICUM; POPULATION; DISEASE; FALCONS; BIRDS
AB The aim of this study was to investigate the occurrence of Mycoplasma spp., Mycoplasma galissepticum (MG) and Mycoplasma synoviae (MS) in captive psittacines. Eighty-five wild birds from Parque Estadual Dois Irmaos, Pernambuco state, northeastern Brazil, were used. From each psittacid analyzed three samples were obtained through cloaca, palate and conjunctiva swabs, totaling 255 samples. Samples collected were submitted to DNA extraction and Polimerase Chain Reaction (PCR). Mycoplasma spp. DNA was detected in 16.47% (14/85) of psittacines studied. From 255 samples, 6.66% (17/255) were positive for Mycoplasma spp.: 41.18% (7/17) of positivity in conjunctiva, 35.29% (6/17) in palate and 23.53% (4/17) in cloaca. There was no positive sample for MG or MS in PCR. Similar colonies were found for members of the Mollicutes Class in 17.64% of the samples (3/17). The results confirmed Mycoplasma spp. DNA in conjunctiva, palate and cloaca from the wild birds analyzed. This is the first record of Mycoplasma spp. in captive psittacines from northeastern Brazil.
C1 [Silva, L. T. R.; Santos, S. B.; Amorim, M. M. R.; Almeida, J. C.; Oliveira, A. A. F.; Mota, R. A.] Univ Fed Rural Pernambuco UFRPE, Recife, PE, Brazil.
   [Rameh-de-Albuquerque, L. C.; Siqueira, D. B.] Zool Parque Estadual Dois Irmaos, Recife, PE, Brazil.
RP Oliveira, AAF (corresponding author), Univ Fed Rural Pernambuco UFRPE, Recife, PE, Brazil.
EM andreaafo@hotmail.com
RI Oliveira, Andrea Alice AAFO Fonseca/B-1415-2012; Amorim, Melania
   M/C-5807-2013; ALMEIDA, JONATAS/AAB-4140-2020
OI Oliveira, Andrea Alice AAFO Fonseca/0000-0002-3728-177X; Amorim, Melania
   M/0000-0003-1047-2514; ALMEIDA, JONATAS/0000-0002-2282-4268
CR [Anonymous], 2001, AVIAN MYC
   BOLSKE G, 1982, AVIAN DIS, V26, P406, DOI 10.2307/1590113
   Buchala F. G., 2006, Arqivos do Instituto Biologico Sao Paulo, V73, P143
   CARVALHO A. M., 2012, THESIS U FEDERAL GOI
   DUARTE V. V., 2006, ENCONTRO ASM AREAS S, P22
   Faustino CR, 2004, J ANIM ECOL, V73, P651, DOI 10.1111/j.0021-8790.2004.00840.x
   Fischer JR, 1997, EMERG INFECT DIS, V3, P69, DOI 10.3201/eid0301.970110
   FRIEND M., 1999, FIELD MANUAL WILDLIF, P115
   FURR PM, 1977, VET REC, V100, P72, DOI 10.1136/vr.100.4.72
   Gerlach Helga, 1994, P1053
   Gomes AM, 2010, BRAZ J POULTRY SCI, V12, P75, DOI 10.1590/S1516-635X2010000200001
   GOMES A. M., 2012, REV CLIN VET, P104
   KUPPEVELD V. F. J. M., 1993, APPL ENVIRON MICROB, V58, P2606
   Lauerman LH, 1998, MYCOPLASMA PCR ASSAY
   Lecis R, 2010, RES VET SCI, V89, P58, DOI 10.1016/j.rvsc.2009.12.016
   LEMOS M., 2007, ENCONTRO INT MED CON, P25
   Lierz M, 2000, J VET MED B, V47, P63, DOI 10.1046/j.1439-0450.2000.00309.x
   Lierz M, 2009, VET REC, V164, P629, DOI 10.1136/vr.164.20.629
   Nascimento E.R., 2000, DOENCAS AVES, P217
   OIE, 2008, OIE MANUAL DIAGNOSTI, P482
   POVEDA JB, 1990, AVIAN PATHOL, V19, P779, DOI 10.1080/03079459008418729
   RAZIN S, 1994, MOL CELL PROBE, V8, P497, DOI 10.1006/mcpr.1994.1071
   Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998
   Sampaio I. B. M., 1998, ESTATISTICA APLICADA
   Regueira RFS, 2012, BIOL CONSERV, V149, P16, DOI 10.1016/j.biocon.2012.02.009
   VANKUPPEVELD FJM, 1994, APPL ENVIRON MICROB, V60, P149, DOI 10.1128/AEM.60.1.149-152.1994
   WHITFORD H.W., 1994, MYCOPLASMOSIS ANIMAL
NR 27
TC 1
Z9 1
U1 0
U2 15
PU ARQUIVO BRASILEIRO MEDICINA VETERINARIA ZOOTECNIA
PI MINAS GERAIS
PA FEDERAL MINAS GERAIS CAIXA POSTAL 567-BELO HORIZ, MINAS GERAIS, BRAZIL
SN 0102-0935
EI 1678-4162
J9 ARQ BRAS MED VET ZOO
JI Arq. Bras. Med. Vet. Zootec.
PD JAN-FEB
PY 2016
VL 68
IS 1
BP 113
EP 118
DI 10.1590/1678-4162-8387
PG 6
WC Veterinary Sciences
SC Veterinary Sciences
GA DC5CG
UT WOS:000369237800015
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Herclio, SD
   de Araujo, TA
   Souza, LSR
   Cahen, K
   Lima, SF
   de Souza, PRE
   Amorim, MMR
AF Herclio, Sandra de Andrade
   de Araujo, Thais Antunes
   Rolland Souza, Alex Sandro
   Cahen, Kristiane
   Lima Junior, Sergio Ferreira
   Eleuterio de Souza, Paulo Roberto
   Ramos Amorim, Melania Maria
TI Prevalence of HPV-induced lesions in the anal canal among women with
   cervical intraepithelial neoplasia 2 and 3: cross-sectional study
SO REVISTA BRASILEIRA DE GINECOLOGIA E OBSTETRICIA
LA Portuguese
DT Article
DE Papillomaviridae; Anal canal/injuries; Anal canal/citology; Cervical
   intraepithelial neoplasia
AB PURPOSE: To determine the prevalence of HPV-induced lesions in the anal canal of women with cervical intraepithelial neoplasia (CIN) grade 2/3. METHODS: A cross-sectional study was carried out from December 2008 to June 2009, in Pernambuco, northeastern Brazil. Only women with grade 2/3 CIN were included, and those who could not undergo anoscopy during their first visit were excluded. A cyttobrush was used for sample collection in order to identify HPV DNA through PCR and anal cytology. An anal biopsy was obtained in cases of abnormal anal cytology or major alterations in high resolution anoscopy (HRA). RESULTS: Thirty-two percent (n= 37/115) of HRA were normal and 63.5% (n= 73/115) showed acetowhite epithelium. Twenty-two percent (n= 26/115) of anal cytologies were abnormal. Among the latter, 12.2% (n= 14/26) were low-grade anal intraepithelial lesions and 3.4% (n= 4/26) were high-grade anal intraepithelial lesions. Twenty-two anal biopsies were performed, 13.7% of which (n= 3/22) were grade 2 anal intraepithelial neoplasia (AIN2) and 9% (n= 2/22) were grade 3 AIN. Th HPV DNA was identified in 72.1% of cases (n= 83/115). CONCLUSION: Women with CIN grade 2/3 showed a high prevalence of anal HPV infection and HPV-induced lesions.
C1 [Herclio, Sandra de Andrade; de Araujo, Thais Antunes; Rolland Souza, Alex Sandro; Cahen, Kristiane; Lima Junior, Sergio Ferreira; Eleuterio de Souza, Paulo Roberto; Ramos Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira IMP, Recife, PE, Brazil.
RP Herclio, SD (corresponding author), Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
CR Arain Shehla, 2005, Cytojournal, V2, P4, DOI 10.1186/1742-6413-2-4
   Balsitis SJ, 2003, MOL CELL BIOL, V23, P9094, DOI 10.1128/MCB.23.24.9094-9103.2003
   Crawford R, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-473
   Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365
   de Lima SF, 2011, REV BRAS GINECOL OBS, V33, P315, DOI 10.1590/S0100-72032011001000008
   Dermen KH, 2011, PSYCHOL ADDICT BEHAV, V25, P583, DOI 10.1037/a0025472
   Edgren G, 2007, LANCET ONCOL, V8, P311, DOI 10.1016/S1470-2045(07)70043-8
   FERNANDES AM, 2000, CAD SAUDE PUBLICA S1, V16, pS103
   Fritsch H, 2007, ANAT REC, V290, P1449, DOI 10.1002/ar.20589
   Giraldo P, 2009, EUR J OBSTET GYN R B, V142, P73, DOI 10.1016/j.ejogrb.2008.09.014
   Heraclio SA, 2015, INT J GYNECOL OBSTET, V128, P216, DOI 10.1016/j.ijgo.2014.09.014
   Heraclio SD, 2011, ACTA CYTOL, V55, P218, DOI 10.1159/000320922
   Hessol NA, 2009, AIDS, V23, P59, DOI 10.1097/QAD.0b013e32831cc101
   Koppe DC, 2011, DIS COLON RECTUM, V54, P442, DOI 10.1007/DCR.0b013e3182061b34
   Koshiol J, 2008, AM J EPIDEMIOL, V168, P123, DOI 10.1093/aje/kwn036
   Marrazzo JM, 2001, AM J PUBLIC HEALTH, V91, P947, DOI 10.2105/AJPH.91.6.947
   Nahas CSR, 2009, DIS COLON RECTUM, V52, P1854, DOI 10.1007/DCR.0b013e3181b98f36
   Nyitray AG, 2012, SEX HEALTH, V9, P538, DOI 10.1071/SH12021
   Oh JK, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-13
   Park IU, 2009, GYNECOL ONCOL, V114, P399, DOI 10.1016/j.ygyno.2009.05.008
   Piketty C, 2003, ANN INTERN MED, V138, P453, DOI 10.7326/0003-4819-138-6-200303180-00008
   Richart RM, 1998, ACTA CYTOL, V42, P50, DOI 10.1159/000331534
   Roura E, 2014, INT J CANCER, V135, P453, DOI 10.1002/ijc.28666
   Santoso JT, 2010, OBSTET GYNECOL, V116, P578, DOI 10.1097/AOG.0b013e3181ea1834
   Schlecht NF, 2003, J NATL CANCER I, V95, P1336, DOI 10.1093/jnci/djg037
   Scholefield JH, 2005, BRIT J SURG, V92, P1133, DOI 10.1002/bjs.4994
   SCHOLEFIELD JH, 1992, LANCET, V340, P1271, DOI 10.1016/0140-6736(92)92961-E
   Shai A, 2007, CANCER RES, V67, P1626, DOI 10.1158/0008-5472.CAN-06-3344
   Silling S, 2012, J CLIN VIROL, V53, P325, DOI 10.1016/j.jcv.2011.12.029
   Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114
   van der Zee RP, 2013, NETH J MED, V71, P401
   Varnai AD, 2006, INT J COLORECTAL DIS, V21, P135, DOI 10.1007/s00384-005-0777-7
   Veo CAR, 2008, EUR J OBSTET GYN R B, V140, P103, DOI 10.1016/j.ejogrb.2008.02.024
NR 33
TC 0
Z9 0
U1 0
U2 0
PU FEDERACAO BRASILEIRA SOC GINECOLOGIA & OBSTETRICIA-FEBRASGO
PI RIO DE JANEIRO RJ
PA AV DAS AMERICAS, 8445, SALA 711-BARRA DA TIJUCA, RIO DE JANEIRO RJ,
   22793-081, BRAZIL
SN 0100-7203
EI 1806-9339
J9 REV BRAS GINECOL OBS
JI Rev. Bras. Ginecol. Obstet.
PD OCT
PY 2015
VL 37
IS 10
BP 480
EP 485
DI 10.1590/SO100-720320150005279
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA VA8ZW
UT WOS:000410573000007
PM 26465167
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Cursino, T
   Katz, L
   Coutinho, I
   Amorim, M
AF Cursino, Telma
   Katz, Leila
   Coutinho, Isabela
   Amorim, Melania
TI Diuretics vs. placebo for postpartum blood pressure control in
   preeclampsia (DIUPRE): a randomized clinical trial
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Preeclampsia; Very high blood pressure; Diuretics; Randomized controlled
   trial
ID HYPERTENSIVE DISORDERS; PREGNANCY; MANAGEMENT; STATEMENT; ECLAMPSIA
AB Background: Hypertension affects about 10 % of pregnancies and is responsible for both maternal and neonatal devastating complications such as eclampsia, HELLP syndrome, prematurity and maternal and neonatal death. The resolution of the disease occurs in the first twelve weeks postpartum. The behavior of blood pressure and occurrence of very high blood pressure episodes among women with severe preeclampsia is related to remodeling of the dynamics of body fluids with consequent increase in intravascular volume. The persistence of hypertension in critical levels results in increased puerperal morbidity.
   Objectives: To evaluate the effectiveness of furosemide in accelerating blood pressure recovery among women with severe preeclampsia.
   Methods/design: A triple-masked placebo controlled clinical trial, will be conducted including 120 postpartum women with severe preeclampsia, after eclampsia prophylaxis with magnesium sulfate and with adequate diuresis. Women with chronic hypertension and users of diuretics will be deleted. Informed consent will be obtained from all participants. Patients will be randomized to receive furosemide (40 mg orally every twenty four hours) or placebo. The variables are systolic and diastolic blood pressure, frequency of hypertensive crises, need for maintenance of antihypertensive therapy, number of antihypertensive agents used to control blood pressure, urine output, length of hospital stay, adverse effects and maternal complications. This study was approved by the Research Ethics Committee in humans of our institution. All participants will be duly informed about the aims of the project and will be included only if they agree to participate voluntarily, signing the informed consent.
C1 [Cursino, Telma; Katz, Leila; Coutinho, Isabela; Amorim, Melania] Inst Med Integral Prof Fernando Figuei, Recife, PE, Brazil.
   [Amorim, Melania] Univ Fed Campina Grande, Dept Obstet & Gynecol, Campina Grande, PB, Brazil.
RP Amorim, M (corresponding author), Inst Med Integral Prof Fernando Figuei, Recife, PE, Brazil.
EM melania.amorim@gmail.com
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013; Kiseleva,
   Tatyana F/Q-4317-2016; KISELEV, VLADIMIR Mikhailivich/I-2745-2016;
   Kiselev, Vladimir M./B-6746-2014
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917;
   Kiseleva, Tatyana F/0000-0003-1886-3544; KISELEV, VLADIMIR
   Mikhailivich/0000-0001-7193-778X; Kiselev, Vladimir
   M./0000-0003-0401-5659
FU Instituto de Medicina Integral Prof. Fernando Figueira (IMIP)
FX Instituto de Medicina Integral Prof. Fernando Figueira (IMIP).
CR Ascarelli MH, 2005, OBSTET GYNECOL, V105, P29, DOI 10.1097/01.AOG.0000148270.53433.66
   CASTRO LC, 1994, AM J OBSTET GYNECOL, V171, P1642, DOI 10.1016/0002-9378(94)90416-2
   Chames MC, 2002, AM J OBSTET GYNECOL, V186, P1174, DOI 10.1067/mob.2002.123824
   David Churchill, COCHRANE LIB, DOI 10.1002/14651858.CD003106.pub3
   DAVISON JM, 1984, SEMIN NEPHROL, V4, P198
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Hutcheon JA, 2011, BEST PRACT RES CL OB, V25, P391, DOI 10.1016/j.bpobgyn.2011.01.006
   Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4
   Laura Magee, COCHRANE LIB, DOI [10.1002/14651858.CD004351.pub1, DOI 10.1002/14651858.CD004351.PUB1]
   Lelia Duley, COCHRANE LIB, DOI 10.1002/14651858.CD002960.pub1
   Lelia Duley, COCHRANE LIB, DOI 10.1002/14651858.CD000127.pub2
   Lelia Duley, COCHRANE LIB, DOI 10.1002/14651858.CD000128.pub2
   Lelia Duley, COCHRANE LIB, DOI 10.1002/14651858.CD007388.pub8
   Lelia Duley, COCHRANE LIB, DOI 10.1002/14651858.CD000025.pub3
   Matthews G., 1997, Journal of Obstetrics and Gynaecology (Abingdon), V17, P30
   Norwitz ER, 2015, UPTODATE 2015 TOPIC
   PEARSON JF, 1992, BRIT J HOSP MED, V48, P47
   Ray JG, 2005, LANCET, V366, P1797, DOI 10.1016/S0140-6736(05)67726-4
   Ray JG, 2012, HEART, V98, P1136, DOI 10.1136/heartjnl-2011-301548
   Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101
   Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88
   Ronsmans C, 2006, LANCET, V368, P1189, DOI 10.1016/S0140-6736(06)69380-X
   Sanctos M., 2004, THESIS I MED INTEGRA
   Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332
   Tranquilli AL, 2014, PREGNANCY HYPERTENS, V4, P97, DOI [10.1016/j.preghy.2014.02.001, 10.1016/j.preghy.2014.04.007, 10.1016/j.preghy.2014.04.017]
   von Dadelszen P, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-014-0454-8
   Zanette E, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-4
NR 27
TC 2
Z9 2
U1 0
U2 5
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD AUG 5
PY 2015
VL 12
AR 66
DI 10.1186/s12978-015-0057-0
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CO2CO
UT WOS:000358963100001
PM 26242730
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Amorim, MMR
   Neto, AHF
   Katz, L
   Coutinho, I
   Melo, I
   Leal, NV
AF Ramos Amorim, Melania Maria
   Franca Neto, Antonio Henriques
   Katz, Leila
   Coutinho, Isabela
   Melo, Ines
   Leal, Nicole Viana
TI Selective Episiotomy Compared With Implementation of a Nonepisiotomy
   Protocol A Randomized Clinical Trial
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 63rd Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 02-06, 2015
CL San Francisco, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Ramos Amorim, Melania Maria] Inst Med Integral, Recife, PE, Brazil.
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2015
VL 125
SU 1
MA 113
BP 41S
EP 42S
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CH6EI
UT WOS:000354128700135
DA 2020-12-01
ER

PT J
AU Amorim, MMR
   Leal, CC
   Souza, ASR
   Katz, L
   Neto, AHF
   Leal, NV
AF Ramos Amorim, Melania Maria
   Leal, Carlos Campos, Jr.
   Rolland Souza, Alex Sandro
   Katz, Leila
   Franca Neto, Antonio Henriques
   Leal, Nicole V.
TI Effectiveness of Loading Dose of Oral Compared With Sublingual
   Nifedipine for Tocolysis A Randomized Controlled Trial
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 63rd Annual Clinical and Scientific Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY MAY 02-06, 2015
CL San Francisco, CA
SP Amer Coll Obstetricians & Gynecologists
C1 [Ramos Amorim, Melania Maria] Inst Med Integral, Recife, PE, Brazil.
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013; Souza, Alex
   Sandro Rolland/AAG-2471-2019
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514;
   Souza, Alex Sandro Rolland/0000-0001-7039-2052
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2015
VL 125
SU 1
MA 112
BP 41S
EP 41S
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CH6EI
UT WOS:000354128700134
DA 2020-12-01
ER

PT J
AU Amorim, MMR
   Noronha-Neto, C
   Maia, SB
   Souza, ASR
   Katz, L
   Neto, AHF
AF Ramos Amorim, Melania Maria
   Noronha-Neto, Carlos
   Maia, Sabina Bastos
   Rolland Souza, Alex Sandro
   Katz, Leila
   Franca Neto, Antonio Henriques
TI Clonidine Compared With Captopril for Severe Postpartum Hypertension
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 61st Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists - Women's Health
   Care Physicians
CY MAY 07, 2013
CL New Orleans, LA
SP Amer Coll Obstetricians & Gynecologists
C1 [Ramos Amorim, Melania Maria] Inst Med Integral, Recife, PE, Brazil.
RI Amorim, Melania M/C-5807-2013; Souza, Alex Sandro Rolland/AAG-2471-2019;
   Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052; Katz, Leila/0000-0001-9854-7917
NR 0
TC 1
Z9 1
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2015
VL 125
SU 1
MA 114
BP 42S
EP 42S
DI 10.1097/01.AOG.0000463056.75838.b3
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CH6EI
UT WOS:000354128700136
DA 2020-12-01
ER

PT J
AU Neto, AHF
   Amorim, MMR
   Katz, L
   Morais, I
   Lemos, A
   Leal, NV
AF Franca Neto, Antonio Henriques
   Ramos Amorim, Melania Maria
   Katz, Leila
   Morais, Italo
   Lemos, Andrea
   Leal, Nicole V.
TI Cryotherapy for the Control of Perineal Pain Following Vaginal Delivery
   A Randomized Clinical Trial
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 61st Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists - Women's Health
   Care Physicians
CY MAY 07, 2013
CL New Orleans, LA
SP Amer Coll Obstetricians & Gynecologists
C1 [Franca Neto, Antonio Henriques] Inst Med Integral, Recife, PE, Brazil.
RI Morais, Italo/I-3643-2017; Katz, Leila/M-5291-2013; Amorim, Melania
   M/C-5807-2013
OI Morais, Italo/0000-0001-7137-4761; Katz, Leila/0000-0001-9854-7917;
   Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 1
Z9 1
U1 1
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2015
VL 125
SU 1
MA 194
BP 64S
EP 65S
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CH6EI
UT WOS:000354128700214
DA 2020-12-01
ER

PT J
AU Melo, A
   Amorim, MMR
   Belo, MCF
   Pinto, MD
   Sena, ASS
   Martins, FD
AF Melo, Adriana
   Ramos Amorim, Melania Maria
   Farias Belo, Maira Creusa
   Pinto, Maria do Carmo
   Santos Sena, Aline Silva
   Martins, Felipe Dias
TI Respiratory Muscle Strength During Pregnancy A Cohort Study
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 61st Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists - Women's Health
   Care Physicians
CY MAY 07, 2013
CL New Orleans, LA
SP Amer Coll Obstetricians & Gynecologists
C1 [Melo, Adriana] Inst Pesquisa Prof Amorim Neto IPESQ, Campina Grande, Brazil.
RI Amorim, Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016
OI Amorim, Melania M/0000-0003-1047-2514; 
NR 0
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2015
VL 125
SU 1
MA 217
BP 71S
EP 71S
DI 10.1097/01.AOG.0000463121.86172.25
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CH6EI
UT WOS:000354128700238
DA 2020-12-01
ER

PT J
AU Melo, FO
   Amorim, MMR
   Melo, A
   Barros, VD
   Tavares, JD
   Leal, NV
AF Melo, Fabiana O.
   Ramos Amorim, Melania Maria
   Melo, Adriana
   Barros, Vivianne de Oliveira
   Tavares, Jousilene de Sales
   Leal, Nicole V.
TI Maternal Anthropometric Measures and Visceral Fat in the Newborn
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 61st Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists - Women's Health
   Care Physicians
CY MAY 07, 2013
CL New Orleans, LA
SP Amer Coll Obstetricians & Gynecologists
C1 [Melo, Fabiana O.] Inst Pesquisa Prof Joaquim Amorim Neto, Campina Grande, Paraiba, Brazil.
RI Amorim, Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016
OI Amorim, Melania M/0000-0003-1047-2514; 
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2015
VL 125
SU 1
MA 233
BP 75S
EP 76S
DI 10.1097/01.AOG.0000463158.43323.f9
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CH6EI
UT WOS:000354128700254
DA 2020-12-01
ER

PT J
AU Melo, FO
   Amorim, MMR
   Macedo, LC
   Leal, NV
   Vasconcelos, DA
   Medeiros, MS
AF Melo, Fabiana O.
   Ramos Amorim, Melania Maria
   Macedo, Lorena C.
   Leal, Nicole V.
   Vasconcelos, Danilo A.
   Medeiros, Marina S.
TI Functionality of the Pelvic Floor Muscles in Nulliparous Women According
   to the Level of Physical Activity
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 61st Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists - Women's Health
   Care Physicians
CY MAY 07, 2013
CL New Orleans, LA
SP Amer Coll Obstetricians & Gynecologists
C1 [Melo, Fabiana O.] Inst Pesquisa Prof Joaquim Amorim Neto, Campina Grande, Brazil.
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2015
VL 125
SU 1
MA 234
BP 76S
EP 76S
DI 10.1097/01.AOG.0000463159.20452.b2
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CH6EI
UT WOS:000354128700255
DA 2020-12-01
ER

PT J
AU Leal, NV
   Amorim, MMR
   Neto, AHF
   Souza, ASR
   Melo, FO
   Patriota, AF
AF Leal, Nicole V.
   Ramos Amorim, Melania Maria
   Franca Neto, Antonio Henriques
   Rolland Souza, Alex Sandro
   Melo, Fabiana O.
   Patriota, Adriane Farias
TI Effect of Amniotic Fluid Volume on Perinatal and Maternal Outcomes in
   Women With Preterm Premature Rupture of Membranes
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 61st Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists - Women's Health
   Care Physicians
CY MAY 07, 2013
CL New Orleans, LA
SP Amer Coll Obstetricians & Gynecologists
C1 [Leal, Nicole V.] Inst Pesquisa Prof Joaquim Amorim Neto, Campina Grande, Paraiba, Brazil.
RI Souza, Alex Sandro Rolland/AAG-2471-2019; Amorim, Melania M/C-5807-2013
OI Souza, Alex Sandro Rolland/0000-0001-7039-2052; Amorim, Melania
   M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2015
VL 125
SU 1
MA 390
BP 121S
EP 121S
DI 10.1097/01.AOG.0000463212.79642.bd
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CH6EI
UT WOS:000354128700408
DA 2020-12-01
ER

PT J
AU Marques, RMCD
   Souza, ASR
   da Costa, AAR
   Feitosa, FED
   Amorim, MMR
AF Carvalho de Paiva Marques, Rossana Mariana
   Rolland Souza, Alex Sandro
   Ribeiro da Costa, Aurelio Antonio
   de Lucena Feitosa, Francisco Edson
   Ramos Amorim, Melania Maria
TI Factors associated with vaginal delivery in hypertensive and
   normotensive pregnant women submitted to labor induction with
   misoprostol: a cohort study
SO HYPERTENSION IN PREGNANCY
LA English
DT Article
DE Hypertensive syndromes; Induced labor; Labor; Misoprostol; Vaginal
   delivery
ID UNFAVORABLE CERVIX; TRANSVAGINAL ULTRASOUND; CESAREAN DELIVERY; PRELABOR
   RUPTURE; WEEKS GESTATION; RISK; TERM; PREECLAMPSIA; MANAGEMENT;
   MEMBRANES
AB Objective: To determine the factors associated with vaginal delivery in hypertensive and normotensive pregnant women submitted to induction of labor with misoprostol. Methods: A cohort study. Results: The factors associated with vaginal delivery in both normotensive and hypertensive women were, respectively, Bishop score >= 4 (OR = 1.87; 95% CI: 1.06-3.29; p = 0.03) and (OR = 2.31; 95% CI: 1.25-4.28; p = 0.008) and parity >= 1 (OR = 4.36; 95% CI: 2.16-8.80; p50.0001) and (OR = 2.61; 95% CI: 1.36-5.04; p = 0.004). Conclusion: The factors associated with vaginal delivery were Bishop score >= 4 and parity >= 1 irrespective of whether or not the women were hypertensive.
C1 [Carvalho de Paiva Marques, Rossana Mariana; Rolland Souza, Alex Sandro; Ribeiro da Costa, Aurelio Antonio; Ramos Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira IMIP, Dept Obstet & Gynecol, Recife, PE, Brazil.
   [Rolland Souza, Alex Sandro; Ribeiro da Costa, Aurelio Antonio] HBL, Dept Obstet, Recife, PE, Brazil.
   [Rolland Souza, Alex Sandro] Policlin Maternidade Prof Arnaldo Marques, Dept Obstet, Recife, PE, Brazil.
   [de Lucena Feitosa, Francisco Edson] Univ Fed Ceara, Dept Obstet & Gynecol, Fortaleza, Ceara, Brazil.
   [Ramos Amorim, Melania Maria] Univ Fed Campina Grande, Dept Obstet & Gynecol, Campina Grande, Paraiba, Brazil.
RP Souza, ASR (corresponding author), Av Rui Barbosa 579,Apto 406, BR-52011040 Recife, PE, Brazil.
EM alexrolland@uol.com.br
RI Amorim, Melania M/C-5807-2013; feitosa, francisco e/H-8431-2014; Souza,
   Alex Sandro Rolland/AAG-2471-2019
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052
CR ACOG Committee on Practice Bulletins -- Obstetrics, 2009, Obstet Gynecol, V114, P386, DOI 10.1097/AOG.0b013e3181b48ef5
   BISHOP EH, 1964, OBSTET GYNECOL, V24, P266
   Bortolus R, 1999, EUR J OBSTET GYN R B, V87, P137, DOI 10.1016/S0301-2115(99)00107-4
   Cabral Simone Angélica Leite de Carvalho Silva, 2003, Rev. Bras. Ginecol. Obstet., V25, P739, DOI 10.1590/S0100-72032003001000007
   Chandra S, 2001, OBSTET GYNECOL, V98, P2, DOI 10.1016/S0029-7844(01)01386-2
   Costa Aurélio Antônio Ribeiro, 2002, Rev. Bras. Ginecol. Obstet., V24, P455, DOI 10.1590/S0100-72032002000700005
   Crane J M G, 2004, J Matern Fetal Neonatal Med, V15, P319, DOI 10.1080/14767050410001702195
   Cunha Alfredo de Almeida, 2002, Rev. Bras. Ginecol. Obstet., V24, P21, DOI 10.1590/S0100-72032002000100004
   Edwards C, 1997, INT J GYNECOL OBSTET, V57, P39, DOI 10.1016/S0020-7292(97)02854-3
   Faundes A, 1991, Cad Saude Publica, V7, P150, DOI 10.1590/S0102-311X1991000200003
   Fettosa FEL, 2006, INT J GYNECOL OBSTET, V94, P91, DOI 10.1016/j.ijgo.2006.04.031
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Goffinet F, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, P638
   Gonen R, 1998, Eur J Ultrasound, V7, P183, DOI 10.1016/S0929-8266(98)00042-1
   Guerra GV, 2009, BJOG-INT J OBSTET GY, V116, P1762, DOI 10.1111/j.1471-0528.2009.02348.x
   Hannah ME, 1996, NEW ENGL J MED, V334, P1005, DOI 10.1056/NEJM199604183341601
   Kim LH, 2010, J MATERN-FETAL NEO M, V23, P383, DOI 10.3109/14767050903168432
   Lydon-Rochelle MT, 2007, MED CARE, V45, P505, DOI 10.1097/MLR.0b013e3180330e26
   Magann EF, 1998, AM J OBSTET GYNECOL, V178, P1279, DOI 10.1016/S0002-9378(98)70334-5
   Magann EF, 1999, INT J GYNECOL OBSTET, V65, P1, DOI 10.1016/S0020-7292(98)00262-8
   Patah LEM, 2011, REV SAUDE PUBL, V45, P185, DOI 10.1590/s0034-89102011000100021
   Mann T., 1996, CLIN GUIDELINES USIN
   Ministerio da Saude, 2010, GEST ALT RISC MAN TE, P257
   MORRISON JJ, 1995, BRIT J OBSTET GYNAEC, V102, P101, DOI 10.1111/j.1471-0528.1995.tb09060.x
   Ottervanger HP, 1996, J PERINAT MED, V24, P237, DOI 10.1515/jpme.1996.24.3.237
   PATERSONBROWN S, 1991, EUR J OBSTET GYN R B, V40, P17, DOI 10.1016/0028-2243(91)90039-N
   Pevzner L, 2009, OBSTET GYNECOL, V114, P261, DOI 10.1097/AOG.0b013e3181ad9377
   Rane SM, 2003, ULTRASOUND OBST GYN, V22, P45, DOI 10.1002/uog.166
   Sampaio ZS, 2004, REV BRAS GINECOL OBS, V26, P21
   Scholz HS, 1999, PREV MED, V29, P263, DOI 10.1006/pmed.1999.0536
   Souza ASR, 2013, INT J GYNECOL OBSTET, V123, P207, DOI 10.1016/j.ijgo.2013.06.028
   Tam T, 2013, ARCH GYNECOL OBSTET, V287, P407, DOI 10.1007/s00404-012-2582-1
   Tan BP, 2007, COCHRANE DB SYST REV, V2
   Vahratian A, 2005, OBSTET GYNECOL, V105, P698, DOI 10.1097/01.AOG.0000157436.68847.3b
   Ware V, 2000, AM J OBSTET GYNECOL, V182, P1030, DOI 10.1067/mob.2000.105399
   Watson WJ, 1996, OBSTET GYNECOL, V88, P990
   Williams MC, 1997, OBSTET GYNECOL, V90, P784, DOI 10.1016/S0029-7844(97)00415-8
   Wing DA, 2002, AM J OBSTET GYNECOL, V186, P1237, DOI 10.1067/mob.2002.123740
   World Health Organization, 2011, WHO REC IND LAB 2011
   Xenakis EMJ, 1997, OBSTET GYNECOL, V90, P235, DOI 10.1016/S0029-7844(97)00259-7
NR 40
TC 1
Z9 1
U1 0
U2 4
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1064-1955
EI 1525-6065
J9 HYPERTENS PREGNANCY
JI Hypertens. Pregnancy
PD MAY
PY 2015
VL 34
IS 2
BP 153
EP 170
DI 10.3109/10641955.2014.988351
PG 18
WC Obstetrics & Gynecology; Physiology; Peripheral Vascular Disease
SC Obstetrics & Gynecology; Physiology; Cardiovascular System & Cardiology
GA CF4UY
UT WOS:000352549000003
PM 25549056
DA 2020-12-01
ER

PT J
AU Amorim, MMR
   Katz, L
   Barros, AS
   Almeida, TSF
   Souza, ASR
   Faundes, A
AF Amorim, Melania M. R.
   Katz, Leila
   Barros, Amanda S.
   Almeida, Tainara S. F.
   Souza, Alex Sandro R.
   Faundes, Anibal
TI Maternal outcomes according to mode of delivery in women with severe
   preeclampsia: a cohort study
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE Caesarean; complications; delivery; labour; obstetrics; pre-eclampsia;
   prognosis
ID CESAREAN DELIVERY; HYPERTENSIVE DISORDERS; INDUCTION; LABOR;
   COMPLICATIONS; MORBIDITY
AB Objective: To determine the association between mode of delivery and maternal complications in patients with severe preeclampsia.
   Methods: A prospective cohort study was conducted with 500 pregnant women with severe preeclampsia. The mode of delivery, vaginal or caesarean section, was considered the exposure, while the postpartum maternal complications and severe maternal morbidity were the outcomes. Logistic regression analysis was performed to determine the adjusted risk and 95% confidence intervals (95% CI) of maternal morbidity.
   Results: Labour was spontaneous in 22.0% and induced in 28.2%, while 49.8% had an elective caesarean section. Ninety-five (67.4%) of the patients in whom labour was induced delivered vaginally. Total Caesarean rate was 68.2%. The risk of severe maternal morbidity was significantly greater in patients submitted to Caesarean section (54.0% versus 32.7%) irrespective of the presence of labour. Factors that remained associated with severe maternal morbidity following multivariate analysis were a diagnosis of HELLP syndrome after delivery (OR = 3.73; 95% CI: 1.55-9.88) and having a caesarean (OR = 1.91; 95% CI: 1.52-4.57).
   Conclusions: Caesareans are often performed in patients with severe preeclampsia and are associated with significant postpartum maternal morbidity. Induction of labour should be considered a feasible option in these patients.
C1 [Amorim, Melania M. R.; Katz, Leila; Souza, Alex Sandro R.] Inst Med Integral Prof Fernando Figueira IMIP, Dept Maternal & Child Hlth, Recife, PE, Brazil.
   [Amorim, Melania M. R.] Univ Fed Campina Grande, Dept Obstet, BR-58406120 Campina Grande, Paraiba, Brazil.
   [Barros, Amanda S.; Almeida, Tainara S. F.] FPS, Recife, PE, Brazil.
   [Souza, Alex Sandro R.] Univ Fed Pernambuco UFPE, Dept Maternal & Child Hlth, Recife, PE, Brazil.
   [Faundes, Anibal] Univ Campinas UNICAMP, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Amorim, MMR (corresponding author), Univ Fed Campina Grande, Dept Obstet, Rua Neuza Borborema de Souza 300, BR-58406120 Campina Grande, Paraiba, Brazil.
EM melania.amorim@gmail.com
RI Souza, Alex Sandro Rolland/AAG-2471-2019; Katz, Leila/M-5291-2013;
   Amorim, Melania M/C-5807-2013
OI Souza, Alex Sandro Rolland/0000-0001-7039-2052; Katz,
   Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX The authors thank National Council for Scientific and Technological
   Development (CNPq) for the financial support.
CR Alanis MC, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.076
   [Anonymous], 2002, OBSTET GYNECOL, V99, P159
   Blackwell S C, 2001, J Matern Fetal Med, V10, P305
   CATANZARITE V, 1991, AM J PERINAT, V8, P7, DOI 10.1055/s-2007-999327
   Coppage KH, 2002, AM J OBSTET GYNECOL, V186, P921, DOI 10.1067/mob.2002.124041
   Dissanayake VHW, 2007, J OBSTET GYNAECOL RE, V33, P56, DOI 10.1111/j.1447-0756.2007.00475.x
   Drife J, 2006, BJOG, V113, pS81
   Eskild A, 2009, ACTA OBSTET GYN SCAN, V88, P154, DOI 10.1080/00016340802613242
   Gandhi SK, 2001, NEW ENGL J MED, V344, P17, DOI 10.1056/NEJM200101043440103
   Geller EJ, 2010, J PERINATOL, V30, P258, DOI 10.1038/jp.2009.150
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Gowri V, 2010, HYPERTENS PREGNANCY, V29, P231, DOI 10.3109/10641950903115038
   Kuklina EV, 2009, OBSTET GYNECOL, V113, P1299, DOI 10.1097/AOG.0b013e3181a45b25
   LIANO F, 1993, NEPHRON, V63, P21, DOI 10.1159/000187139
   Machado LC, 2009, CAD SAUDE PUBLICA, V25, P124, DOI 10.1590/S0102-311X2009000100013
   Magee LA, 2008, J OBSTET GYNAECOL CA, V30, pS1, DOI 10.1016/S1701-2163(16)32776-1
   Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X
   Mozurkewich E, 2009, BJOG-INT J OBSTET GY, V116, P626, DOI 10.1111/j.1471-0528.2008.02065.x
   Nassar AH, 1998, AM J OBSTET GYNECOL, V179, P1210, DOI 10.1016/S0002-9378(98)70133-4
   National Collabourating Centre for Women's and Children's Health, 2004, CAES SECT, P142
   Neto CN, 2010, REV BRAS GINECOL OBS, V32, P459, DOI 10.1590/S0100-72032010000900008
   Ng SY, 2008, ANAESTH INTENS CARE, V36, P113, DOI 10.1177/0310057X0803600121
   Pallasmaa N, 2010, ACTA OBSTET GYN SCAN, V89, P896, DOI 10.3109/00016349.2010.487893
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P311, DOI 10.1016/0002-9378(90)90376-I
   Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2
   Souza ASR, 2008, BJOG-INT J OBSTET GY, V115, P1340, DOI 10.1111/j.1471-0528.2008.01872.x
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55
   Xenakis EMJ, 1997, OBSTET GYNECOL, V89, P600, DOI 10.1016/S0029-7844(97)00043-4
NR 30
TC 9
Z9 10
U1 0
U2 6
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD APR
PY 2015
VL 28
IS 6
BP 654
EP 660
DI 10.3109/14767058.2014.928689
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CI2VU
UT WOS:000354606400008
PM 24866351
DA 2020-12-01
ER

PT J
AU Heraclio, SA
   Schettini, J
   Oliveira, ML
   Souza, ASR
   Souza, PRE
   Amorim, MMR
AF Heraclio, Sandra A.
   Schettini, Juliana
   Oliveira, Micheline L.
   Souza, Alex Sandro R.
   Souza, Paulo Roberto E.
   Amorim, Melania Maria R.
TI High-resolution anoscopy in women with cervical neoplasia
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Anal neoplasia; Cervical intraepithelial neoplasia; Early cancer
   detection; Papillomaviridae
ID SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS INFECTION; ANAL
   DYSPLASIA; AGREEMENT; HISTOPATHOLOGY; PREVALENCE; CYTOLOGY
AB Objective: To describe high-resolution anoscopy (HRA) findings and compare them with histopathology results. Methods: In a cross-sectional, observational study performed between December 2008 and December 2009, women receiving care at a center in Recife, Brazil, after a histopathologic diagnosis of cervical intraepithelial neoplasia or cervical cancer were screened for anal neoplasia by HRA. Patients with anal lesions were divided into groups A (metaplasia and/or human papillomavirus infection) and B (anal intraepithelial neoplasia [AIN]). Patients with squamous cell atypia in group A and all patients in group B underwent histopathologic analysis. Agreement between HRA and histopathology findings was estimated for group B. Results: HRA was done in 324 women, 204 (63.0%) of whom had anal lesions. Overall, 169 cases (82.8%) were classified as group A and 35 (172%) as group B. Histopathologic data were obtained for 28 of the 35 group B cases. Histopathology was suggestive of AIN in 19 (67.9%), resulting in a kappa coefficient of 0.45 (95% confidence interval [CI] 0.26-0.65; P < 0.001). Relative to histopathology, HRA had sensitivity of 57.6% (95% Cl 40.8%-72.7%), specificity of 86.1% (95% Cl 75.7%-92.5%), positive likelihood ratio of 4.1 (95% CI 3.1-5.5), negative likelihood ratio of 0.5 (95% Cl 0.4-0.5), and accuracy of 76.5% (95% Cl 672%-83.8%). Conclusion: HRA findings can be systematized, reducing the subjectivity of interpretation. (C) 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Heraclio, Sandra A.; Schettini, Juliana; Souza, Alex Sandro R.; Amorim, Melania Maria R.] Womens Healthcare Ctr, Inst Materna Inland Prof Fernando Figueira, Dept Lower Genital Tract Pathol, Recife, Pernambuco, Brazil.
   [Oliveira, Micheline L.] Pernambuco Publ Hlth Lab, Cytopathol Div, Recife, PE, Brazil.
   [Souza, Paulo Roberto E.] Univ Fed Rural Pernambuco, Dept Biol, Recife, PE, Brazil.
RP Heraclio, SA (corresponding author), Av Dr Malaquias 195-2701, BR-50070550 Recife, Pernambuco, Brazil.
EM sandra_heraclio@hotmail.com
RI Amorim, Melania M/C-5807-2013; Souza, Alex Sandro Rolland/AAG-2471-2019
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052; Souza, Paulo/0000-0002-9186-9849
CR BOSCH FX, 1995, J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796
   Bowring J, 2010, J LOW GENIT TRACT DI, V14, P301, DOI 10.1097/LGT.0b013e3181d77756
   Centers for Disease Control and Prevention, BAS INF HPV ASS CANC
   Darvishian F, 2009, ANN CLIN LAB SCI, V39, P270
   De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116
   Dean AG, OPENEPI OPEN SOURCE
   Durdi GS, 2009, J TURK-GER GYNECOL A, V10, P205
   Heraclio SD, 2011, ACTA CYTOL, V55, P218, DOI 10.1159/000320922
   Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703
   Hong DG, 2010, INT J CLIN ONCOL, V15, P65, DOI 10.1007/s10147-009-0012-6
   Hwang LY, 2009, J ADOLESCENT HEALTH, V44, P103, DOI 10.1016/j.jadohealth.2008.10.006
   Jay N, 1997, DIS COLON RECTUM, V40, P919, DOI 10.1007/BF02051199
   Koshiol J, 2008, AM J EPIDEMIOL, V168, P123, DOI 10.1093/aje/kwn036
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Mathews WC, 2004, JAIDS-J ACQ IMM DEF, V37, P1610, DOI 10.1097/00126334-200412150-00014
   Nahas CSR, 2009, DIS COLON RECTUM, V52, P1854, DOI 10.1007/DCR.0b013e3181b98f36
   Nathan M, 2010, AIDS, V24, P373, DOI 10.1097/QAD.0b013e328333ab8e
   Olaniyan Olayinka Babafemi, 2002, Afr J Reprod Health, V6, P59, DOI 10.2307/3583258
   Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011
   Pineda CE, 2008, DIS COLON RECTUM, V51, P829, DOI 10.1007/s10350-008-9233-4
   Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784
   Quaas J, 2013, GEBURTSH FRAUENHEILK, V73, P904, DOI 10.1055/s-0033-1350824
   RICHART RM, 1990, OBSTET GYNECOL, V75, P131
   Santoso JT, 2010, OBSTET GYNECOL, V116, P578, DOI 10.1097/AOG.0b013e3181ea1834
   Scholefield JH, 2005, BRIT J SURG, V92, P1133, DOI 10.1002/bjs.4994
   Winer RL, 2003, AM J EPIDEMIOL, V157, P218, DOI 10.1093/aje/kwf180
NR 26
TC 3
Z9 7
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD MAR
PY 2015
VL 128
IS 3
BP 216
EP 219
DI 10.1016/j.ijgo.2014.09.014
PG 4
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA CC1JG
UT WOS:000350096400007
PM 25468048
DA 2020-12-01
ER

PT J
AU Lemos, A
   Amorim, MMR
   de Andrade, AD
   de Souza, AI
   Cabral, JE
   Correia, JB
AF Lemos, Andrea
   Amorim, Melania M. R.
   de Andrade, Armele Dornelas
   de Souza, Ariani I.
   Cabral Filho, Jose Eulalio
   Correia, Jailson B.
TI Pushing/bearing down methods for the second stage of labour
SO COCHRANE DATABASE OF SYSTEMATIC REVIEWS
LA English
DT Review
ID RANDOMIZED CONTROLLED-TRIAL; LUMBAR EPIDURAL ANALGESIA; 2ND STAGE;
   NULLIPAROUS WOMEN; PUSHING TECHNIQUES; IMMEDIATE; DELIVERY; MANAGEMENT;
   DURATION; BEARING
AB Background
   Maternal pushing during the second stage of labour is an important and indispensable contributor to the involuntary expulsive force developed by uterus contraction. Currently, there is no consensus on an ideal strategy to facilitate these expulsive efforts and there are contradictory results about the influence on mother and fetus.
   Objectives
   To evaluate the benefits and possible disadvantages of different kinds of techniques regarding maternal pushing/breathing during the expulsive stage of labour on maternal and fetal outcomes.
   Search methods
   We searched the Cochrane Pregnancy and Childbirth Group's Trials Register (28 January 2015) and reference lists of retrieved studies.
   Selection criteria
   Randomised and quasi-randomised assessing the effects of pushing/bearing down techniques (type and/or timing) performed during the second stage of labour on maternal and neonatal outcomes. Cluster-RCTs were eligible for inclusion but none were identified. Studies using a cross-over design and those published in abstract form only were not eligible for inclusion.
   We considered the following comparisons.
   Timing of pushing: to compare pushing, which begins as soon as full dilatation has been determined versus pushing which begins after the urge to push is felt.
   Type of pushing: to compare pushing techniques that involve the 'Valsalva Manoeuvre' versus all other pushing techniques.
   Data collection and analysis
   Two review authors independently assessed trials for inclusion and risk of bias. Two review authors independently extracted data. Data were checked for accuracy.
   Main results
   We included 20 studies in total, seven studies (815 women) comparing spontaneous pushing versus directed pushing, with or without epidural analgesia and 13 studies (2879 women) comparing delayed pushing versus immediate pushing with epidural analgesia. The results come from studies with a high or unclear risk of bias, especially selection bias and selective reporting bias.
   Comparison 1: types of pushing: spontaneous pushing versus directed pushing
   Overall, for this comparison there was no difference in the duration of the second stage (mean difference (MD) 11.60 minutes; 95% confidence interval (CI) -4.37 to 27.57, five studies, 598 women, random-effects, I-2: 82%; T-2: 220.06). There was no clear difference in perineal laceration (risk ratio (RR) 0.87; 95% CI 0.45 to 1.66, one study, 320 women) and episiotomy (average RR 1.05; 95% CI 0.60 to 1.85, two studies, 420 women, random-effects, I-2 = 81%; T-2 = 0.14). The primary neonatal outcomes such as five-minute Apgar score less than seven was no different between groups (RR 0.35; 95% CI 0.01 to 8.43, one study, 320 infants), and the number of admissions to neonatal intensive care (RR 1.08; 95% CI 0.30 to 3.79, two studies, n = 393) also showed no difference between spontaneous and directed pushing and no data were available on hypoxic ischaemic encephalopathy.
   The duration of pushing (secondary maternal outcome) was five minutes less for the spontaneous group (MD -5.20 minutes; 95% CI -7.78 to -2.62, one study, 100 women).
   Comparison 2: timing of pushing: delayed pushing versus immediate pushing (all women with epidural)
   For the primary maternal outcomes, delayed pushing was associated with an increase of 54 minutes in the duration of the second stage of labour (MD 54.29 minutes; 95% CI 38.14 to 70.43; 10 studies, 2797 women, random-effects; I-2 = 91%; T-2 = 543.38), and there was no difference in perineal laceration (RR 0.94; 95% CI 0.78 to 1.14, seven studies. 2775 women) and episiotomy (RR 0.95; 95% CI 0.87 to 1.04, five studies, 2320 women). Delayed pushing was also associated with a 20-minute decrease in the duration of pushing (MD -20.10; 95% CI -36.19 to -4.02, 10 studies, 2680 women, random-effects, I-2 = 96%; T-2 = 604.37) and an increase in spontaneous vaginal delivery (RR 1.07; 95% CI 1.03 to 1.11, 12 studies, 3114 women).
   For the primary neonatal outcomes, there was no difference between groups in admission to neonatal intensive care (RR 0.98; 95% CI 0.67 to 1.41, three studies, n = 2197) and five-minute Apgar score less than seven (RR 0.15; 95% CI 0.01 to 3.00, three studies, n = 413). There were no data on hypoxic ischaemic encephalopathy. Delayed pushing was associated with a greater incidence of low umbilical cord blood pH (RR 2.24; 95% CI 1.37 to 3.68) and increased the cost of intrapartum care by CDN$ 68.22 (MD 68.22, 95% CI 55.37, 81.07, one study, 1862 women).
   Authors' conclusions
   This review is based on a total of 20 included studies that were of a mixed methodological quality.
   Timing of pushing with epidural is consistent in that delayed pushing leads to a shortening of the actual time pushing and increase of spontaneous vaginal delivery at the expense of an overall longer duration of the second stage of labour and double the risk of a low umbilical cord pH (based only on one study). Nevertheless, there was no difference in the caesarean and instrumental deliveries, perineal laceration and episiotomy, and in the other neonatal outcomes (admission to neonatal intensive care, five-minute Apgar score less than seven and delivery room resuscitation) between delayed and immediate pushing. Futhermore, the adverse effects on maternal pelvic floor is still unclear. Therefore, there is insufficient evidence to justify routine use of any specific timing of pushing since the maternal and neonatal benefits and adverse effects of delayed and immediate pushing are not well established.
   For the type of pushing, with or without epidural, there is no conclusive evidence to support or refute any specific style or recommendation as part of routine clinical practice. Women should be encouraged to bear down based on their preferences and comfort. In the absence of strong evidence supporting a specific method or timing of pushing, patient preference and clinical situations should guide decisions.
   Further properly well-designed randomised controlled trials are required to add evidence-based information to the current knowledge. These trials should address clinically important maternal and neonatal outcomes and will provide more complete data to be incorporated into a future update of this review.
C1 [Lemos, Andrea] Univ Fed Pernambuco, Phys Therapy, BR-50670901 Recife, PE, Brazil.
   [Amorim, Melania M. R.; de Souza, Ariani I.; Cabral Filho, Jose Eulalio; Correia, Jailson B.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
   [de Andrade, Armele Dornelas] Univ Fed Pernambuco, Master Degree Programin Phys Therapy, Phys Therapy, BR-50670901 Recife, PE, Brazil.
RP Lemos, A (corresponding author), Univ Fed Pernambuco, Phys Therapy, Dept Fisioterapia, Cidade Univ,Av Prof Moraes Rego 1235, BR-50670901 Recife, PE, Brazil.
EM andrealemos4@gmail.com
RI Amorim, Melania M/C-5807-2013; Souza, Ariani I/C-1568-2015; de Souza,
   Ariani Impieri/AAR-6884-2020
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Ariani
   I/0000-0002-7917-5983; de Souza, Ariani Impieri/0000-0002-7917-5983
FU Universidade Federal de Pernambuco, Physical Therapy Department -
   Recife-PE, Brazil; Instituto de Medicina Integral Prof. Fernando
   Figueira- Recife-PE, Brazil
FX Internal sources; Universidade Federal de Pernambuco, Physical Therapy
   Department - Recife-PE, Brazil.; Instituto de Medicina Integral Prof.
   Fernando Figueira- Recife-PE, Brazil.
CR ADERHOLD KJ, 1991, J NURSE-MIDWIFERY, V36, P267, DOI 10.1016/0091-2182(91)90041-M
   Albers LL, 2007, J MIDWIFERY WOM HEAL, V52, P246, DOI 10.1016/j.jmwh.2006.12.008
   ALDRICH CJ, 1995, BRIT J OBSTET GYNAEC, V102, P448, DOI 10.1111/j.1471-0528.1995.tb11316.x
   BARNETT MM, 1982, BIRTH-ISS PERINAT C, V9, P221, DOI 10.1111/j.1523-536X.1982.tb01667.x
   BATES RG, 1985, BRIT J OBSTET GYNAEC, V92, P1246, DOI 10.1111/j.1471-0528.1985.tb04870.x
   BEYNON CL, 1957, J OBSTET GYNAECOL, V64, P815
   Bloom SL, 2006, AM J OBSTET GYNECOL, V194, P10, DOI 10.1016/j.ajog.2005.06.022
   Boulvain M, 1998, 21 C SWISS SOC GYN O, P5
   Brancato RM, 2008, JOGNN-J OBST GYN NEO, V37, P4, DOI [10.1111/J.1552-6909.2007.00205.x, 10.1111/j.1552-6909.2007.00205.x]
   Brincat C, 2009, INT J GYNECOL OBSTET, V106, P236, DOI 10.1016/j.ijgo.2009.04.018
   Buhimschi CS, 2002, AM J OBSTET GYNECOL, V186, P1339, DOI 10.1067/mob.2002.122402
   BUXTON EJ, 1988, J OBSTET GYNAECOL, V8, P258, DOI 10.3109/01443618809012295
   Buxton EJ, 1989, P SILV JUBL BRIT C O, P80
   Caldeyro-Barcia R., 1990, COMMUNICATION
   CALDEYROBARCIA R, 1981, J PERINAT MED, V9, P63, DOI 10.1515/jpme.1981.9.s1.63
   Chang SC, 2011, MIDWIFERY, V27, P825, DOI 10.1016/j.midw.2010.08.009
   Cunningham FG, 2001, WILLIAMS OBSTET
   Fitzpatrick M, 2002, BJOG-INT J OBSTET GY, V109, P1359, DOI 10.1046/j.1471-0528.2002.02109.x
   Fitzpatrick M., 2000, American Journal of Obstetrics and Gynecology, V182, pS37
   Fraser WD, 2000, AM J OBSTET GYNECOL, V182, P1165, DOI 10.1067/mob.2000.105197
   Fraser WD, 1997, ACTA OBSTET GYNECO S, V76, P45
   Fraser WD, 1998, SOC OBST GYN CAN 54, P36
   Gillesby E, 2010, JOGNN-J OBST GYN NEO, V39, P635, DOI 10.1111/j.1552-6909.2010.01195.x
   Gillesby EJ, 2010, JOGNN-J OBST GYN NEO, V39, pS87, DOI 10.1111/j.1552-6909.2010.01123_1.x
   GLEESON NC, 1991, BRIT J CLIN PRACT, V45, P90
   GOODFELLOW CF, 1979, BRIT J CLIN PRACT, V33, P287
   Gupta JK, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002006.pub3
   Hansen SL, 2002, OBSTET GYNECOL, V99, P29, DOI 10.1016/S0029-7844(01)01642-8
   Hanson L, 2009, J PERINAT NEONAT NUR, V23, P31, DOI 10.1097/JPN.0b013e318196526b
   Hauspurg A., 2014, PASSIVE DESCENT OBES
   Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049
   Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13
   Jahdi F, 2011, INT J COLLAB RES INT, V3, P159
   Kelly M, 2010, MCN-AM J MATERN-CHIL, V35, P81, DOI 10.1097/NMC.0b013e3181cae7ad
   KNAUTH DG, 1986, NURS RES, V35, P49
   Lai ML, 2009, J NURS RES, V17, P62, DOI 10.1097/JNR.0b013e3181999e78
   Lam C. W, 2006, THESIS
   Lam CCO, 2010, HONG KONG J GYNAECOL, V10, P13
   Le Ray C, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.08.002
   Le Ray C, 2008, AM J OBSTET GYNECOL, V199, pS37, DOI 10.1016/j.ajog.2008.09.111
   Lin P, 2000, J Fam Pract, V49, P783
   Liston RM, 1996, COMMUNICATION
   Liston RM, 1987, P 19 ANN M SOC OBST, P94
   Low LK, 2013, INT UROGYNECOL J, V24, P453, DOI 10.1007/s00192-012-1884-y
   Low LK, 2010, FEMALE PELVIC MED S2, V16, pS70
   MARESH M, 1983, BRIT J OBSTET GYNAEC, V90, P623, DOI 10.1111/j.1471-0528.1983.tb09278.x
   Martinez-Lopez V, 1984, P 31 M SOC GYN INV 1
   Matsuo K, 2009, J OBSTET GYNAECOL RE, V35, P672, DOI 10.1111/j.1447-0756.2008.01010.x
   Mayberry L J, 1999, J Perinatol, V19, P26, DOI 10.1038/sj.jp.7200076
   MCQUEEN J, 1977, BRIT MED J, V1, P640
   Menez-Orieux C, 2005, J Gynecol Obstet Biol Reprod (Paris), V34, P440
   Minato JF, 2001, AWHONN LIFELINES, V4, P20
   Mulvey SF., MCROBERTS MANOEUVRE
   PARNELL C, 1993, ACTA OBSTET GYN SCAN, V72, P31, DOI 10.3109/00016349309013345
   Parnell C, 1993, UGESKRIFT LAEGER, V155, P2259
   Parnell C, 1992, ACTA PAEDIATR, P17
   Petrou S, 2000, AM J OBSTET GYNECOL, V182, P1158, DOI 10.1067/mob.2000.104213
   Phipps H, 2007, J PAEDIAT CHILD H S1, V43, pA67
   Phipps H, 2009, AUST NZ J OBSTET GYN, V49, P274, DOI 10.1111/j.1479-828X.2009.00984.x
   Pickrell MD, 1989, P SILV JUB BRIT C OB
   Plunkett BA, 2003, OBSTET GYNECOL, V102, P109, DOI 10.1016/S0029-7844(03)00479-4
   Plunkett Beth, 2001, American Journal of Obstetrics and Gynecology, V184, pS119
   Prins M, 2011, BJOG-INT J OBSTET GY, V118, P662, DOI 10.1111/j.1471-0528.2011.02910.x
   RAVINDRAN RS, 1981, ANESTH ANALG, V60, P524
   Roberts CL, 2004, BJOG-INT J OBSTET GY, V111, P1333, DOI 10.1111/j.1471-0528.2004.00282.x
   Roberts J, 1996, J Obstet Gynecol Neonatal Nurs, V25, P415, DOI 10.1111/j.1552-6909.1996.tb02446.x
   Roberts J E, 1987, J Obstet Gynecol Neonatal Nurs, V16, P48, DOI 10.1111/j.1552-6909.1987.tb01438.x
   Roberts JE, 2002, J MIDWIFERY WOM HEAL, V47, P2, DOI 10.1016/S1526-9523(01)00233-1
   Schaffer J, 2005, AM J OBSTET GYNECOL, V192, P1692, DOI 10.1016/j.ajog.2004.11.043
   Simpson KR, 2005, NURS RES, V54, P149
   Snyder S, 1996, COMMUNICATION
   Spiby H., 1990, COMMUNICATION
   The Nordic Cochrane Centre The Cochrane Collaboration, 2011, REV MAN REVMAN 5 1 W
   THOMSON AM, 1995, J ADV NURS, V22, P1027
   THOMSON AM, 1993, J ADV NURS, V18, P171, DOI 10.1046/j.1365-2648.1993.18020171.x
   Thomson AM., 1990, THESIS
   Thomson AM., 1991, P 22 INT C CONF MIDW, P76
   Thorp JA, 1996, BIRTH-ISS PERINAT C, V23, P63, DOI 10.1111/j.1523-536X.1996.tb00833.x
   Tuuli MG, 2012, OBSTET GYNECOL, V120, P660, DOI 10.1097/AOG.0b013e3182639fae
   Vause S, 1998, BRIT J OBSTET GYNAEC, V105, P186, DOI 10.1111/j.1471-0528.1998.tb10050.x
   Vause S, 1998, BRIT J OBSTET GYNAEC, V105, P85
   Wai CY, 2011, INT UROGYNECOL J, V22, P1293, DOI 10.1007/s00192-011-1438-8
   Walker C, 2012, INT UROGYNECOL J, V23, P1249, DOI 10.1007/s00192-012-1675-5
   YEATES DA, 1984, J NURSE-MIDWIFERY, V29, P3, DOI 10.1016/0091-2182(84)90324-0
   Yildirim G, 2008, BIRTH-ISS PERINAT C, V35, P25, DOI 10.1111/j.1523-536X.2007.00208.x
NR 85
TC 24
Z9 25
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1469-493X
EI 1361-6137
J9 COCHRANE DB SYST REV
JI Cochrane Database Syst Rev.
PY 2015
IS 10
AR CD009124
DI 10.1002/14651858.CD009124.pub2
PG 95
WC Medicine, General & Internal
SC General & Internal Medicine
GA CX9XO
UT WOS:000366060300039
PM 26451755
DA 2020-12-01
ER

PT J
AU Silva, FX
   Katz, L
   Souza, ASR
   Amorim, MMR
AF Silva, Flavio Xavier
   Katz, Leila
   Rolland Souza, Alex Sandro
   Ramos Amorim, Melania Maria
TI Mammography in asymptomatic women aged 40-49 years
SO REVISTA DE SAUDE PUBLICA
LA English
DT Article
DE Women; Mammography; Mass Screening; Breast Neoplasms, diagnosis;
   Cross-Sectional Studies
ID BREAST; MORTALITY; RISK
AB OBJECTIVE: To assess findings of mammography of and interventions resulting from breast cancer screening in women aged 40-49 years with no increased risk (typical risk) of breast cancer.
   METHODS: This cross-sectional study evaluated women aged 40-49 years who underwent mammography screening in a mastology reference center in Recife, PE, Northeastern Brazil, between January 2010 and October 2011. Women with breast-related complaints, positive findings in the physical examination, or high risk of breast cancer were excluded.
   RESULTS: The 1,000 mammograms performed were classified into the following Breast Imaging-Reporting and Data System (BI-RADS) categories BI-RADS 0, 232; BI-RADS 1, 294; BI-RADS 2, 294; BI-RADS 3, 16; BI-RADS 4A, 2; BI-RADS 5, 1. There was one case of grade II invasive ductal carcinoma and various interventions, including 469 ultrasound scans, 53 referrals to mastologists, 11 cytological examinations, and 8 biopsies.
   CONCLUSIONS: Mammography screening in women aged 40-49 years with typical risk of breast cancer led to the performance of other interventions. However, it also resulted in increased costs without demonstrable efficacy in decreasing mortality.
C1 [Silva, Flavio Xavier; Katz, Leila; Rolland Souza, Alex Sandro; Ramos Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira, Ctr Atencao Mulher, Recife, PE, Brazil.
   [Rolland Souza, Alex Sandro] Univ Fed Pernambuco, Dept Materno Infantil, Recife, PE, Brazil.
   [Ramos Amorim, Melania Maria] Univ Fed Campina Grande, Dept Ginecol & Obstet, Campina Grande, PB, Brazil.
RP Amorim, MMR (corresponding author), Rua Neuza Borborema Souza,300 Santo Antonio, BR-58406120 Campina Grande, PB, Brazil.
EM melania.amorim@gmail.com
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013; Souza, Alex
   Sandro Rolland/AAG-2471-2019
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514;
   Souza, Alex Sandro Rolland/0000-0001-7039-2052
CR American College of Obstetricians-Gynecologists, 2011, Obstet Gynecol, V118, P372, DOI 10.1097/AOG.0b013e31822c98e5
   American College of Radiology, 2003, BREAST IM REP DAT SY
   Berry DA, 2009, J CLIN ONCOL, V27, P639, DOI 10.1200/JCO.2008.17.9341
   Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008
   Dickinson J, 2011, CAN MED ASSOC J, V183, P1991, DOI 10.1503/cmaj.110334
   El Saghir NS, 2011, BREAST, V20, pS3, DOI 10.1016/j.breast.2011.02.006
   Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4
   Heywang-Kobrunner SH, 2011, BREAST CARE, V6, P199, DOI 10.1159/000329005
   Kettritz Ute, 2010, Breast Care (Basel), V5, P119
   Kosters J. P., 2003, COCHRANE DB SYST REV, V2003, P2, DOI DOI 10.1002/14651858.CD003373
   Le-Petross HT, 2011, SEMIN ULTRASOUND CT, V32, P266, DOI 10.1053/j.sult.2011.03.005
   Magnus MC, 2011, J WOMENS HEALTH, V20, P845, DOI 10.1089/jwh.2010.2098
   Mark K, 2014, OBSTET GYNECOL, V123, P734, DOI 10.1097/AOG.0000000000000139
   Martins CA, 2013, REV BRAS CANCEROL, V59, P341
   Miller AB, 2014, BMJ-BRIT MED J, V348, P366, DOI DOI 10.1136/BMJ.G366
   Moss S, 2005, BRIT J CANCER, V92, P949, DOI 10.1038/sj.bjc.6602396
   Tice JA, 2008, ANN INTERN MED, V148, P337, DOI 10.7326/0003-4819-148-5-200803040-00004
   van Ravesteyn NT, 2012, ANN INTERN MED, V156, P609, DOI 10.7326/0003-4819-156-9-201205010-00002
   Yaffe MJ, 2011, RADIOLOGY, V258, P98, DOI 10.1148/radiol.10100655
NR 19
TC 5
Z9 6
U1 0
U2 17
PU REVISTA DE SAUDE PUBLICA
PI SAO PAULO
PA FACULDADE SAUDE PUBL DA USP, AV DR ARNALDO 715, 01246-904SP SAO PAULO,
   BRAZIL
SN 0034-8910
EI 1518-8787
J9 REV SAUDE PUBL
JI Rev. Saude Publica
PD DEC
PY 2014
VL 48
IS 6
BP 931
EP 939
DI 10.1590/S0034-8910.2014048005349
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA CA0EC
UT WOS:000348587400008
PM 26039396
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Couceiro, TCD
   Valenca, MM
   Raposo, MCF
   de Orange, FA
   Amorim, MMR
AF de Menezes Couceiro, Tania Cursino
   Valenca, Marcelo Moraes
   Falcao Raposo, Maria Cristina
   de Orange, Flavia Augusta
   Amorim, Melania M. R.
TI Prevalence of Post-Mastectomy Pain Syndrome and Associated Risk Factors:
   A Cross-Sectional Cohort Study
SO PAIN MANAGEMENT NURSING
LA English
DT Article
ID BREAST-CANCER; NODE BIOPSY; SURGERY
AB This study was designed to determine the prevalence of post-mastectomy pain and its associated risk factors in women submitted to surgical treatment for breast cancer. A cross-sectional cohort study was conducted involving 250 women treated surgically for breast cancer. The variables evaluated were (a) post-mastectomy pain syndrome (PMPS) (as a dependent variable or outcome) and (b) the patients' social characteristics (schooling, marital status), biological characteristics (body mass index, skin color, age), prior history of headache and dysmenorrhea, occurrence of acute postoperative pain, and type of surgery (mastectomy or quadrantectomy) (as independent or predictive variables). The prevalence ratios (PR) and their respective 95% confidence intervals (95% CI) were calculated as a measure of the risk of PMPS. Multivariate analysis was performed using a hierarchical model of stepwise logistic regression that included possible explanatory variables, calculating the adjusted risk of PMPS fromthe odds ratio (OR) and the 95% CI at a significance level of 5%. PMPS was found in 44.4% of patients. The variables that remained strongly associated with PMPS following multiple logistic regression analysis were quadrantectomy with axillary lymphadenectomy (OR = 2.83; 95% CI: 1.60-5.02), prior history of headache (OR = 1.92; 95% CI: 1.10-3.34), and age <50 years (OR = 4.37; 95% CI: 2.43-7.86). PMPS is a common condition, particularly in women submitted to quadrantectomy with axillary lymphadenectomy, those under 50 years of age, and those with a prior history of headache. Attention should be paid to these factors at pre-operative evaluation and counseling, and they should be taken into consideration in postoperative management. (C) 2014 by the American Society for Pain Management Nursing
C1 [de Menezes Couceiro, Tania Cursino] Univ Fed Pernambuco, Dept Neuropscyhiatry & Behav Sci, BR-50070110 Recife, PE, Brazil.
   [Valenca, Marcelo Moraes; Falcao Raposo, Maria Cristina; de Orange, Flavia Augusta] Univ Fed Pernambuco, BR-50070110 Recife, PE, Brazil.
   [Amorim, Melania M. R.] Univ Fed Campina Grande, Recife, PE, Brazil.
RP de Orange, FA (corresponding author), Univ Fed Pernambuco, Dept Anesthesiol, Rua Simao Mendes 200-2302, BR-50070110 Recife, PE, Brazil.
EM orangeflavia@gmail.com
RI Valenca, Marcelo/A-4302-2013; Amorim, Melania M/C-5807-2013
OI Valenca, Marcelo/0000-0003-0678-3782; Amorim, Melania
   M/0000-0003-1047-2514
CR ANDERSCH B, 1982, AM J OBSTET GYNECOL, V144, P655, DOI 10.1016/0002-9378(82)90433-1
   Bigal Marcelo E, 2007, J Headache Pain, V8, P263, DOI 10.1007/s10194-007-0418-3
   Caffo O, 2003, BREAST CANCER RES TR, V80, P39, DOI 10.1023/A:1024435101619
   Carpenter JS, 1998, J CLIN EPIDEMIOL, V51, P1285, DOI 10.1016/S0895-4356(98)00121-8
   Chan YHY, 2011, ASIAN J SURG, V34, P81, DOI 10.1016/S1015-9584(11)60024-9
   Collins SL, 1997, PAIN, V72, P95, DOI 10.1016/S0304-3959(97)00005-5
   Dworkin RH, 2005, PAIN, V113, P9, DOI 10.1016/j.pain.2004.09.012
   GARFINKEL L, 1994, CANCER, V74, P222, DOI 10.1002/cncr.2820741304
   Gartner R, 2009, JAMA-J AM MED ASSOC, V302, P1985, DOI 10.1001/jama.2009.1568
   Instituto Nacional do Cancer/Ministerio da Saude, 2009, ESTIMATIVA DA INCIDE
   Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI 10.3322/caac.20115
   Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360
   Katz J, 2005, PAIN, V119, P16, DOI 10.1016/j.pain.2005.09.008
   Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X
   Loukas M, 2011, AM SURGEON, V77, P566
   Macdonald L, 2005, BRIT J CANCER, V92, P225, DOI 10.1038/sj.bjc.6602304
   Mansel RE, 2006, J NATL CANCER I, V98, P599, DOI 10.1093/jnci/djj158
   Miguel R, 2001, Cancer Control, V8, P427
   Pimenta C A, 1996, Rev Esc Enferm USP, V30, P473
   Poleshuck EL, 2006, J PAIN, V7, P626, DOI 10.1016/j.jpain.2006.02.007
   Ries LAG, 2000, CANCER, V88, P2398, DOI 10.1002/(SICI)1097-0142(20000515)88:10<2398::AID-CNCR26>3.0.CO;2-I
   Schrenk P, 2000, CANCER, V88, P608, DOI 10.1002/(SICI)1097-0142(20000201)88:3<608::AID-CNCR17>3.0.CO;2-K
   Steer RA, 1999, GEN HOSP PSYCHIAT, V21, P106, DOI 10.1016/S0163-8343(98)00070-X
   Sullivan K., 2006, OPEN EPI OPEN SOURCE
   Tasmuth T, 1997, ACTA ONCOL, V36, P625, DOI 10.3109/02841869709001326
   TASMUTH T, 1995, ANN ONCOL, V6, P453, DOI 10.1093/oxfordjournals.annonc.a059215
   Toda K, 2006, CLIN RHEUMATOL, V25, P728, DOI 10.1007/s10067-005-0161-6
   TURK DC, 1987, PAIN, V30, P177, DOI 10.1016/0304-3959(87)91073-6
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Vilholm OJ, 2008, BRIT J CANCER, V99, P604, DOI 10.1038/sj.bjc.6604534
   Wallace A. M., 1997, ANESTHESIOL CLIN N A, V15, P353, DOI DOI 10.1016/S0889-8537(05)70338-2
   WOOD KM, 1978, SOUTHERN MED J, V71, P662, DOI 10.1097/00007611-197806000-00016
NR 32
TC 29
Z9 32
U1 0
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1524-9042
EI 1532-8635
J9 PAIN MANAG NURS
JI Pain Manag. Nurs.
PD DEC
PY 2014
VL 15
IS 4
BP 731
EP 737
DI 10.1016/j.pmn.2013.07.011
PG 7
WC Nursing
SC Nursing
GA AU2ES
UT WOS:000345429800004
PM 24144570
DA 2020-12-01
ER

PT J
AU Braga, GC
   Clementino, STP
   da Luz, PFN
   Scavuzzi, A
   Neto, CN
   Amorim, MMR
AF Braga, Giordana Campos
   Pereira Clementino, Suelem Tais
   Neves da Luz, Patricia Ferreira
   Scavuzzi, Adriana
   Noronha Neto, Carlos
   Ramos Amorim, Melania Maria
TI Risk factors for episiotomy: a case-control study
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Article
DE episiotomy; natural childbirth; risk factors; perineum/injuries;
   case-control studies
ID OPERATIVE VAGINAL DELIVERY
AB Objective: obtaining information on the factors associated with episiotomy will be useful in sensitizing professionals to the need to minimize its incidence. Therefore, the objective of this study was to evaluate risk factors for episiotomy in pregnant women who had undergone vaginal delivery at a university maternity hospital in northeastern Brazil.
   Methods: a case-control study was conducted with pregnant women submitted to episiotomy (cases) and pregnant women not submitted to episiotomy (controls) between March 2009 and July 2010 at the Professor Fernando Figueira Integral Medicine Institute (IMIP) in Recife, Brazil, in a ratio of 1 case to 2 controls. The study variables consisted of whether episiotomy was performed, demographic, obstetric and fetal characteristics (primiparity, analgesia, instrumental delivery, fetal distress, etc.), external factors (day and time of delivery, professional attending delivery) and factors directly related to delivery. Odds ratios (OR) and 95% confidence intervals (95%CI) were calculated. Multivariate analysis was performed to determine the adjusted risk of episiotomy.
   Results: a total of 522 women (173 cases and 349 controls) were included. It was found that deliveries with episiotomy were more likely to have been attended by staff physicians (OR = 1.88; 95%Cl: 1.01 - 3.48), to have required forceps (OR = 12.31; 95%CI: 4.9 - 30.1) and to have occurred in primiparas (OR = 4.24; 9596CI: 2.61 - 6.89). The likelihood of a nurse having attended the delivery with episiotomy was significantly lower (OR = 0.29; 95%C1: 0.16 - 0.55).
   Conclusion: episiotomy was found to be strongly associated with deliveries attended by staff physicians, with primiparity, and with instrumental delivery, and was less common in deliveries attended by nurses.
C1 [Braga, Giordana Campos; Pereira Clementino, Suelem Tais; Neves da Luz, Patricia Ferreira; Scavuzzi, Adriana; Noronha Neto, Carlos; Ramos Amorim, Melania Maria] Prof Fernando Figueira Integral Med Inst IMIP, Recife, PE, Brazil.
RP Braga, GC (corresponding author), Rua Jose Saretta 155, BR-14026593 Ribeirao Preto, SP, Brazil.
EM giordanacb@yahoo.com.br
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
FU National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq)
FX National Council for Scientific and Technological Development (CNPq).
   Scientific initiation grant.
CR Allen RE, 2005, J AM BOARD FAM PRACT, V18, P8, DOI 10.3122/jabfm.18.1.8
   Amorim MMR, 2008, FEMINA, V36, P47
   Anim-Somuah M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000331.pub3
   [Anonymous], 2003, MAN COMPL PREGN CHIL
   Carroli G, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000081.pub2
   Colman Atalie, 2006, N Z Med J, V119, pU2146
   Coomarasamy A, 2005, BJOG-INT J OBSTET GY, V112, P1461, DOI 10.1111/j.1471-0528.2005.00702.x
   Eckman A, 2010, J GYNECOL OBST BIO R, V39, P37, DOI 10.1016/j.jgyn.2009.09.013
   Faruel-Fosse H., 2006, J GYNECOL OBSTET B S, V35, p1S68
   Goldberg J, 2006, J REPROD MED, V51, P603
   Gupta JK, 2012, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD002006.PUB3
   Hatem M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004667.pub2
   Hueston WJ, 1996, OBSTET GYNECOL, V87, P1001, DOI 10.1016/0029-7844(96)00068-3
   Levitt C, 2011, J OBSTET GYNAECOL CA, V33, P1208, DOI 10.1016/S1701-2163(16)35104-0
   Macleod M, 2008, BJOG-INT J OBSTET GY, V115, P1688, DOI 10.1111/j.1471-0528.2008.01961.x
   de Carvalho CCM, 2010, REV ASSOC MED BRAS, V56, P333, DOI 10.1590/S0104-42302010000300020
   Myers-Helfgott MG, 1999, OBSTET GYN CLIN N AM, V26, P305, DOI 10.1016/S0889-8545(05)70077-2
   Paris AE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.006
   Raisanen SH, 2009, ACTA OBSTET GYN SCAN, V88, P1365, DOI 10.3109/00016340903295626
   Rodriguez A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.11.007
   Steiner N, 2012, ARCH GYNECOL OBSTET, V286, P1369, DOI 10.1007/s00404-012-2460-x
   Tracy Sally K, 2007, Women Birth, V20, P41, DOI 10.1016/j.wombi.2007.03.005
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   World Health Organization, 1996, MAT NEWB HLTH SAF MO
   Yeomans ER, 2010, OBSTET GYNECOL, V115, P645, DOI 10.1097/AOG.0b013e3181cfbefd
NR 25
TC 11
Z9 14
U1 0
U2 12
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
SN 0104-4230
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD SEP-OCT
PY 2014
VL 60
IS 5
BP 465
EP 472
DI 10.1590/1806-9282.60.05.015
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA AT9SK
UT WOS:000345266200013
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Maia, SB
   Katz, L
   Neto, CN
   Caiado, BVR
   Azevedo, APRL
   Amorim, MMR
AF Maia, Sabina B.
   Katz, Leila
   Noronha Neto, Carlos
   Caiado, Barbara V. R.
   Azevedo, Ana P. R. L.
   Amorim, Melania M. R.
TI Abbreviated (12-hour) versus traditional (24-hour) postpartum magnesium
   sulfate therapy in severe pre-eclampsia
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE Magnesium sulfate therapy; Postpartum; Pre-eclampsia
ID CLINICAL-PARAMETERS; PROPHYLAXIS; WOMEN; RISK
AB Objective: To compare the use of magnesium sulfate for 12 hours versus 24 hours in postpartum women with stable severe pre-eclampsia. Methods: In 2011, an open randomized clinical trial was conducted with 120 postpartum women with severe pre-eclampsia who gave birth at a tertiary hospital in Brazil; 60 women received magnesium sulfate for 24 hours and 60 for 12 hours. The analysis was by intention-to-treat and the intervention was not masked. Results: Abbreviated (12-hour) magnesium sulfate therapy was associated with less exposure to the drug, and clinical outcomes were similar in both groups. No woman developed eclampsia and there was no need to re-initiate treatment after completing the scheduled magnesium sulfate therapy in either group. Magnesium sulfate therapy was extended in only three women in the 12-hour group. In addition, in this group, significant reductions were found in the duration of postpartum use of an indwelling bladder catheter, the time to ambulation, and the time to maternal contact with the newborn. Conclusion: Abbreviated postpartum magnesium sulfate therapy in patients with stable severe pre-eclampsia was associated with less drug exposure, similar outcomes, and benefits such as a reduction in the time to contact with the newborn. Clinical trials registration: clinicaltrials.gov NCT1408979 (C) 2014 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
C1 [Maia, Sabina B.; Katz, Leila; Noronha Neto, Carlos; Azevedo, Ana P. R. L.; Amorim, Melania M. R.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Caiado, Barbara V. R.] Fac Pernambucana Saude, Recife, PE, Brazil.
RP Amorim, MMR (corresponding author), Rua Neuza Borborema Souza,300 Bairro Santo Antoni, BR-58406120 Campina Grande, PB, Brazil.
EM melania.amorim@gmail.com
RI Katz, Leila/M-5291-2013; Lengruber, Albert/AAD-9113-2019; Amorim,
   Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Lengruber, Albert/0000-0003-2977-9946;
   Amorim, Melania M/0000-0003-1047-2514
CR ACOG, 2002, OBSTET GYNECOL, V99, P869
   Amorim Melania Maria Ramos de, 2006, Rev. Bras. Saude Mater. Infant., V6, ps55, DOI 10.1590/S1519-38292006000500008
   Ascarelli MH, 1998, AM J OBSTET GYNECOL, V179, P952, DOI 10.1016/S0002-9378(98)70195-4
   Bates SM, 2008, CHEST, V133, p844S, DOI 10.1378/chest.08-0761
   Conde-Agudelo A, 2011, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD00
   Darngawn L, 2012, INT J GYNECOL OBSTET, V116, P237, DOI 10.1016/j.ijgo.2011.09.028
   Duley L, 2010, COCHRANE DB SYST REV, V4
   Duley L, 2007, BJOG-INT J OBSTET GY, V114, P300, DOI 10.1111/j.1471-0528.2006.01166.x
   Duley L, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000025.pub2
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Ehrenberg HM, 2006, OBSTET GYNECOL, V108, P833, DOI 10.1097/01.AOG.0000236493.35347.d8
   Fontenot MT, 2005, AM J OBSTET GYNECOL, V192, P1788, DOI 10.1016/j.ajog.2004.12.056
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Isler CM, 2003, OBSTET GYNECOL, V101, P66, DOI 10.1016/S0029-7844(02)02317-7
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   Kullima AA, 2009, ANN AFR MED, V8, P81, DOI 10.4103/1596-3519.56233
   Likert R., 1932, ARCH PSYCHOL, V22, P1, DOI DOI 10.1111/J.1540
   Maki DG, 2001, EMERG INFECT DIS, V7, P342, DOI 10.3201/eid0702.010240
   Neto CN, 2010, REV BRAS GINECOL OBS, V32, P459, DOI 10.1590/S0100-72032010000900008
   Sibai BM, 2005, OBSTET GYNECOL, V105, P402, DOI 10.1097/01.AOG.0000152351.13671.99
   Sibai BM, 2004, AM J OBSTET GYNECOL, V190, P1520, DOI 10.1016/j.ajog.2003.12.057
   Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6
   World Health Organization, MAN COMPL PREGN CHIL
   World Health Organization, WHO REC PREV TREATM
NR 24
TC 9
Z9 9
U1 0
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD SEP
PY 2014
VL 126
IS 3
BP 260
EP 264
DI 10.1016/j.ijgo.2014.03.024
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA AO0FB
UT WOS:000340983400016
PM 24890747
DA 2020-12-01
ER

PT J
AU Melo, I
   Katz, L
   Coutinho, I
   Amorim, MM
AF Melo, Ines
   Katz, Leila
   Coutinho, Isabela
   Amorim, Melania Maria
TI Selective episiotomy vs. implementation of a non episiotomy protocol: a
   randomized clinical trial
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Episiotomy; Vaginal delivery; Perineum; Randomized controlled trial
ID TRAUMA
AB Background: World Health Organization ( WHO) recommends that the episiotomy rate should be around 10%, which is already a reality in many European countries. Currently the use of episiotomy should be restricted and physicians are encouraged to use their clinical judgment to decide when the procedure is necessary. There is no clinical evidence corroborating any indication of episiotomy, so until the present moment it is not yet known whether episiotomy is indeed necessary in any context of obstetric practice.
   Objectives: To compare maternal and perinatal outcomes in women undergoing a protocol of not performing episiotomy versus selective episiotomy.
   Methods/Design: An open label randomized clinical trial will be conducted including laboring women with term pregnancy, maximum dilation of 8 cm, live fetus in cephalic vertex presentation. Women with bleeding disorders of pregnancy, indication for caesarean section and those without capacity to consent and without legal guardians will be excluded. Primary outcomes will be frequency of episiotomy, delivery duration, frequency of spontaneous lacerations and perineal trauma, frequency of instrumental delivery, postpartum blood loss, need for perineal suturing, number of sutures, Apgar scores at one and five minutes, need for neonatal resuscitation and pH in cord blood. As secondary outcomes frequency complications of perineal suturing, postpartum perineal pain, maternal satisfaction, neonatal morbidity and admission newborn in NICU will be assessed. Women will be invited to participate and those who agree will sign the consent form and will be then assigned to a protocol of not conducting episiotomy ( experimental group) or to a group that episiotomy is performed selectively according to the judgment of the provider of care delivery ( control Group). The present study was approved by IMIP's Research Ethics Committee.
C1 [Melo, Ines; Katz, Leila; Coutinho, Isabela; Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Amorim, Melania Maria] Univ Fed Campina Grande, Dept Obstet & Gynecol, Campina Grande, PB, Brazil.
RP Amorim, MM (corresponding author), Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
EM melania.amorim@gmail.com
RI Katz, Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Amorim, Melania M/0000-0003-1047-2514
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [Process 482010/2012-6]
FX The study was sponsored by CNPq (Process 482010/2012-6).
CR American College of Obstetricians and Gynecologists, 2006, OBSTET GYNECOL, V71, P957
   Amorim MM, 2014, OBSTET GYNECOL, V123, p38S, DOI 10.1097/01.AOG.0000447314.51968.54
   Carroli G, COCHRANE LIB, DOI 10.1002/14651858.CD000081.pub2
   Carroli G, 2007, COCHRANE DB SYST REV, V4
   de Amorim MMR, 2008, FEMINA, V36, P47
   Helewa ME, 1997, CAN MED ASSOC J, V156, P811
   Leal NV, 2014, OBSTET GYNECOL, V123, p63S, DOI 10.1097/01.AOG.0000447369.00977.4c
   Myers-Helfgott MG, 1999, OBSTET GYN CLIN N AM, V26, P305, DOI 10.1016/S0889-8545(05)70077-2
   D'Gregorio RP, 2010, INT J GYNECOL OBSTET, V111, P201, DOI 10.1016/j.ijgo.2010.09.002
   Schulz KF, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c332
   Scott JR, 2005, OBSTET GYN CLIN N AM, V32, P307, DOI 10.1016/j.ogc.2004.12.001
   SLEEP J, 1984, BRIT MED J, V289, P587, DOI 10.1136/bmj.289.6445.587
   Steiner N, 2012, ARCH GYNECOL OBSTET, V286, P1369, DOI 10.1007/s00404-012-2460-x
   World Health Organization Division of Family Health Maternal Health and Safe Motherhood, 1996, CAR NORM BIRTH PRACT
NR 14
TC 21
Z9 23
U1 0
U2 18
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD AUG 14
PY 2014
VL 11
AR 66
DI 10.1186/1742-4755-11-66
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA AO2AG
UT WOS:000341116300001
PM 25124938
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Amorim, MM
   Franca-Neto, AH
   Tavares, JS
   Melo, AS
   Leite, SF
   Leal, NV
AF Amorim, Melania M.
   Franca-Neto, Antonio H.
   Tavares, Jousilene S.
   Melo, Adriana S.
   Leite, Suzana F.
   Leal, Nicole V.
TI Maternal Hemodynamic Responses During Two Types of Moderate-Intensity
   Physical Exercise in Pregnancy
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 62nd Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY APR 26-30, 2014
CL Chicago, IL
SP Amer Coll Obstetricians & Gynecologists
C1 [Amorim, Melania M.; Franca-Neto, Antonio H.; Tavares, Jousilene S.; Melo, Adriana S.; Leite, Suzana F.; Leal, Nicole V.] Inst Paraibano Pesquisa Prof Joaquim Amorim Neto, Campina Grande, Paraiba, Brazil.
RI Melo, Adriana S O/H-5650-2016; Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 1
Z9 1
U1 0
U2 4
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0029-7844
EI 1873-233X
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2014
VL 123
SU 1
BP 37S
EP 38S
DI 10.1097/01.AOG.0000447313.44345.d6
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA AL4CG
UT WOS:000339079900078
DA 2020-12-01
ER

PT J
AU Amorim, MM
   Franca-Neto, AH
   Leal, NV
   Melo, FO
   Maia, SB
   Alves, JN
AF Amorim, Melania M.
   Franca-Neto, Antonio H.
   Leal, Nicole V.
   Melo, Fabiana O.
   Maia, Sabina B.
   Alves, Janio N.
TI Is It Possible to Never Perform Episiotomy During Vaginal Delivery?
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 62nd Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY APR 26-30, 2014
CL Chicago, IL
SP Amer Coll Obstetricians & Gynecologists
C1 [Amorim, Melania M.; Franca-Neto, Antonio H.; Leal, Nicole V.; Melo, Fabiana O.; Maia, Sabina B.; Alves, Janio N.] Inst Paraibano Pesquisa Campina Grande, Campina Grande, Paraiba, Brazil.
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 12
Z9 13
U1 0
U2 8
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0029-7844
EI 1873-233X
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2014
VL 123
SU 1
BP 38S
EP 38S
DI 10.1097/01.AOG.0000447314.51968.54
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA AL4CG
UT WOS:000339079900079
DA 2020-12-01
ER

PT J
AU Franca-Neto, AH
   Amorim, MM
   Barros, VD
   Tavares, JD
   Leal, NV
AF Franca-Neto, Antonio H.
   Amorim, Melania M.
   Barros, Vivianne de Oliveira
   Tavares, Jousilene de Sales
   Leal, Nicole Viana
TI Correlation Between Visceral Adipose Tissue and Biochemical Rates
   Related to Obesity in Newborns
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 62nd Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY APR 26-30, 2014
CL Chicago, IL
SP Amer Coll Obstetricians & Gynecologists
C1 [Franca-Neto, Antonio H.; Amorim, Melania M.; Barros, Vivianne de Oliveira; Tavares, Jousilene de Sales; Leal, Nicole Viana] Univ Fed Campina Grande, Campina Grande, PB, Brazil.
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0029-7844
EI 1873-233X
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2014
VL 123
SU 1
BP 51S
EP 51S
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA AL4CG
UT WOS:000339079900105
DA 2020-12-01
ER

PT J
AU Franca-Neto, AH
   Amorim, MM
   Barros, VD
   Tavares, JD
   Leal, NV
AF Franca-Neto, Antonio H.
   Amorim, Melania M.
   Barros, Vivianne de Oliveira
   Tavares, Jousilene de Sales
   Leal, Nicole Viana
TI Is Newborn Abdominal Adiposity Associated With Maternal Factors?
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 62nd Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY APR 26-30, 2014
CL Chicago, IL
SP Amer Coll Obstetricians & Gynecologists
C1 [Franca-Neto, Antonio H.; Amorim, Melania M.; Barros, Vivianne de Oliveira; Tavares, Jousilene de Sales; Leal, Nicole Viana] Univ Fed Campina Grande, Campina Grande, PB, Brazil.
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0029-7844
EI 1873-233X
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2014
VL 123
SU 1
BP 51S
EP 51S
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA AL4CG
UT WOS:000339079900106
DA 2020-12-01
ER

PT J
AU Leal, NV
   Amorim, MM
   Franca-Neto, AH
   Leite, DF
   Melo, FO
   Alves, JN
AF Leal, Nicole V.
   Amorim, Melania M.
   Franca-Neto, Antonio H.
   Leite, Debora F.
   Melo, Fabiana O.
   Alves, Janio N.
TI Factors Associated With Perineal Lacerations Requiring Suture in Vaginal
   Births Without Episiotomy
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 62nd Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY APR 26-30, 2014
CL Chicago, IL
SP Amer Coll Obstetricians & Gynecologists
C1 [Leal, Nicole V.; Amorim, Melania M.; Franca-Neto, Antonio H.; Leite, Debora F.; Melo, Fabiana O.; Alves, Janio N.] Inst Pesquisa, Campina Grande, Paraiba, Brazil.
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
NR 0
TC 6
Z9 6
U1 0
U2 6
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0029-7844
EI 1873-233X
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2014
VL 123
SU 1
BP 63S
EP 64S
DI 10.1097/01.AOG.0000447369.00977.4c
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA AL4CG
UT WOS:000339079900134
DA 2020-12-01
ER

PT J
AU Leal, NV
   Amorim, MM
   Franca-Neto, AH
   Katz, L
   Maia, SB
   Noronha-Neto, C
AF Leal, Nicole V.
   Amorim, Melania M.
   Franca-Neto, Antonio H.
   Katz, Leila
   Maia, Sabina B.
   Noronha-Neto, Carlos
TI 12-Hour Compared With 24-Hour Postpartum Magnesium Sulfate Therapy in
   Preeclampsia A Randomized Clinical Trial
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 62nd Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY APR 26-30, 2014
CL Chicago, IL
SP Amer Coll Obstetricians & Gynecologists
C1 [Leal, Nicole V.; Amorim, Melania M.; Franca-Neto, Antonio H.; Katz, Leila; Maia, Sabina B.; Noronha-Neto, Carlos] Inst Paraibano Pesquisa, Campina Grande, Paraiba, Brazil.
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
NR 0
TC 4
Z9 4
U1 0
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0029-7844
EI 1873-233X
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2014
VL 123
SU 1
BP 64S
EP 64S
DI 10.1097/01.AOG.0000447370.59285.a5
PG 1
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA AL4CG
UT WOS:000339079900135
DA 2020-12-01
ER

PT J
AU Amorim, MM
   Macedo, LC
   Franca-Neto, AH
   Katz, L
   Leal, NV
   Oliveira, AL
AF Amorim, Melania M.
   Macedo, Lorena C.
   Franca-Neto, Antonio H.
   Katz, Leila
   Leal, Nicole V.
   Oliveira, Andrea L.
TI Correlation Between Electromyography and Perineometry in Nulligravidas
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Meeting Abstract
CT 62nd Annual Clinical Meeting of the
   American-College-of-Obstetricians-and-Gynecologists
CY APR 26-30, 2014
CL Chicago, IL
SP Amer Coll Obstetricians & Gynecologists
C1 [Amorim, Melania M.; Macedo, Lorena C.; Franca-Neto, Antonio H.; Katz, Leila; Leal, Nicole V.; Oliveira, Andrea L.] Inst Paraibano Pesquisa Campina Grande, Campina Grande, Paraiba, Brazil.
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0029-7844
EI 1873-233X
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD MAY
PY 2014
VL 123
SU 1
BP 102S
EP 103S
DI 10.1097/01.AOG.0000447449.47292.e6
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA AL4CG
UT WOS:000339079900214
DA 2020-12-01
ER

PT J
AU Melo, B
   Amorim, M
   Katz, L
   Cutinh, I
   Figueiroa, JN
AF Melo, Brena
   Amorim, Melania
   Katz, Leila
   Cutinh, Isabela
   Figueiroa, Jose Natal
TI Hypertension, pregnancy and weather: is seasonality involved?
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Article
DE preeclampsia; hypertension; pregnancy; temperature; humidity
ID PREECLAMPSIA; ASSOCIATION; DEATH
AB Objective: The present study aimed at assessing the association between environmental temperature and the relative humidity of the air with frequency of hypertensive disorders of pregnancy.
   Methods: A prospective and retrospective, descriptive, ecological study was held at a teaching maternity in Recife, Brazil. Data from all 26.125 pregnant women admitted between 2000 and 2006 were analysed and 5.051 had the diagnosis of hypertensive disorder of pregnancy. The incidence percentages were calculated monthly per deliveries. Data on mean monthly temperature and relative humidity of the air were collected and monthly comparisons were conducted. February was chosen as the reference month due to its lowest incidence of the disease. The relative chance of hypertensive disorders of pregnancy for each other month was estimated by odds ratio and Pearson's correlation coefficient was used to calculate the relation between the incidence of hypertensive disorders of pregnancy and the mean monthly temperature and relative air humidity.
   Results: February presented the lowest mean monthly incidence (9.95%) and August the highest (21.54%). Pearson's correlation coefficient revealed a higher incidence of hypertensive disorders of pregnancy in the cooler months (r= -0.26; p=0.046) and no significant effect of relative air humidity (r=0.20; p=0.128).
   Conclusion: The incidence of hypertensive disorders of pregnancy may be affected by variations in temperature, increasing during cooler periods.
C1 [Melo, Brena; Figueiroa, Jose Natal] Inst Integrat Med Prof Fernando Figuelra, Recife, PE, Brazil.
   [Amorim, Melania; Katz, Leila] Campinas State Univ UNICAMP, Campinas, SP, Brazil.
   [Cutinh, Isabela] Univ Fed Pernambuco UFPE, Campinas, SP, Brazil.
RP Katz, L (corresponding author), CAM, Inst Med Integral Prof Fernando Figueira IMIP, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM katzlella@gmail.com
RI melo, brena CP/I-8407-2017; Katz, Leila/M-5291-2013; Amorim, Melania
   M/C-5807-2013
OI melo, brena CP/0000-0002-7671-2122; Katz, Leila/0000-0001-9854-7917;
   Amorim, Melania M/0000-0003-1047-2514
CR Algert CS, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.04.020
   Bodnar LM, 2006, HYPERTENS PREGNANCY, V25, P271, DOI 10.1080/10641950600913057
   Elongi JP, 2011, GYNECOL OBSTET FERTI, V39, P132, DOI 10.1016/j.gyobfe.2010.12.010
   Gerber Y, 2006, J AM COLL CARDIOL, V48, P287, DOI 10.1016/j.jacc.2006.02.065
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9
   MAGANN EF, 1995, AM J OBSTET GYNECOL, V172, P204, DOI 10.1016/0002-9378(95)90114-0
   Magnus P, 2001, BRIT J OBSTET GYNAEC, V108, P1116, DOI 10.1016/S0306-5456(01)00273-X
   Makhseed M, 1999, AUST NZ J OBSTET GYN, V39, P196, DOI 10.1111/j.1479-828X.1999.tb03372.x
   Mignini LE, 2006, AM J OBSTET GYNECOL, V194, P317, DOI 10.1016/j.ajog.2005.08.065
   Okafor Ugochukwu Vincent, 2009, Pan Afr Med J, V2, P7
   Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7
   Shental O, 2010, HYPERTENS PREGNANCY, V29, P342, DOI 10.3109/10641950902968692
   Siffel C, 2005, BIRTH DEFECTS RES A, V73, P655, DOI 10.1002/bdra.20207
   Subramaniam Vidya, 2007, BMC Womens Health, V7, P18, DOI 10.1186/1472-6874-7-18
   Tam WH, 2008, GYNECOL OBSTET INVES, V66, P22, DOI 10.1159/000114252
   TePoel MRW, 2011, J REPROD IMMUNOL, V89, P140, DOI 10.1016/j.jri.2011.01.020
NR 17
TC 2
Z9 5
U1 0
U2 8
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
EI 1806-9282
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD MAR-APR
PY 2014
VL 60
IS 2
BP 105
EP 110
DI 10.1590/1806-9282.60.02.006
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA AH3GX
UT WOS:000336012800004
PM 24918996
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Tavares, MCM
   de Macedo, JL
   de Lima, SF
   Heraclio, SD
   Amorim, MMR
   Maia, MDD
   de Souza, PRE
AF Mansur Tavares, Mayara Costa
   de Macedo, Jamilly Lopes
   de Lima Junior, Sergio Ferreira
   Heraclio, Sandra de Andrade
   Ramos Amorim, Melania Maria
   Diniz Maia, Maria de Mascena
   Eleuterio de Souza, Paulo Roberto
TI Chlamydia trachomatis infection and human papillomavirus in women with
   cervical neoplasia in Pernambuco-Brazil
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE Human papillomavirus; Abnormal cytology; Chlamydia trachomatis; Risk
   factors; Brazilian population
ID VIRAL LOAD; NATURAL-HISTORY; HPV INFECTIONS; RISK-FACTORS; YOUNG-WOMEN;
   PREVALENCE; CANCER; POPULATION; PERSISTENCE; CLASSIFICATION
AB Chlamydia trachomatis (CT) is the most common bacterial cause of sexually transmitted disease. High-risk human papillomavirus (HR-HPV) is considered the main etiological agent for cervical neoplasia. Evidences showed that the presence of co-infection of CT and HR-HPV plays a central role in the etiology of cervical intraepithelial neoplasia (CIN) and cervical cancer. The goals of this study were: evaluate the human papillomavirus (HPV) and CT prevalence among Brazilian women with abnormal cytology and provide the effect of this association on the severity of cervical neoplasia. The population of this study was composed by 142 women with incident histological incidence of CIN grades I, II, III or cervical cancer from Recife, Northeast of Brazil. The polymerase chain reaction method on a cervical brush specimen was used to detect both agents and the automatic sequencing method was used for HPV genotyping assay. The prevalence of HPV and CT was 100 and 24.65 %, respectively. Thirteen types of HPV were detected; HPV 16, 18, 31 and 33 were the most common. The most prevalent HPV types were HPV 16 and 18. A significant association between CT positive and HPV 16 infection was found (p < 0.0106; OR = 5.31; 95 % IC 1.59-17.67). In the study population, there was diversity of HPV infections, with high-risk types being the most common. Also, the data collected suggest that CT infection may play an important role in the natural history of HPV infection.
C1 [Mansur Tavares, Mayara Costa; de Lima Junior, Sergio Ferreira] Univ Fed Pernambuco UFPE, Recife, PE, Brazil.
   [de Macedo, Jamilly Lopes] Univ Pernambuco UPE, Recife, PE, Brazil.
   [Heraclio, Sandra de Andrade] Inst Med Integral Prof Fernando Figueira IMIP, Dept Lower Genital Tract Pathol, Womens Healthcare Ctr, Recife, PE, Brazil.
   [Ramos Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira IMIP, Maternal & Child Healthcare Dept, Recife, PE, Brazil.
   [Diniz Maia, Maria de Mascena; Eleuterio de Souza, Paulo Roberto] Univ Fed Rural Pernambuco UFRPE, Dept Biol, Recife, PE, Brazil.
RP Tavares, MCM (corresponding author), Univ Fed Pernambuco UFPE, Recife, PE, Brazil.
EM mayaramansur@gmail.com; jamillylopes@hotmail.com;
   sergioflimajr@hotmail.com; sandra_heraclio@hotmail.com;
   melamorim@uol.com.br; mascenadiniz@hotmail.com; prsouza30@gmail.com
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Paulo/0000-0002-9186-9849
FU Brazilian funding agency FACEPE (Fundacao de Amparo a Ciencia e
   Tecnologia do Estado de Pernambuco)
FX We thank the patients and their families, whose collaboration and
   understanding have made this work possible. This study was supported by
   the Brazilian funding agency FACEPE (Fundacao de Amparo a Ciencia e
   Tecnologia do Estado de Pernambuco). We are also grateful for the
   facilities of the Laboratorio de Genetica, Bioquimica e Sequenciamento
   de DNA Prof<SUP>a</SUP> Tania Falcao of Universidade Federal Rural de
   Pernambuco, where the experiments were performed.
CR Albring L, 2006, REV BRAS ANAL CLIN, V38, P87
   Almonte M, 2008, VACCINE, V26, pL16, DOI 10.1016/j.vaccine.2008.06.008
   Araujo RSC, 2006, EUR J CLIN MICROBIOL, V25, P397, DOI 10.1007/s10096-006-0142-y
   Baldez da Silva M F P T, 2009, Genet Mol Res, V8, P1437, DOI 10.4238/vol8-4gmr677
   BELL DA, 1993, J NATL CANCER I, V85, P1159, DOI 10.1093/jnci/85.14.1159
   Bhatla N, 2013, INDIAN J MED RES, V137, P533
   Burd EM, 2003, CLIN MICROBIOL REV, V16, P1, DOI 10.1128/CMR.16.1.1-17.2003
   Chopjitt P, 2009, INT J INFECT DIS, V13, P212, DOI 10.1016/j.ijid.2008.06.017
   Clifford G, 2006, VACCINE, V24, P26, DOI 10.1016/j.vaccine.2006.05.026
   Cricca M, 2009, J VIROL METHODS, V158, P180, DOI 10.1016/j.jviromet.2009.01.005
   Deluca GD, 2011, BRAZ J INFECT DIS, V15, P567, DOI [10.1590/S1413-86702011000600011, 10.1016/S1413-8670(11)70252-5]
   Di Felice V, 2005, CELL MOL LIFE SCI, V62, P4, DOI 10.1007/s00018-004-4367-6
   Drain PK, 2002, INT J CANCER, V100, P199, DOI 10.1002/ijc.10453
   Fernandes APM, 2005, VIROLOGY, V334, P294, DOI 10.1016/j.virol.2005.01.029
   Fernandes Jose V, 2010, BMC Res Notes, V3, P96, DOI 10.1186/1756-0500-3-96
   Fontaine J, 2008, J CLIN VIROL, V43, P307, DOI 10.1016/j.jcv.2008.07.013
   Franceschi S, 2007, SEX TRANSM DIS, V34, P563, DOI 10.1097/01.olq.0000258417.66619.0e
   Freitas Taíse Palmeiras, 2007, Rev. Inst. Med. trop. S. Paulo, V49, P297, DOI 10.1590/S0036-46652007000500005
   Giraldo PC, 2000, TRATADO GINECOLOGIA, P1047
   Goncalves MAG, 1999, INT J STD AIDS, V10, P803, DOI 10.1258/0956462991913583
   Gopalkrishna V, 2000, CLIN MICROBIOL INFEC, V6, P88, DOI 10.1046/j.1469-0691.2000.00024.x
   HUSMAN AMDR, 1995, J GEN VIROL, V76, P1057
   Josefsson AM, 2000, LANCET, V355, P2189, DOI 10.1016/S0140-6736(00)02401-6
   Kirkpatrick A, 2004, GYNECOL ONCOL, V92, P675, DOI 10.1016/j.ygyno.2003.11.025
   Kjaer SK, 2002, BRIT MED J, V325, P572, DOI 10.1136/bmj.325.7364.572
   Krech T, 2009, J VIROL METHODS, V162, P291, DOI 10.1016/j.jviromet.2009.08.011
   Levi JE, 2002, J CLIN MICROBIOL, V40, P3341, DOI 10.1128/JCM.40.9.3341-3345.2002
   Lippman SA, 2010, INT J STD AIDS, V21, P105, DOI 10.1258/ijsa.2009.008436
   Lorenzato F, 2000, INT J GYNECOL CANCER, V10, P143, DOI 10.1046/j.1525-1438.2000.00007.x
   Machado A. C. S., 2007, Infectious Diseases in Obstetrics and Gynecology, V2007, P24816, DOI 10.1155/2007/24816
   Magi JC, 2002, REV BRAS COLOPROCTOL, V22, P178
   Magi João Carlos, 2006, Rev bras. colo-proctol., V26, P233, DOI 10.1590/S0101-98802006000300001
   Manavi K, 2006, BEST PRACT RES CL OB, V20, P941, DOI 10.1016/j.bpobgyn.2006.06.003
   MANOS MM, 1989, CANCER CEL, V7, P209
   Miller WC, 2004, JAMA-J AM MED ASSOC, V291, P2229, DOI 10.1001/jama.291.18.2229
   Miranda AE, 2004, SEX TRANSM DIS, V31, P542, DOI 10.1097/01.olq.0000137899.25542.75
   Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641
   Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6
   Munoz N, 2006, VACCINE, V24, P1, DOI 10.1016/j.vaccine.2006.05.115
   Nonnemacher MR, 2003, BIOMED PHARMACOTHER, V57, P34, DOI 10.1016/S0753-3322(02)00334-7
   Oliveira MD, 2008, BRAZ J INFECT DIS, V12, P324, DOI 10.1590/S1413-86702008000400014
   Oliveira-Silva M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-4
   Ramanakumar AV, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-326
   Rodrigues LRE, 2011, ACTA MEDICA PORT, V24, P367
   Safaeian M, 2010, JNCI-J NATL CANCER I, V102, P1794, DOI 10.1093/jnci/djq436
   Samoff E, 2005, AM J EPIDEMIOL, V162, P668, DOI 10.1093/aje/kwi262
   Oliveira LHS, 2010, REV SOC BRAS MED TRO, V43, P4, DOI 10.1590/S0037-86822010000100002
   Schiffman M, 2007, LANCET, V370, P890, DOI 10.1016/S0140-6736(07)61416-0
   Seadi Claudete Farina, 2002, J. Bras. Patol. Med. Lab., V38, P125, DOI 10.1590/S1676-24442002000200009
   Sellors JW, 2000, CAN MED ASSOC J, V163, P503
   Silins I, 2005, INT J CANCER, V116, P110, DOI 10.1002/ijc.20970
   Simonetti AC, 2009, MICROBES INFECT, V11, P435, DOI 10.1016/j.micinf.2009.01.004
   Sjoeborg KD, 2010, GYNECOL ONCOL, V118, P29, DOI 10.1016/j.ygyno.2010.03.007
   Smith JS, 2007, INT J CANCER, V121, P621, DOI 10.1002/ijc.22527
   Smith JS, 2002, J INFECT DIS, V185, P324, DOI 10.1086/338569
   Soares VD, 2003, TROP MED INT HEALTH, V8, P595, DOI 10.1046/j.1365-3156.2003.01078.x
   Stanley M, 2008, GYNECOL ONCOL, V109, pS15, DOI 10.1016/j.ygyno.2008.02.003
   SYRJANEN K, 1985, BRIT J OBSTET GYNAEC, V92, P1086, DOI 10.1111/j.1471-0528.1985.tb03017.x
   Tamim H, 2002, DIAGN MICR INFEC DIS, V43, P277, DOI 10.1016/S0732-8893(02)00403-0
   van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002
   VANRANST M, 1992, J GEN VIROL, V73, P2653, DOI 10.1099/0022-1317-73-10-2653
   Wallin KL, 2002, INT J CANCER, V101, P371, DOI 10.1002/ijc.10639
   WHO, 2007, GLOB STRAT INT CONTR
   World Health Organization, 2005, SEX TRANSM OTH REPR
   Wu YP, 2006, J CLIN VIROL, V35, P264, DOI 10.1016/j.jcv.2005.07.011
   Bosch FX, 2008, VACCINE, V26, pK1, DOI 10.1016/j.vaccine.2008.05.064
   zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690
NR 67
TC 14
Z9 14
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD FEB
PY 2014
VL 41
IS 2
BP 865
EP 874
DI 10.1007/s11033-013-2927-2
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA AA1MR
UT WOS:000330860900033
PM 24395291
DA 2020-12-01
ER

PT J
AU Haddad, SM
   Cecatti, JG
   Souza, JP
   Sousa, MH
   Parpinelli, MA
   Costa, ML
   Pacagnella, RC
   Brum, IR
   Moraes, OB
   Feitosa, FE
   Menezes, CA
   Guanabara, EM
   Moreira, JL
   Peret, FA
   Schmaltz, LE
   Katz, L
   Lima, ACB
   Amorim, MM
   Martins, MG
   Nascimento, DJ
   Paiva, CS
   Rohloff, RD
   Costa, SM
   Luz, AG
   Lobato, G
   Cordioli, E
   Peracoli, JC
   Maia, NL
   Quintana, SM
   Lotufo, FA
   Andreucci, CB
   Aquino, MM
   Mattar, R
AF Haddad, Samira Maerrawi
   Cecatti, Jose Guilherme
   Souza, Joao Paulo
   Sousa, Maria Helena
   Parpinelli, Mary Angela
   Costa, Maria Laura
   Pacagnella, Rodolfo C.
   Brum, Ione R.
   Moraes Filho, Olimpio B.
   Feitosa, Francisco E.
   Menezes, Carlos A.
   Guanabara, Everardo M.
   Moreira, Joaquim L.
   Peret, Frederico A.
   Schmaltz, Luiza E.
   Katz, Leila
   Barbosa Lima, Antonio C.
   Amorim, Melania M.
   Martins, Marilia G.
   Nascimento, Denis J.
   Paiva, Claudio S.
   Rohloff, Roger D.
   Costa, Sergio M.
   Luz, Adriana G.
   Lobato, Gustavo
   Cordioli, Eduardo
   Peracoli, Jose C.
   Maia Filho, Nelson L.
   Quintana, Silvana M.
   Lotufo, Fatima A.
   Andreucci, Carla B.
   Aquino, Marcia M.
   Mattar, Rosiane
TI Applying the Maternal Near Miss Approach for the Evaluation of Quality
   of Obstetric Care: A Worked Example from a Multicenter Surveillance
   Study
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID NEWBORN HEALTH; MORBIDITY; MORTALITY
AB Objective. To assess quality of care of women with severe maternal morbidity and to identify associated factors. Method. This is a national multicenter cross-sectional study performing surveillance for severe maternal morbidity, using the World Health Organization criteria. The expected number of maternal deaths was calculated with the maternal severity index (MSI) based on the severity of complication, and the standardized mortality ratio (SMR) for each center was estimated. Analyses on the adequacy of care were performed. Results. 17 hospitals were classified as providing adequate and 10 as nonadequate care. Besides almost twofold increase in maternal mortality ratio, the main factors associated with nonadequate performance were geographic difficulty in accessing health services (P < 0.001), delays related to quality of medical care (P = 0.012), absence of blood derivatives (P = 0.013), difficulties of communication between health services (P = 0.004), and any delay during the whole process (P = 0.039). Conclusions. This is an example of how evaluation of the performance of health services is possible, using a benchmarking tool specific to Obstetrics. In this study the MSI was a useful tool for identifying differences in maternal mortality ratios and factors associated with nonadequate performance of care.
C1 [Haddad, Samira Maerrawi; Cecatti, Jose Guilherme; Souza, Joao Paulo; Parpinelli, Mary Angela; Costa, Maria Laura; Pacagnella, Rodolfo C.] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynaecol, BR-13083881 Campinas, SP, Brazil.
   [Cecatti, Jose Guilherme; Sousa, Maria Helena] Ctr Res Reprod Hlth Campinas Cemicamp, BR-13083888 Campinas, SP, Brazil.
   [Brum, Ione R.] Univ Fed Amazonas, Manaus, Amazonas, Brazil.
   [Moraes Filho, Olimpio B.] Sch Med Sci, CISAM, Recife, PE, Brazil.
   [Feitosa, Francisco E.] Univ Fed Ceara, Fortaleza, Ceara, Brazil.
   [Menezes, Carlos A.] Univ Fed Bahia, Salvador, BA, Brazil.
   [Guanabara, Everardo M.] Hosp Geral Cesar Cals, Fortaleza, Ceara, Brazil.
   [Moreira, Joaquim L.] Hosp Geral Fortaleza, Fortaleza, Ceara, Brazil.
   [Peret, Frederico A.] Maternidade Odete Valadares, Belo Horizonte, MG, Brazil.
   [Schmaltz, Luiza E.] Hosp Materno Infantil, Goiania, Go, Brazil.
   [Katz, Leila] Inst Materno Infantil Pernambuco, Recife, PE, Brazil.
   [Barbosa Lima, Antonio C.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Amorim, Melania M.] Univ Fed Campina Grande, Campina Grande, PB, Brazil.
   [Martins, Marilia G.] Univ Fed Maranhao, Sao Luis, MA, Brazil.
   [Nascimento, Denis J.] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil.
   [Paiva, Claudio S.] Univ Fed Paraiba, BR-58059900 Joao Pessoa, Paraiba, Brazil.
   [Rohloff, Roger D.] Hosp Maternidade Fernando Magalhaes, Rio De Janeiro, RJ, Brazil.
   [Costa, Sergio M.] Univ Fed Rio Grande do Sul, Porto Alegre, RS, Brazil.
   [Luz, Adriana G.] Hosp Maternidade Celso Pierro, Campinas, SP, Brazil.
   [Lobato, Gustavo] Inst Fernandes Figueira Fiocruz, Rio De Janeiro, RJ, Brazil.
   [Cordioli, Eduardo] Hosp Israelita Albert Einstein, Sao Paulo, Brazil.
   [Peracoli, Jose C.] Univ State Sao Paulo, Botucatu, SP, Brazil.
   [Maia Filho, Nelson L.] Jundiai Sch Med, Jundiai, SP, Brazil.
   [Quintana, Silvana M.] Univ Sao Paulo, BR-14049 Ribeirao Preto, SP, Brazil.
   [Lotufo, Fatima A.] Santa Casa Limeira, Limeira, SP, Brazil.
   [Andreucci, Carla B.] Santa Casa Sao Carlos, Sao Carlos, SP, Brazil.
   [Aquino, Marcia M.] Maternidade Leonor Mendes de Barros, Sao Paulo, Brazil.
   [Mattar, Rosiane] Univ Fed Sao Paulo, Sao Paulo, Brazil.
RP Cecatti, JG (corresponding author), Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynaecol, R Alexander Fleming 101,POB 6030, BR-13083881 Campinas, SP, Brazil.
EM cecatti@unicamp.br
RI Amorim, Melania M/C-5807-2013; Quintana, Silvana Maria/D-6953-2015;
   Andreucci, Carla B/J-4845-2015; Cordioli, Eduardo/X-1934-2019; Polido,
   Carla Betina Andreucci/Y-9743-2019; Cecatti, Jose Guilherme/M-5945-2013;
   CORDIOLI, EDUARDO/AAR-6100-2020; Souza, Joao Paulo/G-1982-2010; Costa,
   Maria Laura/I-4980-2019; de Carvalho Pacagnella, Rodolfo/H-9390-2019;
   Katz, Leila/M-5291-2013; Peracoli, Jose Carlos/G-4923-2012
OI Amorim, Melania M/0000-0003-1047-2514; Quintana, Silvana
   Maria/0000-0002-9311-786X; Andreucci, Carla B/0000-0002-5590-108X;
   Polido, Carla Betina Andreucci/0000-0002-5590-108X; Cecatti, Jose
   Guilherme/0000-0003-1285-8445; CORDIOLI, EDUARDO/0000-0001-5405-9380;
   Souza, Joao Paulo/0000-0002-2288-4244; Costa, Maria
   Laura/0000-0001-8280-3234; de Carvalho Pacagnella,
   Rodolfo/0000-0002-5739-0009; Katz, Leila/0000-0001-9854-7917; Peracoli,
   Jose Carlos/0000-0002-3273-3001
FU CNPq/DECIT (The National Research Council and the Department of Science
   and Technology of the Brazilian Ministry of Health)National Council for
   Scientific and Technological Development (CNPq) [402702/2008-5]
FX This study was funded by CNPq/DECIT (The National Research Council and
   the Department of Science and Technology of the Brazilian Ministry of
   Health), Grant number 402702/2008-5. The content is solely the
   responsibility of the authors and does not necessarily represent the
   official views of CNPq. It did not influence the content of the paper.
   Brazilian Network for the Surveillance of Severe Maternal Morbidity
   Group consisted of Joao L. Pinto e. Silva, Fernanda G. Surita, Rodolfo
   C. Pacagnella, Rodrigo S. Camargo, Vilma Zotareli, Lucio T. Gurgel, Lale
   Say, Robert C. Pattinson, Marilza V. Rudge, Iracema M. Calderon, Maria
   V. Bahamondes, Danielly S. Santana, Simone P. Goncalves, Olimpio B.
   Moraes Filho, Simone A. Carvalho, Francisco E. Feitosa, George N.
   Chaves, Ione R. Brum, Gloria C. Saint'Ynes, Carlos A. Menezes, Patricia
   N. Santos, Everardo M. Guanabara, Elson J. Almeida Jr, Joaquim L.
   Moreira, Maria R. Sousa, Frederico A. Peret, Liv B. Paula, Luiza E.
   Schmaltz, Cleire Pessoni, Leila Katz, Adriana Bione, Antonio C. Barbosa
   Lima, Edilberto A. Rocha Filho, Melania M. Amorim, Debora Leite, Ivelyne
   Radaci, Marilia G. Martins, Frederico Barroso, Fernando C. Oliveira Jr,
   Denis J. Nascimento, Claudio S. Paiva, Moises D. Lima, Djacyr M. Freire,
   Roger D. Rohloff, Simone M. Rodrigues, Sergio M. Costa, Lucia C.
   Pfitscher, Adriana G. Luz, Daniela Guimaraes, Gustavo Lobato, Marcos
   Nakamura-Pereira, Eduardo Cordioli, Alessandra Peterossi, Cynthia D.
   Perez, Jose C. Peracoli, Roberto A. Costa, Nelson L. Maia Filho, Jacinta
   P. Matias, Silvana M. Quintana, Elaine C. Moises, Fatima A. Lotufo, Luiz
   E. Carvalho, Carla B. Andreucci, Marcia M. Aquino, Maria H. Ohnuma,
   Rosiane Mattar, and Felipe F. Campanharo.
CR [Anonymous], 2010, TRENDS MAT MORT 1990
   Cecatti JG, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-22
   Cecatti Jose G, 2009, Reprod Health, V6, P15, DOI 10.1186/1742-4755-6-15
   Cochet L, 2003, SAMJ S AFR MED J, V93, P700
   De Savigny D., 2009, SYSTEMS THINKING HLT
   Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2
   Donati S, 2012, ACTA OBSTET GYN SCAN, V91, P452, DOI 10.1111/j.1600-0412.2012.01352.x
   Haddad SM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-283
   Higgins Thomas L, 2007, J Intensive Care Med, V22, P141, DOI 10.1177/0885066607299520
   Lapinsky SE, 2011, J CRIT CARE, V26, DOI 10.1016/j.jcrc.2010.10.003
   Maine D, 1999, AM J PUBLIC HEALTH, V89, P480, DOI 10.2105/AJPH.89.4.480
   Mantel GD, 1998, BRIT J OBSTET GYNAEC, V105, P985, DOI 10.1111/j.1471-0528.1998.tb10262.x
   Mhyre JM, 2011, ANESTHESIOLOGY, V115, P963, DOI 10.1097/ALN.0b013e318233042d
   Raven J, 2011, INT J GYNECOL OBSTET, V114, P4, DOI 10.1016/j.ijgo.2011.02.007
   Say L, 2004, REPROD HLTH, V1, P3, DOI DOI 10.1186/1742-4755-1-3
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8
   Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129
   Strand K, 2008, ACTA ANAESTH SCAND, V52, P467, DOI 10.1111/j.1399-6576.2008.01586.x
   THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7
   Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089
   World Health Organization, 2011, EV QUAL CAR SEV PREG
NR 22
TC 18
Z9 20
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PY 2014
VL 2014
AR 989815
DI 10.1155/2014/989815
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA AM8XF
UT WOS:000340161700001
PM 25147830
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Amorim, MM
   Nakamura-Pereira, M
   Takemoto, MLS
   Knobel, R
   Katz, L
   Andreucci, CB
AF Amorim, M. M.
   Nakamura-Pereira, M.
   Takemoto, M. L. S.
   Knobel, R.
   Katz, L.
   Andreucci, C. B.
TI Elective caesarean section at 38 versus 39 weeks of gestation: neonatal
   and maternal outcomes in a randomised controlled trial Are we
   trivialising neonatal intensive care unit admissions?
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Letter
ID TERM
C1 [Amorim, M. M.; Katz, L.] Inst Paraibano Pesquisa Prof Joaquim Amorim Neto, Campina Grande, Paraiba, Brazil.
   [Amorim, M. M.; Katz, L.] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Nakamura-Pereira, M.] Fundacao Oswaldo Cruz, Inst Fernandes Figueira, Rio De Janeiro, Brazil.
   [Takemoto, M. L. S.] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil.
   [Knobel, R.] Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
   [Andreucci, C. B.] Univ Fed Sao Carlos, Sao Paulo, Brazil.
RP Amorim, MM (corresponding author), Inst Paraibano Pesquisa Prof Joaquim Amorim Neto, Campina Grande, Paraiba, Brazil.
RI Polido, Carla Betina Andreucci/Y-9743-2019; TAKEMOTO, MAIRA
   LS/G-7889-2018; Knobel, Roxana/S-4550-2019; Katz, Leila/M-5291-2013;
   Nakamura-Pereira, Marcos/X-1107-2019; Andreucci, Carla B/J-4845-2015;
   Amorim, Melania M/C-5807-2013; Nakamura-Pereira, Marcos/O-4496-2014
OI Polido, Carla Betina Andreucci/0000-0002-5590-108X; TAKEMOTO, MAIRA
   LS/0000-0002-7016-2879; Knobel, Roxana/0000-0001-9180-4685; Katz,
   Leila/0000-0001-9854-7917; Nakamura-Pereira, Marcos/0000-0002-4231-0205;
   Andreucci, Carla B/0000-0002-5590-108X; Amorim, Melania
   M/0000-0003-1047-2514; Nakamura-Pereira, Marcos/0000-0002-4231-0205
CR CLARK SL, 2009, AM J OBSTET GYNECOL, V200
   Hansen AK, 2008, BMJ-BRIT MED J, V336, P85, DOI 10.1136/bmj.39405.539282.BE
   Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267
NR 3
TC 0
Z9 0
U1 0
U2 3
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD DEC
PY 2013
VL 120
IS 13
BP 1702
EP 1703
DI 10.1111/1471-0528.12470
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 248OW
UT WOS:000326712000023
PM 24589005
OA Bronze
DA 2020-12-01
ER

PT J
AU Scavuzzi, A
   Souza, ASR
   Costa, AAR
   Amorim, MMR
AF Scavuzzi, Adriana
   Souza, Alex S. R.
   Costa, Aurelio A. R.
   Amorim, Melania M. R.
TI Misoprostol prior to inserting an intrauterine device in nulligravidas:
   a randomized clinical trial
SO HUMAN REPRODUCTION
LA English
DT Article
DE intrauterine devices; misoprostol; nulligravidas; contraception
ID VAGINAL MISOPROSTOL; DIFFERENT ROUTES; RISK; IUD
AB How effective is the vaginal administration of misoprostol in dilating the cervix prior to inserting an intrauterine device (IUD) in nulligravidas?
   The use of misoprostol at a dose of 400 g administered vaginally 4 h prior to IUD insertion increased the ease of insertion and reduced the incidence of pain during the procedure, although the frequency of cramps increased following misoprostol use.
   Misoprostol has been widely used in Obstetrics and Gynecology; however, its usefulness and efficacy in facilitating IUD insertion in nulligravidas have yet to be established. The present study shows that the benefits of misoprostol use prior to IUD insertion include facilitating insertion and reducing pain during the procedure; therefore, weighing up the benefits encountered against the only negative side effect (cramps prior to insertion), these results suggest that misoprostol use should become standard practice to facilitate IUD insertion in nulligravidas.
   A randomized, double-blind clinical trial was conducted.
   Nulligravid women of reproductive age were submitted to IUD insertion between July 2009 and November 2011 at the Instituto de Medicina Integral Prof. Fernando Figueira in Recife, Pernambuco, Brazil. A total of 179 women were randomly allocated to two groups: 86 to receive 400 g of misoprostol vaginally 4 h prior to IUD insertion and 93 to receive placebo. Risk ratios (RRs) were calculated as measures of relative risk, together with their 95 confidence intervals (95 CI). The number needed to treat (NNT) and the number needed to harm (NNH) were also calculated.
   Significant differences were found between the groups for all the immediate end points studied, with less difficulty in inserting the IUD [RR 0.49 (23/86 versus 51/93); 95 CI: 0.330.72; P 0.00005], a lower risk of dilatation 4 mm [RR 0.48 (24/86 versus 54/93); 95 CI: 0.330.70; P 0.0001], a reduction in moderate-to-severe pain at IUD insertion [RR 0.56 (32/86 versus 62/93]; 95 CI: 0.410.76; P 0.00008), as well as a lesser likelihood of experiencing a disagreeable or very disagreeable sensation [RR 0.49(29/86 versus 64/93); 95 CI: 0.350.68; P 0.000004] in the group that was given misoprostol compared with the group that received placebo. There was no significant difference between the groups in relation to complications during IUD insertion. There were no cases of uterine perforation in either group. The frequency of cramps was 40 higher in the misoprostol group.
   The present study showed a positive balance between the benefits and risks of the use of misoprostol; however, it is not feasible to conclude that its use is imperative prior to IUD insertion in nulligravidas and IUD insertion should not be canceled when the medication is unavailable.
   In view of its effect in promoting cervical dilatation, misoprostol may be used prior to IUD insertion both in nulligravidas and in any women with cervical stenosis irrespective of parity.
   This study was funded by the Instituto de Medicina Integral Prof Fernando Figueira.
   None.
C1 [Scavuzzi, Adriana; Souza, Alex S. R.; Costa, Aurelio A. R.; Amorim, Melania M. R.] Inst Med Integral Prof Fernando Figueira IMIP, Postgrad Program Maternal & Child Hlth, Recife, PE, Brazil.
   [Costa, Aurelio A. R.] FPS, Recife, PE, Brazil.
   [Amorim, Melania M. R.] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
RP Scavuzzi, A (corresponding author), Rua Edson Alvares 317-1702, BR-52061450 Recife, PE, Brazil.
EM adrianascavuzzi@hotmail.com
RI Amorim, Melania M/C-5807-2013; Souza, Alex Sandro Rolland/AAG-2471-2019
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052
FU Instituto de Medicina Integral Prof Fernando Figueira
FX This study was funded by the Instituto de Medicina Integral Prof
   Fernando Figueira.
CR Allen RH, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007373.pub2
   American College of Obstetricians and Gynecologists, 2007, Obstet Gynecol, V110, P1493
   Arias F, 2000, CLIN OBSTET GYNECOL, V43, P455, DOI 10.1097/00003081-200009000-00006
   Aronsson A, 2004, HUM REPROD, V19, P81, DOI 10.1093/humrep/deh005
   Bahamondes M Valeria, 2011, Contraception, V84, pe11, DOI 10.1016/j.contraception.2011.05.012
   d'Arcangues C, 2007, CONTRACEPTION, V75, pS2, DOI 10.1016/j.contraception.2006.12.024
   Dijkhuizen K, 2011, HUM REPROD, V26, P323, DOI 10.1093/humrep/deq348
   Edelman AB, 2011, CONTRACEPTION, V84, P234, DOI 10.1016/j.contraception.2011.01.016
   ELREFAEY H, 1995, NEW ENGL J MED, V332, P983, DOI 10.1056/NEJM199504133321502
   Fiala C, 2007, INT J GYNECOL OBSTET, V99, pS168, DOI 10.1016/j.ijgo.2007.09.005
   Forthofer KV, 2009, JOGNN-J OBST GYN NEO, V38, P693, DOI 10.1111/j.1552-6909.2009.01067.x
   GRIMES DA, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001327
   Hamoda H, 2004, AM J OBSTET GYNECOL, V190, P55, DOI 10.1016/j.ajog.2003.08.025
   Heikinheimo O, 2010, CONTRACEPTION, V81, P481, DOI 10.1016/j.contraception.2010.01.020
   Hubacher D, 2001, NEW ENGL J MED, V345, P561, DOI 10.1056/NEJMoa010438
   Li YT, 2005, INT J GYNECOL OBSTET, V89, P67, DOI 10.1016/j.ijgo.2005.01.036
   Morgan KW, 2006, J MIDWIFERY WOM HEAL, V51, P464, DOI 10.1016/j.jmwh.2006.06.008
   Saav I, 2007, HUM REPROD, V22, P2647, DOI 10.1093/humrep/dem244
   Scavuzzi A, 2009, INT J GYNAECOL OBS S, V107, pS330
   Schaefer E, 2010, CONTRACEPTION, V82, P188, DOI 10.1016/j.contraception.2010.04.043
   Stanback J, 2008, CONTRACEPTION, V77, P227, DOI 10.1016/j.contraception.2008.01.001
   Tang OS, 2007, INT J GYNECOL OBSTET, V99, pS160, DOI 10.1016/j.ijgo.2007.09.004
   Tang OS, 2002, HUM REPROD, V17, P332, DOI 10.1093/humrep/17.2.332
   Ward K, 2011, CONTRACEPTION, V84, P594, DOI 10.1016/j.contraception.2011.03.011
   World Health Organization (WHO), 2004, IMPR ACC QUAL CAR FA, P17
NR 25
TC 27
Z9 27
U1 0
U2 6
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0268-1161
EI 1460-2350
J9 HUM REPROD
JI Hum. Reprod.
PD AUG
PY 2013
VL 28
IS 8
BP 2118
EP 2125
DI 10.1093/humrep/det240
PG 8
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA 190LT
UT WOS:000322342200013
PM 23739219
OA Bronze
DA 2020-12-01
ER

PT J
AU Noronha-Neto, C
   Katz, L
   Coutinho, IC
   Maia, SB
   Souza, ASR
   Amorim, MMR
AF Noronha-Neto, Carlos
   Katz, Leila
   Coutinho, Isabela C.
   Maia, Sabina B.
   Rolland Souza, Alex Sandro
   Ramos Amorim, Melania Maria
TI Clonidine versus captopril for treatment of postpartum very high blood
   pressure: study protocol for a randomized controlled trial (CLONCAP)
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Severe preeclampsia; Hypertension; Pregnancy; Postpartum; Very high
   blood pressure; Randomized controlled trial; Antihypertensive agents
ID HYPERTENSION; ECLAMPSIA; PREECLAMPSIA; PREGNANCY
AB Background: The behavior of arterial blood pressure in postpartum of women with hypertension and pregnancy and the best treatment for very high blood pressure in this period still need evidence. The Cochrane systematic review assessing prevention and treatment of postpartum hypertension found only two trials (120 patients) comparing hydralazine with nifedipine and labetalol for the treatment of severe hypertension and did not find enough evidence to know how best to treat women with hypertension after birth. Although studies have demonstrated the effectiveness of treatment with captopril, side effects were reported. Because of these findings, new classes of antihypertensive drugs began to be administered as an alternative therapy. Data on the role of clonidine in this particular group of patients, its effects in the short and long term are still scarce in the literature.
   Objectives: To determine the effectiveness of clonidine, compared to captopril, for the treatment of postpartum very high blood pressure in women with hypertension in pregnancy.
   Methods/design: The study is a triple blind randomized controlled trial including postpartum women with diagnosis of hypertension in pregnancy presenting very high blood pressure, and exclusion criteria will be presence of heart disease, smoking, use of illicit drugs, any contraindication to the use of captopril or clonidine and inability to receive oral medications.
   Eligible patients will be invited to participate and those who agree will be included in the study and receive captopril or clonidine according to a random list of numbers. The subjects will receive the study medication every 20 minutes until blood pressure is over 170 mmHg of systolic blood pressure and 110 mmHg diastolic blood pressure. A maximum of six pills a day for very high blood pressure will be administered. In case of persistent high blood pressure levels, other antihypertensive agents will be used.
   During the study the women will be subject to strict control of blood pressure and urine output. This proposal has already obtained approval of the local Institutional Review Board of the coordinating center (IMIP, Recife, Brazil) and of the National Council for Ethics in Research (CONEP) of the Brazilian Ministry of Health.
C1 [Noronha-Neto, Carlos; Katz, Leila; Coutinho, Isabela C.; Maia, Sabina B.; Rolland Souza, Alex Sandro; Ramos Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira, Obstet Intens Care Unit, Recife, PE, Brazil.
   [Ramos Amorim, Melania Maria] Univ Fed Campina Grande, Dept Obstet & Gynecol, Campina Grande, PB, Brazil.
RP Amorim, MMR (corresponding author), Inst Med Integral Prof Fernando Figueira, Obstet Intens Care Unit, Recife, PE, Brazil.
EM melania.amorim@gmail.com
RI Katz, Leila/M-5291-2013; Souza, Alex Sandro Rolland/AAG-2471-2019;
   Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052; Amorim, Melania M/0000-0003-1047-2514
FU National Counsel of Technological and Scientific Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fund for Research Support (FAPE)-IMIP
FX National Counsel of Technological and Scientific Development (CNPq) and
   Fund for Research Support (FAPE)-IMIP.
CR BARRETO S, 2003, REV HOSP MATERN INFA, V22, P116
   BOND AL, 1989, AM J OBSTET GYNECOL, V160, P1112, DOI 10.1016/0002-9378(89)90171-3
   BUNJES R, 1993, CLIN PHARMACY, V12, P178
   CASTRO LC, 1994, AM J OBSTET GYNECOL, V171, P1642, DOI 10.1016/0002-9378(94)90416-2
   Chames MC, 2002, AM J OBSTET GYNECOL, V186, P1174, DOI 10.1067/mob.2002.123824
   Chan AW, 2013, ANN INTERN MED, V158, P200, DOI 10.7326/0003-4819-158-3-201302050-00583
   Clark SL, 2010, AM J OBSTET GYNECOL, V203, pe1, DOI [DOI 10.1155/2012/252676.5.K0REN, DOI 10.1016/J.AJ0G.2010.05.036]
   Cooper WO, 2006, NEW ENGL J MED, V354, P2443, DOI 10.1056/NEJMoa055202
   DAVISON JM, 1984, SEMIN NEPHROL, V4, P198
   DEVLIN RG, 1981, J CLIN PHARMACOL, V21, P110, DOI 10.1002/j.1552-4604.1981.tb01759.x
   DOUGLAS KA, 1994, BMJ-BRIT MED J, V309, P1395, DOI 10.1136/bmj.309.6966.1395
   DRUMMER OH, 1986, MED RES REV, V6, P75, DOI 10.1002/med.2610060104
   Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010
   Firoz T, 2011, BEST PRACT RES CL OB, V25, P549, DOI 10.1016/j.bpobgyn.2011.03.003
   Ghuman N, 2009, J CLIN HYPERTENS, V11, P726, DOI 10.1111/j.1751-7176.2009.00186.x
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Gilstrap III LC, 2002, ACOG PRACTICE B, V33, P1
   Goldenberg RL, 2011, INT J GYNECOL OBSTET, V113, P91, DOI 10.1016/j.ijgo.2011.01.002
   HARTIKAINENSORRI AL, 1987, OBSTET GYNECOL, V69, P598
   Lambot MA, 2001, LANCET, V357, P1619, DOI 10.1016/S0140-6736(00)04757-7
   Magee L, COCHRANE DB SYST REV, V5, DOI [10.1002/14651858.CD004351.pub1, DOI 10.1002/14651858.CD004351.PUB1]
   Paula LG, 2003, FEMINA, V31, P803
   Podymow T, 2011, SEMIN NEPHROL, V31, P70, DOI 10.1016/j.semnephrol.2010.10.007
   Roberts CL, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000101
   Sanctos M., 2004, THESIS I MED INTEGRA
   Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18
   Sibai BM, 2012, AM J OBSTET GYNECOL, V206, P470, DOI 10.1016/j.ajog.2011.09.002
   Tan LK, 2002, BJOG-INT J OBSTET GY, V109, P733, DOI 10.1111/j.1471-0528.2002.01012.x
   Vasquez D, 1995, REV COLOMB OBSTET GI, V46, P41
   Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20
   ZUSPAN FP, 1978, AM J OBSTET GYNECOL, V131, P591, DOI 10.1016/0002-9378(78)90816-5
NR 31
TC 0
Z9 2
U1 0
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD JUL 30
PY 2013
VL 10
AR 37
DI 10.1186/1742-4755-10-37
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 196RG
UT WOS:000322792600001
PM 23899372
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Katz, L
   Amorim, M
   Souza, JP
   Haddad, SM
   Cecatti, JG
AF Katz, Leila
   Amorim, Melania
   Souza, Joao P.
   Haddad, Samira M.
   Cecatti, Jose G.
CA COHELLP Study Grp
TI COHELLP: collaborative randomized controlled trial on corticosteroids in
   HELLP syndrome
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Severe preeclampsia; HELLP syndrome; Corticosteroids; Randomized
   controlled trial
ID ELEVATED LIVER-ENZYMES; LOW PLATELETS; HEMOLYSIS; THERAPY; MANAGEMENT;
   WOMEN
AB Background: Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome is one of the most severe forms of preeclampsia and aggravates both maternal and perinatal prognosis. The systematic review available in Cochrane Library compared corticosteroid (dexamethasone, betamethasone, or prednisolone) given during pregnancy, just after delivery or in the postnatal period, or both before and after birth, with placebo or no treatment. Those receiving steroids showed significantly greater improvement in platelet counts which was greater for those receiving dexamethasone than those receiving betamethasone. There was no clear evidence of any effect of corticosteroids on substantive clinical outcomes. These benefits appear to be greater in Class I HELLP syndrome.
   Objectives: To determine the effectiveness of dexamethasone for accelerating postpartum recovery in patients with Class I HELLP syndrome in a multicenter randomized controlled trial.
   Methods/Design: The study is a triple blind randomized controlled trial including women with class I HELLP syndrome, and exclusion criteria were dexamethasone use in the last 15 days before diagnosis of HELLP syndrome; chronic use of corticosteroids; chronic diseases that alter laboratory parameters of HELLP Syndrome, such as chronic liver disease or purpura, patients unable to consent (coma or critical clinical condition) and without accompanying persons that may consent to study participation.
   Eligible patients will be invited to participate and those who agree will be included in the study and receive placebo or dexamethasone according to a random list of numbers and subjects will receive the study medication every 12 hours for two days.
   During the study the women will be subject to strict control of blood pressure and urine output. Laboratory tests will be performed at regular intervals during treatment and 24 hours and 48 hours after its suspension. If worsening of clinical or laboratory variables is observed, a rescue scheme of dexamethasone will be administrated. This proposal has already obtained approval of the local Institutional Review Board of the coordinating center (IMIP, Recife, Brazil), all other participating centers and of the National Council for Ethics in Research (CONEP) of the Brazilian Ministry of Health.
   Trial Registration: Clinical Trials Register under the number NCT00711841.
C1 [Katz, Leila] Inst Med Integral Prof Fernando Figueira, Obstet Intens Care Unit, Recife, PE, Brazil.
   [Amorim, Melania] Univ Fed Campina Grande, Dept Obstet & Gynecol, Campina Grande, PB, Brazil.
   [Souza, Joao P.] WHO, UNDP UNFPA WHO World Bank Special Programme Res, CH-1211 Geneva, Switzerland.
   [Souza, Joao P.] WHO, CH-1211 Geneva, Switzerland.
   [Souza, Joao P.] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland.
   [Haddad, Samira M.; Cecatti, Jose G.] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Katz, L (corresponding author), Inst Med Integral Prof Fernando Figueira, Obstet Intens Care Unit, Recife, PE, Brazil.
EM katzleila@gmail.com
RI Katz, Leila/M-5291-2013; Souza, Joao Paulo/G-1982-2010; Quintana,
   Silvana Maria/D-6953-2015; Amorim, Melania M/C-5807-2013
OI Katz, Leila/0000-0001-9854-7917; Souza, Joao Paulo/0000-0002-2288-4244;
   Quintana, Silvana Maria/0000-0002-9311-786X; Amorim, Melania
   M/0000-0003-1047-2514
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [475586/2008-5]; FACEPE [APQ-1338-4.00/08]
FX The authors thank the local investigators who are responsible for the
   implementation of this study in the Brazilian Network of Studies in
   Reproductive and Perinatal Health. The study was partially sponsored by
   CNPq (Process 475586/2008-5) and FACEPE (Process APQ-1338-4.00/08).
CR Dreyfus M, 1999, EUR J OBSTET GYN R B, V85, P233, DOI 10.1016/S0301-2115(99)00022-6
   Fonseca JE, 2005, AM J OBSTET GYNECOL, V193, P1591, DOI 10.1016/j.ajog.2005.07.037
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Heller CS, 1997, J REPROD MED, V42, P743
   HEYBORNE KD, 1990, J REPROD MED, V35, P53
   Katz L, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.797
   Magann EF, 1999, CLIN OBSTET GYNECOL, V42, P532, DOI 10.1097/00003081-199909000-00009
   MAGANN EF, 1994, AM J OBSTET GYNECOL, V171, P1148, DOI 10.1016/0002-9378(94)90054-X
   MAGANN EF, 1995, EUR J OBSTET GYN R B, V59, P217, DOI 10.1016/0028-2243(94)01995-J
   O'Brien JM, 2002, AM J OBSTET GYNECOL, V186, P475, DOI 10.1067/mob.2002.121074
   *OPENCLINICA, 2004, OPENCLINICA COMM ED
   Schlembach D, 2000, J PERINAT MED, V28, P502, DOI 10.1515/JPM.2000.068
   Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18
   SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P311, DOI 10.1016/0002-9378(90)90376-I
   Suresh MS, 1998, ANESTHESIOL CLIN N A, V16, P332
   THIAGARAJAH S, 1984, AM J OBSTET GYNECOL, V150, P1
   VIGILDEGRACIA PE, 1996, GIN OBSTET MEX, V64, P337
   WOUDSTRA DM, 2010, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.ART.N0.CD008148
   Yalcin OT, 1998, INT J GYNECOL OBSTET, V61, P141, DOI 10.1016/S0020-7292(98)00036-8
NR 19
TC 10
Z9 12
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD MAY 22
PY 2013
VL 10
AR 28
DI 10.1186/1742-4755-10-28
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 151LM
UT WOS:000319462000001
PM 23697398
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU da Silva, MA
   Cabral, JE
   Amorim, MMR
   Neto, GHF
AF da Silva, Maria Arleide
   Cabral Filho, Jose Eulalio
   Ramos Amorim, Melania Maria
   Falbo Neto, Gilliatt Hanois
TI Female homicide victims in Recife, Pernambuco State, Brazil, 2009-2010:
   a descriptive study
SO CADERNOS DE SAUDE PUBLICA
LA Portuguese
DT Article
DE Homicide; Violence; Women
ID VIOLENCE; GENDER; WOMEN
AB This study investigated the epidemiological profile of female homicide victims in Recife, Pernambuco State, Northeast Brazil. An observational descriptive and prospective study included all homicides from March 2009 to February 2010 with female victims from Recife, 10 to 49 years of age. A questionnaire was used to record socioeconomic, demographic, and biological risk factors. Relatives of the victims were interviewed, and data were collected from death certificates. We identified 60 homicides during the study period. Most victims were adult women with brown skin color and low schooling and low income. Other characteristics included smoking in 39.7%, alcohol and illicit drugs in 48.3% and 24.1%, respectively, and physical and/or sexual violence in the 12 months prior to the murder in 29.3%. Firearms were used in 69% of these homicides.
C1 [da Silva, Maria Arleide; Cabral Filho, Jose Eulalio; Ramos Amorim, Melania Maria; Falbo Neto, Gilliatt Hanois] Inst Med Integral Prof Fernando Figueira, BR-50070550 Recife, PE, Brazil.
RP da Silva, MA (corresponding author), Inst Med Integral Prof Fernando Figueira, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM arleide@imip.org.br
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
CR Arnold MW, 2007, REV BRAS SAUDE MA S1, V7, P23
   Botega NJ, 2010, REV BRAS PSIQUIATR, V32, P250, DOI 10.1590/S1516-44462010005000016
   da Silva MA, 2010, CAD SAUDE PUBLICA, V26, P264, DOI 10.1590/S0102-311X2010000200006
   Departamento de Analise e Situacao de Saude Secretaria de Vigilancia em Saude Ministerio da Saude, 2010, SAUD BRAS 2008 AN SI
   Departamento de Analise e Situacao de Saude Secretaria de Vigilancia em Saude Ministerio da Saude, 2006, SAUD BRAS 2006 AN SI
   Faundes A, 2000, Cad Saude Publica, V16, P671, DOI 10.1590/S0102-311X2000000300015
   Gawryszewski VP, 2005, REV SAUDE PUBL, V39, P627, DOI 10.1590/S0034-89102005000400017
   KATZ ME, 1995, AM J PUBLIC HEALTH, V85, P1135, DOI 10.2105/AJPH.85.8_Pt_1.1135
   KHAN T., 1999, SAO PAULO PERSPECT, V13, P42
   Krug EG, 2002, RAPPORT MONDIAL VIOL
   Meetoo V, 2007, WOMEN STUD INT FORUM, V30, P187, DOI 10.1016/j.wsif.2007.03.001
   Meneghel SN, 2011, REV SAUDE PUBL, V45, P564, DOI [10.1590/S0034-89102011000300015, 10.1590/s0034-89102011000300015]
   Palma-Solis M, 2008, ANN EPIDEMIOL, V18, P322, DOI 10.1016/j.annepidem.2007.11.007
   Reichenheim Michael Eduardo, 2006, Cad. Saúde Pública, V22, P425, DOI 10.1590/S0102-311X2006000200020
   Reza A, 2001, INJURY PREV, V7, P102
   Santos Sony Maria dos, 2007, Saude soc., V16, P87, DOI 10.1590/S0104-12902007000200009
   Schraiber LB, 2007, REV SAUDE PUBL, V41, P797, DOI 10.1590/S0034-89102007000500014
   Soares AMS, 2007, EPIDEMIOL SERV SAUDE, V16, P7
NR 18
TC 6
Z9 9
U1 0
U2 6
PU CADERNOS SAUDE PUBLICA
PI RIO DE JANIERO
PA RUA LEOPOLDO BUHOES 1480, RIO DE JANIERO, RJ 210410210, BRAZIL
SN 0102-311X
EI 1678-4464
J9 CAD SAUDE PUBLICA
JI Cad. Saude Publica
PD FEB
PY 2013
VL 29
IS 2
BP 391
EP 396
PG 6
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 099WY
UT WOS:000315656200025
PM 23459824
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU Lins, MM
   Amorim, M
   Vilela, P
   Viana, M
   Ribeiro, RC
   Pedrosa, A
   Lucena-Silva, N
   Howard, SC
   Pedrosa, F
AF Lins, Mecneide Mendes
   Amorim, Melania
   Vilela, Paulo
   Viana, Michelle
   Ribeiro, Raul C.
   Pedrosa, Arli
   Lucena-Silva, Norma
   Howard, Scott C.
   Pedrosa, Francisco
TI Delayed Diagnosis of Leukemia and Association With Morbid-Mortality in
   Children in Pernambuco, Brazil
SO JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
LA English
DT Article
DE leukemia; pediatric; oncology; diagnostic delay; Brazil
ID ACUTE LYMPHOBLASTIC-LEUKEMIA; CHILDHOOD-CANCER; TUMORS; TIME
AB The objectives of this study were to describe the interval between symptom onset and diagnosis of acute leukemia, to assess risk factors for delayed diagnosis, and its effect on early morbid-mortality and event-free survival (EFS). Records of children aged 1 month to 18 years diagnosed with acute leukemia were reviewed for clinical, demographic, and health care provider factors, and for time to diagnosis. Of 288 patients diagnosed, 55% had a delay in diagnosis. The median time to diagnosis was 31 days. There were significant associations between the diagnostic delay and the distance from the tertiary care hospital (P = 0.04), initial consultation in an outpatient clinic (P = 0.04), presenting symptoms of bone/joint pain (P = 0.04), family with more than 3 children (P = 0.02), birth order of third or greater (P = 0.009), paternal age < 30 years (P = 0.03), and paternal education < 8 years (P = 0.008). There was no association between delayed diagnosis and early morbid-mortality or EFS at 5 years. Initial consultation in an outpatient setting, presenting symptoms of bone/joint pain, and birth order of third or greater remained statistically significant in multivariate analyses, but the delay did not have an impact on early morbid-mortality or EFS. Education of primary care providers in atypical presentations of acute leukemia may decrease the diagnostic delay.
C1 [Lins, Mecneide Mendes; Viana, Michelle; Lucena-Silva, Norma] IMIP Hosp, Pediat Oncol Unit, Recife, PE, Brazil.
   [Amorim, Melania; Vilela, Paulo] IMIP Hosp, Postgrad & Res Dept, Recife, PE, Brazil.
   [Pedrosa, Arli; Pedrosa, Francisco] Pediat Hematol & Oncol Ctr, Recife, PE, Brazil.
   [Ribeiro, Raul C.; Howard, Scott C.] St Jude Hosp, Dept Pediat Hematol Oncol, Memphis, TN USA.
RP Lins, MM (corresponding author), Rua Joaquim Inacio 187, BR-50070290 Recife, PE, Brazil.
EM mecneide.mendes@cehope.com.br
RI Amorim, Melania M/C-5807-2013; Howard, Scott C/K-3401-2013;
   Lucena-Silva, Norma/AAH-9437-2019
OI Amorim, Melania M/0000-0003-1047-2514; Howard, Scott
   C/0000-0003-2244-1686; 
CR Chantada G, 1999, ARCH DIS CHILD, V80, P171, DOI 10.1136/adc.80.2.171
   Dang-Tan T, 2007, CANCER-AM CANCER SOC, V110, P703, DOI 10.1002/cncr.22849
   Dang-Tan T, 2010, INT J CANCER, V126, P1936, DOI 10.1002/ijc.24906
   Campos LMD, 2008, REV ASSOC MED BRAS, V54, P132, DOI 10.1590/S0104-42302008000200015
   de Souza Reis Rejane, 2011, PEDIAT BLOOD CANC, V56, P58
   Dixon-Woods M, 2001, LANCET, V357, P670, DOI 10.1016/S0140-6736(00)04130-1
   Dobrovoljac M, 2002, EUR J PEDIATR, V161, P663, DOI 10.1007/s00431-002-1088-4
   Eden T, 2002, BRIT J HAEMATOL, V118, P945, DOI 10.1046/j.1365-2141.2002.03670.x
   Fajardo-Gutierrez A, 2002, MED PEDIATR ONCOL, V39, P25, DOI 10.1002/mpo.10100
   Haimi M, 2004, PEDIATR HEMAT ONCOL, V21, P37, DOI 10.1080/08880010490263579
   Hamre MR, 2000, MED PEDIATR ONCOL, V34, P343, DOI 10.1002/(SICI)1096-911X(200005)34:5<343::AID-MPO5>3.0.CO;2-B
   Howard SC, 2004, JAMA-J AM MED ASSOC, V291, P2471, DOI 10.1001/jama.291.20.2471
   James BO, 2009, AFR HEALTH SCI, V9, P247
   Klein-Geltink JE, 2005, PEDIATR BLOOD CANCER, V44, P318, DOI 10.1002/pbc.20156
   Metzger ML, 2003, LANCET, V362, P706, DOI 10.1016/S0140-6736(03)14228-6
   Ozturkmen S, 2010, TURKISH J PEDIATR, V52, P552
   POLLOCK BH, 1991, J PEDIATR-US, V119, P725, DOI 10.1016/S0022-3476(05)80287-2
   PRATT CB, 1978, PEDIATRICS, V61, P30
   Pui CH, 2003, INT J HEMATOL, V78, P383, DOI 10.1007/BF02983810
   Rodrigues Karla Emilia, 2003, Rev. Assoc. Med. Bras., V49, P29, DOI 10.1590/S0104-42302003000100030
   Rubnitz JE, 2008, PEDIATR CLIN N AM, V55, P21, DOI 10.1016/j.pcl.2007.11.003
   Starfield B., 1998, PRIMARY CARE BALANCI, P448
   Stefan DC, 2011, PEDIATR BLOOD CANCER, V56, P80, DOI 10.1002/pbc.22714
   Thulesius H, 2000, ACTA ONCOL, V39, P873, DOI 10.1080/028418600750063640
   Victora CG, 1997, INT J EPIDEMIOL, V26, P224, DOI 10.1093/ije/26.1.224
   Workman GM, 2007, J CANCER EDUC, V22, P181, DOI 10.1007/BF03174334
NR 26
TC 12
Z9 13
U1 0
U2 5
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1077-4114
EI 1536-3678
J9 J PEDIAT HEMATOL ONC
JI J. Pediatr. Hematol. Oncol.
PD OCT
PY 2012
VL 34
IS 7
BP E271
EP E276
DI 10.1097/MPH.0b013e3182580bea
PG 6
WC Oncology; Hematology; Pediatrics
SC Oncology; Hematology; Pediatrics
GA 012EN
UT WOS:000309218400002
PM 22935656
DA 2020-12-01
ER

PT J
AU Melo, ASD
   Silva, JLP
   Tavares, JS
   Barros, VO
   Leite, DFB
   Amorim, MMR
AF de Oliveria Melo, Adriana S.
   Silva, Joao Luiz P.
   Tavares, Jousilene S.
   Barros, Vivianne O.
   Leite, Debora F. B.
   Amorim, Melania M. R.
TI Effect of a Physical Exercise Program During Pregnancy on Uteroplacental
   and Fetal Blood Flow and Fetal Growth A Randomized Controlled Trial
SO OBSTETRICS AND GYNECOLOGY
LA English
DT Article
ID FETOPLACENTAL GROWTH; AEROBIC EXERCISE; DOPPLER; RESPONSES; WOMEN;
   PREDICTION; WEIGHT
AB OBJECTIVE: To estimate the effect of supervised physical exercise on maternal physical fitness, fetoplacental blood flow, and fetal growth.
   METHODS: This was a randomized controlled trial comparing three groups of pregnant women. Groups were as follows: exercise initiated at 13 weeks (group A); exercise initiated at 20 weeks (group B); and a control group (no supervised exercise; group C). The women in groups A and B walked at moderate intensity three times weekly. Physical fitness level was evaluated at weeks 13, 20, and 28. Fetal growth and uteroplacental blood flow were evaluated monthly. Birth weight was registered. Analysis of variance for repeat measures was used for outcomes evaluated throughout pregnancy. Risk ratio was used as a measure of the relative risk of preeclampsia, fetal growth restriction, macrosomia, small-for-gestational-age new-borns, and large-for-gestational-age newborns.
   RESULTS: All the women analyzed completed more than 85% of the program. According to the evaluation conducted at week 28, physical fitness improved, with mean maximal oxygen consumptions (VO2max) of 27.3 +/- 4.3 (group A), 28 +/- 3.3 (group B), and 25.5 +/- 3.8 (group C; P=.03). Mean birth weights were 3,279 +/- 453 g (group A), 3,285 +/- 477 g (group B), and 3,378 +/- 593 g (group C; P=.53), with no difference in the frequency of large for gestational age or small for gestational age. No association was found between the practice of physical activity and the variables investigated (preeclampsia, fetal weight, blood pressure, and pulsatility index of the uterine, umbilical, and middle cerebral arteries).
   CONCLUSION: Moderate-intensity walking improved the physical fitness level of healthy, pregnant, previously sedentary women without affecting fetoplacental blood flow or fetal growth.
C1 [de Oliveria Melo, Adriana S.] Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, BR-58100000 Campina Grande, Paraiba, Brazil.
   Univ Estadual Campinas, Sch Med Sci, Dept Obstet, Campinas, Brazil.
   Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Melo, ASD (corresponding author), Inst Pesquisa Prof Joaquim Amorim Neto IPESQ, Rua Duque de Caxias 330, BR-58100000 Campina Grande, Paraiba, Brazil.
EM asomelo@gmail.com
RI Amorim, Melania M/C-5807-2013; Melo, Adriana S O/H-5650-2016
OI Amorim, Melania M/0000-0003-1047-2514; 
FU Brazilian National Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Paraiba Research Foundation (FAPESQ)
FX Supported by the Brazilian National Council for Scientific and
   Technological Development (CNPq) and by the Paraiba Research Foundation
   (FAPESQ).
CR Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X
   [Anonymous], 2002, OBSTET GYNECOL, V99, P171
   ARDUINI D, 1990, J PERINAT MED, V18, P165, DOI 10.1515/jpme.1990.18.3.165
   ASO Melo, EX PREGN RAND CLIN T
   Barakat R, 2009, INT J OBESITY, V33, P1048, DOI 10.1038/ijo.2009.150
   BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012
   Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008
   Cecatti J G, 2000, Cad Saude Publica, V16, P1083, DOI 10.1590/S0102-311X2000000400026
   Clapp JF, 2006, PLACENTA, V27, P527, DOI 10.1016/j.placenta.2005.07.010
   Clapp JF, 2000, AM J OBSTET GYNECOL, V183, P1484, DOI 10.1067/mob.2000.107096
   Clapp JF, 2003, EUR J OBSTET GYN R B, V110, pS80, DOI 10.1016/S0301-2115(03)00176-3
   COLLINGS CA, 1983, AM J OBSTET GYNECOL, V145, P702, DOI 10.1016/0002-9378(83)90576-8
   Cooley SM, 2011, J PERINAT MED, V39, P143, DOI [10.1515/JPM.2010.130, 10.1515/jpm.2010.130]
   CURET LB, 1976, J APPL PHYSIOL, V40, P725
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   GRAMELLINI D, 1992, OBSTET GYNECOL, V79, P416, DOI 10.1097/00006250-199203000-00018
   Haakstad LAH, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-66
   HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4
   Kennelly MM, 2002, AM J OBSTET GYNECOL, V187, P661, DOI 10.1067/mob.2002.125741
   Kramer MS, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000180.pub2
   LOTGERING FK, 1983, J APPL PHYSIOL, V55, P834
   MacPhail A, 2000, OBSTET GYNECOL, V96, P565, DOI 10.1016/S0029-7844(00)00940-6
   Marquez-Sterling S, 2000, MED SCI SPORT EXER, V32, P58
   Mesquita A, 1996, Rev Port Cardiol, V15, P139
   Mesquita A, 1996, REV PORT CARDIOL, V15, P101
   Mottola MF, 2006, MED SCI SPORT EXER, V38, P1389, DOI 10.1249/01.mss.0000228940.09411.9c
   Plasencia W, 2007, ULTRASOUND OBST GYN, V30, P742, DOI 10.1002/uog.5157
   Rafla N. M., 1998, Journal of Obstetrics and Gynaecology (Abingdon), V18, P14
   Rafla N. M., 1999, Journal of Obstetrics and Gynaecology (Abingdon), V19, P385
   Santos IA, 2005, OBSTET GYNECOL, V106, P243, DOI 10.1097/01.AOG.0000171113.36624.86
   Silva Francisco Trindade, 2007, Rev. Bras. Ginecol. Obstet., V29, P490, DOI 10.1590/S0100-72032007000900009
   V Diretrizes da Sociedade Brasileira de Hipertensao Arterial, 5 DIR SOC BRAS HIP A
   WLADIMIROFF JW, 1986, BRIT J OBSTET GYNAEC, V93, P471, DOI 10.1111/j.1471-0528.1986.tb08656.x
NR 33
TC 44
Z9 43
U1 0
U2 24
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0029-7844
J9 OBSTET GYNECOL
JI Obstet. Gynecol.
PD AUG
PY 2012
VL 120
IS 2
BP 302
EP 310
DI 10.1097/AOG.0b013e31825de592
PN 1
PG 9
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 978BF
UT WOS:000306713100016
PM 22825089
DA 2020-12-01
ER

PT J
AU Knobel, R
   Takemoto, MLS
   Jones, RH
   Amorim, MMR
AF Knobel, R.
   Takemoto, M. L. S.
   Jones, R. H.
   Amorim, M. M. R.
TI Episiotomy characteristics and risk for obstetric anal sphincter
   injuries: a case-control study Authors' Reply
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Letter
ID MEDIOLATERAL EPISIOTOMY; DELIVERY; ANGLE
C1 [Knobel, R.] Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
   [Knobel, R.; Takemoto, M. L. S.; Jones, R. H.; Amorim, M. M. R.] ReHuNa, Brasilia, DF, Brazil.
   [Takemoto, M. L. S.] Univ Estado Rio de Janeiro, BR-20550011 Rio De Janeiro, Brazil.
   [Amorim, M. M. R.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Knobel, R (corresponding author), Univ Fed Santa Catarina, Florianopolis, SC, Brazil.
RI Knobel, Roxana/S-4550-2019; knobel, roxana/I-3081-2013; TAKEMOTO, MAIRA
   LS/G-7889-2018; Amorim, Melania M/C-5807-2013
OI Knobel, Roxana/0000-0001-9180-4685; knobel, roxana/0000-0001-9180-4685;
   TAKEMOTO, MAIRA LS/0000-0002-7016-2879; Amorim, Melania
   M/0000-0003-1047-2514
CR Andrews V, 2006, BIRTH-ISS PERINAT C, V33, P117, DOI 10.1111/j.0730-7659.2006.00088.x
   de Leeuw JW, 2008, BJOG-INT J OBSTET GY, V115, P104, DOI 10.1111/j.1471-0528.2007.01554.x
   Eogan M, 2006, BJOG-INT J OBSTET GY, V113, P190, DOI 10.1111/j.1471-0528.2005.00835.x
   Kalis V, 2012, BJOG-INT J OBSTET GY, V119, P1147, DOI 10.1111/j.1471-0528.2012.03390.x
   Kalis V, 2008, INT J GYNECOL OBSTET, V103, P5, DOI 10.1016/j.ijgo.2008.05.026
   Stedenfeldt M, 2012, BJOG-INT J OBSTET GY, V119, P1148, DOI [10.1111/j.1471-0528.2012.03391.x, 10.1111/j.1471-0528.2012.03392.x]
   Tincello DG, 2003, BJOG-INT J OBSTET GY, V110, P1041, DOI 10.1016/S1470-0328(03)03930-2
   van Dillen J, 2010, INT J GYNECOL OBSTET, V108, P97, DOI 10.1016/j.ijgo.2009.08.021
NR 8
TC 2
Z9 2
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD AUG
PY 2012
VL 119
IS 9
BP 1148
EP 1149
DI 10.1111/j.1471-0528.2012.03392.x
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 971RH
UT WOS:000306221000017
PM 22780821
DA 2020-12-01
ER

PT J
AU de Carvalho, VDV
   de Macedo, JL
   de Lima, CAD
   de Lima, MDG
   Heraclio, SD
   Amorim, M
   Maia, MDD
   Porto, ALF
   de Souza, PRE
AF Vasconcelos de Carvalho, Viviane do Carmo
   de Macedo, Jamilly Lopes
   Dantas de Lima, Camilla Albertina
   Gomes de Lima, Maria da Conceicao
   Heraclio, Sandra de Andrade
   Amorim, Melania
   Diniz Maia, Maria de Mascena
   Figueiredo Porto, Ana Lucia
   Eleuterio de Souza, Paulo Roberto
TI IFN-gamma and IL-12B polymorphisms in women with cervical
   intraepithellial neoplasia caused by human papillomavirus
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Article
DE HPV; CIN; Polymorphism; Interferon-gamma; IL-12B
ID NON-HODGKIN-LYMPHOMA; GENE POLYMORPHISMS; INTERFERON-GAMMA; ALLELE
   FREQUENCIES; CANCER; RISK; INTERLEUKIN-12; ASSOCIATION; INFECTION;
   SUSCEPTIBILITY
AB The Human Papillomavirus (HPV) is a sexually transmitted organism associated with Cervical Intraepithelial Neoplasia (CIN) and cervical cancer, the second main cause of malignancy in women worldwide. The virus itself, however, is not enough to cause lesions on the cervix. Several studies suggest that some polymorphic sites changes the cytokines levels and influence the cancer development in HPV infected patients. In this study, we evaluated the presence of functional polymorphisms at +874 (T/A) IFNG and +1188 (A/C) IL-12B genes in cervical smears samples from 76 healthy women and 162 women, HPV positive, with CIN lesion-CIN I (45), CIN II (55), CIN III (53) and cervical cancer (9)-in Brazilian population. There was no significant differences in genotype (p = 0.4192) and allele (p = 0.370; OR = 1.20) distributions between CIN patients and control groups on IFNG allelic polymorphism. Moreover, for IL-12B gene, there was a significant difference in genotype (p = 0.015) and allele distribution (p = 0.014; OR = 0.5754) between the groups. When samples were stratified according to grade of cervical lesion, the AA genotype and A allele were less frequent in the group with low-grade cervical lesions than in group with high-grade cervical lesions (p = 0.0036 and p = 0.0010; OR = 0.3819, respectively), suggesting that the C allele (mutant) may protect against the emergence of CIN lesions and its progression.
C1 [Vasconcelos de Carvalho, Viviane do Carmo; de Macedo, Jamilly Lopes; Dantas de Lima, Camilla Albertina; Gomes de Lima, Maria da Conceicao; Diniz Maia, Maria de Mascena; Figueiredo Porto, Ana Lucia; Eleuterio de Souza, Paulo Roberto] Univ Fed Rural Pernambuco, Lab Genoma, Dept Biol, BR-52171900 Recife, PE, Brazil.
   [Heraclio, Sandra de Andrade; Amorim, Melania] Inst Materno Infantil Pernambuco, BR-50070550 Recife, PE, Brazil.
   [Figueiredo Porto, Ana Lucia] Univ Fed Rural Pernambuco, Lab Tecnol Prod Bioat LABTECBIO, Dept Morfol & Fisiol Anim, BR-52171900 Recife, PE, Brazil.
RP de Souza, PRE (corresponding author), Univ Fed Rural Pernambuco, Lab Genoma, Dept Biol, Rua Dom Manoel de Medeiros S-N, BR-52171900 Recife, PE, Brazil.
EM prsouza30@gmail.com
RI Amorim, Melania M/C-5807-2013; porto, ana/R-4619-2018
OI Amorim, Melania M/0000-0003-1047-2514; porto, ana/0000-0001-5561-5158;
   Souza, Paulo/0000-0002-9186-9849; Lima, Camilla/0000-0003-0320-3674
CR Abbas AK, 2008, IMUNOLOGIA CELULAR M
   Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002
   Bhat P, 2011, IMMUNOL REV, V239, P85, DOI 10.1111/j.1600-065X.2010.00966.x
   Cerhan JR, 2007, BLOOD, V109, P5439, DOI 10.1182/blood-2006-11-058040
   Chen XJ, 2009, CLIN CANCER RES, V15, P400, DOI 10.1158/1078-0432.CCR-08-1829
   Clerici M, 1997, J NATL CANCER I, V89, P245, DOI 10.1093/jnci/89.3.245
   de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033
   Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776
   Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006
   El-Sherif AM, 2001, J PATHOL, V195, P179, DOI 10.1002/path.929
   Farzaneh F, 2006, BJOG-INT J OBSTET GY, V113, P961, DOI 10.1111/j.1471-0528.2006.00956.x
   Gangwar R, 2009, BJOG-INT J OBSTET GY, V116, P1671, DOI 10.1111/j.1471-0528.2009.02307.x
   Govan Vandana A, 2003, J Carcinog, V2, P3, DOI 10.1186/1477-3163-2-3
   Han SS, 2008, EUR J OBSTET GYN R B, V140, P71, DOI 10.1016/j.ejogrb.2008.02.007
   Haws ALF, 2004, J VIROL METHODS, V122, P87, DOI 10.1016/j.jviromet.2004.08.007
   Hoffmann TW, 2009, TRANSPL P, V41, P654, DOI 10.1016/j.transproceed.2008.12.002
   Yu H, 2006, WORLD J GASTROENTERO, V12, P2928, DOI 10.3748/wjg.v12.i18.2928
   Matos GI, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-33
   Kanodia S, 2007, CURR CANCER DRUG TAR, V7, P79, DOI 10.2174/156800907780006869
   Lai HC, 2005, INT J CANCER, V113, P712, DOI 10.1002/ijc.20637
   Lan Q, 2006, BLOOD, V107, P4101, DOI 10.1182/blood-2005-10-4160
   Mant C, 1997, J VIROL METHODS, V66, P169, DOI 10.1016/S0166-0934(97)00056-6
   Marcos M, 2009, CYTOKINE, V45, P158, DOI 10.1016/j.cyto.2008.11.003
   Morahan G, 2002, GENES IMMUN, V3, P414, DOI 10.1038/sj.gene.6363909
   Muller-Steinhardt M, 2004, AM J TRANSPLANT, V4, P402, DOI 10.1111/j.1600-6143.2004.00356.x
   Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641
   Navaglia F, 2005, J MED GENET, V42, P503, DOI 10.1136/jmg.2004.022723
   Nieters A, 2005, CANCER, V103, P740, DOI 10.1002/cncr.20842
   Pao CC, 1996, BIOCHEM BIOPH RES CO, V222, P116, DOI 10.1006/bbrc.1996.0707
   Peghini BC, 2009, PERFIL RESPOSTA IMUN
   Perrey C, 1999, TRANSPL IMMUNOL, V7, P127, DOI 10.1016/S0966-3274(99)80030-6
   Phawong C, 2010, IMMUNOGENETICS, V62, P345, DOI 10.1007/s00251-010-0439-y
   Poli F, 2002, EUR J IMMUNOGENET, V29, P237, DOI 10.1046/j.1365-2370.2002.00303.x
   Pravica V, 2000, HUM IMMUNOL, V61, P863, DOI 10.1016/S0198-8859(00)00167-1
   Purdue MP, 2007, CARCINOGENESIS, V28, P704, DOI 10.1093/carcin/bgl200
   Reynard MP, 2000, EUR J IMMUNOGENET, V27, P241, DOI 10.1046/j.1365-2370.2000.00227.x
   Seegers D, 2002, GENES IMMUN, V3, P419, DOI 10.1038/sj.gene.6363919
   Selvaraj P, 2008, CYTOKINE, V43, P26, DOI 10.1016/j.cyto.2008.04.011
   Sousa CS, 2003, BIOSCI J, V19, P65
   Tamandani M. K. Kordi, 2008, Experimental Oncology, V30, P224
   Tangwattanachuleeporn M, 2007, CLIN RHEUMATOL, V26, P1921, DOI 10.1007/s10067-007-0699-6
   Torres OA, 2010, INFECT GENET EVOL, V10, P682, DOI 10.1016/j.meegid.2010.03.009
   Urbanowicz I, 2010, PATHOL ONCOL RES, V16, P213, DOI 10.1007/s12253-009-9209-2
   Vallinoto ACR, 2010, HUM IMMUNOL, V71, P692, DOI 10.1016/j.humimm.2010.03.008
   von Linsingen R, 2009, J INTERF CYTOK RES, V29, P285, DOI 10.1089/jir.2008.0081
   Zafra G, 2007, MICROBES INFECT, V9, P1049, DOI 10.1016/j.micinf.2007.04.010
NR 46
TC 15
Z9 16
U1 0
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD JUL
PY 2012
VL 39
IS 7
BP 7627
EP 7634
DI 10.1007/s11033-012-1597-9
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 947CP
UT WOS:000304404600045
PM 22327783
DA 2020-12-01
ER

PT J
AU de Orange, FA
   Passini, R
   Amorim, MMR
   Almeida, T
   Barros, A
AF de Orange, F. A.
   Passini, R.
   Amorim, M. M. R.
   Almeida, T.
   Barros, A.
TI Maternal temperature increase Reply
SO BRITISH JOURNAL OF ANAESTHESIA
LA English
DT Letter
EM orangeflavia@gmail.com
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
CR de Orange FA, 2011, BRIT J ANAESTH, V107, P762, DOI 10.1093/bja/aer218
   FUSI L, 1989, LANCET, V1, P1250, DOI 10.1016/S0140-6736(89)92341-6
NR 2
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0007-0912
J9 BRIT J ANAESTH
JI Br. J. Anaesth.
PD APR
PY 2012
VL 108
IS 4
BP 700
EP 701
DI 10.1093/bja/aes084
PG 2
WC Anesthesiology
SC Anesthesiology
GA 915IB
UT WOS:000302016600027
OA Bronze
DA 2020-12-01
ER

PT J
AU Coelho, MDL
   Katz, L
   Coutinho, I
   Hofmann, A
   Miranda, L
   Amorim, M
AF Lima Coelho, Marta de Andrade
   Katz, Leila
   Coutinho, Isabela
   Hofmann, Aline
   Miranda, Larissa
   Amorim, Melania
TI Profile of women admitted at an obstetric ICU due to non-obstetric
   causes
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA Portuguese
DT Article
DE Cohort studies; intensive care unit; maternal mortality; obstetrics
ID INTENSIVE-CARE-UNIT; CLINICAL CHARACTERISTICS; ADMISSIONS; OUTCOMES;
   MORBIDITY
AB Profile of women admitted at an obstetric ICU due to non-obstetric causes Objective: To characterize patients admitted during the pregnancy-puerperal cycle for non-obstetric causes in the obstetric intensive care unit (ICU) of a tertiary hospital in northeastern Brazil. Methods: A descriptive study, analyzing the participants from a bidirectional cohort study was conducted between January 2005 and October 2010. A total of 500 patients admitted during the pregnancy-puerperal cycle due to non-obstetric causes in an obstetric ICU in northeastern Brazil were included; cases of gestational trophoblastic disease (GTD), ectopic pregnancy, death or ICU stay lasting < 24 hours, and lack of signed informed consent form (ICE) were excluded. The biological, socio-demographic, obstetric, and clinical variables were analyzed. Statistical analysis was performed using Epi-Info 3.5.3. Results: Of 5,078 obstetric admissions in the service, 500 patients (9.8%) were due to non-obstetric causes. The mean age was 25.9 years, the predominant ethnicity was mixed-race (68.9%), and mean BMI was 27.5. In 79.9% of cases, women had a partner, and schooling over eight years was observed in 49.2%. The main clinical diagnoses seen at ICU admission were heart disease, deep vein thrombosis (DVT), urinary tract infection (UTI), asthma, acute pulmonary edema (APE), and community-acquired pneumonia (CAP). Central access was used in 10.2% of patients, 11% were on mechanical ventilation, 20.4% received blood transfusions, and 4.0% of the patients died. Conclusion: Women admitted at the obstetric ICU due to non-obstetric causes represent a significant number of patients in this sector. They are mostly young women, and the main admission diagnoses were cardiovascular, respiratory, and infectious diseases, with a fatality rate of 4%.
C1 [Lima Coelho, Marta de Andrade; Katz, Leila; Coutinho, Isabela; Hofmann, Aline; Miranda, Larissa; Amorim, Melania] Inst Med Integral Prof Fernando Figueira, UTI Obstet, Recife, PE, Brazil.
RP Katz, L (corresponding author), Rua Barao de Itamaraca 160-1501, BR-52020070 Recife, PE, Brazil.
EM katzleila@yahoo.com.br
RI Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Amorim, Melania M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
CR Amorim Melania Maria Ramos de, 2006, Rev. Bras. Saude Mater. Infant., V6, ps55, DOI 10.1590/S1519-38292006000500008
   Bibi S, 2008, J Ayub Med Coll Abbottabad, V20, P109
   Cartin-Ceba R, 2008, CRIT CARE MED, V36, P2746, DOI 10.1097/CCM.0b013e318186b615
   Cole Daniel E, 2005, Crit Care Med, V33, pS269, DOI 10.1097/01.CCM.0000182478.14181.DA
   Costa RT, 2009, MED INTENSIVA BASEAD, P135
   Hazelgrove JF, 2001, CRIT CARE MED, V29, P770, DOI 10.1097/00003246-200104000-00016
   IBGE, 2008, PROJ POP BRAS SEX ID, V24
   Karnad DR, 2004, CRIT CARE MED, V32, P1294, DOI 10.1097/01.CCM.0000128549.72276.00
   Keizer JL, 2006, EUR J OBSTET GYN R B, V128, P152, DOI 10.1016/j.ejogrb.2005.12.013
   Leung Natalie Y. W., 2010, Hong Kong Medical Journal, V16, P18
   McCaw-Binns A, 2007, INT J GYNECOL OBSTET, V96, P226, DOI 10.1016/j.ijgo.2006.12.002
   Neto AFO, 2009, INT J GYNECOL OBSTET, V105, P252, DOI 10.1016/j.ijgo.2009.01.025
   Perez A, 2010, MEDICC REV, V12, P27
   Souza ASR, 2008, REV ASSOC MED BRAS, V54, P232, DOI 10.1590/S0104-42302008000300016
   Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007
   Soubra Said H, 2005, Crit Care Med, V33, pS248, DOI 10.1097/01.CCM.0000183159.31378.6A
   Sousa Maria Helena de, 2006, Rev. Bras. Saude Mater. Infant., V6, P161, DOI 10.1590/S1519-38292006000200002
   Togal T, 2010, J CRIT CARE, V25, P628, DOI 10.1016/j.jcrc.2010.02.015
   Vasquez DN, 2007, CHEST, V131, P718, DOI 10.1378/chest.06-2388
   Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089
NR 20
TC 4
Z9 5
U1 0
U2 3
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
EI 1806-9282
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD MAR-APR
PY 2012
VL 58
IS 2
BP 160
EP 167
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA 927RD
UT WOS:000302926900013
PM 22569610
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Orange, FA
   Passini, R
   Melo, ASO
   Katz, L
   Coutinho, IC
   Amorim, MMR
AF de Orange, Flavia Augusta
   Passini-, Renato, Jr.
   Melo, Adriana S. O.
   Katz, Leila
   Coutinho, Isabela Cristina
   Amorim, Melania M. R.
TI Combined spinal-epidural anesthesia and non-pharmacological methods of
   pain relief during normal childbirth and maternal satisfaction: a
   randomized clinical trial
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA English
DT Article
DE Labor pain; labor, obstetric; patient satisfaction; analgesia,
   obstetrical
ID LABOR; EXPERIENCES
AB Objective: The objective of this study was to compare maternal satisfaction with childbirth according to whether or not combined spinal-epidural anesthesia (CSE) of pain relief was used during labor. Methods: A randomized, open clinical trial was performed with 70 pregnant women, 35 of whom received CSE anesthesia while 35 received only non-pharmacological forms of pain relief during labor. The variables evaluated were visual analogue scale (VAS) pain score, maternal satisfaction with the technique of pain relief used during childbirth and with delivery, the patient's intention to request the same technique in a subsequent delivery, and loss of control during delivery. Results: VAS pain score decreased significantly in patients receiving CSE during vaginal delivery. Furthermore, maternal satisfaction with the technique of pain relief and with delivery was higher in the CSE group, and around 97% of the patients would repeat the same technique at future deliveries compared to 82.4% of the women in the group using only non-pharmacological methods. With respect to the women's impressions of their control during delivery, approximately half the women in both groups felt that they had lost control at some point during the process. Conclusion: The use of CSE was associated with a significant reduction in VAS pain scores during delivery and with greater maternal satisfaction with the pain relief method and with the childbirth process.
C1 [de Orange, Flavia Augusta; Passini-, Renato, Jr.; Melo, Adriana S. O.; Katz, Leila; Coutinho, Isabela Cristina; Amorim, Melania M. R.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP de Orange, FA (corresponding author), Rua Coelhos 200, BR-52025011 Recife, PE, Brazil.
EM orangeflavia@gmail.com
RI Melo, Adriana S O/H-5650-2016; Passini Junior, Renato/O-6169-2016;
   Amorim, Melania M/C-5807-2013; Katz, Leila/M-5291-2013
OI Passini Junior, Renato/0000-0001-8247-4549; Amorim, Melania
   M/0000-0003-1047-2514; Katz, Leila/0000-0001-9854-7917
CR Callister L C, 2001, MCN Am J Matern Child Nurs, V26, P28, DOI 10.1097/00005721-200101000-00008
   Chalmers B, 2002, BIRTH-ISS PERINAT C, V29, P79, DOI 10.1046/j.1523-536X.2002.00148.x
   Chang Ching-Yi, 2006, Hu Li Za Zhi, V53, P98
   Chapman RS, 1990, MANAGEMENT PAIN, P580
   Cheung W, 2007, MIDWIFERY, V23, P123, DOI 10.1016/j.midw.2006.05.001
   Christiansen Pia, 2002, Ugeskr Laeger, V164, P4927
   Cook TM, 2000, ANAESTHESIA, V55, P42, DOI 10.1046/j.1365-2044.2000.01157.x
   Cooper GM, 2010, INT J OBSTET ANESTH, V19, P31, DOI 10.1016/j.ijoa.2009.05.004
   De Luca RS, 1999, THESIS, V60, P3015
   Gibbins J, 2001, MIDWIFERY, V17, P302, DOI 10.1054/midw.2001.0263
   Graham JE, 2002, PSYCHOL WOMEN QUART, V26, P222, DOI 10.1111/1471-6402.00061
   Hodges S, 2000, BIRTH-ISS PERINAT C, V27, P281, DOI 10.1046/j.1523-536x.2000.00281.x
   Hodnett ED, 2002, AM J OBSTET GYNECOL, V186, pS160, DOI 10.1067/mob.2002.121141
   Johnson Maree, 2002, Int J Nurs Pract, V8, P127, DOI 10.1046/j.1440-172X.2002.00353.x
   Lachin JM, 2000, CONTROL CLIN TRIALS, V21, P167, DOI 10.1016/S0197-2456(00)00046-5
   Lally JE, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-7
   Lavender T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005461.pub2
   Likert R., 1932, ARCH PSYCHOL, V22, P1, DOI DOI 10.1111/J.1540
   McCourt C, 1998, BIRTH-ISS PERINAT C, V25, P73, DOI 10.1046/j.1523-536x.1998.00073.x
   Nystedt A, 2006, MIDWIFERY, V22, P56, DOI 10.1016/j.midw.2005.05.003
   Orange FA, 2011, BRIT J ANAESTH, V107, P762
   Simmons SW, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003401.pub2
   Taghinejad H, 2010, WOMENS HEALTH, V6, P377, DOI [10.2217/whe.10.15, 10.2217/WHE.10.15]
   Terp JM, 1998, BRIT J PSYCHIAT, V172, P521
   Vernis L, 2004, EUR J ANAESTH, V21, P186, DOI 10.1017/S0265021504003047
   Walker M, 1997, J Hum Lact, V13, P131, DOI 10.1177/089033449701300214
   World Health Organization, 2000, IMPAC INT MAN PREGN
NR 27
TC 7
Z9 10
U1 0
U2 8
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
EI 1806-9282
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD JAN-FEB
PY 2012
VL 58
IS 1
BP 112
EP 117
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 898LF
UT WOS:000300743200022
PM 22392325
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU de Orange, FA
   Passini, R
   Amorim, MMR
   Almeida, T
   Barros, A
AF de Orange, F. A.
   Passini, R., Jr.
   Amorim, M. M. R.
   Almeida, T.
   Barros, A.
TI Combined spinal and epidural anaesthesia and maternal intrapartum
   temperature during vaginal delivery: a randomized clinical trial
SO BRITISH JOURNAL OF ANAESTHESIA
LA English
DT Article
DE combined anaesthesia; epidural analgesia; fever; labour pain; obstetric
   labour; obstetrical analgesia
ID ANALGESIA; LABOR; FEVER
AB Background. We determined the association between combined spinal-epidural (CSE) anaesthesia and an increase in maternal intrapartum temperature and intrapartum fever.
   Methods. A randomized, open clinical trial was performed with 70 pregnant women, 35 receiving CSE and 35 receiving only non-pharmacological methods of pain relief during delivery. Association between CSE and changes in the patient's temperature, the risk of maternal fever, and other maternal and perinatal outcomes was determined at a 5% significance level. Number needed to harm (NNH) was calculated for maternal fever.
   Results. Patients receiving CSE anaesthesia during vaginal delivery experienced a significant increase in intrapartum temperature and five (14%) developed fever, whereas no cases occurred in the group receiving only non-pharmacological methods of pain relief (P=0.027). None of the women who developed fever received antibiotics or were submitted to further investigation; however, all progressed without complication. No case of chorioamnionitis or any maternal or neonatal infection was detected. NNH for maternal fever was 7.0 (95% confidence interval: 3.8-51.9).
   Conclusions. The use of CSE is associated with a significant increase in maternal temperature and in the incidence of intrapartum maternal fever. However, the increase in maternal temperature does not appear to provoke any deleterious effects on the mother or child.
C1 [de Orange, F. A.; Amorim, M. M. R.] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
   [de Orange, F. A.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [de Orange, F. A.] IMIP Teaching & Training Ctr Anesthesiol, Recife, PE, Brazil.
   [Passini, R., Jr.] Univ Campinas UNICAMP, Sch Med Sci, Dept Obstet & Gynecol, Sao Paulo, Brazil.
   [Amorim, M. M. R.] Univ Fed Campina Grande, Dept Obstet & Gynecol, Paraiba, Brazil.
   [Almeida, T.; Barros, A.] Inst Materno Infantil Pernambuco, Escola Pernambucana Saude, Recife, PE, Brazil.
RP de Orange, FA (corresponding author), Secretaria Mestrado IMIP, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM orangeflavia@gmail.com
RI Amorim, Melania M/C-5807-2013; Passini Junior, Renato/O-6169-2016
OI Amorim, Melania M/0000-0003-1047-2514; Passini Junior,
   Renato/0000-0001-8247-4549
CR Abrao KC, 2009, OBSTET GYNECOL, V113, P41, DOI 10.1097/AOG.0b013e31818f5eb6
   American College of Obstetrics and Gynecology Committee on Practice Bulletins-Obstetrics, 2003, Obstet Gynecol, V102, P1445
   Anim-Somuah M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000331.pub2
   Anim-Somuah M, 2010, COCHRANE DB SYST REV, V12
   Brow C S, 2000, CRNA, V11, P51
   CAMANN WR, 1991, BRIT J ANAESTH, V67, P565, DOI 10.1093/bja/67.5.565
   Chang Ching-Yi, 2006, Hu Li Za Zhi, V53, P98
   Davis CS, 2002, STAT METHODS ANAL RE
   Fernandez-Guisasola J, 2005, Rev Esp Anestesiol Reanim, V52, P217
   Friedman LM, 1999, FUNDAMENTALS CLIN TR, P94
   FUSI L, 1989, LANCET, V1, P1250, DOI 10.1016/S0140-6736(89)92341-6
   Glosten B, 1998, ACTA ANAESTH SCAND, V42, P442, DOI 10.1111/j.1399-6576.1998.tb05139.x
   Goetzl Laura, 2003, J Perinatol, V23, P457, DOI 10.1038/sj.jp.7210967
   GOODLIN RC, 1982, AM J OBSTET GYNECOL, V143, P97, DOI 10.1016/0002-9378(82)90689-5
   Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE
   Herbst A, 1997, BRIT J OBSTET GYNAEC, V104, P363, DOI 10.1111/j.1471-0528.1997.tb11469.x
   Howell CJ, 2005, COCHRANE DB SYST REV, V4
   Lachin JM, 2000, CONTROL CLIN TRIALS, V21, P167, DOI 10.1016/S0197-2456(00)00046-5
   Lavender T, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005461.pub2
   Lieberman E, 2000, PEDIATRICS, V106, P983, DOI 10.1542/peds.106.5.983
   Lieberman E, 1997, PEDIATRICS, V99, P415, DOI 10.1542/peds.99.3.415
   Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X
   Nageotte MP, 1997, NEW ENGL J MED, V337, P1715, DOI 10.1056/NEJM199712113372402
   Petrova A, 2001, OBSTET GYNECOL, V98, P20, DOI 10.1016/S0029-7844(01)01361-8
   Philip J, 1999, ANESTHESIOLOGY, V90, P1271, DOI 10.1097/00000542-199905000-00008
   Sharma S K, 2000, Curr Opin Anaesthesiol, V13, P257, DOI 10.1097/00001503-200006000-00003
   Sharma SK, 2002, ANESTHESIOLOGY, V96, P546, DOI 10.1097/00000542-200203000-00007
   Simmons SW, 2007, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003401.PUB2
   Taghinejad H, 2010, WOMENS HEALTH, V6, P377, DOI [10.2217/whe.10.15, 10.2217/WHE.10.15]
   Thierrin L, 2005, J Gynecol Obstet Biol Reprod (Paris), V34, P423
   Tortosa JC, 2003, BRIT J ANAESTH, V91, P532, DOI 10.1093/bja/aeg214
   Tsen LC, 1999, ANESTHESIOLOGY, V91, P920, DOI 10.1097/00000542-199910000-00010
   Viscomi CM, 2000, REGION ANESTH PAIN M, V25, P549, DOI 10.1053/rapm.2000.8932
   World Health Organization, 2000, IMPAC INT MAN PREGN
   World Health Organization, 1996, CAR NORM BIRTH PRACT
   Yancey MK, 2001, OBSTET GYNECOL, V98, P763, DOI 10.1016/S0029-7844(01)01537-X
   Yokoe DS, 2001, EMERG INFECT DIS, V7, P837
NR 37
TC 15
Z9 15
U1 0
U2 4
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0007-0912
EI 1471-6771
J9 BRIT J ANAESTH
JI Br. J. Anaesth.
PD NOV
PY 2011
VL 107
IS 5
BP 762
EP 768
DI 10.1093/bja/aer218
PG 7
WC Anesthesiology
SC Anesthesiology
GA 834RN
UT WOS:000295981100016
PM 21743067
OA Bronze
DA 2020-12-01
ER

PT J
AU Alves, JG
   Sarinho, F
   Barros, V
   Amorim, MM
AF Alves, Joao G.
   Sarinho, Felipe
   Barros, Vivianne
   Amorim, Melania M.
TI A Measurement Model of Infants Physical Activity Using Pedometer
SO JOURNAL OF DEVELOPMENTAL ORIGINS OF HEALTH AND DISEASE
LA English
DT Meeting Abstract
C1 [Alves, Joao G.; Sarinho, Felipe; Amorim, Melania M.] Inst Med Integral Prof Fernando Figueira IMIP, Pernambuco, Brazil.
   [Barros, Vivianne] Univ Fed Paraiba, Joao Pessoa, Paraiba, Brazil.
RI Amorim, Melania M/C-5807-2013; Alves, Joao G/J-6483-2013
OI Amorim, Melania M/0000-0003-1047-2514; Alves, Joao G/0000-0002-9170-0808
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CAMBRIDGE UNIV PRESS
PI CAMBRIDGE
PA EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND
SN 2040-1744
J9 J DEV ORIG HLTH DIS
JI J. Dev. Orig. Health Dis.
PD SEP
PY 2011
VL 2
SU 1
BP S64
EP S64
PG 1
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA 837CK
UT WOS:000296168500213
DA 2020-12-01
ER

PT J
AU Porto, AMF
   Coutinho, IC
   Correia, JB
   Amorim, MMR
AF Feitosa Porto, Ana Maria
   Coutinho, Isabela Cristina
   Correia, Jailson Barros
   Ramos Amorim, Melania Maria
TI Effectiveness of Antenatal Corticosteroids in Reducing Respiratory
   Disorders in Late Preterm Infants: Randomized Clinical Trial EDITORIAL
   COMMENT
SO OBSTETRICAL & GYNECOLOGICAL SURVEY
LA English
DT Editorial Material
C1 [Feitosa Porto, Ana Maria; Coutinho, Isabela Cristina; Correia, Jailson Barros; Ramos Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Porto, AMF (corresponding author), Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
CR 2005, BMJ, V331, P662
NR 1
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0029-7828
J9 OBSTET GYNECOL SURV
JI Obstet. Gynecol. Surv.
PD AUG
PY 2011
VL 66
IS 8
BP 473
EP 474
DI 10.1097/OGX.0b013e31823520c2
PG 2
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 842MZ
UT WOS:000296604900005
DA 2020-12-01
ER

PT J
AU Porto, AMF
   Coutinho, IC
   Correia, JB
   Amorim, MMR
AF Feitosa Porto, Ana Maria
   Coutinho, Isabela Cristina
   Correia, Jailson Barros
   Ramos Amorim, Melania Maria
TI Effectiveness of antenatal corticosteroids in reducing respiratory
   disorders in late preterm infants: randomised clinical trial
SO BMJ-BRITISH MEDICAL JOURNAL
LA English
DT Article
ID ELECTIVE CESAREAN-SECTION; DISTRESS-SYNDROME; TRANSIENT TACHYPNEA;
   GESTATIONAL-AGE; TERM NEWBORNS; PREVENTION; MORBIDITY; BIRTH;
   BETAMETHASONE; METAANALYSIS
AB Objectives To determine the effectiveness of corticosteroids in reducing respiratory disorders in infants born at 34-36 weeks' gestation.
   Design Randomised triple blind clinical trial.
   Setting A large tertiary teaching hospital in northeast of Brazil.
   Participants Women at 34-36 weeks of pregnancy at risk of imminent premature delivery.
   Interventions Betamethasone 12 mg or placebo intramuscularly for two consecutive days.
   Main outcomes measures Primary outcome was the incidence of respiratory disorders (respiratory distress syndrome and transient tachypnoea of the newborn). Secondary outcomes included the need for ventilatory support, neonatal morbidity, and duration of stay in hospital.
   Results 320 women were randomised, 163 of whom were assigned to the treatment group and 157 to the controls. Final analysis included 143 and 130 infants, respectively. The rate of respiratory distress syndrome was low (two (1.4%) in the corticosteroid group; one (0.8%) in the placebo group; P=0.54), while the rate of transient tachypnoea was high in both groups (34 (24%) v 29 (22%); P=0.77). There was no reduction in the risk of respiratory morbidity with corticosteroid use even after adjustment for subgroups of gestational age (34-34(+6) weeks, 35-35(+6) weeks, and >= 36 weeks). The adjusted risk of respiratory morbidity was 1.12 (95% confidence interval 0.74 to 1.70). The need for ventilatory support was around 20% in both groups. There was no difference in neonatal morbidity (88 (62%) v 93 (72%); P=0.08) or in the duration of stay in hospital between the two groups (5.12 v 5.22 days; P=0.87). Phototherapy for jaundice was required less often in babies whose mothers received corticosteroids (risk ratio 0.63, 0.44 to 0.91).
   Conclusions Antenatal treatment with corticosteroids at 34-36 weeks of pregnancy does not reduce the incidence of respiratory disorders in newborn infants.
C1 [Feitosa Porto, Ana Maria] Inst Med Integral Prof Fernando Figueira, Med Residency Programme Gynaecol & Obstet, Recife, PE, Brazil.
   [Ramos Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira, Postgrad Programme Maternal & Child Hlth, Recife, PE, Brazil.
RP Amorim, MMR (corresponding author), Rua Neuza Borborema de Souza 300, BR-58406120 Campina Grande, PB, Brazil.
EM melamorim@uol.com.br
RI Amorim, Melania M/C-5807-2013; Correia, Jailson B./J-4331-2015
OI Amorim, Melania M/0000-0003-1047-2514; 
FU Instituto de Medicina Integral Prof Fernando Figueira-IMIP, Recife,
   Pernambuco, Brazil
FX This study was supported by the Instituto de Medicina Integral Prof
   Fernando Figueira-IMIP (www.imip.org.br), a private, not for profit
   healthcare organisation based in Recife, Pernambuco, Brazil, where the
   study was carried out. The institute did not interfere with study design
   or analysis and the funding covered all study expenses, including
   purchase of the drug and placebo.
CR Amorim MMR, 1999, AM J OBSTET GYNECOL, V180, P1283, DOI 10.1016/S0002-9378(99)70630-7
   BALLARD PL, 1995, AM J OBSTET GYNECOL, V173, P254, DOI 10.1016/0002-9378(95)90210-4
   Bonanno C, 2009, AM J OBSTET GYNECOL, V200, P448, DOI 10.1016/j.ajog.2008.12.011
   CROWLEY PA, 1995, AM J OBSTET GYNECOL, V173, P322, DOI 10.1016/0002-9378(95)90222-8
   Davidoff MJ, 2006, SEMIN PERINATOL, V30, P8, DOI 10.1053/j.semperi.2006.01.009
   Escobar GJ, 2006, SEMIN PERINATOL, V30, P28, DOI 10.1053/j.semperi.2006.01.005
   Fuchs K, 2006, CLIN PERINATOL, V33, P793, DOI 10.1016/j.clp.2006.09.010
   GAMSU HR, 1989, BRIT J OBSTET GYNAEC, V96, P401, DOI 10.1111/j.1471-0528.1989.tb02413.x
   Guglani L, 2008, PEDIATR REV, V29, pE59, DOI 10.1542/pir.29-11-e59
   Helve Otto, 2009, Neonatology, V95, P347, DOI 10.1159/000209300
   Jain L, 2006, SEMIN PERINATOL, V30, P34, DOI 10.1053/j.semperi.2006.01.006
   Jain L, 2008, AM J PERINAT, V25, P75, DOI 10.1055/s-2007-1022471
   Kramer MS, 2000, JAMA-J AM MED ASSOC, V284, P843, DOI 10.1001/jama.284.7.843
   Kurl S, 1997, CLIN PEDIATR, V36, P285, DOI 10.1177/000992289703600506
   LIGGINS GC, 1972, PEDIATRICS, V50, P515
   Mac Bird T, 2010, PEDIATRICS, V126, pE311, DOI 10.1542/peds.2009-2869
   Riskin A, 2005, AM J PERINAT, V22, P377, DOI 10.1055/s-2005-872594
   Roberts D, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004454.pub2
   Santos IS, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-71
   SINCLAIR JC, 1995, AM J OBSTET GYNECOL, V173, P335, DOI 10.1016/0002-9378(95)90223-6
   Sotiriadis A, 2009, COCHRANE DB SYST REV, V4
   Stutchfield P, 2005, BMJ-BRIT MED J, V331, P662, DOI 10.1136/bmj.38547.416493.06
   Tomashek KM, 2006, SEMIN PERINATOL, V30, P61, DOI 10.1053/j.semperi.2006.02.003
   Ventolini G, 2008, AM J PERINAT, V25, P79, DOI 10.1055/s-2007-1022470
   Wang ML, 2004, PEDIATRICS, V114, P372, DOI 10.1542/peds.114.2.372
   Young PC, 2007, PEDIATRICS, V119, pE659, DOI 10.1542/peds.2006-2486
   Zanardo V, 2004, ACTA PAEDIATR, V93, P643, DOI [10.1111/j.1651-2227.2004.tb02990.x, 10.1080/08035250410026671]
NR 27
TC 73
Z9 79
U1 0
U2 8
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1756-1833
J9 BMJ-BRIT MED J
JI BMJ-British Medical Journal
PD APR 12
PY 2011
VL 342
AR d1696
DI 10.1136/bmj.d1696
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 752UV
UT WOS:000289721300002
PM 21487057
OA Green Published, Other Gold
DA 2020-12-01
ER

PT J
AU Leite, SRRF
   Amorim, MMR
   Sereno, PFB
   Leite, TNF
   Ferreira, JAC
   Ximenes, RAA
AF Leite, S. R. R. F.
   Amorim, M. M. R.
   Sereno, P. F. B.
   Leite, T. N. F.
   Ferreira, J. A. C.
   Ximenes, R. A. A.
TI Randomized clinical trial comparing the efficacy of the vaginal use of
   metronidazole with a Brazilian pepper tree (Schinus) extract for the
   treatment of bacterial vaginosis
SO BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH
LA English
DT Article
DE Bacterial vaginosis; Gardnerella vaginalis; Brazilian pepper tree;
   Metronidazole vaginal gel
ID GRAM STAIN; GEL; CLINDAMYCIN; DIAGNOSIS; THERAPY; WOMEN
AB A 7.4% vaginal extract of the Brazilian pepper tree (Schinus terebinthifolius Raddi) was compared with 0.75% vaginal metronidazole, both manufactured by the Hebron Laboratory, for the treatment of bacterial vaginosis, used at bedtime for 7 nights. The condition was diagnosed using the combined criteria of Amsel and Nugent in two groups of 140 and 137 women, aged between 18 and 40 years. Intention-to-treat analysis was performed. Women were excluded from the study if they presented delayed menstruation, were pregnant, were using or had used any topical or systemic medication, presented any other vaginal infections, presented hymen integrity, or if they reported any history suggestive of acute pelvic inflammatory disease. According to Amsel's criteria separately, 29 patients (21.2%) treated with the extract and 87 (62.1%) treated with metronidazole were considered to be cured (P < 0.001). According to Nugent's score separately, 19 women (13.9%) treated with the extract and 79 (56.4%) treated with metronidazole were considered to be cured (P < 0.001). Using the two criteria together, the so-called total cure was observed in 17 women (12.4%) treated with the extract and in 79 women (56.4%) treated with metronidazole (P < 0.001). In conclusion, the cure rate for bacterial vaginosis using a vaginal gel from a pepper tree extract was lower than the rate obtained with metronidazole gel, while side effects were infrequent and non-severe in both groups.
C1 [Leite, S. R. R. F.; Ximenes, R. A. A.] Univ Fed Pernambuco, Dept Posgrad Med Trop, Recife, PE, Brazil.
   [Amorim, M. M. R.] Inst Med Integral Prof Fernando Figueira, Posgrad Saude Maternoinfantil, Recife, PE, Brazil.
   [Amorim, M. M. R.] Inst Pesquisa Prof Joaquim Amorim Neto, Campina Grande, PB, Brazil.
   [Ferreira, J. A. C.] Fac Pernambucana Saude, CNPq, PIBIC, Recife, PE, Brazil.
RP Leite, SRRF (corresponding author), Rua Felix de Brito & Melo 854,Apto 1302, BR-51020260 Recife, PE, Brazil.
EM soniarfigueiredo@uol.com.br
RI Amorim, Melania M/C-5807-2013; Iats, Inct/K-2300-2013
OI Amorim, Melania M/0000-0003-1047-2514; 
FU Hebron Laboratory
FX Research partially supported by Hebron Laboratory by supplying the
   medication used
CR Amorim Melania Maria Ramos de, 2003, Rev. Bras. Ginecol. Obstet., V25, P95, DOI 10.1590/S0100-72032003000200004
   AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9
   Brotman RM, 2007, J PEDIATR ADOL GYNEC, V20, P225, DOI 10.1016/j.jpag.2006.11.009
   Cauci S, 2002, AM J OBSTET GYNECOL, V187, P877, DOI 10.1067/mob.2002.127454
   *CDCP, 2006, MMWR-MORBID MORTAL W, V55, P50
   Costerton W, 2003, J CLIN INVEST, V112, P1466, DOI 10.1172/JCI200320365
   Drago L, 2007, J ALTERN COMPLEM MED, V13, P435, DOI 10.1089/acm.2006.6040
   FERRIS DG, 1995, J FAM PRACTICE, V41, P443
   Gutman RE, 2005, OBSTET GYNECOL, V105, P551, DOI 10.1097/01.AOG.0000145752.97999.67
   HILLIER SL, 1993, OBSTET GYNECOL, V81, P963
   Larsson PG, 2005, APMIS, V113, P305, DOI 10.1111/j.1600-0463.2005.apm_113501.x
   NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991
   Nyirjesy P, 2008, INFECT DIS CLIN N AM, V22, P637, DOI 10.1016/j.idc.2008.05.002
   Nyirjesy P, 2007, SEX TRANSM DIS, V34, P197, DOI 10.1097/01.olq.0000235152.98601.d7
   O'Brien RF, 2005, CURR OPIN PEDIATR, V17, P473, DOI 10.1097/01.mop.0000170516.35272.45
   Patterson JL, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.027
   Pereira L, 2005, AM J OBSTET GYNECOL, V193, P746, DOI 10.1016/j.ajog.2005.01.069
   SANTOS LC, 2002, FEMINA, V30, P339
   Simoes CMO, 1988, PLANTAS MED POPULAR
   Simoes JA, 2006, BRIT J CLIN PHARMACO, V61, P211, DOI 10.1111/j.1365-2125.2005.02550.x
   Sobel JD, 2006, AM J OBSTET GYNECOL, V194, P1283, DOI 10.1016/j.ajog.2005.11.041
   Sobel JD, 2005, INFECT DIS CLIN N AM, V19, P387, DOI 10.1016/j.idc.2005.03.001
   SPIEGEL CA, 1983, J CLIN MICROBIOL, V18, P170, DOI 10.1128/JCM.18.1.170-177.1983
   Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039
   Wilson J, 2004, SEX TRANSM INFECT, V80, P8, DOI 10.1136/sti.2002.002733
   Yudin MH, 2005, CLIN PERINATOL, V32, P617, DOI 10.1016/j.clp.2005.05.007
NR 26
TC 12
Z9 13
U1 0
U2 9
PU ASSOC BRAS DIVULG CIENTIFICA
PI RIBEIRAO PRETO
PA FACULDADE MEDICINA, CASA 10, 14049 RIBEIRAO PRETO, RIBEIRAO PRETO, SP
   14049, BRAZIL
SN 0100-879X
EI 1414-431X
J9 BRAZ J MED BIOL RES
JI Brazilian J. Med. Biol. Res.
PD MAR
PY 2011
VL 44
IS 3
BP 245
EP 252
DI 10.1590/S0100-879X2011007500003
PG 8
WC Biology; Medicine, Research & Experimental
SC Life Sciences & Biomedicine - Other Topics; Research & Experimental
   Medicine
GA 732YB
UT WOS:000288224500012
PM 21243318
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Heraclio, SD
   de Souza, ASR
   Pinto, FRG
   Amorim, MMR
   Oliveira, MD
   de Souza, PRE
AF Heraclio, Sandra de Andrade
   Rolland de Souza, Alex Sandro
   Gomes Pinto, Fatima Regina
   Ramos Amorim, Melania Maria
   Oliveira, Micheline de Lucena
   Eleuterio de Souza, Paulo Roberto
TI Agreement between Methods for Diagnosing HPV-Induced Anal Lesions in
   Women with Cervical Neoplasia
SO ACTA CYTOLOGICA
LA English
DT Article
DE Anal cancer; Anal intraepithelial neoplasia; Anoscopy; Cervical
   intraepithelial neoplasia; Cytology; Human papillomavirus
ID SQUAMOUS INTRAEPITHELIAL LESIONS; HUMAN-PAPILLOMAVIRUS INFECTION;
   RISK-FACTORS; FOLLOW-UP; CYTOLOGY; PREVALENCE; CANCER; HIV; DYSPLASIA;
   ABNORMALITIES
AB Objective: To evaluate agreement between 3 methods for screening anal intraepithelial lesions: anal cytology, anoscopy and human papillomavirus (HPV) detection by PCR. Study Design: This prospective, cross-sectional study screened 324 women with cervical neoplasia for anal neoplasia. Agreement between methods was calculated using the kappa coefficient. Results: Of 324 anal cytologies performed, 31.5% (n = 102) were found to be abnormal: low-grade anal lesions were detected in 19.1% (n = 62) of cases, high-grade lesions in 3.1% (n = 10) and atypical squamous cells of undetermined significance in 9.3% (n = 30). With respect to the biopsies, 25.7% (n = 20) were positive, consisting of 7 cases of HPV infection, 5 anal intraepithelial neoplasia (AIN) grade 1, 6 AIN grade 2, and 2 AIN grade 3. Twenty-one samples (6.5%) were inadequate for HPV analysis. Of the 303 adequate samples, 84.2% (n = 255) tested positive for HPV. Agreement between cytology and anoscopy was fair (kappa = 0.31). Agreement between PCR for HPV and cytology was slight (kappa = 0.08) and no agreement was found between PCR for HPV and anoscopy (kappa = 0.00). Conclusion: Agreement between the different methods of diagnosing HPV-induced anal lesions is slight to fair; however, anal cytology permits identification of cases in which lesions are present, allowing them to be referred for anoscopy and biopsy. Copyright (C) 2011 S. Karger AG, Basel
C1 [Heraclio, Sandra de Andrade; Gomes Pinto, Fatima Regina] Univ Fed Pernambuco, Dept Lower Genital Tract Pathol, Womens Healthcare Ctr, Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Heraclio, Sandra de Andrade; Gomes Pinto, Fatima Regina] Univ Fed Pernambuco, Cytopathol Div, Pernambuco Publ Hlth Lab, Recife, PE, Brazil.
   [Ramos Amorim, Melania Maria] Univ Fed Pernambuco, Maternal & Child Healthcare Dept, Recife, PE, Brazil.
   [Rolland de Souza, Alex Sandro] Univ Fed Pernambuco, Dept Obstet & Gynecol & Fetal Med, Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Oliveira, Micheline de Lucena] Univ Fed Pernambuco, Pernambuco Womens Specialized Clin Anal Lab LACEN, Recife, PE, Brazil.
   [Eleuterio de Souza, Paulo Roberto] Univ Fed Pernambuco, Dept Biol, Recife, PE, Brazil.
RP Heraclio, SD (corresponding author), Av Dr Malaquias 195-2701, BR-50070550 Recife, PE, Brazil.
EM sandra_heraclio@hotmail.com
RI Amorim, Melania M/C-5807-2013; Souza, Alex Sandro Rolland/AAG-2471-2019
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052; Souza, Paulo/0000-0002-9186-9849
CR *ASS BRAS GEN, NOM LAUD COLP
   Chiao EY, 2006, CLIN INFECT DIS, V43, P223, DOI 10.1086/505219
   CLANCY CM, GUIDE CLIN PREVENTIV
   Colquhoun P, 2003, DIS COLON RECTUM, V46, P1332, DOI 10.1007/s10350-004-6744-5
   Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365
   Damay A, 2010, J MED VIROL, V82, P592, DOI 10.1002/jmv.21732
   De Vuyst H, 2009, INT J CANCER, V124, P1626, DOI 10.1002/ijc.24116
   Evans HS, 2003, GYNECOL ONCOL, V90, P131, DOI 10.1016/S0090-8258(03)00231-2
   Fox PA, 2005, SEX TRANSM INFECT, V81, P142, DOI 10.1136/sti.2003.008318
   Friedlander MA, 2004, CANCER CYTOPATHOL, V102, P19, DOI 10.1002/cncr.11888
   Fritsch H, 2007, ANAT REC, V290, P1449, DOI 10.1002/ar.20589
   Giraldo P, 2009, EUR J OBSTET GYN R B, V142, P73, DOI 10.1016/j.ejogrb.2008.09.014
   Goldie SJ, 1999, JAMA-J AM MED ASSOC, V281, P1822, DOI 10.1001/jama.281.19.1822
   Hernandez BY, 2005, CANCER EPIDEM BIOMAR, V14, P2550, DOI 10.1158/1055-9965.EPI-05-0460
   Hessol NA, 2009, AIDS, V23, P59, DOI 10.1097/QAD.0b013e32831cc101
   Holly EA, 2001, J NATL CANCER I, V93, P843, DOI 10.1093/jnci/93.11.843
   Jay N, 1997, DIS COLON RECTUM, V40, P919, DOI 10.1007/BF02051199
   Johnson LG, 2004, CANCER-AM CANCER SOC, V101, P281, DOI 10.1002/cncr.20364
   Kreuter A, 2005, J AM ACAD DERMATOL, V52, P603, DOI 10.1016/j.jaad.2004.11.026
   LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310
   Lytwyn A, 2005, CANCER-AM CANCER SOC, V103, P1447, DOI 10.1002/cncr.20927
   Mathews Christopher, 2007, Open AIDS J, V1, P11, DOI 10.2174/1874613600701010011
   Mathews WC, 2004, JAIDS-J ACQ IMM DEF, V37, P1610, DOI 10.1097/00126334-200412150-00014
   *MED ADV SECR, 2007, AN DYSPL SCREEN EV B
   Moscicki AB, 1999, CANCER-AM CANCER SOC, V85, P1139, DOI 10.1002/(SICI)1097-0142(19990301)85:5<1139::AID-CNCR18>3.0.CO;2-8
   Moscicki AB, 1999, CANCER EPIDEM BIOMAR, V8, P173
   Nahas CSR, 2009, DIS COLON RECTUM, V52, P1854, DOI 10.1007/DCR.0b013e3181b98f36
   Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009
   Nathan M, 2010, AIDS, V24, P373, DOI 10.1097/QAD.0b013e328333ab8e
   Ogilvie JW, 2008, J AM COLL SURGEONS, V207, P914, DOI 10.1016/j.jamcollsurg.2008.08.005
   Park IU, 2009, GYNECOL ONCOL, V114, P399, DOI 10.1016/j.ygyno.2009.05.008
   Salvia PND, 2004, INT J GYNECOL CANCER, V14, P126, DOI 10.1111/j.1048-891x.2004.014030.x
   Scholefield JH, 2005, BRIT J SURG, V92, P1133, DOI 10.1002/bjs.4994
   SCHOLEFIELD JH, 1992, LANCET, V340, P1271, DOI 10.1016/0140-6736(92)92961-E
   Scholefield JH, 1998, CYTOPATHOLOGY, V9, P15
   Smith RA, 2004, CA-CANCER J CLIN, V54, P41, DOI 10.3322/canjclin.54.1.41
   Sobhani I, 2001, GASTROENTEROLOGY, V120, P857, DOI 10.1053/gast.2001.22446
   Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114
   SONNEX C, 1991, GENITOURIN MED, V67, P21
   Vajdic CM, 2005, SEX TRANSM INFECT, V81, P415, DOI 10.1136/sti.2004.014407
   Veo CAR, 2008, EUR J OBSTET GYN R B, V140, P103, DOI 10.1016/j.ejogrb.2008.02.024
NR 41
TC 7
Z9 10
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0001-5547
EI 1938-2650
J9 ACTA CYTOL
JI Acta Cytol.
PY 2011
VL 55
IS 2
BP 218
EP 224
DI 10.1159/000320922
PG 7
WC Pathology
SC Pathology
GA 725PI
UT WOS:000287657400018
PM 21325811
DA 2020-12-01
ER

PT J
AU Souza, AR
   Amorim, MR
   Costa, AAR
   Neto, CN
AF Souza, Alex R.
   Amorim, Melania R.
   Costa, Aurelio A. R.
   Neto, Carlos N.
TI ANTIHYPERTENSIVE TREATMENT IN PREGNANCY
SO ACTA MEDICA PORTUGUESA
LA Portuguese
DT Review
ID PHARMACOLOGICAL-TREATMENT; HYPERTENSIVE DISORDERS; NIFEDIPINE; CHILDREN
AB ANTIHYPERTENSIVE TREATMENT IN PREGNANCY Pregnancy hypertensive disorders represent a frequent gestational pathology. It is one of the most important causes of maternal demise and perinatal morbidity/mortality in the world. Antihypertensive treatment is part of a vast therapeutic arsenal used for prevention of severe complications. However, data from literature research have been controversial about benefits of antihypertensive treatment. We performed a literature review about antihypertensive treatment in severe pre-eclampsia, describing drugs' pharmacological particularities and scientific evidences about their efficacy and safety. It is not controversial that treatment of hypertensive emergency must be instituted. The ideal medication used in those cases is not defined, therefore the real benefits of maintenance antihypertensive treatment in pre-eclampsia remains unclear.
C1 [Souza, Alex R.; Amorim, Melania R.; Costa, Aurelio A. R.; Neto, Carlos N.] Inst Mat Infantil Prof Fernando Figueira, Serv Ginecol & Obstet, Recife, PE, Brazil.
RP Souza, AR (corresponding author), Inst Mat Infantil Prof Fernando Figueira, Serv Ginecol & Obstet, Recife, PE, Brazil.
RI Amorim, Melania M/C-5807-2013; Souza, Alex Sandro Rolland/G-3446-2013
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052
CR Abalos E, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002252.pub2, 10.1002/14651858.CD002252.pub3]
   *ACOG, 2002, ACOG PRACT B, V33, P1
   BARRETO S, 2003, REV HOSP MATERN INFA, V22, P116
   Barrilleaux PS, 2002, CLIN OBSTET GYNECOL, V45, P22, DOI 10.1097/00003081-200203000-00005
   Bortolus R, 2000, BRIT J OBSTET GYNAEC, V107, P792, DOI 10.1111/j.1471-0528.2000.tb13342.x
   Churchill D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004451.pub2
   COLLINS R, 1985, BMJ-BRIT MED J, V290, P17, DOI 10.1136/bmj.290.6461.17
   DULEY L, 2007, COCHRANE LIB
   Easterling TR, 2001, OBSTET GYNECOL, V98, P427, DOI 10.1016/S0029-7844(01)01477-6
   Elhassan E M, 2002, East Afr Med J, V79, P172
   FENAKEL K, 1991, OBSTET GYNECOL, V77, P331
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Gilstrap LC, 2001, OBSTET GYNECOL, V98, P144
   JAYAWARDANA J, 1994, CEYLON MED J, V9, P87
   MAGEE LA, 2007, COCHRANE LIB
   *MIN SAUD SECR POL, 2002, AR TECN SAUD MULH MA
   MULROW C, 2007, COCHRANE LIB
   Parazzini F, 1998, BRIT J OBSTET GYNAEC, V105, P718
   Phillips B, 1998, LEVELS EVIDENCE
   Rey E, 1997, CAN MED ASSOC J, V157, P1245
   Romero JP, 2003, AN FM, V64, P43
   Rosenthal T, 2002, J HUM HYPERTENS, V16, P293, DOI 10.1038/sj.jhh.1001400
   Sibai BM, 2002, OBSTET GYNECOL, V100, P369, DOI 10.1016/S0029-7844(02)02128-2
   Smith P, 2000, BRIT J OBSTET GYNAEC, V107, P299, DOI 10.1111/j.1471-0528.2000.tb13222.x
   Solomon CG, 2006, ENDOCRIN METAB CLIN, V35, P157, DOI 10.1016/j.ecl.2005.09.003
   Sorensen HT, 2001, ACTA OBSTET GYN SCAN, V80, P397, DOI 10.1034/j.1600-0412.2001.d01-4.x
   Yankowitz J, 2004, J PERINAT NEONAT NUR, V18, P230, DOI 10.1097/00005237-200407000-00006
NR 27
TC 5
Z9 5
U1 0
U2 0
PU ORDEM MEDICOS
PI LISBON
PA AV ALMIRANTE GAGO COUTINHO, 151, LISBON, 1749-084, PORTUGAL
SN 1646-0758
J9 ACTA MEDICA PORT
JI Acta Medica Port.
PD JAN-FEB
PY 2010
VL 23
IS 1
BP 77
EP 84
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA 572VO
UT WOS:000275862200008
PM 20353709
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Souza, ASR
   Amorim, MMR
   Cristina, I
   Coutinho, ANC
   Lima, MMD
   Neto, CN
   Figueroa, JN
AF Rolland Souza, Alex Sandro
   Ramos Amorim, Melania Maria
   Cristina, Isabela
   Coutinho, A. N. C.
   de Souza Lima, Marcelo Marques
   Noronha Neto, Carlos
   Figueroa, Jose Natal
TI Effect of the Loading Dose of Magnesium Sulfate (MgSO4) on the
   Parameters of Doppler Flow Velocity in the Uterine, Umbilical and Middle
   Cerebral Arteries in Severe Preeclampsia
SO HYPERTENSION IN PREGNANCY
LA English
DT Article
ID BLOOD-FLOW; PREGNANT-WOMEN
AB Objective. To evaluate Doppler velocimetry parameters (resistance index [RI], pulsatility index [PI] and systolic/diastolic [S/D] ratio) of maternal-fetal circulation before and after magnesium sulfate administration in pregnant women with severe preeclampsia. Methods. A prospective observational cohort analysis of 40 women with severe preeclampsia was performed. Doppler ultrasonography scans were performed before and 20 minutes after intravenous administration of magnesium sulfate. Maternal parameters such as heart rate, and systolic, diastolic and mean arterial pressure were recorded. Doppler flow velocity parameters (RI, PI and S/D ratio) were evaluated in the uterine, umbilical and middle cerebral arteries. The different mean values obtained before and after magnesium sulphate were analyzed using the paired t-test. Results. There was a statistically significant increase in mean maternal heart rate and a statistically significant decrease in systolic, diastolic and mean maternal blood pressure before and after administration of magnesium sulphate (p < 0.001). Resistance index decreased in the umbilical (p = 0.003; 95% CI: 0.008 - 0.03) and middle cerebral artery (p = 0.001; 95% CI: 0.01 - 0.05) and in both uterine arteries. Likewise, there was a significant reduction in the PI and S/D ratio in all the arteries assessed. Conclusions. Maternal administration of intravenous magnesium sulfate in preeclampsia leads to an increase in maternal heart rate and a decrease in systolic, diastolic and mean arterial blood pressure. A reduction in the resistance index, pulsatility index and S/D ratio was recorded in the uterine, umbilical and cerebral arteries.</.
C1 [Rolland Souza, Alex Sandro; Ramos Amorim, Melania Maria; Cristina, Isabela; Coutinho, A. N. C.; de Souza Lima, Marcelo Marques; Noronha Neto, Carlos; Figueroa, Jose Natal] Inst Med Integral Prof Fernando Figueira IMIP, Recife, PE, Brazil.
RP Souza, ASR (corresponding author), Av Rui Barbosa 579,Apto 406, BR-52011040 Recife, PE, Brazil.
EM alexrolland@uol.com.br
RI Souza, Alex Sandro Rolland/AAG-2471-2019; Amorim, Melania M/C-5807-2013
OI Souza, Alex Sandro Rolland/0000-0001-7039-2052; Amorim, Melania
   M/0000-0003-1047-2514
CR ABRAMOWICZ JS, 1989, J ULTRAS MED, V8, P219
   AYROMLOOI J, 1982, PEDIATR PHARMACOL, V2, P305
   BARRETO S, 2003, REV HOSP MATERN INFA, V22, P116
   BELFORT MA, 1993, ACTA OBSTET GYN SCAN, V72, P526, DOI 10.3109/00016349309058156
   Belfort MA, 1999, AM J OBSTET GYNECOL, V180, P601, DOI 10.1016/S0002-9378(99)70261-9
   BELFORT MA, 1995, AM J OBSTET GYNECOL, V172, P1395, DOI 10.1016/0002-9378(95)90468-9
   Costa Aurélio Antônio Ribeiro, 2002, Rev. Bras. Ginecol. Obstet., V24, P455, DOI 10.1590/S0100-72032002000700005
   COTTON DB, 1984, AM J OBSTET GYNECOL, V148, P162, DOI 10.1016/S0002-9378(84)80169-6
   Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0
   DULEY L, 2006, COCHRANE LIB
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Gilstrap III LC, 2002, ACOG PRACTICE B, V33, P1
   Gosling R., 1975, ARTERIES VEINS, P61
   Houlihan DD, 2004, J PERINAT MED, V32, P315, DOI 10.1515/JPM.2004.058
   KEELEY MM, 1993, OBSTET GYNECOL, V81, P191
   Kovac CM, 2003, AM J OBSTET GYNECOL, V189, P839, DOI 10.1067/S0002-9378(03)00851-2
   LIN CC, 1988, AM J PERINAT, V5, P208, DOI 10.1055/s-2007-999687
   NASCIMENTO JC, 2001, FEMINA, V29, P673
   POURCELOT L, 1974, VELOCIMETRIE ULTRASO, P213
   Rantonen T, 2001, CRIT CARE MED, V29, P1460, DOI 10.1097/00003246-200107000-00026
   SCARDO JA, 1995, AM J OBSTET GYNECOL, V173, P1249, DOI 10.1016/0002-9378(95)91364-5
   Schauf B, 2004, HYPERTENS PREGNANCY, V23, P331, DOI 10.1081/PRG-200030319
   STUART B, 1980, BRIT J OBSTET GYNAEC, V87, P780, DOI 10.1111/j.1471-0528.1980.tb04613.x
   Touyz R. M., 2003, Molecular Aspects of Medicine, V24, P107, DOI 10.1016/S0098-2997(02)00094-8
NR 24
TC 11
Z9 12
U1 0
U2 2
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1064-1955
EI 1525-6065
J9 HYPERTENS PREGNANCY
JI Hypertens. Pregnancy
PY 2010
VL 29
IS 2
BP 123
EP 134
DI 10.3109/10641950902875772
PG 12
WC Obstetrics & Gynecology; Physiology; Peripheral Vascular Disease
SC Obstetrics & Gynecology; Physiology; Cardiovascular System & Cardiology
GA 581JO
UT WOS:000276518800001
PM 19891531
DA 2020-12-01
ER

PT J
AU Lima, MM
   Diniz, CP
   Souza, ASR
   Porto, AMF
   Amorim, MMR
   Moron, AF
AF Lima, M. M.
   Diniz, C. P.
   Souza, A. S. R.
   Porto, A. M. F.
   Amorim, M. M. R.
   Moron, A. F.
TI Hotelling's test, multiple t-tests, and uterine artery Doppler
   evaluation Reply
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Letter
C1 [Lima, M. M.; Diniz, C. P.; Souza, A. S. R.; Porto, A. M. F.; Amorim, M. M. R.] Prof Fernando Figueira Inst Integrated Med Care I, Recife, PE, Brazil.
   [Moron, A. F.] Fed Univ Sao Paulo UNIFESP, Sao Paulo, Brazil.
RP Lima, MM (corresponding author), Prof Fernando Figueira Inst Integrated Med Care I, Recife, PE, Brazil.
EM mmslnet@terra.com.br
RI Souza, Alex Sandro Rolland/AAG-2471-2019; Amorim, Melania M/C-5807-2013
OI Souza, Alex Sandro Rolland/0000-0001-7039-2052; Amorim, Melania
   M/0000-0003-1047-2514; moron, antonio/0000-0002-7963-1758
CR Davis CS, 2002, STAT METHODS ANAL RE
   Gollo CA, 2008, REV BRAS GINECOL OBS, V30, P5, DOI 10.1590/S0100-72032008000100002
   Haas DM, 2009, OBSTET GYNECOL, V113, P585, DOI 10.1097/AOG.0b013e318199924a
   Lima MMD, 2009, ULTRASOUND OBST GYN, V34, P311, DOI 10.1002/uog.6445
   MAYMON R, 1995, GYNECOL OBSTET INVES, V40, P24, DOI 10.1159/000292296
NR 5
TC 0
Z9 0
U1 0
U2 0
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 0960-7692
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD JAN
PY 2010
VL 35
IS 1
BP 121
EP 123
DI 10.1002/uog.7490
PG 3
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 544SO
UT WOS:000273679800022
OA Bronze
DA 2020-12-01
ER

PT J
AU Lima, MMD
   Souza, ASR
   Diniz, C
   Porto, AMF
   Amorim, MMR
   Moron, AF
AF Lima, M. M. De S.
   Souza, A. S. R.
   Diniz, C.
   Porto, A. M. F.
   Amorim, M. M. R.
   Moron, A. F.
TI Doppler velocimetry of the uterine, umbilical and fetal middle cerebral
   arteries in pregnant women undergoing tocolysis with oral nifedipine
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Article
DE Doppler; middle cerebral artery; nifedipine; obstetric labor; premature;
   tocolysis; ultrasonography; umbilical arteries
ID ANTENATAL CARE; PRETERM BIRTH; PREVENTION; THERAPY; TRIAL
AB Objectives To evaluate Doppler velocimetry (resistance index (RI) and peak systolic velocity (PSV)) in the maternal-fetal circulation before and 5 and 24 h after tocolysis with oral nifedipine.
   Methods This was a prospective, observational, analytic cohort study performed in 47 pregnant women undergoing nifedipine tocolysis, each subject acting as her own control. Doppler assessment of uterine, umbilical and fetal middle cerebral (MCA) arteries was performed before and 5 and 24 h after an initial 20-mg sublingual dose, which was repeated twice at 20-min intervals if contractions failed to diminish. The maintenance dose consisted of 20 mg orally every 6 h for 24 h up to a total of 100-120 mg nifedipine. We analyzed whether there was a time effect and compared values at the different time-points.
   Results The MCA-RI bad decreased significantly after 24 h of tocolysis (0 h = 0.85; 5 h = 0.85; 24 h = 0.81; P = 0.001), with no differences in uterine or umbilical arteries or in the MCA to umbilical artery ratio. The MCA-PSV bad reduced significantly after 5 h (0 h = 41.5 cm/s; 5 h = 34.7 cm/s; P = 0.001), returning close to baseline levels between 5 and 24 h. The PSV increased significantly between 5 and 24 h in the right uterine artery (5 h = 55.1 cm/s; 24 h 65.0 cm/s; P = 0.037) and in the umbilical artery (5 h 28.4 cm/s; 24 h = 33.1 cm/s; P = 0.038).
   Conclusions Nifedipine tocolysis is associated with a reduction in RI in the MCA but not in the uterine or umbilical arteries, a reduction in PSV in the MCA after 5 h but returning to baseline within 24 h, and an increase in PSV between 5 and 24 h in the umbilical and right uterine arteries. Copyright (C) 2009 ISUOG. Published by John Wiley & Sons, Ltd.
C1 [Lima, M. M. De S.; Souza, A. S. R.; Diniz, C.; Porto, A. M. F.; Amorim, M. M. R.] Inst Med Integral Prof Fernando Figueira, Dept Maternal Care, Fetal Med Div, Recife, PE, Brazil.
   [Lima, M. M. De S.; Diniz, C.] Hosp IMIP Dom Malan, Petrolina, PE, Brazil.
   [Lima, M. M. De S.; Diniz, C.; Moron, A. F.] Univ Fed Sao Paulo, Sao Paulo, Brazil.
RP Lima, MMD (corresponding author), Rua Francisco Alves Correia 118, BR-56302515 Petrolina, PE, Brazil.
EM mmslnet@terra.com.br
RI Amorim, Melania M/C-5807-2013; Souza, Alex Sandro Rolland/AAG-2471-2019;
   MORON, ANTONIO F./H-4987-2013
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052; MORON, ANTONIO F./0000-0002-7963-1758
CR ACOG Committee on Practice Bulletins--Obstetrics, 2003, Int J Gynaecol Obstet, V82, P127
   Carvalho Francisco Herlânio C., 2005, Rev. Assoc. Med. Bras., V51, P221, DOI 10.1590/S0104-42302005000400019
   Economy KE, 2001, SEMIN PERINATOL, V25, P264, DOI 10.1053/sper.2001.27165
   Garcia-Velasco JA, 1998, INT J GYNECOL OBSTET, V61, P239, DOI 10.1016/S0020-7292(98)00053-8
   Gilbert WM, 2006, BJOG-INT J OBSTET GY, V113, P4, DOI 10.1111/j.1471-0528.2006.01117.x
   Guclu S, 2006, ULTRASOUND OBST GYN, V27, P403, DOI 10.1002/uog.2728
   Guclu S, 2004, ULTRASOUND OBST GYN, V24, P761, DOI 10.1002/uog.1770
   Khan-Neelofur D, 1998, PAEDIATR PERINAT EP, V12, P7, DOI 10.1046/j.1365-3016.12.s2.6.x
   King JF, 2003, COCHRANE DB SYST REV, V1
   Magriples U, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.05.040
   Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102
   MARI G, 1989, AM J OBSTET GYNECOL, V161, P1514, DOI 10.1016/0002-9378(89)90915-0
   Oppenheimer GM, 1996, AM J PUBLIC HEALTH, V86, P870, DOI 10.2105/AJPH.86.6.870
   Piazze J, 2005, INT J GYNECOL OBSTET, V91, P233, DOI 10.1016/j.ijgo.2005.08.015
   PIRHONEN JP, 1990, OBSTET GYNECOL, V76, P807, DOI 10.1097/00006250-199011000-00016
   Pryde PG, 2001, SEMIN PERINATOL, V25, P316, DOI 10.1053/sper.2001.27547
   Romero R, 2007, ULTRASOUND OBST GYN, V30, P675, DOI 10.1002/uog.5174
   Sikorski J, 1996, BRIT MED J, V312, P546, DOI 10.1136/bmj.312.7030.546
   Spong CY, 2007, OBSTET GYNECOL, V110, P405, DOI 10.1097/01.AOG.0000275287.08520.4a
   Villar J, 2001, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000934
   Wise P H, 1995, J Am Med Womens Assoc (1972), V50, P152
NR 21
TC 23
Z9 24
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
PD SEP
PY 2009
VL 34
IS 3
BP 311
EP 315
DI 10.1002/uog.6445
PG 5
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA 495CP
UT WOS:000269867500012
PM 19705408
OA Bronze
DA 2020-12-01
ER

PT J
AU Germano, EM
   Mello, MJG
   Sena, DF
   Correia, JB
   Amorim, MMR
AF Germano, Eliane M.
   Mello, Maria Julia G.
   Sena, Dayse Figueredo
   Correia, Jailson B.
   Amorim, Melania M. R.
TI Incidence and risk factors of corneal epithelial defects in mechanically
   ventilated children
SO CRITICAL CARE MEDICINE
LA English
DT Article
DE cornea; pulmonary ventilation; fluorescein; intensive care; nursing; eye
ID CARE-UNIT PATIENTS; CRITICALLY-ILL; EYE CARE; ANESTHESIA
AB Objective: To determine the incidence of corneal defects and the main risk factors in children exposed to mechanical ventilation (MV) in the pediatric intensive care unit between March 28 and November 4, 2001.
   Methods: A cohort study where characteristics of 53 children exposed to MV were evaluated and risk factors relating to the occurrence of corneal defects were identified. Patients' corneas were evaluated on a daily basis using a fluorescein test and a portable slit lamp. Risk ratios and 95% confidence intervals were calculated. A multiple logistic regression analysis was performed using a nonconditional model. The model selects variables that maintain associations with corneal defects at a 5% level of significance. The variables with the highest predictive value were identified.
   Results: Twenty-five percent of children exposed to MV developed corneal defects. From this percent, almost 54% of the defects occurred in both eyes, and 46% in the left eye alone. Most defects (69%) were detected within the first week of MV, and a large number were detected within the first 48 hours (46% of cases). In those children who exhibited failure of at least one organ in addition to the lungs, 43% developed defects. Among the children who died, 44% showed corneal defects. After adjusting for potential confounding variables in the multivariate analysis, the maintenance of opened eyes and sepsis remained as prognostic factors for corneal defects.
   Conclusions: A high incidence (25%) of corneal defects was found in children exposed to MV, as is also observed with adult patients. The main risk factors associated with corneal defects were the maintenance of opened eyes and the presence of sepsis. (Crit Care Med 2009; 37:1097-1100)
C1 [Germano, Eliane M.; Mello, Maria Julia G.; Correia, Jailson B.; Amorim, Melania M. R.] Inst Materno Infantil Prof Fernando Figueira, Recife, PE, Brazil.
   [Sena, Dayse Figueredo] Massachusetts Eye & Ear Infirm, Boston, MA 02114 USA.
RP Germano, EM (corresponding author), Inst Materno Infantil Prof Fernando Figueira, Recife, PE, Brazil.
EM elianegermano@imlp.org.br
RI Correia, Jailson B./J-4331-2015; Sena, Dayse F/H-5232-2013; Amorim,
   Melania M/C-5807-2013
OI Sena, Dayse F/0000-0002-9426-0166; Amorim, Melania M/0000-0003-1047-2514
CR ANDERSON EL, 1981, CLIN PEDIATR, V21, P123
   BATRA YK, 1977, ANESTH ANALG, V56, P363
   Dua HS, 1998, LANCET, V351, P387, DOI 10.1016/S0140-6736(05)78351-3
   Farrell M, 1993, Intensive Crit Care Nurs, V9, P137, DOI 10.1016/0964-3397(93)90055-3
   Hernandez EV, 1997, AM J OPHTHALMOL, V124, P212, DOI 10.1016/S0002-9394(14)70786-X
   HILTON F, 1983, LANCET, P1318
   Imanaka H, 1997, ANESTH ANALG, V85, P343, DOI 10.1097/00000539-199708000-00018
   Iroha E O, 1998, West Afr J Med, V17, P168
   KIRWAN JF, 1997, BRIT MED J, P314
   Laight S E, 1996, Intensive Crit Care Nurs, V12, P16, DOI 10.1016/S0964-3397(96)81623-5
   MATTAR DB, 1996, ORG CORNEA CLIN CIRU, P33
   Mercieca F, 1999, EYE, V13, P231, DOI 10.1038/eye.1999.57
   ORLIN SE, 1989, ANESTH ANALG, V69, P384
   Parkin B, 2000, INTENS CARE MED, V26, P155, DOI 10.1007/s001340050038
   Reedy JS, 2000, INTENS CARE MED, V26, P1386, DOI 10.1007/s001340000623
   Roth S, 1996, ANESTHESIOLOGY, V85, P1020, DOI 10.1097/00000542-199611000-00009
   SCARPI MJ, 1996, ORG CORNEA CLIN CIRU, P285
   Suresh P, 2000, INTENS CARE MED, V26, P162, DOI 10.1007/s001340050040
   TOROK PG, AM FAM PHYS, V53, P2521
   Wincek J, 1989, J Neurosci Nurs, V21, P241
NR 20
TC 11
Z9 16
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0090-3493
J9 CRIT CARE MED
JI Crit. Care Med.
PD MAR
PY 2009
VL 37
IS 3
BP 1097
EP 1100
DI 10.1097/CCM.0b013e318196227d
PG 4
WC Critical Care Medicine
SC General & Internal Medicine
GA 413FW
UT WOS:000263779300042
PM 19237923
DA 2020-12-01
ER

PT J
AU Araruna, AA
   Amorim, MM
   Caetano, LB
   Santoro, IL
   Fernandes, ALG
AF Araruna, A. A.
   Amorim, M. M.
   Caetano, L. B.
   Santoro, I. L.
   Fernandes, A. L. G.
TI Effect of Oral Corticosteroid Addiction in Treatment of Controlled
   Asthma Patients: A Randomized Clinical Trial
SO AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
LA English
DT Meeting Abstract
C1 [Araruna, A. A.; Amorim, M. M.; Caetano, L. B.; Santoro, I. L.; Fernandes, A. L. G.] Univ Fed Sao Paulo, Div Resp, Sao Paulo, Brazil.
EM alexandreararuna@hotmail.com
RI Santoro, Ilka L/G-9913-2014; Amorim, Melania M/C-5807-2013
OI Santoro, Ilka L/0000-0002-9575-8361; Amorim, Melania
   M/0000-0003-1047-2514
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER THORACIC SOC
PI NEW YORK
PA 61 BROADWAY, FL 4, NEW YORK, NY 10006 USA
SN 1073-449X
J9 AM J RESP CRIT CARE
JI Am. J. Respir. Crit. Care Med.
PY 2009
VL 179
MA A1031
PG 1
WC Critical Care Medicine; Respiratory System
SC General & Internal Medicine; Respiratory System
GA V29FA
UT WOS:000208733100032
DA 2020-12-01
ER

PT J
AU de Melo, BCP
   Amorim, MMR
   Katz, L
   Coutinho, I
   Verissimo, G
AF Pinto de Melo, Brena Carvalho
   Ramos Amorim, Melania Maria
   Katz, Leila
   Coutinho, Isabela
   Verissimo, Giselly
TI EPIDEMIOLOGICAL PROFILE AND POSTPARTUM OUTCOME IN SEVERE PREECLAMPSIA
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA Portuguese
DT Article
DE Preeclampsia; Post partum period; Complications
ID UTERINE ARTERY DOPPLER; HYPERTENSION; PREGNANCY; DURATION; CARE; RISK
AB EPIDEMIOLOGICAL PROFILE AND POSTPARTUM OUTCOME IN SEVERE PREECLAMPSIA
   BACKGROUND. To describe maternal characteristics and blood pressure behavior in the puerperium of women admitted, during pregnancy, with diagnosis of severe preeclampsia.
   METHODS. A cohort study was conducted including pregnant women with gestational age of 28 weeks or more, with diagnosis of preeclampsia, not in labor, at the Instituto Materno Infantil Professor Fernando Figueira (IMIP) from November 2006 to September 2007. Patients with chronic hypertension, autoimmune diseases, gestational diabetes, multiple pregnancy and signs of clinical instability were excluded. Biological, demographic and obstetrical characteristics were analyzed, as well as the behavior of systolic and diastolic blood pressure post partum.
   RESULTS. 154 patients with severe preeclampsia were included. The mean maternal age was 25.1 + 6.5 years. Regarding education only 45.5% had completed 11 years of schooling. Only 20.1% of deliveries were vaginal and preterm newborns occurred in 59.8% of cases. Two cases of eclampsia, eighteen cases of HELLP syndrome and 43 cases of oliguria were registered. Length of post partum hospital stay varied from one to 30 days, and 45% of patients were in hospital until the seventh day after delivery. Hypertensive emergencies were registered in 53.9% of the patients during puerperium and use of antihypertensive drugs was maintained in 76.5% of the women.
   CONCLUSIONS. Preeclamptic women tend to have controlled blood pressures after the third day of puerperium and are likely to be discharged from hospital still using anti-hypertensive drugs. Key-words: Severe preeclampsia, post partum period complications. [Rev Assoc Med Bras 2009; 55(2): 175-80]
C1 [Pinto de Melo, Brena Carvalho; Ramos Amorim, Melania Maria] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Ramos Amorim, Melania Maria; Katz, Leila] Univ Estadual Campinas, Subarea Tocoginecol, Recife, PE, Brazil.
   [Katz, Leila] Inst Materno Infantil Pernambuco, UTI Obstet, Recife, PE, Brazil.
   [Coutinho, Isabela; Verissimo, Giselly] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Amorim, MMR (corresponding author), Rua Neusa Borborema Sousa 300, BR-58103313 Campina Grande, PB, Brazil.
EM melamorim@uol.com.br
RI Coutinho, Isabel/J-4165-2016; melo, brena CP/I-8407-2017; Katz,
   Leila/M-5291-2013; Amorim, Melania M/C-5807-2013
OI melo, brena CP/0000-0002-7671-2122; Katz, Leila/0000-0001-9854-7917;
   Amorim, Melania M/0000-0003-1047-2514
CR Amorim MMR, 2006, REV BRAS SAUDE MATER, V6, P55
   [Anonymous], 1985, LANCET, V2, P436
   [Anonymous], 7 REP JOINT NAT COM
   Ascarelli MH, 2005, OBSTET GYNECOL, V105, P29, DOI 10.1097/01.AOG.0000148270.53433.66
   Axt-Fliedner R., 2005, Archives of Gynecology and Obstetrics, V271, P53, DOI 10.1007/s00404-004-0648-4
   BELLAMY L, BMJ
   FERRAZZANI S, 1994, AM J OBSTET GYNECOL, V171, P506, DOI 10.1016/0002-9378(94)90290-9
   Fontenot MT, 2005, AM J OBSTET GYNECOL, V192, P1788, DOI 10.1016/j.ajog.2004.12.056
   FUJITANI S, 2005, CRIT CARE MED S, V33, P354
   Garovic VD, 2007, NAT CLIN PRACT NEPHR, V3, P613, DOI 10.1038/ncpneph0623
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   *GOV EST PERN, DAD DEM
   Graves CR, 2002, CLIN OBSTET GYNECOL, V45, P369, DOI 10.1097/00003081-200206000-00008
   Keizer JL, 2006, EUR J OBSTET GYN R B, V128, P152, DOI 10.1016/j.ejogrb.2005.12.013
   Loverro G, 2001, Arch Gynecol Obstet, V265, P195, DOI 10.1007/s004040000160
   Magee L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004351.pub2
   Mantel GD, 2001, BEST PRACT RES CL OB, V15, P563
   Martin JN, 2005, OBSTET GYNECOL, V105, P246, DOI 10.1097/01.AOG.0000151116.84113.56
   Melo Adriana Suely de Oliveira, 2007, Rev. bras. epidemiol., V10, P249, DOI 10.1590/S1415-790X2007000200012
   Papageorghiou AT, 2005, BJOG-INT J OBSTET GY, V112, P703, DOI 10.1111/j.1471-0528.2005.00519.x
   Papageorghiou AT, 2004, BEST PRACT RES CL OB, V18, P383, DOI 10.1016/j.bpobgyn.2004.02.003
   Plasencia W, 2007, ULTRASOUND OBST GYN, V30, P742, DOI 10.1002/uog.5157
   Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7
   SANCTOS M, 2004, THESIS IMIP
   Santos LC, 2004, TERAPIA INTENSIVA OB
   *SAV CHILDR, SAT WORLDS MOTH 2007
   SIBAI BM, 1990, AM J OBSTET GYNECOL, V162, P311, DOI 10.1016/0002-9378(90)90376-I
   Vigil-De Gracia P, 2006, EUR J OBSTET GYN R B, V128, P157, DOI 10.1016/j.ejogrb.2006.02.015
NR 28
TC 6
Z9 8
U1 0
U2 1
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
EI 1806-9282
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PY 2009
VL 55
IS 2
BP 175
EP 180
DI 10.1590/S0104-42302009000200022
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 452UH
UT WOS:000266566200022
PM 19488654
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Hinrichsen, SCA
   Souza, ASR
   Costa, A
   Amorim, MMR
   Hinrichsen, MGML
   Hinrichsen, SL
AF Hinrichsen, Sonia Cristina Araujo
   Souza, Alex Sandro Rolland
   Costa, Aurelio
   Amorim, Melania Maria Ramos
   Hinrichsen, Maria Gabriela M. L.
   Hinrichsen, Sylvia Lemos
TI FACTORS ASSOCIATED WITH BACTERIURIA AFTER INDWELLING URETHRAL
   CATHETERIZATION IN GYNECOLOGIC SURGERY
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA Portuguese
DT Article
DE Urine; Bacteriuria; Cross infection; Surgery; Urinary catheterization;
   Urinary tract infections
ID URINARY-TRACT-INFECTIONS
AB FACTORS ASSOCIATED WITH BACTERIURIA AFTER INDWELLING URETHRAL CATHETERIZATION IN GYNECOLOGIC SURGERY
   OBJECTIVES. To determine the frequency and risk factors associated to bacteriuria after urinary catheterization in women submitted to elective gynecological surgery.
   METHODS. A cohort study was carried out among women submitted to gynecological surgery after urinary catheterization. This study took place at the "Instituto de Medicina Integral Professor Fernando Figueira" from January to May of 2007. Uroculture samples were collected during two periods: in the first 24 hours and seven to ten days after catheter removal. To demonstrate the association between risk factors and bacteriuria, the relative risk was calculated with a confidence interval of 95%.
   RESULTS. This study included 249 women. At 24 hours after catheter removal, 23.6% of the urocultures collected were positive, while on days 7 to 10 this was reduced to 11.1%. Of all participants studied only 2.4% had symptomatic bacteriuria. Risk of bacteriuria at 7/10 days was reduced when the patient reported a positive history of treatment for vulvovaginitis in the previous three months. However this association was not found after multivariate analysis. There was no significant association with age, education, stage of reproductive phase, number of pregnancies and deliveries, type and duration of surgery, type of anesthetics, use of prophylactic antibiotic, professional who introduced the catheter and time of urinary catheterization.
   CONCLUSION. Frequency of bacteriruria was 23.6% at 24 hours and 11.1% seven days after catheter removal. There was no association between bacteriuria at 7/10 days and any of the variables analyzed. [Rev Assoc Med Bras 2009; 55(2): 181-7]
C1 [Hinrichsen, Maria Gabriela M. L.] Inst Med Integral Prof Fernando Figueira PIBIC CN, Programa Iniciacao Cient, Recife, PE, Brazil.
   [Hinrichsen, Sonia Cristina Araujo; Souza, Alex Sandro Rolland; Costa, Aurelio; Amorim, Melania Maria Ramos] Inst Med Integral Prof Fernando Figueira, Recife, PE, Brazil.
   [Hinrichsen, Sylvia Lemos] Univ Fed Pernambuco, Recife, PE, Brazil.
RP Amorim, MMR (corresponding author), Rua Neuza Borborema,300 Santo Antonio, BR-58103313 Campina Grande, PB, Brazil.
EM melamorim@uol.com.br
RI Souza, Alex Sandro Rolland/AAG-2471-2019; Amorim, Melania M/C-5807-2013
OI Souza, Alex Sandro Rolland/0000-0001-7039-2052; Amorim, Melania
   M/0000-0003-1047-2514
CR BAKEY WM, 2006, J AM ACAD PHYS ASSIS, V19, P53
   Bond Penny, 2005, Nurs Times, V101, P58
   *BRIT MEDASS, 2006, HEALTHC ASS INF
   *CDC, 1979, NAT NOS INF STUD REP, P2
   Dunn S, 2000, MANAGEMENT SHORT TER, V4, P1
   Rodriguez JFG, 2006, AM J INFECT CONTROL, V34, P182, DOI 10.1016/j.ajic.2005.09.011
   Getliffe K, 1996, Nurs Stand, V11, P47
   Ghezzi F, 2007, J MINIM INVAS GYN, V14, P706, DOI 10.1016/j.jmig.2007.06.013
   GIVENS CD, 1980, J UROLOGY, V124, P646, DOI 10.1016/S0022-5347(17)55596-2
   Gokula RRM, 2004, AM J INFECT CONTROL, V32, P196, DOI 10.1016/j.ajic.2003.08.007
   Gonzalez CM, 1999, WORLD J UROL, V17, P372, DOI 10.1007/s003450050163
   Graves N, 2007, AM J INFECT CONTROL, V35, P387, DOI 10.1016/j.ajic.2006.09.006
   Griffiths R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004011.pub3
   GROSS JC, 2007, UROL NURS, V27, P236
   Heilberg Ita Pfeferman, 2003, Rev. Assoc. Med. Bras., V49, P109, DOI 10.1590/S0104-42302003000100043
   Kelly P, 2007, EJC SUPPL, V5, P27, DOI 10.1016/S1359-6349(08)70065-X
   Laupland KB, 2007, INFECTION, V35, P150, DOI 10.1007/s15010-007-6180-2
   Lawrence EL, 2005, MED ENG PHYS, V27, P443, DOI 10.1016/j.medengphy.2004.12.013
   MAKI DG, 2004, EMERG INFECT DIS, V7, P2
   Mannien J, 2006, INFECT CONT HOSP EP, V27, P1340, DOI 10.1086/509842
   McLaughlin SP, 2004, MED CLIN N AM, V88, P417, DOI 10.1016/S0025-7125(03)00148-2
   Mohanty S, 2007, INDIAN J MED RES, V126, P216
   *NAT COMM CLIN LAB, M100S14 NCCLS
   NIELWEISE BS, 2007, COCHRANE LIB
   Raffaeli W, 2006, EUR J ANAESTH, V23, P605, DOI 10.1017/S026502150600038X
   Schiotz HA, 2006, ACTA OBSTET GYN SCAN, V85, P476, DOI 10.1080/00016340500409877
   Sedor J, 1999, UROL CLIN N AM, V26, P821, DOI 10.1016/S0094-0143(05)70222-6
   Stamm A M, 1999, Rev Assoc Med Bras (1992), V45, P27
   Stamm WE, 2002, AM J MED, V113, p1S
   STEVENS E, 2005, MEDSURG NURSING, V14, P4
   Tambyah PA, 2000, ARCH INTERN MED, V160, P678, DOI 10.1001/archinte.160.5.678
   Tang KK, 2005, AUST NZ J OBSTET GYN, V45, P380, DOI 10.1111/j.1479-828X.2005.00443.x
NR 32
TC 1
Z9 1
U1 0
U2 3
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
EI 1806-9282
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PY 2009
VL 55
IS 2
BP 181
EP 187
DI 10.1590/S0104-42302009000200023
PG 7
WC Medicine, General & Internal
SC General & Internal Medicine
GA 452UH
UT WOS:000266566200023
PM 19488655
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Souza, ASR
   Amorim, MMR
   Feitosa, FEL
AF Souza, A. S. R.
   Amorim, M. M. R.
   Feitosa, F. E. L.
TI Comparison of sublingual versus vaginal misoprostol for the induction of
   labour: a systematic review
SO BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
LA English
DT Review
DE 'delivery, obstetric'; induced labour; 'labour, obstetric'; literature
   review; meta-analysis; misoprostol; parturition
ID ORAL MISOPROSTOL; TERM; QUALITY; TRIALS
AB Background The induction of full-term labour in women with a live fetus remains a major challenge in modern obstetrics.
   Objectives To determine, using the best level of evidence available, the efficacy and safety of sublingual administration of misoprostol compared with vaginal misoprostol in the third trimester of pregnancy for the induction of labour, according to initial doses, in women with a live, full-term fetus and an unripe cervix.
   Search strategy Pubmed/Medline, Lilacs and Scielo databases were consulted, as well as clinical trials registered in the Cochrane Register from January 1996 to February 2008, using the keywords 'misoprostol', 'labour, obstetric', 'delivery, obstetric', 'induced labour' and 'parturition' with the search limits of 'clinical trials' and 'randomised clinical trials'.
   Selection criteria This review contains randomised clinical trials in which the sublingual and vaginal routes of administration of misoprostol were compared. Participants were pregnant women with an indication for induction of labour and a live fetus more than 37 weeks of gestational age.
   Data collection and analysis The primary analysis compared sublingual and vaginal routes of administration of misoprostol. Secondary analyses compared different routes and initial doses of misoprostol. Statistical analysis included odds ratios and their respective 95% CI. To evaluate the heterogeneity of the studies, the I-squared test was used, studies being considered heterogeneous when I-2 was greater than 50%.
   Main results Five good quality clinical trials involving a total of 740 women were eligible, and all were included. No statistically significant difference was found between the sublingual and the vaginal misoprostol groups with respect to the rate of vaginal delivery not achieved within 24 hours (OR 1.27, 95% CI 0.87-1.84), uterine hyperstimulation syndrome (OR 1.20, 95% CI 0.61-2.33) or caesarean section (OR 1.33, 95% CI 0.96-1.85). An increased risk of uterine tachysystole was found in the sublingual misoprostol group (OR 1.70, 95% CI 1.02-2.83). When the studies were grouped according to the initial dose of misoprostol, no significant difference was found between sublingual or vaginal groups.
   Author's conclusions The sublingual route of administration is as effective as the vaginal route in inducing labour in full-term pregnancies with live fetuses. However, the safety, adverse effects, optimal dose and perinatal outcome related to this route of administration remain to be established, and it cannot be recommended for routine use in obstetric practice.
C1 [Souza, A. S. R.; Amorim, M. M. R.] Inst Materno Infantil Pernambuco, Dept Obstet, BR-52011040 Recife, PE, Brazil.
   [Feitosa, F. E. L.] Univ Fed Ceara, Dept Obstet & Gynaecol, Fortaleza, Ceara, Brazil.
RP Souza, ASR (corresponding author), Inst Materno Infantil Pernambuco, Dept Obstet, Av Rui Barbosa,579 Apto 406, BR-52011040 Recife, PE, Brazil.
EM alexrolland@uol.com.br
RI Amorim, Melania M/C-5807-2013; Souza, Alex Sandro Rolland/AAG-2471-2019;
   feitosa, francisco e/H-8431-2014
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052; 
FU Instituto Materno Infantil Prof Fernando Figueira
FX This study was funded by Instituto Materno Infantil Prof Fernando
   Figueira.
CR ACOG Committee Opinion. American College of Obstetrician and Gynecologist, 2003, Obstet Gynecol, V101, P1049
   Alfirevic Z, 2007, COCHRANE LIB
   Bartusevicius A, 2006, BJOG-INT J OBSTET GY, V113, P1431, DOI 10.1111/j.1471-0528.2006.01108.x
   Caliskan E, 2005, GYNECOL OBSTET INVES, V59, P155, DOI 10.1159/000083255
   Carlan SJ, 2002, AM J OBSTET GYNECOL, V186, P229, DOI 10.1067/mob.2002.119630
   Crane JMG, 2006, BJOG-INT J OBSTET GY, V113, P1366, DOI 10.1111/j.1471-0528.2006.01111.x
   de Moraes OB, 2005, REV BRAS GINECOL OBS, V27, P24, DOI 10.1590/S0100-72032005000100006
   Feitosa Francisco Edson de Lucena, 2006, Rev. Assoc. Med. Bras., V52, P251, DOI 10.1590/S0104-42302006000400026
   Fettosa FEL, 2006, INT J GYNECOL OBSTET, V94, P91, DOI 10.1016/j.ijgo.2006.04.031
   Higgins JPT, 2005, COCHRANE LIB
   Ho PC, 1997, OBSTET GYNECOL, V90, P735, DOI 10.1016/S0029-7844(97)00419-5
   HOFMEYR GJ, 2007, COCHRANE LIB
   Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4
   MARGULIES M, 1991, PRENSA MED ARGENT, V78, P9
   MARGULIES M, 1992, LANCET, V339, P64, DOI 10.1016/0140-6736(92)90194-8
   Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5
   MUZONZINI G, 2007, COCHRANE LIB
   Nassar AH, 2007, BJOG-INT J OBSTET GY, V114, P1215, DOI 10.1111/j.1471-0528.2007.01492.x
   SENIOR J, 1993, BRIT J PHARMACOL, V108, P501, DOI 10.1111/j.1476-5381.1993.tb12832.x
   Shetty A, 2002, AM J OBSTET GYNECOL, V186, P72, DOI 10.1067/mob.2002.118917
   Shetty A, 2002, BJOG-INT J OBSTET GY, V109, P645, DOI 10.1111/j.1471-0528.2002.01459.x
   Tang OS, 2002, HUM REPROD, V17, P332, DOI 10.1093/humrep/17.2.332
   Wolf SB, 2005, OBSTET GYNECOL, V105, P365, DOI 10.1097/01.AOG.0000151992.75614.8d
NR 23
TC 30
Z9 32
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1470-0328
EI 1471-0528
J9 BJOG-INT J OBSTET GY
JI BJOG
PD OCT
PY 2008
VL 115
IS 11
BP 1340
EP 1349
DI 10.1111/j.1471-0528.2008.01872.x
PG 10
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 348PZ
UT WOS:000259223700003
PM 18823486
OA Bronze
DA 2020-12-01
ER

PT J
AU De Souza, AR
   Amorim, MR
   Costa, AR
AF De Souza, Alex R.
   Amorim, Melania R.
   Costa, Aurelio R.
TI NIFEDIPINE ANTIHYPERTENSIVE TREATMENT EFFECTS IN PRE-ECLAMPSIA
SO ACTA MEDICA PORTUGUESA
LA Portuguese
DT Review
ID PREGNANCY; FLOW; THERAPY; CHILDREN; UTERINE; RISK
AB Literature analysis has been controversial about pre-eclampsia. It is known that not pregnant patients should be treated due cardiovascular benefits. However, the real benefits of antihypertensive treatment in pre-eclampsia were not demonstrated. Yet, there are many drugs that can be used for antihypertensive treatment in pregnancy. Calcium channel blockers, particularly nifedipine, are used as a second line treatment. There are just a few evidences about nifedipine treatment in hypertension during pregnancy. Recently, researches were performed to evaluate the effects of nifedipine on maternal-fetal binomial, more safety, efficacy, and effectiveness were found using it. This literature review concludes that hypertension treatment only must be done in severe cases and emergency hypertensive. Therefore nifedipine can be used in antihypertensive treatment during pregnancy without serious complications.
C1 [De Souza, Alex R.] Inst Materno Infantil Fernando Figueira, Setor Med Fetal, Ctr Atencao Mulher, Recife, PE, Brazil.
   [Amorim, Melania R.; Costa, Aurelio R.] Univ Estadual Campinas, Serv Tocoginecol, Campinas, SP, Brazil.
   [Amorim, Melania R.; Costa, Aurelio R.] Inst Materno Infantil Fernando Figueira, Serv Materno Infantil, Recife, PE, Brazil.
RP De Souza, AR (corresponding author), Inst Materno Infantil Fernando Figueira, Setor Med Fetal, Ctr Atencao Mulher, Recife, PE, Brazil.
RI Amorim, Melania M/C-5807-2013; Souza, Alex Sandro Rolland/G-3446-2013
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052
CR Abalos E, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002252.pub2, 10.1002/14651858.CD002252.pub3]
   Bernucci L, 2006, PLACENTA, V27, P1082, DOI 10.1016/j.placenta.2005.12.007
   Bortolus R, 2000, BRIT J OBSTET GYNAEC, V107, P792, DOI 10.1111/j.1471-0528.2000.tb13342.x
   CONSTANTINE G, 1987, BRIT J OBSTET GYNAEC, V94, P1136, DOI 10.1111/j.1471-0528.1987.tb02312.x
   Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0
   DULEY L, 2007, COCHRANE LIB
   *FDA, 1982, FDA DRUG B, V12, P24
   FENAKEL K, 1991, OBSTET GYNECOL, V77, P331
   Ferrão Mauro Henrique de Lima, 2006, Rev. Assoc. Med. Bras., V52, P390, DOI 10.1590/S0104-42302006000600016
   Guclu S, 2006, ULTRASOUND OBST GYN, V27, P403, DOI 10.1002/uog.2728
   HANRETTY KP, 1989, BRIT MED J, V299, P1205, DOI 10.1136/bmj.299.6709.1205
   Houlihan DD, 2004, J PERINAT MED, V32, P315, DOI 10.1515/JPM.2004.058
   ISMAIL AAA, 1993, INT J GYNECOL OBSTET, V40, P39, DOI 10.1016/0020-7292(93)90770-W
   Jayawardana J, 1994, Ceylon Med J, V39, P87
   King J, 2007, COCHRANE LIB
   LEVIN AC, 1994, ANN PHARMACOTHER, V28, P1371, DOI 10.1177/106002809402801208
   LINDOW SW, 1988, BRIT J OBSTET GYNAEC, V95, P1276, DOI 10.1111/j.1471-0528.1988.tb06818.x
   Magee LA, 2005, AM J OBSTET GYNECOL, V193, P153, DOI 10.1016/j.ajog.2004.11.059
   Magee LA, 2003, BMJ-BRIT MED J, V327, P955, DOI 10.1136/bmj.327.7421.955
   Magee LA, 1996, AM J OBSTET GYNECOL, V174, P823, DOI 10.1016/S0002-9378(96)70307-1
   *MIN SAUD SECR POL, 2002, AR TECN SAUD MULH MA
   MORETTI MM, 1990, AM J OBSTET GYNECOL, V163, P1844, DOI 10.1016/0002-9378(90)90762-V
   Parazzini F, 1998, BRIT J OBSTET GYNAEC, V105, P718
   PIRHONEN JP, 1990, OBSTET GYNECOL, V76, P807, DOI 10.1097/00006250-199011000-00016
   RODRIGUEZ RJW, 1991, GINECOL OBSTETR MEXI, V59, P81
   Rosenthal T, 2002, J HUM HYPERTENS, V16, P293, DOI 10.1038/sj.jhh.1001400
   SIBAI BM, 1992, AM J OBSTET GYNECOL, V167, P879, DOI 10.1016/S0002-9378(12)80005-6
   Smith P, 2000, BRIT J OBSTET GYNAEC, V107, P299, DOI 10.1111/j.1471-0528.2000.tb13222.x
   Sorensen HT, 2001, ACTA OBSTET GYN SCAN, V80, P397, DOI 10.1034/j.1600-0412.2001.d01-4.x
   THALER I, 1991, J ULTRAS MED, V10, P301
   Yankowitz J, 2004, J PERINAT NEONAT NUR, V18, P230, DOI 10.1097/00005237-200407000-00006
NR 31
TC 3
Z9 4
U1 0
U2 1
PU ORDEM MEDICOS
PI LISBON
PA AV ALMIRANTE GAGO COUTINHO, 151, LISBON, 1749-084, PORTUGAL
SN 1646-0758
J9 ACTA MEDICA PORT
JI Acta Medica Port.
PD JUL-AUG
PY 2008
VL 21
IS 4
BP 351
EP 358
PG 8
WC Medicine, General & Internal
SC General & Internal Medicine
GA 439PB
UT WOS:000265638400006
PM 19094810
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU De Souza, AR
   Amorim, MR
AF De Souza, Alex Rolland
   Amorim, Melania Ramos
TI INTRAPARTUM FETAL VITALITY ASSESSMENT
SO ACTA MEDICA PORTUGUESA
LA Portuguese
DT Article
ID PULSE OXIMETRY; STIMULATION; CARDIOTOCOGRAPHY; MANAGEMENT; TRIAL; FLUID
AB The incidence of morbidity and mortality resulting from perinatal hypoxia is variable around the world, reaching 33 to 1.000 alive newborns in developing countries. Although the greater part of cases of perinatal morbidity and morbidity cannot be prevented with labor monitoring, failure of appropriate actions are considered important contributing factors. Intrapartum cardiotocography have been largely used for monitoring of fetal heart rate and diagnosis of fetal well-being, but several studies suggest that there aren't advantages of this method when compared with intermittent auscultation in terms of improving neonatal outcome. Nowadays, other technologies have been proposed for fetal intrapartum assessment, like stimulation tests, near-infrared spectroscopy, fetal pulse oximetry and fetal electrocardiography.
RI Amorim, Melania M/C-5807-2013; Souza, Alex Sandro Rolland/G-3446-2013
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052
CR ALFIREVIC Z, 2007, COCHRANE LIB, P4
   *AM COLL OBST GYN, 2001, OBSTET GYNECOL, V98, P523
   *AM COLL OBST GYN, 1989, ACOG TECHN B, V132
   Amer-Wahlin I, 2001, LANCET, V358, P534, DOI 10.1016/S0140-6736(01)05703-8
   [Anonymous], 1995, INT J GYNECOL OBSTET, V51, P65
   Becker S, 2007, EUR J OBSTET GYN R B, V132, P46, DOI 10.1016/j.ejogrb.2006.05.032
   Boehm FH, 1999, OBSTET GYN CLIN N AM, V26, P623, DOI 10.1016/S0889-8545(05)70103-0
   BRICKER L, 2007, COCHRANE LIB
   Carbonne B, 1997, AM J OBSTET GYNECOL, V177, P593, DOI 10.1016/S0002-9378(97)70151-0
   Committee on Obstetric Practice American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V106, P1469
   Devane D, 2005, J ADV NURS, V52, P133, DOI 10.1111/j.1365-2648.2005.03575.x
   Dildy GA, 2005, OBSTET GYN CLIN N AM, V32, P255, DOI 10.1016/j.ogc.2005.01.005
   Dildy GA, 1996, AM J OBSTET GYNECOL, V175, P1, DOI 10.1016/S0002-9378(96)70242-9
   EAST CE, 2007, COCHRANE LIB, P4
   EAST CE, 2007, COCHRANE LIB
   EDINGTON PT, 1975, BRIT MED J, V3, P341
   Elimian A, 1997, OBSTET GYNECOL, V89, P373, DOI 10.1016/S0029-7844(96)00525-X
   Graham EM, 2006, OBSTET GYNECOL, V108, P656, DOI 10.1097/01.AOG.0000230533.62760.ef
   Hamilton RJ, 1996, BAILLIERE CLIN OB GY, V10, P307, DOI 10.1016/S0950-3552(96)80040-X
   HOWARTH GR, 2007, COCHRANE LIB
   Impey L, 2003, LANCET, V361, P465, DOI 10.1016/S0140-6736(03)12464-6
   INGEMARSSON I, 1989, BRIT J OBSTET GYNAEC, V96, P562, DOI 10.1111/j.1471-0528.1989.tb03256.x
   Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5
   MACDONALD D, 1985, AM J OBSTET GYNECOL, V152, P524, DOI 10.1016/0002-9378(85)90619-2
   MOZURKEWICH E, 2007, COCHRANE LIB
   NEILSON JP, 2007, COCHRANE LIB, P4
   Nelson KB, 1996, NEW ENGL J MED, V334, P613, DOI 10.1056/NEJM199603073341001
   ODENT M, 2006, MIDWIFERY TODAY INT, V80, P66
   *ORG MUND SAUD, 1996, OMSSRFMSM9624 OPAS U
   Parer JT, 1997, AM J OBSTET GYNECOL, V177, P1385
   PEEBLES DM, 1992, AM J OBSTET GYNECOL, V166, P1369, DOI 10.1016/0002-9378(92)91606-B
   Royal College of Obstetricians and Gynaecologists, 2001, US EL FET MON US INT, V8
   Schmidt S, 2003, EUR J OBSTET GYN R B, V110, pS127, DOI 10.1016/S0301-2115(03)00183-0
   SHIONO PH, 1987, OBSTET GYNECOL, V69, P696
   Skupski DW, 2002, OBSTET GYNECOL, V99, P129, DOI 10.1016/S0029-7844(01)01645-3
   SMYTH R, 2007, COCHRANE LIB
   TAN KH, 2007, COCHRANE LIB, P4
   THACKER SB, 1995, OBSTET GYNECOL, V86, P613, DOI 10.1016/S0029-7844(95)80027-1
   *US DEP HHS, 1991, MMWR-MORBID MORTAL W, V41, P285
   Velaphi S, 2006, CLIN PERINATOL, V33, P29, DOI 10.1016/j.clp.2005.11.014
   VINTZILEOS AM, 1995, OBSTET GYNECOL, V85, P149, DOI 10.1016/0029-7844(94)00320-D
   VINTZILEOS AM, 1993, OBSTET GYNECOL, V81, P899
NR 42
TC 0
Z9 0
U1 0
U2 2
PU ORDEM MEDICOS
PI LISBON
PA AV ALMIRANTE GAGO COUTINHO, 151, LISBON, 1749-084, PORTUGAL
SN 1646-0758
J9 ACTA MEDICA PORT
JI Acta Medica Port.
PD MAY-JUN
PY 2008
VL 21
IS 3
BP 229
EP 240
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA 439PA
UT WOS:000265638300004
PM 18674415
OA DOAJ Gold
DA 2020-12-01
ER

PT J
AU Souza, ASR
   Amorim, MMR
   Coelho, ICN
   Lima, MMD
   Noronha, C
   Figueroa, JN
AF Rolland Souza, Alex Sandro
   Ramos Amorim, Melania Maria
   Neiva Coelho, Isabela Coutinho
   De Souza Lima, Marcelo Marques
   Noronha Neto, Carlos
   Figueroa, Jose Natal
TI Doppler of the umbilical and fetal middle cerebral arteries after
   magnesium sulfate in preeclampsia
SO REVISTA DA ASSOCIACAO MEDICA BRASILEIRA
LA Portuguese
DT Article
ID BLOOD-FLOW; PREGNANCY; PRESSURE; PERFUSION; VESSELS; WOMEN
AB BACKGROUND. To compare the ratio between the fetal middle cerebral artery and the umbilical artery using Doppler flow velocimetry indicies (resistance Index, pulsatility Index and A/B relation) before and after administration of magnesium sulfate to pregnant women with severe preeclampsia (pure or superimposed).
   METHODS. A prospective cohort study was conducted with each pregnant woman representing her own control Forty severe preeclamptic women were Included and underwent Doppler sonography before and 20 minutes after administration of 6g of magnesium sulfate, Analysis variables were the Doppler flow velocimetry Indices evaluating the ratio of the fetal middle cerebral artery to the umbilical artery, To compare the mean indicies before and after magnesium sulfate for the same patient, the "t-paired" Student test was used The Stuart-Maxwell chi(2) was applied to determine the difference of fetal diagnosis (normal, brain-sparing or reduced middle cerebral artery resistance) before and after magnesium sulfate.
   RESULTS. No significant difference of the mean ratio between the middle cerebral artery and the umbilical artery, before and after administration of magnesium sulfate was observed. After magnesium sulfate (25.0% x 47.5%; p = 0.01), there was an Increased frequency of isolated lower Doppler flow velocimetry indices in the middle cerebral artery.
   CONCLUSION. Intravenous administration of magnesium sulfate in patients with severe preeclampsia associated with Increased frequency of fetal Doppler diagnosis of reduced resistance In the middle cerebral artery.
C1 [Rolland Souza, Alex Sandro; Ramos Amorim, Melania Maria; Neiva Coelho, Isabela Coutinho; De Souza Lima, Marcelo Marques; Noronha Neto, Carlos; Figueroa, Jose Natal] Trabalho Realizado Inst Mat Infantil Prof Fernand, Recife, PE, Brazil.
   [Rolland Souza, Alex Sandro; Ramos Amorim, Melania Maria; Neiva Coelho, Isabela Coutinho; De Souza Lima, Marcelo Marques; Noronha Neto, Carlos; Figueroa, Jose Natal] Ctr Atencao Mulher, Setor Med Fetal, Recife, PE, Brazil.
RP Souza, ASR (corresponding author), Av Rui Barbosa,579,Apto 406 Gracas, BR-52011040 Recife, PE, Brazil.
EM alexrolland@uol.com.br
RI Amorim, Melania M/C-5807-2013; Souza, Alex Sandro Rolland/AAG-2471-2019
OI Amorim, Melania M/0000-0003-1047-2514; Souza, Alex Sandro
   Rolland/0000-0001-7039-2052
CR ARDUINI D, 1990, J PERINAT MED, V18, P165, DOI 10.1515/jpme.1990.18.3.165
   Belfort MA, 1999, AM J OBSTET GYNECOL, V181, P402, DOI 10.1016/S0002-9378(99)70569-7
   BELFORT MA, 1993, ACTA OBSTET GYN SCAN, V72, P526, DOI 10.3109/00016349309058156
   Belfort MA, 1999, AM J OBSTET GYNECOL, V180, P601, DOI 10.1016/S0002-9378(99)70261-9
   BELFORT MA, 1995, AM J OBSTET GYNECOL, V172, P1395, DOI 10.1016/0002-9378(95)90468-9
   Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0
   DULEY L, 2007, COCHRANE LIB
   Franzin CMMO, 2001, REV BRAS GINECOL OBS, V23, P659
   Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928
   Gosling R., 1975, ARTERIES VEINS, P61
   Houlihan DD, 2004, J PERINAT MED, V32, P315, DOI 10.1515/JPM.2004.058
   KEELEY MM, 1993, OBSTET GYNECOL, V81, P191
   Kovac CM, 2003, AM J OBSTET GYNECOL, V189, P839, DOI 10.1067/S0002-9378(03)00851-2
   Nomura RMY, 2001, REV BRAS GINECOL OBS, V23, P137
   POURCELOT L, 1974, VELOCIMETRIE ULTRASO, P213
   Quintero Janeth, 2002, Rev Obstet Ginecol Venez, V62, P153
   Rantonen T, 2001, CRIT CARE MED, V29, P1460, DOI 10.1097/00003246-200107000-00026
   SAITO M, 1996, MED FETAL DIAGNOSTIC, P297
   Sibai BM, 2004, AM J OBSTET GYNECOL, V190, P1520, DOI 10.1016/j.ajog.2003.12.057
   Standley PR, 2002, AM J HYPERTENS, V15, P565, DOI 10.1016/S0895-7061(02)02272-0
   STUART B, 1980, BRIT J OBSTET GYNAEC, V87, P780, DOI 10.1111/j.1471-0528.1980.tb04613.x
   Touyz R. M., 2003, Molecular Aspects of Medicine, V24, P107, DOI 10.1016/S0098-2997(02)00094-8
   Wallace Craig, 2003, Emerg Med (Fremantle), V15, P92, DOI 10.1046/j.1442-2026.2003.00417.x
   WLADIMIROFF JW, 1986, BRIT J OBSTET GYNAEC, V93, P471, DOI 10.1111/j.1471-0528.1986.tb08656.x
NR 24
TC 29
Z9 32
U1 0
U2 0
PU ASSOC MEDICA BRASILEIRA
PI SAO PAULO
PA RUA SAO CARLOS DO PINHAL 324, CAIXA POSTAL 8904, SAO PAULO, SP, BRAZIL
SN 0104-4230
J9 REV ASSOC MED BRAS
JI Rev. Assoc. Med. Bras.
PD MAY-JUN
PY 2008
VL 54
IS 3
BP 232
EP 237
DI 10.1590/S0104-42302008000300016
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 322VM
UT WOS:000257403400015
PM 18604401
OA DOAJ Gold, Green Published
DA 2020-12-01
ER

PT J
AU da Costa, AR
   Pinto-Neto, AM
   Amorim, M
   Paiva, LHSC
   Scavuzzi, A
   Schettini, J
AF da Costa, Aurlio Ribeiro
   Pinto-Neto, Aarao Mendes
   Amorim, Melania
   Paiva, Lucia Helena Simoes Costa
   Scavuzzi, Adriana
   Schettini, Juliana
TI Use of misoprostol prior to hysteroscopy in postmenopausal women: A
   randomized, placebo-controlled clinical trial
SO JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY
LA English
DT Article
DE hysteroscopy; menopause; misoprostol; clinical trial
ID VAGINAL MISOPROSTOL; COMPLICATIONS
AB Study Objective: To compare results of diagnostic hysteroscopy in postmenopausal women using misoprostol for cervical ripening.
   Design: A randomized, placebo-controlled clinical trial (Canadian Task Force classification Ib).
   Setting: Hospital Barao de Lucena, Instituto Materno Infantil de Pernambuco.
   Patients: One hundred-twenty postmenopausal women.
   Intervention: Postmenopausal women received 200 mu g of vaginal misoprostol or placebo before hysteroscopy.
   Measurements and Main Results: Variables measured were procedure time, frequency of hysteroscopy carried out in each group (misoprostol and placebo), degree of pain during procedure, need for dilation, side effects, and complications of hysteroscopy. The chi(2), Fisher's exact, and Mann-Whitney tests were used and considered significant when alpha error was <5%. There were similarities between the groups in age (p = .09), body mass index (p = .55), time since menopause (p = .52), and genital bleeding (p = .52). Pain during the procedure, as measured by visual analog scale, was less severe in the misoprostol group than in the placebo group (median of 05 vs 07, p = .02), but there were similarities in duration (2.4 min vs 2.0 min, p = .3), pain during procedure and biopsy (p = .74 vs p = .19), need for dilation (p = .66), side effects, and complications. There were no differences in severity of post-procedure pain.
   Conclusions: Previous use of misoprostol reduced pain severity during hysteroscopy.
C1 [Amorim, Melania] Univ Fed Campina Grande, Sch Med, Campina Grande, Paraiba, Brazil.
   [da Costa, Aurlio Ribeiro; Amorim, Melania; Scavuzzi, Adriana; Schettini, Juliana] Inst Maternal Infant Hlth, Dept Obstet & Gynecol, Recife, PE, Brazil.
   [Pinto-Neto, Aarao Mendes; Paiva, Lucia Helena Simoes Costa] Univ Estadual Campinas, UNICAMP, Sao Paulo, PE, Brazil.
RP Amorim, M (corresponding author), Univ Fed Campina Grande, Sch Med, Campina Grande, Paraiba, Brazil.
EM melamorim@uol.com.br
RI Costa-Paiva, Lucia/A-6012-2015; Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
CR Arias F, 2000, CLIN OBSTET GYNECOL, V43, P455, DOI 10.1097/00003081-200009000-00006
   Barcaite E, 2005, INT J GYNECOL OBSTET, V91, P141, DOI 10.1016/j.ijgo.2005.06.019
   Bisharah M, 2003, J AM ASSOC GYN LAP, V10, P390, DOI 10.1016/S1074-3804(05)60269-1
   Blanchard K, 2002, OBSTET GYNECOL, V99, P316, DOI 10.1016/S0029-7844(01)01701-X
   COLLINS SL, 1997, REV PAIN, V95, P95
   FILHO O, 2005, REV BRAS GINECOL OBS, V27, P24
   FLEISS W, 1981, STAT METHODS RATES P, P38
   GEORGE AV, 2005, BAILLIERES BEST PRAC, V19, P727
   HOFMEYR GJ, 2002, COCHRANE LIB, V2
   Jansen FW, 2000, OBSTET GYNECOL, V96, P266, DOI 10.1016/S0029-7844(00)00865-6
   KARIM A, 1987, PROSTAGLANDINS, V33, P40, DOI 10.1016/0090-6980(87)90047-5
   Machado Maria Karenina N., 2003, Rev. Bras. Ginecol. Obstet., V25, P237, DOI 10.1590/S0100-72032003000400003
   Magram AJ, 1999, AM J INFECT CONTROL, V27, P97
   Moher D, 2001, LANCET, V357, P1191, DOI 10.1016/S0140-6736(00)04337-3
   MUZONZINI G, 2006, COCHRANE LIB, V1
   Ngai SW, 2001, HUM REPROD, V16, P1486, DOI 10.1093/humrep/16.7.1486
   Perez-Medina T, 2000, INT J GYNECOL OBSTET, V71, P33, DOI 10.1016/S0020-7292(00)00249-6
   PINTONETO AM, 2003, MENOPAUSA DIAGNOSTIC, P23
   Preutthipan S, 1999, OBSTET GYNECOL, V94, P427, DOI 10.1016/S0029-7844(99)00285-9
   Propst AM, 2000, OBSTET GYNECOL, V96, P517, DOI 10.1016/S0029-7844(00)00958-3
   Sackett D, 2000, EVIDENCE BASED MED P
   Scavuzzi Adriana, 2003, Rev. Bras. Ginecol. Obstet., V25, P229, DOI 10.1590/S0100-72032003000400002
   SCHOENHARD G, 1985, DIGEST DIS SCI, V30, pS126, DOI 10.1007/BF01309397
   Song J, 2000, OBSTET GYNECOL SURV, V55, P503, DOI 10.1097/00006254-200008000-00023
   SPIRLET MB, 2002, GYNECOL OBSTET FERTI, V30, P317
   Tantini C., 2002, HISTEROSCOPIA DIAGNO, P119
   Thomas JA, 2002, AM J OBSTET GYNECOL, V186, P876, DOI 10.1067/mob.2002.123411
   Zieman M, 1997, OBSTET GYNECOL, V90, P88, DOI 10.1016/S0029-7844(97)00111-7
NR 28
TC 34
Z9 35
U1 0
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 1553-4650
EI 1553-4669
J9 J MINIM INVAS GYN
JI J. Minim. Invasive Gynecol.
PD JAN-FEB
PY 2008
VL 15
IS 1
BP 67
EP 73
DI 10.1016/j.jmig.2007.08.596
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 265FP
UT WOS:000253344800014
PM 18262147
DA 2020-12-01
ER

PT J
AU Fettosa, FEL
   Sampaio, ZS
   Alencar, CA
   Amorim, MMR
   Passini, R
AF Fettosa, F. E. L.
   Sampaio, Z. S.
   Alencar, C. A., Jr.
   Amorim, M. M. R.
   Passini, R., Jr.
TI Sublingual vs. vaginal misoprostol for induction of labor
SO INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
LA English
DT Article
DE misoprostol; sublingual misoprostol; vaginal misoprostol; induction of
   tabor; effectiveness; safety
ID TERM; TRIAL
AB Objective: To compare sublingual with vaginal misoprostol for the induction of tabor. Methods: This double-blind clinical trial randomized 150 women to receive every 6 h 25 mu g of sublingual misoprostol and vaginal placebo or 25 mu g of vaginal misoprostol and subtinguat placebo. Maternal and neonatal outcomes were analyzed and risk ratios (RRs) with 95% confidence intervals (Cls) calculated. The significance level was 5%. Results: Vaginal delivery rates were 57% in the subtingual group and 69% in the vaginal group (RR, 0.8; 95% Cl, 0.6-1.1). There were 11 cases of fetal distress in the subtinguat group and 4 cases in the vaginal group (RR, 2.7; 95% Cl, 0.9-8.2). There were no significant differences in the number of doses needed, interval between first dose and delivery, incidence of contractility disturbances, or neonatal results. Conclusion: The administration of misoprostol 25 mu g by the sublinguat route was neither more effective nor safer than the same dose administered vaginally. (c) 2006 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.
C1 Univ Fed Ceara, Matern Escola, Fortaleza, Ceara, Brazil.
   Inst Maternoinfantil Pernambuco, Recife, PE, Brazil.
   Univ Estadual Campinas, UNICAMP, Sch Med, Dept Obstet & Gynecol, Campinas, SP, Brazil.
RP Fettosa, FEL (corresponding author), Rua Batista Oliveira,1000 Apto 1401-Bairro Coco, BR-60176030 Fortaleza, Ceara, Brazil.
EM edsonlucena@secrel.com.br
RI Passini Junior, Renato/O-6169-2016; Amorim, Melania M/C-5807-2013
OI Passini Junior, Renato/0000-0001-8247-4549; Amorim, Melania
   M/0000-0003-1047-2514
CR ALFIREVIC Z, 2001, COCHRANE DB SYST REV, V2, P1338
   Arvidsson C, 2005, EUR J OBSTET GYN R B, V123, P87, DOI 10.1016/j.ejogrb.2005.02.019
   Caliskan E, 2005, GYNECOL OBSTET INVES, V59, P155, DOI 10.1159/000083255
   FRIEDMAN LM, 1998, FUNDAMENTALS CLIN TR, P61
   Friedman LM, 1998, FUNDAMENTALS CLIN TR, P94
   HOFMEYR GJ, 2003, COCHRANE DB SYST REV, V1
   MARGULIES M, 1992, LANCET, V339, P64, DOI 10.1016/0140-6736(92)90194-8
   Moraes-Filho OB, 2005, REV BRAS GINECOL OBS, V27, P20
   Muzonzini G, 2004, COCHRANE DB SYST REV, V18, P4221
   *ROYAL COLL OBST G, 2001, CLIN GUID ROYAL COLL, V9
   Royal College of Obstetricians and Gynaecologists, 2001, US EL FET MON US INT, V8
   Saxena P, 2006, EUR J OBSTET GYN R B, V125, P109, DOI 10.1016/j.ejogrb.2005.07.022
   Shetty A, 2002, AM J OBSTET GYNECOL, V186, P72, DOI 10.1067/mob.2002.118917
   Shetty A, 2002, BJOG-INT J OBSTET GY, V109, P645, DOI 10.1111/j.1471-0528.2002.01459.x
   Wolf SB, 2005, OBSTET GYNECOL, V105, P365, DOI 10.1097/01.AOG.0000151992.75614.8d
   2003, OBSTET GYNECOL, V101, P1049
NR 16
TC 26
Z9 28
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0020-7292
EI 1879-3479
J9 INT J GYNECOL OBSTET
JI Int. J. Gynecol. Obstet.
PD AUG
PY 2006
VL 94
IS 2
BP 91
EP 95
DI 10.1016/j.ijgo.2006.04.031
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 082XM
UT WOS:000240420500002
PM 16828095
DA 2020-12-01
ER

PT J
AU Duarte, MCMB
   Amorim, MR
   Cuevas, LE
   Cabral, JE
   Correia, JB
AF Duarte, MCMB
   Amorim, MR
   Cuevas, LE
   Cabral, JE
   Correia, JB
TI Risk factors for death from meningococcal infection in Recife, Brazil
SO JOURNAL OF TROPICAL PEDIATRICS
LA English
DT Article
ID CASE-FATALITY RATE; PROGNOSTIC SCORE; DISEASE; CHILDREN; MANAGEMENT;
   SEPTICEMIA; PATHOPHYSIOLOGY; PREVENTION; CARE
AB To determine the case fatality rate and risk factors for death in children with invasive meningococcal infection, 163 children admitted with meningococcal disease to the Instituto Materno Infantil de Pernambuco, a tertiary paediatric teaching hospital in Recife, Brazil, were included in this retrospective cohort study. Cases were categorised as meningitis, septicaemia and septicaemia with meningitis. Forty-six (28.2 per cent) children had meningitis alone, 88 (54 per cent) septicaemia and meningitis and 29 (17.8 per cent) only septicaemia. Four of the patients with meningitis died (8.7 per cent), compared to 31 out of the 88 (35.2 per cent) with septicaemia and meningitis and 18 of the 29 (62.1 per cent) with septicaemia alone (p < 0.001). Symptoms < 24 h (AOR 3.8, 95 per cent CI 1.1-13.1), platelet count < 100 000 mm(3) (AOR 13.8, 95 per cent CI 3.1-60.9) and acidosis (AOR 6.0, 95 per cent CI 1.7-21) were the significant risk factors for death. Invasive meningococcal infection has a high case-fatality rate in this tertiary centre in Recife, especially in the septic forms. The identification of risk factors for death could contribute to the early recognition of patients with higher risk on admission in a middle-income country population.
C1 Inst Materno Infantil Pernambuco, Paediat Intens Care Unit, BR-50070550 Recife, PE, Brazil.
   Univ Liverpool, Liverpool Sch Trop Med, Liverpool L69 3BX, Merseyside, England.
   Univ Liverpool, Dept Med Microbiol & Genitourinary Med, Liverpool L69 3BX, Merseyside, England.
RP Duarte, MCMB (corresponding author), Inst Materno Infantil Pernambuco, Paediat Intens Care Unit, Rua Coelhos 300, BR-50070550 Recife, PE, Brazil.
EM mestrado@imip.org.br
RI Solebo, Colette N/B-6615-2008; Correia, Jailson B./J-4331-2015; Amorim,
   Melania M/C-5807-2013; Cuevas, Luis E/I-3697-2015
OI Solebo, Colette N/0000-0001-9764-2541; Amorim, Melania
   M/0000-0003-1047-2514; Cuevas, Luis E/0000-0002-6581-0587
CR Abramson JS, 2000, PEDIATRICS, V106, P1500
   Ajayi-Obe EK, 1998, B WORLD HEALTH ORGAN, V76, P149
   ANSARI BM, 1979, POSTGRAD MED J, V55, P780, DOI 10.1136/pgmj.55.649.780
   Barquet N, 1999, ARCH INTERN MED, V159, P2329, DOI 10.1001/archinte.159.19.2329
   Booy R, 2001, ARCH DIS CHILD, V85, P386, DOI 10.1136/adc.85.5.386
   Cartwright KAV, 1999, INFECT DIS CLIN N AM, V13, P661, DOI 10.1016/S0891-5520(05)70100-8
   CORREIA J, 2003, CLIN EVID, V9, P879
   de Kleijn ED, 1998, EUR J PEDIATR, V157, P869, DOI 10.1007/s004310050958
   Donalisio MRC, 2000, REV SAUDE PUBL, V34, P589, DOI 10.1590/S0034-89102000000600005
   FLAEGSTAD T, 1995, ACTA PAEDIATR, V84, P1137, DOI 10.1111/j.1651-2227.1995.tb13513.x
   Gama SGN, 1997, REV SAUDE PUBL, V31, P254, DOI 10.1590/S0034-89101997000300006
   GEDDEDAHL TW, 1990, REV INFECT DIS, V12, P973
   Kirsch EA, 1996, PEDIATR INFECT DIS J, V15, P967, DOI 10.1097/00006454-199611000-00009
   Kornelisse RF, 1997, CLIN INFECT DIS, V25, P640, DOI 10.1086/513759
   Leake JAD, 2000, INFECT MED, V17, P364
   Lodder MC, 1996, J MED MICROBIOL, V45, P16, DOI 10.1099/00222615-45-1-16
   Malley R, 1996, J PEDIATR-US, V129, P702, DOI 10.1016/S0022-3476(96)70153-1
   MATHERS LH, 2000, NELSON TXB PEDIAT, P254
   Mok Q, 1996, INTENS CARE MED, V22, P259, DOI 10.1007/BF01712247
   NIKLASSON P-M, 1971, Scandinavian Journal of Infectious Diseases, V3, P17
   Riordan FAI, 1998, J ACCID EMERG MED, V15, P249
   Salzman MB, 1996, INFECT DIS CLIN N AM, V10, P709, DOI 10.1016/S0891-5520(05)70323-8
   SINCLAIR JF, 1987, LANCET, V2, P38
   THOMSON APJ, 1991, CRIT CARE MED, V19, P26, DOI 10.1097/00003246-199101000-00010
   Thorburn K, 2001, ARCH DIS CHILD, V85, P382, DOI 10.1136/adc.85.5.382
NR 25
TC 2
Z9 3
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0142-6338
EI 1465-3664
J9 J TROP PEDIATRICS
JI J. Trop. Pediatr.
PD AUG
PY 2005
VL 51
IS 4
BP 227
EP 231
DI 10.1093/tropej/fmi006
PG 5
WC Pediatrics; Tropical Medicine
SC Pediatrics; Tropical Medicine
GA 967PP
UT WOS:000232104000008
PM 16000346
OA Bronze
DA 2020-12-01
ER

PT J
AU Amorim, MMR
   Santos, LC
   Faundes, A
AF Amorim, MMR
   Santos, LC
   Faundes, A
TI Corticosteroid therapy for prevention of respiratory distress syndrome
   in severe preeclampsia
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Article
DE antenatal corticosteroids; fetal lung maturity; preeclampsia;
   respiratory distress syndrome
ID PREGNANCY-INDUCED HYPERTENSION; FETAL LUNG MATURITY; BETAMETHASONE;
   INFANTS; TRIAL; CARE
AB OBJECTIVE: The objective of the study was to determine the efficacy and side effects of corticosteroid therapy for pregnant women with severe preeclampsia in the prevention of respiratory distress syndrome in their premature neonates.
   STUDY DESIGN: A prospective double-blind randomized trial enrolled 218 pregnant women with severe preeclampsia and gestational age between 26 and 34 weeks. One hundred ten received betamethasone (12 mg administered intramuscularly, repeated after 24 hours and then once a week) and 108 received placebo. Relative risks and 95% confidence intervals of respiratory distress syndrome and other neonatal and maternal complications were calculated for corticosteroid use.
   RESULTS: Frequency of respiratory distress syndrome was significantly reduced in the corticosteroid group (23%) with respect to the placebo group (43%), with a relative risk of 0.53 (95% confidence interval 0.35-0.82). Relative risks of intraventricular hemorrhage, patent ductus arteriosus, and perinatal infection were significantly decreased in the corticosteroid group: 0.35 (95% confidence interval 0.15-0.86), 0.27 (95% confidence interval 0.08-0.95), and 0.39 (95% confidence interval 0.39-0.97), respectively. There was no significant difference in the frequency of stillbirth, but the neonatal mortality rate was lower in the corticosteroid group (14%) than in the placebo group (28%), with a relative risk of 0.5 (95% confidence interval 0.28-0.89). There was increased risk of gestational diabetes but of no other maternal complication after corticosteroid therapy, and mean blood pressures were similar in the 2 groups.
   CONCLUSIONS: Antenatal corticosteroid therapy with betamethasone for acceleration of fetal lung maturity is a safe and efficient treatment in patients with severe preeclampsia at between 26 and 34 weeks' gestation. (Am J Obstet Gynecol 1999;180:1283-8.).
C1 Univ Estadual Campinas, Fac Ciencias Med, Inst Maternoinfantil Pernambuco, BR-13081970 Campinas, SP, Brazil.
   Univ Estadual Campinas, Fac Ciencias Med, Dept Obstet & Ginecol, BR-13081970 Campinas, SP, Brazil.
   Ctr Pesquisas Doencas Maternoinfantis, Campinas, SP, Brazil.
RP Faundes, A (corresponding author), Caixa Postal 6181, BR-13081970 Campinas, SP, Brazil.
RI Amorim, Melania M/C-5807-2013
OI Amorim, Melania M/0000-0003-1047-2514
CR *AM COLL OBST GYN, 1996, ANT CORT THER FET MA
   [Anonymous], 1994, NIH Consens Statement, V12, P1
   [Anonymous], 1981, AM J OBSTET GYNECOL, V141, P276
   [Anonymous], 1990, AM J OBSTET GYNECOL, V163, P1689
   BARTON JR, 1991, OBSTET GYN CLIN N AM, V18, P165
   Carvalho MA, 1997, INT J GYNECOL OBSTET, V58, P197, DOI 10.1016/S0020-7292(97)00066-0
   CROWLEY PA, 1997, PREGNANCY CHILDBIRTH
   DEAN AG, 1995, EPI INFO VERSION 6 W
   GAMSU HR, 1989, BRIT J OBSTET GYNAEC, V96, P401, DOI 10.1111/j.1471-0528.1989.tb02413.x
   GILSTRAP LC, 1995, JAMA-J AM MED ASSOC, V273, P413, DOI 10.1001/jama.1995.03520290065031
   LIGGINS GC, 1972, PEDIATRICS, V50, P515
   Liggins GC, 1976, 70TH ROSS C PED RES, P97
   MILLIEZ J, 1980, EUR J OBSTET GYN R B, V11, P95, DOI 10.1016/0028-2243(80)90014-3
   NOCHIMSON DJ, 1979, AM J OBSTET GYNECOL, V133, P449
   OSULLIVAN JB, 1964, DIABETES, V13, P278
   PAPAGEORGIOU AN, 1979, PEDIATRICS, V63, P73
   RUVINSKY ED, 1984, AM J OBSTET GYNECOL, V149, P722, DOI 10.1016/0002-9378(84)90110-8
   SCHIFF E, 1993, AM J OBSTET GYNECOL, V169, P1096, DOI 10.1016/0002-9378(93)90262-H
   SCHNEIDER JM, 1989, CLIN EXP HYPERTENS B, V8, P41, DOI 10.3109/10641958909023362
   SCHWARCZ R, 1978, PUB CIENT CTR LATINO, V755
   SEMCHYSHYN S, 1983, AM J OBSTET GYNECOL, V145, P530, DOI 10.1016/0002-9378(83)91190-0
   Wallace EM, 1997, BRIT J OBSTET GYNAEC, V104, P1262, DOI 10.1111/j.1471-0528.1997.tb10972.x
   Zuspan F P, 1966, Clin Obstet Gynecol, V9, P954, DOI 10.1097/00003081-196612000-00010
NR 23
TC 81
Z9 88
U1 0
U2 4
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD MAY
PY 1999
VL 180
IS 5
BP 1283
EP 1288
DI 10.1016/S0002-9378(99)70630-7
PG 6
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA 201PB
UT WOS:000080603000038
PM 10329891
DA 2020-12-01
ER

EF